Therapeutic
effects
of
combined
treatment
using
tetracycline-immobilized
collagen
film
and
root
planing
in
periodontal
furcation
pockets
.
46
upper
lower
molars
with
grade
II
involvement
were
selected
from
16
patients
disease
The
teeth
randomly
allocated
to
the
following
groups
according
;
(
1
)
4
consecutive
administrations
cross-linked
TC
at
intervals
week
group
2
RP
3
combination
+
no
control
therapeutic
each
compared
both
clinically
microbiologically
Records
plaque
index
,
gingival
bleeding
on
probing
depth
attachment
level
microscopic
counts
obtained
0
6
8
weeks
results
showed
marked
decreases
density
micro-organisms
In
particular
was
characterized
by
a
decreased
rate
pocket
an
increased
gain
above
findings
demonstrated
that
planning
is
effective
are
enhanced
local
administration
films
Effect
simvastatin
hemostasis
isolated
hypertriglyceridemia
BACKGROUNDS/AIMS
Elevated
triglyceride
levels
seem
predispose
earlier
development
accelerated
progression
coronary
artery
our
study
we
assessed
for
first
time
whether
affects
coagulation
fibrinolysis
METHODS
included
39
elevated
peripheral
sclerosis
treated
90
days
either
40
mg
daily
or
placebo
Plasma
lipids
glucose
homeostasis
markers
hemostasic
variables
baseline
after
RESULTS
Simvastatin
but
not
administered
these
reduced
plasma
levels/activity
fibrinogen
3.5
±
0.4
2.8
0.3
g/l
p
<
0.01
factor
VII
144.2
16.9
112.5
14.0
%
plasminogen
activator
inhibitor-1
76.9
13.5
50.2
9.2
ng/ml
0.001
without
significant
reduction
von
Willebrand
tended
prolong
prothrombin
partial
thromboplastin
times
CONCLUSION
Our
suggest
statin
produces
multidirectional
effect
this
may
bring
some
benefits
essential
oils
garlic
onion
alimentary
hyperlipemia
SUMMARY
induced
feeding
100
g
butter
has
been
studied
10
healthy
subjects
freshly
extracted
juice
50
as
well
equivalent
amount
their
ether-extracted
four
different
during
one-week
period
Garlic
have
protective
action
against
fat-induced
increases
serum
cholesterol
fibrinolytic
activity
oil
fraction
which
contains
all
taste
odour
exactly
duplicated
beneficial
whole
It
therefore
concluded
active
principle
chemically
sulphur-containing
compounds
mainly
allyl
propyl
disulphide
diallyl
Effects
soy
intake
sex
hormone
metabolism
premenopausal
women
Studies
phytoestrogens
products
impart
hormonal
protect
breast
cancer
Limited
research
suggests
high
isoflavonoid
it
unknown
any
menstrual
function
hormones
common
therapies
such
oral
contraceptives
OC
We
36
20
whom
used
Subjects
consumed
normal
diet
two
cycles
added
beverage
containing
protein
38
total
isoflavones
usual
another
No
differences
observed
estrone
estradiol
hormone-binding
globulin
dehydroepiandrosterone
sulfate
prolactin
progesterone
concentrations
non-OC
changes
cycle
length
urinary
estrogen
metabolite
ratio
2-hydroxyestrone
alpha-hydroxyestrone
seen
Levels
metabolites
significantly
between
Thus
consumption
had
users
[
Postural
biofeedback
locomotion
reeducation
stroke
]
AIMS
To
compare
post-acute
hemiparetic
gait
improvement
conventional
physical
therapy
alone
specialised
balance
retraining
program
PATIENTS
Twenty-six
within
months
onset
randomised
receive
experimental
most
left
hemiplegia
older
than
METHOD
Thirteen
received
early
13
standing
training
BPM
Monitor
Clinical
measures
collected
entry
J0
once
when
began
walk
JM
30
later
Gait
spatiotemporal
parameters
use
Vicon
system
Whatever
method
rehabilitation
clinical
scores
improved
except
spasticity
beginning
walking
velocity
difference
pattern
increase
duration
paretic
limb
single
stance
reception
double
P
=
0.03
Both
unit
visual
forceplate
anticipation
equilibrium
Intervention
pilot
parents
children
autistic
spectrum
disorder
Parents
who
diagnosis
ASD
experience
situational
crisis
related
receiving
causes
feelings
distress
urgency
access
services
affected
child
This
paper
describes
randomized
trial
n
31
conducted
regional
diagnostic
center
large
metropolitan
's
hospital
refine
nursing
intervention
designed
b
identify
methodological
revisions
larger
A
secondary
purpose
test
post-diagnosis
'
reports
stress
impact
event
newly
diagnosed
consisted
care
plus
hours
contact
pediatric
nurse
practitioner
PNP
counseling
instruction
assistance
implementation
recommended
plan
only
1-hour
consultation
session
tests
written
copy
provided
developmental
pediatrician
and/or
Between
"
perceived
statistically
attributed
small
sample
size
feasible
expanded
recruited
additional
recruitment
site
Nurses
working
special
population
must
recognize
information
needs
begin
they
can
address
standardized
multi-component
social
skills
Asperger
syndrome
:
Junior
Detective
Training
Program
BACKGROUND
aimed
investigate
effectiveness
new
AS
7-week
computer
game
sessions
parent
teacher
handouts
Forty-nine
participate
assigned
26
wait-list
23
conditions
Relative
participants
greater
improvements
over
course
indicated
parent-report
Teacher-report
data
also
confirmed
made
functioning
pre-
post-treatment
Treatment
better
able
appropriate
emotion-management
strategies
story
characters
post-intervention
pre-intervention
whereas
However
there
facial
expression
body-posture
recognition
Follow-up
suggested
gains
maintained
5-months
CONCLUSIONS
appeared
be
enhancing
emotional
understanding
Limitations
suggestions
future
discussed
double-blind
placebo-controlled
fluvoxamine
adults
Autistic
fundamental
disturbance
interaction
impairments
communication
markedly
restricted
repertoire
activities
interests
Abnormalities
serotonin
neurotransmitter
identified
persons
autism
consistently
safe
drugs
developed
treating
symptoms
Thirty
completed
12-week
potent
selective
uptake
inhibitor
maleate
Behavioral
ratings
12
Eight
53
15
fluvoxamine-treated
categorized
responders
none
.001
Fluvoxamine
superior
reducing
repetitive
thoughts
behavior
maladaptive
aggression
.03
improving
aspects
relatedness
.04
especially
language
usage
.008
response
correlated
age
full-scale
IQ
Other
mild
sedation
nausea
few
tolerated
dyskinesias
adverse
cardiovascular
events
seizures
occurred
more
short-term
Controlled
studies
other
inhibitors
warranted
adolescents
duloxetine
pain
quality
life
among
chemotherapy-induced
painful
neuropathy
IMPORTANCE
There
known
treatments
OBJECTIVE
determine
60
average
severity
DESIGN
SETTING
AND
Randomized
crossover
National
Cancer
Institute
NCI
-funded
cooperative
networks
enrolled
231
25
years
being
community
academic
settings
April
2008
March
2011
Study
follow-up
July
2012
Stratified
chemotherapeutic
drug
comorbid
risk
followed
Eligibility
required
higher
sensory
Common
Terminology
Criteria
Adverse
Events
least
scale
representing
paclitaxel
taxane
oxaliplatin
INTERVENTIONS
initial
taking
capsule
capsules
MAIN
OUTCOME
MEASURES
primary
hypothesis
would
decreasing
neuropathic
Pain
Brief
Inventory-Short
Form
item
bad
imagined
Individuals
5-week
reported
mean
decrease
1.06
95
CI
0.72-1.40
vs
0.34
0.01-0.66
those
.003
0.513
score
0.73
0.26-1.20
Fifty-nine
percent
initially
RELEVANCE
Among
5
resulted
TRIAL
REGISTRATION
clinicaltrials.gov
Identifier
NCT00489411
Epidemiology
Importance
preventive
pharmacological
elderly
associated
costs
Stroke
major
cause
death
disability
countries
incidence
exponentially
yet
traditionally
many
medical
practitioners
reluctant
treat
hypertension
Since
1991
trials
--
British
Medical
Research
Council
MRC
Swedish
Trial
Old
Patients
Hypertension
STOP-Hypertension
Systolic
Elderly
SHEP
conclusively
established
>
diastolic
systolic
International
guidelines
management
including
Fifth
Report
Joint
Committee
1993
report
World
Health
Organization
Society
second
Working
Party
modified
reflect
emerging
evidence
concerning
Cost-effectiveness
similarly
accord
giving
priority
individuals
Lowering
triglyceride/high-density
lipoprotein
pioglitazone
atherosclerosis
diabetic
insights
PERISCOPE
Pioglitazone
Regression
Intravascular
Sonographic
Coronary
Obstruction
Prospective
Evaluation
OBJECTIVES
factors
favorable
atheroma
Diabetes
mellitus
slowed
glimepiride
360
18
evaluated
serial
intravascular
ultrasound
relationship
biochemical
volume
investigated
Pioglitazone-treated
high-density
HDL-C
reductions
glycated
hemoglobin
triglycerides
C-reactive
Significant
correlations
r
0.15
0.04
triglyceride/HDL-C
0.16
low-density
-0.15
0.05
apolipoprotein
B
-0.16
A-I
-0.20
Substantial
regression
relative
14.2
vs.
7.8
-13.3
-1.9
0.045
-22.5
-9.9
-0.6
-0.3
Multivariable
analysis
revealed
pioglitazone-induced
0.02
Favorable
delayed
finding
highlights
potential
importance
targeting
atherogenic
dyslipidemia
Quality
individual
INR
atrial
fibrillation
nested
case
ACTIVE
W
INTRODUCTION
Time
range
TTR
international
normalized
accepted
measure
anticoagulation
patient
populations
its
usefulness
predicting
understood
MATERIALS
cases
separately
matched
controls
Several
overall
time-dependent
manner
32
ischemic
234
4:1
122
865
respectively
257±154days
222±146days
Compared
respective
53.9
±25.1
63.4
±24.8
p=0.055
56.2
±25.4
±26.8
below
last
month
leading
up
entire
Rather
spent
26.8
±25.9
20.8
±24.0
p=0.001
AF
W.
Maintaining
equal
avoid
low
INRs
relevant
goal
prevent
role
somatostatin
octreotide
regulation
melatonin
secretion
volunteers
hypothyroidism
Somatostatin
found
pineal
gland
several
animal
species
involved
Whether
regulatory
influence
man
never
unequivocally
shown
nocturnal
untreated
state
given
subcutaneous
injections
18:00
h
23:00
saline
Sandostatin
injection
microg
During
nights
similar
recorded
Also
excretion
magnitude
occasions
By
contrast
GH
AUC
22.6+/-5.4
mU/l
x
126.6+/-21.9
Urinary
remained
unchanged
did
TSH
however
562+/-136
851+/-185
thus
suggesting
should
sufficient
inhibit
pinealocytes
if
regulated
exogenous
form
fails
reasonable
assume
endogenous
important
regulator
irrigation
systems
removal
canal
sealer
aim
efficiency
sonic
ultrasonic
hydrodynamic
devices
surface
simulated
irregularities
canals
Fifty-three
grooves
apical
coronal
parts
longitudinally
split
roots
covered
AH
Plus
syringe
CanalBrush
passive
EndoActivator
RinsEndo
specimens
divided
into
N
one
via
randomization
remaining
under
microscope
4-grade
scoring
7-grade
Passive
tested
removing
walls
None
techniques
cleaning
lateral
Within
limitations
protocol
shows
endodontic
retreatment
Cleaning
seems
possible
CLINICAL
Incomplete
re-treatment
failure
Ultrasonic
remove
Gastric
dysrhythmia
infants
gastrointestinal
diseases
measured
epigastric
impedance
Gastrointestinal
association
myoelectrical
where
types
gastric
electrical
described
These
electrogastrography
cutaneous
electrodes
Epigastric
non-invasive
emptying
phasic
At
present
presented
rhythms
means
gastrography
before
21
0-2
suffered
intestinal
obstruction
necrotizing
enterocolitis
pyloric
stenosis.All
fasting
periods
hour
examined
acute
pathologic
result
persistent
19
frequency
11
Short-term
out
32.5
Using
origin
patterns
efficacy
tolerance
nimesulide
suppository
formulation
pain-inflammatory
pathologies
ear
nose
throat
tolerability
pharmaceutical
non-steroid
anti-inflammatory
Nimesulide
blind
flurbiprofen
98
aged
75
suffering
ENT
nature
dose
twice
day
7
analgesic
antipyretic
produced
progressive
typical
inflammatory
complete
remission
evidenced
speed
Assessment
expressed
physician
positive
almost
Is
2-week
stenting
endopyelotomy
?
PURPOSE
Internal
integral
part
animals
show
good
healing
ureterotomy
Inherent
stent
problems
warrant
minimum
compromising
performed
prospective
evaluate
optimum
57
ureteropelvic
junction
undergo
7/14Fr
internal
placement
symptom
based
questionnaire
Followup
done
diuretic
scanning
9
then
yearly
thereafter
renography
available
evaluation
comparable
terms
ipsilateral
glomerular
filtration
Mean
followup
22.3
21.3
35
end
year
24
92.3
90.3
drainage
Stent
proportion
tract
infections
11.5
versus
38.1
Of
64
preferred
Two
allow
functional
restoration
across
complications
Salmeterol
fluticasone
propionate
montelukast
controlled
investigating
airway
inflammation
asthma
Few
poorly
inhaled
corticosteroids
little
about
parallel
salmeterol
FP
Seretide
SFC
FP/M
sputum
responsiveness
lung
adult
asthmatics
Sixty-six
outcome
neutrophil
eosinophil
macrophage
lymphocyte
epithelial
cell
Additional
outcomes
change
cells
although
trend
eosinophils
generally
led
cysteinyl
leukotrienes
1.80
1.09
2.94
eosinophilic
PEF
STUDY
NUMBER
SAM40030
SOLTA
comparison
continuous
femoral
nerve
block
CFNB
epidural
infusion
CEI
postoperative
analgesia
knee
arthroplasty
TKA
Postoperative
EA
FNB
relief
side
vomiting
pruritus
dizziness
hypotension
Some
investigations
less
authors
regarding
stay
LOS
MATERIAL
61
ASA
status
I-III
scheduled
elective
unilateral
spinal
anesthesia
SA
participated
ward
Group
I
0.125
levobupivacaine
morphine
0.0125
mg/ml
ml/hr
VAS
PO6-12
hr
tramadol
IV
requirement
PO6
p-value
PO12
0.004
experienced
PONV
Patient
satisfaction
represents
optimal
fewer
indices
guided
imagery
relaxation
anxiety
bowel
Inflammatory
Bowel
Disease
IBD
impacts
QoL
Psychological
targeted
Fifty-six
outpatients
chosen
waiting-list
attended
three
relaxation-training
audio
disc
home
practice
Evaluations
pre
State-Trait
Anxiety
Inventory
Questionnaire
Visual
Analogue
Scale
depression
mood
monitoring
diary
monitored
study-related
Thirty-nine
Following
while
Findings
indicate
benefit
holistic
New
further
investigation
subject
Review
Multicenter
prophylaxis
deep
venous
thrombosis
etiology
DVT
thought
due
stasis
hypercoagulable
endothelial
damage
Methods
directed
toward
correcting
counteracting
expected
even
dihydroergotamine
DHE
heparin
anticipated
minimize
Based
upon
current
theory
might
include
minimizing
injury
controlling
venomotor
tone
multicenter
United
States
evaluating
prophylactic
0.5
5000
U
2500
General
surgical
undergoing
noncardiac
thoracic
pelvic
operations
moderate
postop
medications
injected
subcutaneously
preoperatively
every
postoperatively
5-7
until
125I-fibrinogen-uptake
RFUT
became
hundred
eighty
eight
entered
744
85
Results
DHE/Hep
agents
ABSTRACT
TRUNCATED
AT
250
WORDS
chemoimmunotherapy
bestatin
nonlymphocytic
leukemia
immunomodulating
agent
INN
Ubenimex
toxicity
long-term
modifications
immunological
immunotherapy
maintenance
chemotherapy
ANLL
After
induction
mg/bw
per
os
po
101
eligible
48
analyzed
achieved
longer
survival
Though
prolongation
15-49
yr
50-65
Bestatin
useful
since
prolonged
side-effects
Regional
ventricular
performance
exercise
young
repair
tetralogy
Fallot
Public-health
recommend
congenital
heart
improve
capacity
hardly
assess
corrected
aerobic
dynamic
one-hour
Pre-
post-training
cardiopulmonary
MRI
echocardiography
tissue-Doppler
imaging
n=28
n=20
One
dropped
Change
right
ventricle
free
wall
peak
E
0.8±2.6
cm/s
0.9±4.1
0.4±2.4
m/s
4.6±18.1
provides
preliminary
3-month
repaired
help
adhere
public-health
URL
http//
www.trialregister.nl
Unique
identifier
NTR2731
Neural
basis
self
representation
FMRI
self-face
Autism
interest
engagement
interactions
self-focus
While
previous
theoretical
approaches
emphasized
altered
interpersonal
recent
shift
towards
disorders
Still
neural
mechanisms
subserving
self-representations
relatively
unexplored
METHODOLOGY/PRINCIPAL
FINDINGS
event-related
fMRI
brain
images
own
face
faces
others
Children
typically
developing
TD
viewed
digital
morphs
gender-matched
self/other
judgments
activated
premotor/prefrontal
identifying
percentage
activation
self-
other-processing
viewing
mostly
CONCLUSIONS/SIGNIFICANCE
dissociation
points
substrate
characteristic
exhibited
lack
shared
representations
possess
understand
cross-over
continuing
dexamethasone
beyond
adjuvant
Uncertainty
remains
anti-emetic
regimen
Many
complain
insomnia
anxiety/agitation
indigestion
prefer
QOL
chemotherapy-naïve
All
intravenous
granisetron
pre-chemotherapy
Primary
endpoints
i
preference
ii
Median
94
51
27-76
79
fluorouracil/epirubicin/cyclophosphamide
doxorubicin/cyclophosphamide
withdrew
pre-cycle
arms
80
stating
28-50
37
35-58
intensity
global
0.06
symptom/QOL
domains
differed
conclusion
regardless
rheumatoid
arthritis
predictive
illness
perceptions
coping
recently
RA
predictors
Twenty-two
history
variety
process
six
assessment
21-month
22
constituted
standard
outpatient
clinic
depressed
set
five
predict
beliefs
consequences
confirm
psychological
independence
document
Changes
fatty
acid
composition
lipid
esters
lipid-lowering
clofibrate
niceritrol
Reduction
linoleate
atherosclerotic
prescribed
ensuing
nicotinic
ester
order
caused
highly
determined
samples
degree
dietary
adherence
content
saturated
monounsaturated
acids
secreased
polyunsaturated
increasing
pulyunsaturated
P/S
Only
minor
phospholipids
partly
reversed
Clofibrate
coincided
amounts
oleate
linoleic
2/18
because
addition
enriched
fats
does
counteracted
fat
Rapid
tightening
blood
leads
transient
deterioration
retinopathy
insulin
dependent
diabetes
Oslo
tight
45
type
diabetics
proliferative
multiple
Near
normoglycaemia
Blind
fluorescein
angiograms
monthly
Half
retinal
cotton
wool
spots
regressed
Control
develop
characterised
decrement
glycosylated
haemoglobin
values
frequent
episodes
hypoglycaemia
severe
rapid
fall
concentration
promote
Necessary
screening
feedback
consider
screener
previously
undetected
inform
physicians
Participating
demonstration
arm
five-month
mixed-model
health
organization
serving
approximately
110,000
enrollees
central
Colorado
PATIENTS/PARTICIPANTS
573
unrecognized
8,000
waiting
room
served
dual
providing
educational
setting
reporting
summarizing
MEASUREMENTS
well-being
Improvement
closely
Conscious
analgesia/sedation
remifentanil
propofol
fentanyl
midazolam
colonoscopy
conscious
Sedation
TIVA
Analgesia/sedation
0.20
0.25
microg/kg/min
titrated
doses
microg/kg
mg/kg
dosage
Cardiorespiratory
bispectral
Numerical
Rating
NRS
recovery
return
psychomotor
Aldrete
Modified
Post
Anesthesia
Discharge
Scoring
MPADS
respect
demographic
painless
0.8
procedure
maximum
reached
-6.9
4.0
25.7
8.4
minutes
arterial
pressure
signs
respiratory
Combined
satisfactory
hemodynamic
stability
allows
discharged
Long-term
phase
III
topotecan
advanced
ovarian
carcinoma
continued
monitor
multicentre
failed
prior
platinum-based
bidimensionally
measurable
1.5
mg/m
/day
175
3-h
alternate
third
line
European
Organisation
Life
EORTC
-C30
anorexia
diarrhoea
fatigue
dyspnea
constipation
226
evaluable
Demographic
characteristics
QOL-30
For
median
18.9
92.6+
censored
14.7
137.3+
12.3
0.076
post-randomisation
63.0
238.4+
20.5
53.0
226.3+
0.44
Topotecan
continues
demonstrate
manageable
non-cumulative
haematological
Non-haematological
indicates
substantial
relapse
Inhaled
reduces
bronchiectasis
Although
corticosteroid
very
infective
4-wk
Twenty-four
female
500
microgram
Accuhaler
device
visit
spirometry
24-h
leukocyte
bacterial
densities
interleukin
IL
-1beta
IL-8
tumor
necrosis
factor-alpha
TNF-alpha
leukotriene
B4
LTB4
IL-1beta
exacerbation
reactions
high-dose
Large-scale
steroid
components
Serum
Beluga
Huso
huso
L.
sampling
clove
powder
solution
exposure
blood-sampled
immediately
subjected
120
240
s
3,000
700
l⁻¹
Blood
fish
immobile
stage
cortisol
lactate
Lactate
dehydrogenase
aspartate
aminotransferase
alanine
Na⁺
Cl⁻
K⁺
Ca²⁺
slow
Bayesian
adaptive
offer
advantages
comparative
example
epilepticus
novel
comparing
uses
stopping
will
enroll
720
unique
emergency
departments
design
efficient
likely
offers
power
analogous
fixed
When
Intravenous
postpartum
anemia
trivalent
ferrum
preparation
AIM
OF
THE
effectivity
safeness
pospartal
TYPE
Department
Obstetric
Gynecology
2nd
Faculty
Charles
University
Teaching
Hospital
Motol
Prague
1st
Bulovka
sacharose
ferric
oxide
Venofer
intravenously
lab
postpartal
comparsion
red
count
recovered
3rd
post
soluble
transferrin
receptors
ferritin
iron
saturation
body
reserves
too
Integral
came
sight
could
become
alternative
transfusion
mid-severe
encountered
serious
saccharose
Comparison
weakness
inclusion
myositis
methotrexate
20mg
down
44
quantitative
muscle
strength
testing
sum
Quantitative
declined
-0.2
-3.4
confidence
interval
-2.5
+9.1
manual
assessments
creatine
kinase
conclude
Distinct
fast
processes
contribute
selection
step
human
Humans
spontaneously
select
minimizes
energy
expenditure
embedded
circuits
generate
so
pre-programmed
Or
perhaps
directly
optimized
sensed
Direct
optimization
compounded
delays
iteration
mechanism
presumably
faster
albeit
direct
applied
perturbations
treadmill
elicit
adjustments
dominating
66
amplitude
SD
occurring
quite
quickly
1.44
1.14
component
smaller
took
tens
seconds
27.56
16.18
completion
indicative
persisted
unusual
closed-loop
conflicted
rendered
energetically
suboptimal
consistent
timing
interpretation
humans
rely
heavily
gaits
rapidly
gradually
fine-tune
Experimental
hyaline
membrane
premature
monkey
antenatal
glucocorticoid
Macaca
nemestrina
model
HMD
Twelve
dams
mg/dose
72
abdominal
delivery
135
+/-
gestation
Infants
dexamethasone-treated
92
males
females
Differences
volume-pressure
excised
lungs
distensibility
20.6
7.1
ml/g
dry
6.1
deflation
Accelerated
production
material
SAM
phospholipid
84.5
8.1
mg/g
75.1
9.9
0.025
alveolar
lavage
fluid
5.65
3.33
3.01
1.84
disaturated
phosphatidylcholine
DPC
2.47
1.05
Incorporation
14C-palmitate
influenced
portion
label
Antenatal
successful
maturation
fetal
pulmonary
functions
limited
synthetic
Salbutamol
mist
bronchiolitis
bronchodilators
controversial
nebulized
salbutamol
fifty-six
episode
wheezing
follows
52
mL
iii
tent
oxygen
procedures
repeated
same
min
Respiratory
presence
cyanosis
retractions
5.2
1.8
0.82
2.4
1.7
1.3
Heart
Oxygen
reaching
statistical
significance
rates
anaesthesia
changing
Propofol
300
600
1200
ml
h-1
loss
consciousness
judged
verbal
slower
104
68
1.2
1.6
2.5
kg-1
300-ml
apnoea
Additive
IOP-reducing
latanoprost
insufficiently
timolol
intraocular
IOP
switching
adding
open
angle
glaucoma
ocular
adequately
6-week
double-masked
multi-centre
capsular
mmHg
run-in
switched
microg/ml
AM
SEM
24.2
0.9
23.8
1.0
26.3
19.6
1.1
17
23.2
17.5
Adding
5.9
5.0
additive
switch
acupuncture
sham
single-blind
tongue
nonacupoints
eye-hand
coordination
practical
reasoning
Griffiths
Mental
Developmental
sensory-motor
affectual
Ritvo-Freeman
Real
Comprehension
Language
Reynell
Total
Score
Age
Symbolic
Play
Test
self-care
cognition
Functional
Independence
Measure
short
various
behavioral
explored
cuff
inflation
self-recorded
continuously
'Finapres
finger
ten
normotensive
seven
hypertensive
self-inflation
just
wearing
inflated
Inflating
instantaneous
rise
mm
Hg
Wearing
muscular
Korotkoff
sounds
already
heard
10-15
inflate
deflate
ionic
nonionic
x-ray
media
myocardial
perfusion
Amidotrizoate
Iopromide
pressures
excitation
formation
transmission
ischaemic
xenon-133
rest
dipyridamole
load
non-ionic
Fluoroscopic
bileaflet
prostheses
intraoperative
valve
orientation
Fluoroscopy
reliable
easy
readily
technique
prosthesis
surgery
represent
limitation
accounting
unsatisfactory
what
extent
feasibility
accuracy
fluoroscopic
prospectively
aortic
mitral
tricuspid
replacement
Sorin
Bicarbon
CarboMedics
Fifty
oriented
perpendicular
position
septum
considered
tilting
disk
projection
through
Doppler
proper
former
impossible
obtain
latter
extremely
angulated
uneasy
often
get
correct
image
Prosthesis
crucially
success
greatly
facilitates
fluoroscopy
detrimental
provide
window
whenever
dysfunction
suspected
Influence
lime
sickle
SCA
triggered
dehydration
acidosis
fever
usually
malaria
Intake
facilitate
clearance
parasite
sought
regular
ameliorate
recurrent
bone
open-labeled
laboratory
113
hospitals
58
55
83
crises
0.64±0.11
1.51±0.34
50.0
92.7
febrile
46.6
87.3
admission
3.4
34.5
hematocrit
26.23±2.03
hepatomegaly
splenomegaly
jaundice
side-effect
Regular
great
nutritional
relevance
paromomycin
endotoxemia
alcoholic
liver
support
gut-derived
endotoxins
nonabsorbable
broad-spectrum
antibiotic
27
cirrhosis
g/day
fashion
Endotoxin
weekly
Groups
biological
items
endotoxin
16.7
5.3
pg/ml
6.9
2.3
verum
8.0
1.9
14.6
4-week
cirrhotics
reproduced
Once-daily
amoxicillin
twice-daily
penicillin
V
beta-haemolytic
streptococcal
pharyngitis
Rheumatic
preventable
chronic
preceded
GABHS
non-inferiority
once-daily
QD
BID
carried
school-based
Zealand
presenting
1500
750
bodyweight
or=30
kg
or=20
Observed
medication
weekend
cards
Eradication
cultures
3-6
12-16
26-36
isolates
serotyped
distinguish
bacteriological
failures
relapses
acquisitions
Non-inferiority
defined
limit
CL
eradication
or=10
353
swabs
177
176
antibiotics
4.9
6.5
8.5
5.8
12.7
10.7
recipients
6.2
11.9
11.3
resolution
noted
unsubstantiated
rheumatic
powered
inferior
pooled
eastern
oncology
intergroup
interferon
melanoma
Nearly
2000
IIB
Eastern
Cooperative
Oncology
Intergroup
IFN-alpha
2b
objectives
update
analyses
analyze
prognostic
EXPERIMENTAL
Survival
updated
2001
Analysis
models
E1684
E1690
E1694
E2696
observation
Obs
713
HDI
Trials
Updated
original
conclusions
now
2.1-12.6
two-sided
univariate
log-rank
7.2
relapse-free
RFS
-but
OS
-was
value
0.006
negatively
impacted
ulceration
enrollment
49
Multivariate
adjusting
high-risk
resected
strong
Analyses
needed
modality
immediate
adjunctive
doxycycline
localized
juvenile
periodontitis
microbiological
14
Measurements
flow
depths
suppuration
sites
radiographic
Subgingival
taken
curettes
Spirochaetes
searched
dark-field
microscopy
Actinobacillus
actinomycetemcomitans
pigmented
non-pigmented
Bacteroides
spp.
Capnocytophaga
Fusobacterium
Actinomyces
spp
cultured
non-selective
Bacterial
comprising
cultivable
flora
Neither
nor
mechanical
debridement
systemic
Goal
attainment
scaling
psychosocial
interventions
GAS
holds
promise
idiographic
approach
measuring
criticized
untested
assumptions
i.e.
ordinal
inter-individual
equivalence
comparability
reliability
coding
methods
equality
descriptions
measurement
measurability
equidistance
difficulty
teachers
researchers
live
videotape
equivalency
representative
varied
sources
reliably
coded
promising
Recommendations
ensure
Smart
Choices
tobacco
prevention
curriculum
four-year
project
diffusion
School
districts
workshop
video
condition
video-trained
implemented
completeness
fidelity
teach
Video-trained
brainstorming
student
presentations/role
plays
Implications
Economic
burden
childhood
estimate
associations
diagnoses
service
caregiver
cost
national
Expenditure
Panel
Survey
linked
Interview
study-specific
survey
annual
utilization
school
ASD-related
family-coordinated
parent-reported
estimated
gender
race/ethnicity
insurance
household
income
country
region
urban/rural
classification
non-ASD-related
illnesses
office
visits
prescription
.05
76
non-ASD-associated
$
3020
1017-
4259
14,061
4390-
24,302
aggregate
non-health
8610
6595-
10,421
adjusted
out-of-pocket
spend
caregiving
economic
sectors
society
Previous
focused
underestimated
particularly
Remote
conditioning
complement
angioplasty
salvage
infarction
preconditioning
attenuates
cardiac
remote
evolving
ST-elevation
percutaneous
333
1:1
computerised
randomisation
n=166
n=167
intermittent
ischaemia
5-min
blood-pressure
Allocation
concealed
opaque
sealed
envelopes
transport
endpoint
area
salvaged
registered
ClinicalTrials.gov
number
NCT00435266
82
excluded
arrival
meet
criteria
lost
77
0.75
IQR
0.50-0.93
n=73
0.55
0.35-0.88
n=69
0.10
0.01-0.22
p=0.0333
0.69
0.27
0.57
0.26
0.12
0.01-0.21
Major
n=3
reinfarction
n=1
INTERPRETATION
favourable
safety
profile
merit
establish
FUNDING
Fondation
Leducq
An
open-label
extension
risperidone
irritability
behaviors
OLE
5-17
fixed-dose
DB
flexibly
dosed
weight
allowed
1.25
mg/day
weighing
1.75
≥
primarily
end-point
71
discontinuations
insufficient
AE
AEs
appetite
n=9
n=7
pyrexia
infection
n=6
nasopharyngitis
n=5
somnolence
n=4
Extrapyramidal
Increase
11-15
mass
5-10
discontinued
potentially
prolactin-related
irregular
menstruation
greatest
sleep
analog
24.6
weight-based
psychiatric
TRIALS
REGISTRY
phase-4
NCT00576732
Teacher
achieving
IEP
goals
encouraging
variability
specialized
programs
predictor
47
COMPASS
Ruble
et
al
collaborative
promoting
competence
students
Springer
York
2012a
Predictors
science
framework
Dunst
Trivette
J
Soc
Sci
8:143-148
exhaustion
elements
accounted
variance
quarter
antipyretics
naproxen
metamizol
peaks
Antipyretic
cautiously
Inference-Based
Approach
Cognitive
Therapy
Obsessive-Compulsive
Disorder
Poor
Insight
24-Session
Obsessive-compulsive
OCD
poor
insight
nonetheless
ever
specifically
poor-insight
psychotherapy
inference-based
IBA
targets
strengthening
sensory-driven
reality
cognitive
CBT
Yale-Brown
Obsessive
Compulsive
YBOCS
Secondary
depressive
Mixed-effects
hoc
subgroup
worst
marginal
-7.77
t
219.45
-2.4
0.017
extreme
AGE-peptides
C-peptide
early-stage
nephropathy
thiamine
pyridoxine
circulatory
AGE-peptide
observe
vitamin
B1
B6
Type
N.=57
N.=27
N.=30
Diabetic
N.=12
B1+B6
N.=15
experimentation
HbA1c
pyrophosphate
pyridoxal
phosphate
AGE-
peptides
P=0.005
P=0.042
P=0.033
P=0.006
P=0.004
parameter
display
emotion
programme
difficulties
target
trialled
co-morbid
ID
intellectual
ability
Participants
4-7
FSIQ
42-107
28
watched
DVD
Transporters
Thomas
Tank
Engine
basic
tasks
mindreading
mind
TOM
chronological
intelligence
anger
generalisation
teaching
Improvements
expressions
-
relatives
twenty
Macquarie
admitted
avoided
instead
back
team
them
comprehensive
assertive
backed
24-hour
majority
63
Initially
somewhat
Relatives
satisfied
clearly
applying
extended
concern
public
education
testicular
unnecessary
threat
eg
accompanied
self-examination
TSE
Male
N=443
+TSE
differ
TC+TSE
message
intention
self-examine
denigration
anxiogenic
acceptance
awareness
Impact
CCND1
A870G
polymorphism
rectal
concurrent
chemoradiotherapy
nucleotide
SNP
capecitabine-based
CRT
Four
capecitabine
accumulated
prostectively
twenty-eight
radiotherapy
Cap-CRT
172
Cap-Oxa-CRT
graded
v.
3.0
CTCAE
v3.0
genotype
detected
polymerase
chain
reaction-based
restriction
fragment
PCR-RFLP
odds
ratios
ORs
CIs
computed
logistic
136
frequencies
genotypes
GG
GA
AA
50.7
32.4
48.1
27.3
Diarrhea
diarrhea
109
15.6
47.7
36.7
24.4
49.5
26.1
1.66-fold
1.03
2.67
0.038
2.34-fold
1.16
4.76
0.018
genetic
biomarker
Time-varying
smoking
abstinence
predicts
cessation
question
planned
quit
attempt
exacerbates
improves
issue
Extant
modeled
between-person
covariation
postquit
trajectories
account
affect
Accordingly
within-person
time-varying
multilevel
MLM
transitions
statuses
participant
236
heavy
drinking
smokers
incorporating
brief
alcohol
Depressive
biochemically
verified
date
MLMs
slight
inverse
relation
indicating
abstinent
appears
concordant
view
intentional
Efforts
highlight
feel
rather
psychologically
successfully
Levobunolol
Fifty-one
raised
ophthalmic
solutions
levobunolol
eyes
equally
8.8
preadolescent
generalization
Social
SST
ASDs
Despite
fact
SSTs
trainings
inconclusive
Moreover
long
term
learned
Additionally
expect
enhance
METHOD/DESIGN
RCT
10-12
calendar
SST-PTI
Parent
&
Involvement
care-as-usual
consists
additionally
actively
homework
assignments
takes
place
moments
socialization
aspect
focus
specific
learn
general
pertaining
multi-informant
perspective
DISCUSSION
Dutch
Strengths
manualized
application
internationally
rating
instruments
raters
NTR2405
Intrathecal
suppresses
NK
natural
killer
underwent
hysterectomy
Forty
intrathecal
IT0.5
0.1
IT0.1
i.v
inhalation
C
withdrawn
chromium
release
assay
K562
catecholamines
23.9
45.7
neither
adrenaline
noradrenaline
changed
long-lasting
suppress
immune
transcranial
electrostimulation
ulcer
traditional
supplemented
electrotherapy
TRANSAIR-02
apparatus
Laboratory
measurements
lactoferrin
LF
tumour
besides
main
depending
facilitated
scarring
dynamics
sympatho-adrenergic
reaction
technics
anaesthetic
endocrine
responses
microsurgical
Simple
mastoidectomies
radical
tympano
plastics
halothane
retroauricular
infiltration
lidocaine
ornipressin
epinephrine
prilocaine
norepinephrine
glycerol
MAP
HR
skin
incision
having
started
drilling
operation
covariance
catecholamine
1-3
variabilities
regard
documented
throughout
whey
concentrate
derived
milk
cows
immunized
Clostridium
difficile
prepared
C.
toxins
toxin
food
difficile-associated
CDAD
anti-C.
anti-CD
WPC
supported
analytical
raw
non-immunized
consuming
examinations
extensive
hematological
consume
Raising
inhibition
cholesteryl
transfer
multidose
torcetrapib
CETP
CP-529,414
raise
Five
n=2
Torcetrapib
completing
correlation
EC50=43
nM
vitro
potency
IC50
proposed
escalating
elevations
91
nonHDL-C
42
lowering
Apolipoprotein
apoB
Cholesteryl
nonHDL
contrasting
HDL
resemble
deficiency
work
serves
prelude
combinations
assessing
Efficacy
selamectin
fleas
heartworms
dogs
cats
veterinary
North
America
series
masked
field
flea
infestations
heartworm
observations
showing
allergy
dermatitis
FAD
topically
6mgkg
-1
Dogs
naturally
topical
220
189
positive-control
product
fenthion
n=81
pyrethrins
n=66
Selamectin
Day
Flea
burdens
comb
evaluations
On
selamectin-treated
92.1
99.0
99.8
fenthion-treated
81.5
86.8
86.1
92.5
98.3
99.3
pyrethrin-treated
66.4
73.9
81.3
alleviating
397
heartworm-endemic
areas
USA
n=298
ivermectin
n=99
negative
microfilariae
antigen
180
673
347
3954
purebred
crossbred
Collies
Bearded
Border
unspecified
need
simultaneous
environment
in-contact
preventing
canine
Use
HIV-1
cohort
Hormonal
widely
unclear
contraceptive
acquisition
HIV-1-infected
male
partners
3790
heterosexual
HIV-1-serodiscordant
couples
participating
longitudinal
African
injectable
non-users
men
seroconversion
Cox
proportional
hazards
structural
modelling
1314
HIV-1-seronegative
partner
18·0
12·6-24·2
6·61
person-years
contraception
3·78
hazard
1·98
1·06-3·68
p=0·03
2476
18·7
12·8-24·2
2·61
1·51
1·97
1·12-3·45
p=0·02
Marginal
generated
much
Women
counselled
protection
condoms
Non-hormonal
low-dose
at-risk
US
Institutes
Bill
Melinda
Gates
Foundation
paliperidone
extended-release
tablets
schizophrenics
explore
81
They
scales
PANSS
schedule
SDSS
emergent
TESS
th
12.0
12.1
3.6
26.2
8.7
24.7
45.0
2.9
93.5
6.8
9.60-16.78
56.5
6.4
2.58-4.26
18.7
5.1
68.1
13.0
-4.28
5.67
5.93
2.78
13.9
10.83
7.6
5.21
But
1.88
-4.49
Paliperidone
Double-blind
doxepin
bupropion
7-day
washout
Antidepressant
Hamilton
Depression
Scales
Global
Severity
Ratings
Zung
Self-Rating
Comparable
13-week
Doxepin
anticholinergic
mouth
sleepiness
tiredness
Protection
influenza
A2
Hong
Kong
virus
amantadine
Prophylactic
mg.
offered
involving
391
epidemic
Helsinki
winter
1969
Serologically
fixation
haemagglutination
192
199
rosuvastatin
monotherapy
fenofibrate
ω-3
subfraction
mixed
dyslipidaemia
metabolic
Raised
TG
predominance
dense
lipoproteins
sdLDL
MetS
dosing
LDL-C
160
200
mg/dl
R
RF
Rω
polyacrylamide
gel
electrophoresis
LDL
prominent
hypotriglyceridemic
resistance
7.7
particles
subclasses
regimens
differential
Data
mining
ScanBrit
gluten-
casein-free
behavioural
psychometric
examination
collaboration
grouped
non-dietary
core
disparity
modification
responder
non-responder
Further
garnered
undertaken
determining
pertinent
inattention
hyperactivity
behaviours
said
presentation
Chronological
strongest
seemed
derive
urine
compound
trans-indolyl-3-acryloylglycine
best
require
independent
replication
joint
attention
play
JA
symbolic
SP
preschool
prediction
boys
Interventions
5-6
Assessments
mother-child
postintervention
testers
expressive
explained
lowest
Prevention
anesthesia-induced
preanesthetic
crystalloids
colloids
prehydration
routinely
prehydrating
infusing
crystalloid
colloid
L/70
challenged
vasopressor
Eighty-five
60-89
hip
Hartmanns
29
Haemaccel
Hypotension
BP
ephedrine
3-mg
boluses
absolute
readings
nausea/vomiting
withholding
carry
systematic
1974-1977
author
transl
explain
structure
evolved
methodic
cancers
worked
cooperation
medicine
French
anticancer
centres
analyse
phases
correspond
give
603
protocols
interrupted
vincristine
cyclophosphamide
5-fluoro-uracil
hand
doxorubicine
or/and
From
emerged
clear
point
initiate
scheme
complex
aims
palliation
cure
how
methodical
Reichert
AT550
non-contact
tonometer
intra-ocular
NCT
Xpert
Goldmann
applanation
Perkins
Thirty-five
university
tonometers
tonometry
Each
trained
observer
Plots
pair
displaying
closest
agreement
represented
narrowest
limits
0.12+/-2.17
Reduced
platelet
thromboxane
dihydropyridine
calcium
channel
blocker
nitrendipine
borderline
IDDM-type
Twenty-nine
IDDM
Nitrendipine
orally
Stimulated
non
exhausting
aggregation
ADP
stimulation
micrograms/ml
mM
arachidonic
resting
Exercise
synthesis
PF4
lowered
Whole
microM
rich
challenges
combining
pervasive
presents
rationale
24-week
structured
noncompliance
tantrums
self-injury
promotes
separate
managed
off
pharmacotherapy
exportable
guide
schedules
gemcitabine
S-1
chemo-naïve
non-small
IIIB/IV
mg/m/d
1000
22.0
28.9
0.606
4.8
4.1
5.5
15.5
18.8
Youth
comprehend
lexicalized
conceptual
metaphors
comprehending
i.e
mappings
structures
building
blocks
metaphoric
thinking
03-22
03
age-matched
e.g.
Susan
warm
person
ones
toasty
chance
metaphor
discuss
implications
intercostal
subarachnoid
post-thoracotomy
Thoracotomy
compromised
Intercostal
INB
SM
act
portions
pathway
modalities
relieving
thoracotomy
resection
bupivacaine
INB+
wound
closure
INB-
cough
movement
forced
expiratory
FEV1
vital
FVC
Opioid
56.6
40.4
54.6
39.6
decline
13.2
.7
modest
do
auditory
integrative
rehabilitative
DSM-4
manifestation
Behavior
Checklist
ABC
quotient
manifestations
Gesell
WPPSI
WISC-R
41
abnormal
DQ
statistics
base
AIT
Chronic
vasodilator
flosequinan
congestive
dilator
Seventeen
digitalis
symptomatology
serially
two-month
flosequinan-treated
Flosequinan
evoked
maximal
effected
digitalis-diuretic
capable
inducing
necessary
subpopulations
benefited
therapeutics
forth
Intermediate-term
mortality
transplantation
single-ventricle
lesions
shunt
objective
Norwood
favor
Blalock-Taussig
ventricle-to-pulmonary
competing
risks
methodology
Parametric
time-to-event
modeling
bootstrapping
549
2.7
Mortality
constant
transplant
Early
socioeconomic
.01
obstructed
ascending
aorta
.02
anatomic
subtype
Constant
gestational
full
atresia
preterm
patent
Lower
pre-Norwood
fractional
anatomy
hypoplastic
independently
.43
Independent
intermediate-term
Term
Right
Atomoxetine
stereotyped
inappropriate
speech
fear
UNLABELLED
Abstract
Objective
atomoxetine
attention-deficit/hyperactivity
ADHD
97
6-17
mg/kg/day
Here
parent-based
Aberrant
CSBQ
subscales
Hyperactivity
Inappropriate
Speech
Stereotypic
subscale
Fear
www.clinicaltrials.gov
registration
NCT00380692
Custom-fit
minimally
invasive
Recently
custom-fit
pin
guides
introduced
reduce
operating
absence
intramedullary
alignment
jigs
lead
magnetic
resonance
-based
MRI-based
cemented
posterior-stabilized
implant
mini-midvastus
drain
bottles
h.
Hb
subtracting
preoperative
Transfusion
requirements
Outcome
Knee
Scores
KSS
flexion
swelling
0.0001
g/dl
n.s
7.5
n.s.
Surgical
LEVEL
EVIDENCE
Level
Cophenylcaine
spray
flexible
nasendoscopy
Practices
vary
UK
fibreoptic
cophenylcaine
nasal
analogue
1-100
record
unpleasantness
discomfort
Overall
minimal
sensation
worse
linear
predicted
secondarily
routine
justified
Ascaris
growth
Three
forty-one
Tanzanian
levamisole
three-month
Weights
heights
tri-monthly
273
weighed
one-year
cent
placebo-treated
.06
78
infected
height
Saccharomyces
boulardii
Certain
probiotic
e.g
Lactobacillus
S.
granulated
d.
medians
stool
0.003
4.7
d
watery
apparent
shorter
3.9
persisting
amelioration
therapeutically
personalised
decision
delivered
internet
faecal
occult
tailoring
messages
participation
Australia
FOBT
Decision
tailored
non-tailored
screen
invited
25,511
people
50-74
eligibility
Eligible
respondents
3,408
Tailored
Personalised
Support
TPDS
Non-Tailored
PDS
NTPDS
CG
intention-to-treat
ITT
on-line
BS
accessed
generic
Those
2270
mailed
requested
ES
re-measured
per-protocol
PP
χ
2.57
.26
33
17.01
74
2.23
.13
positively
kit
2227/2270
wanting
1083/2227
decide
OR
.42
salience
coherence
self-efficacy
aversion
messaging
Online
resources
internet-enabled
uncommitted
attitudes
behaviour
Australian
Registry
ACTRN12610000095066
ketorolac
tromethamine
suppositories
post-cholecystectomy
post-operative
cholecystectomy
Anaesthesia
Service
99
Cholecystectomy
VRS
favour
rescue
complained
shortest
route
Oral
ciprofloxacin
intramuscular
ceftriaxone
empiric
Acute
Because
enteric
pathogens
commonly
requiring
southern
Israel
inconvenience
parenteral
created
formulations
suspension
1996
December
1997
201
ages
70
Pediatric
Emergency
Room
im
106
Stool
Shigella
Salmonella
Campylobacter
diarrheagenic
Escherichia
coli
Days
127
121
73
E.
bacteriologic
MIC50
MIC90
Possible
drug-related
ambulatory
bronchodilator
stable
COPD
reversibility
currently
1s
ΔFEV1
ΔFVC
smooth
hyperinflation
gas
trapping
possibly
Hence
hypothesize
ΔsRAW
characterize
300μg
indacaterol
Spirographic
ΔsRAW-based
intrathoracic
ΔITGV
r=0.61
residual
ΔRV
r=0.60
r=0.44
ΔVAS
r=0.73
r=0.34
p=0.008
p=0.002
p=0.023
stratified
criterion
preferable
FEV1-FVC-based
bronchodilator-induced
mechanics
ultrashort
gonadotropin-releasing
agonist
fertilization
GnRH-a
ovulation
IVF
Aberdeen
Assisted
Reproduction
Unit
Forty-eight
Response
occurrence
spontaneous
luteinizing
LH
surges
pregnancy
always
surge
aquatic
osteoarthritis
Arthritis
classes
societal
20-week
Cost
quality-adjusted
QALY
gained
Sample
reject
null
cost/QALY
exceed
50,000
SUBJECTS
Recruited
249
Washington
State
doctor-confirmed
Well-Being
QWB
Current
Desirability
CHDR
arthritis-specific
HAQ
Center
Epidemiologic
Studies-Depression
CES-D
Perceived
PQOL
postclass
expectancy
tables
QALYs
facilities
diaries/questionnaires
Medicare
reimbursement
Nonparametric
bootstrap
costs/QALY
around
estimates
Aquatic
exercisers
health-related
Outcomes
class
attendance
Costs/QALY
discounted
205,186
32,643
CHRD
exceeded
community-weighted
fell
arbitrary
budget
constraint
participant-weighted
Confidence
wide
Why
HOPE
astounding
ramipril
angiotensin-converting
enzyme
ACE
revascularization
arrest
diabetes-related
itself
Systemic
neurohormonal
renal
steady-state
natriuretic
peptide
hemodynamically
decompensated
Human
hBNP
incompletely
4-hour
microgram/kg/min
losses
replaced
hourly
vasodilatory
capillary
wedge
vascular
1722
139
1101
dynes.s.cm-5
unloading
aldosterone
Renal
hemodynamics
unaffected
resistant
predominant
preload
output
pharmacologically
Antioxidant
supplementation
exercise-induced
oxidative
60-year-old
antipyrine
hydroxylates
antioxidant
SE
BMI
kg/m
dl-alpha-tocopheryl
acetate
ascorbic
beta-carotene
Before
cycled
submaximal
workload
Antipyrine
marker
reacts
hydroxyl
radicals
para-
ortho-hydroxyantipyrine
formed
mono-oxygenase
cytochrome
P450
Daily
alpha-tocopherol
Delta
14.4
3.2
se
micromol/l
thiobarbituric
reactive
substances
angiotensin
receptor
antagonist
Valsartan
hypertrophy
stiffness
ARB
regressive
LVH
peritoneal
dialysis
CAPD
LVMi
110
g/m2
137
valsartan
140/90
large-artery
compliance
wave
reflections
pulse
PWV
augmentation
AI
Periodically
mercury
sphygmomanometer
creatinine
electrolytes
Two-way
145
152
alterations
Identifying
neutropenic
metastatic
doxorubicin
pegylated
liposomal
cycle-based
NC
DOX
PLD
MBC
509
O'Brien
Ann
Oncol
2004
15:440-449
=1.5
cells/L
ie
=grade
next
neutropenia
hematologic
Factors
=0.25
generalized
estimating
equations
backward
elimination
algorithm
0-63
final
Risk
retained
=2.0
precycle
=25
threshold
sensitivity
58.0
specificity
78.7
preventative
granulocyte
colony
stimulating
anthracycline-based
stoma
Eighteen
undergone
self-reported
namely
20-min
audiotaped
instructions
PMRT
Chinese
C-STAI
Index
Colostomy
QoL-Colostomy
version
WHOQoL
F
4.66
4.74
health/independence
perception
demonstrating
Methodology
ECG
adaptation
NOVACODE
Q
Bypass
Angioplasty
Revascularization
Investigation
BARI
Serial
electrocardiographic
critical
large-scale
computerized
St.
Louis
Core
multivessel
bypass
grafting
transluminal
detects
codes
ST
T
Minnesota
code
MC
hierarchical
seven-power
calibrated
loupe
customized
software
referred
coder
verification
rules
adjust
weaknesses
resulting
instability
boundaries
4,244
registry
ECGs
1995
568
13.4
367
8.6
progressions
16.4
697/4,244
259/4,244
Intraobserver
812
Interactive
Screening
Spectrum
Disorders
Toddlers
valid
interactive
toddlers
easily
scored
clinicians
describe
standardization
validation
RITA-T
ASD-specific
validity
delay
DD
/non-ASD
concerns
cutoff
differentiates
DD/non-ASD
tools
0.79
0.77
10.6
.0001
1.00
0.84
0.88
tool
identification
allowing
endoscopic
retrograde
cholangiopancreatography
patient-controlled
anesthetist
Different
ERCP
ease
experiences
PCS
anesthetist-controlled
ACS
department
281
301
bolus
2-8
mg/kg/h
infused
Observer
Alertness/Sedation
OAA/S
2-3
deeply
sedated
desaturation
airways
≥9
ensuring
tryptophan
depletion
drug-free
Twenty
30.5
low-tryptophan
morning
amino
drink
420
separated
Eleven
65
worsening
Tryptophan
whirling
flapping
pacing
banging
hitting
rocking
toe
calm
happy
anxious
86
69
tryptophan-deficient
.005
implicated
dysregulation
precursor
availability
exacerbate
Continued
pathogenesis
Effectiveness
hygienic-dietary
recommendations
enhancers
antidepressant
published
supporting
light
Mediterranean
knowledge
together
strategy
arm-parallel
Eighty
advised
follow
sunlight
If
doctors
systematically
simple
costless
ISRCTN59506583
Bolus
iodine
intracranial
three-dimensional
CT
angiography
arteriovenous
multidetector-row
scanner
tomography
attenuation
source
3D-CTA
MDCT
iopamidol
ml/s
3.7
370
Attenuation
bilateral
carotid
arteries
ICAs
basilar
trunk
cavernous
sinuses
CSs
Galenic
vein
quantitatively
axial
angiographic
four-channel
Injection
high-concentration
iodine-delivery
With
intermediate
High-concentration
ICA
intracavernous
first-pass
Bacteremia
fragilis
appendectomy
B.
bacteremia
profound
lymphocytopenia
culture
organism
abscesses
lymphocytes
containment
unexplained
bacteroides
immunocompromised
occasionally
Lymphocytes
themselves
host-bacterium
host
defenses
Preschoolers
acquire
sharing
pretense
kinds
things
acquired
article
pretend
Experiment
twenty-two
3-
4-year-olds
puppet
nerp
unfamiliar
kind
instance
scenario
ate
disliked
carrot
subsequently
asked
questions
real
nerps
facts
dislike
carrots
thirty-two
4-
5-year-olds
scenarios
lacking
sound
reveal
overlooked
achieve
sinus
cannulation
biventricular
implantation
Biventricular
time-consuming
challenging
pacemaker
CS
dedicated
guiding
catheters
catheter
positioning
GCA
aid
electrophysiology
inside
aided
EPA
Thirty-four
catheterization
10.1
5.4
4.6
dye
search
engage
ostium
0.0
14.3
Cannulation
adjunct
procedural
diets
Maillard
bioavailability
Assays
Caco-2
MRP
monolayers
two-period
named
white
WD
brown
BD
Calcium
solubility
absorption
digestion
accordance
38.2
unaltered
deoxypyridinoline
18.3
2.1
nM/Mm
Cr
turnover
As
adolescence
maximize
osteoporosis
excessive
Safety
immunogenicity
zoster
vaccine
≥60
Incidence
herpes
HZ
postherpetic
neuralgia
age-related
immunity
varicella-zoster
VZV
ZV
210
old
profiles
Immunogenicity
interferon-gamma
IFN-γ
enzyme-linked
immunospot
ELISPOT
glycoprotein
immunosorbent
antibody
gpELISA
Vaccination
Card
vaccine-related
geometric
GMC
spot-forming
mononuclear
prevaccination
32.8
postdose
44.3
42.9
36.5
∼2
titers
GMTs
Correlation
assays
well-tolerated
immunogenic
boost
VZV-specific
droperidol
metoclopramide
Japanese
Breast
mastectomy
axillary
dissection
subhypnotic
antiemetics
0.2
isotonic
suture
anesthetic
sevoflurane
air
investigator
blinded
assignment
questioned
extrapyramidal
maintain
integrity
154
cm
54
comprised
demographics
awakening
prevalences
0.005
0.011
NS
prevalence
0.022
0.043
referential
communicative
formally
M
yr.
4.2
girls
speakers
acted
listeners
mainstream
compulsory
Inclusion/exclusion
Speakers
untrained
Linguistic
Peabody
Picture
Vocabulary
PPVT
Wechsler
Intelligence
WAIS-III
Communicative
abilities
indexes
complexity
self-regulation
task
emitted
Ecological
paradigm
studying
implement
deficient
tunnelling
migration
influences
Tunnelling
distance
inward
transparent
adhesive
dressing
sited
lumbar
Sixty
tunnelled
non-tunnelled
Outward
prodromal
states
psychosis
Germany
concept
Detection
Programme
German
Network
Schizophrenia
GRNS
investigates
multidimensional
projects
interim
Comprehensive
cognitive-behavioural
late
atypical
neuroleptic
amisulpride
January
2003
1212
seeking
mental
screened
putative
More
388
fulfilled
188
48.5
gave
informed
consent
acceptable
Randomised
text
INTERACT
About
take
303
sent
Text
151
Texts
automated
respond
reminded
forgotten
reason
doing
38/151
stopped
completely
14/150
affecting
texts
98/151
occasion
20/151
resuming
Controlled-Trials.com
ISRCTN74757601
branch
formula
digestive
BCAA
nutrition
Nitrogen
albumin
prealbumin
retinol
binding
cumulative
4th
5th
7th
nitrogen
elevation
BCAA-enriched
TPN
isoflurane
investigational
inhalational
nitrous
oxide-oxygen
Induction
thiopental
vecuronium
0-200
micrograms
Duration
emergence
discharge
discontinuation
9.7
0.7
120.6
244
1.4
106.8
282
deeper
13.6
17.0
Prediction
formulae
nomogram
estimation
determination
Clcr
collection
unreliable
Scr
0.83-0.94
0.51-0.69
overestimate
Cockcroft
140
/
0.85
Cockroft
nifedipine
sustained
Ginkgo
biloba
extract
Raynaud
phenomenon
South
Korea
Korean
KOARA
SR
G
2:1
attack
8-week
Ninety-three
50.1
31.0
tolerable
endometriosis-related
infertility
laparoscopic
quyu
jiedu
recipe
Quyu
Jiedu
Recipe
QYJDR
endometriosis
EMs
-related
130
EMs-related
accumulation
lasting
twelve
integrals
endometrium
EMAb
125
CA125
61.33
46/75
45.45
25/55
16.07
6.77
7.25
3.27
15.92
7.51
12.73
6.12
Besides
9.12
6.16
3.48
2.06
conversion
obviously
44.44
15.62
31.88
15.78
U/mL
18.82
10.08
30.63
19.28
18.05
11.20
effectively
elevate
mineral
postmenopausal
survivors
24-month
exercises
risedronate
D
maintaining
BMD
223
=50
adherent
lose
BCS
neck
L1-L4
spine
radius
strength/weight
exercised
preserve
Postmenopausal
1,200
400
IU
exercising
+1.81
+2.85
Alkphase
-8.7
NTx
-16.7
+0.29
+0.34
+0.23
+0.30
-6.5
chi-square
4.63
Strength/weight
Development
tends
progress
microalbuminuria
proteinuria
insufficiency
Little
nondiabetic
retrospectively
4.5
9297
3577
1956
7674
albuminuria
Inclusion
exclusion
impaired
dipstick-positive
1+
Baseline
subsequent
12.6
18.2
12.4
26.7
Any
1859
1542
317
Ramipril
0.87
0.78
0.97
0.0146
People
Microalbuminuria
prevents
Parent-implemented
milieu
disabilities
EMT
therapists
IDs
Down
Seventy-seven
therapist
therapist-only
Separate
regressions
observational
sizes
ranged
1.32
favoring
largest
naturalistic
descriptive
explanatory
peers
Authors
intentions
576
10.06
videotapes
boy
engaging
AUT-D
responded
Adjective
Shared
Activities
rated
favorably
third-
fourth-graders
fifth-graders
grades
responsive
briefly
Limbal
autograft
pterygium
limbal
excision
paired-eye
208
229
124
102
105
corneal
transparency
proliferation
pterygium-like
tissue
22.4
96
42.7
recurred
stem
injured
us
Phase
nasopharyngeal
progression-free
Nasopharyngeal
NPC
radiosensitive
chemosensitive
CCRT
RT
1999
284
1992
American
M0
Similar
fractionation
cisplatin
/d
fluorouracil
96-hour
Kaplan-Meier
141
46.2
143
RT-alone
5-year
72.3
54.2
RT-only
=.0022
71.6
=.0012
leukopenia
emesis
refused
nine
treatment-related
deaths
endemic
Cryoprobe
biopsy
yield
endobronchial
Forceps
endoscopically
visible
combine
forceps
cytology
cryoprobe
bronchoscopic
malignant
stenosis
biopsies
called
cryobiopsies
cryobiopsy
6-year
296
endoluminal
bronchoscopy
consecutively
simultaneously
Pathologic
Comparative
89.1
65.5
artifact-free
sections
89.5
Mild
Cryobiopsy
wood
smoke
Guatemala
ST-segment
electrocardiograms
fine
particulate
matter
PM
pollution
indoor
solid
fuels
RESPIRE
Exposure
Pollution
Indoors
chimney
woodstove
hypotheses
stove
fire
HRV
complementary
designs
between-groups
comparisons
before-and-after
fires
stoves
Electrocardiogram
lasted
38-84
30-min
-1.00
Personal
aerodynamic
diameter
≤
μm
PM₂.₅
exposures
electrocardiogram
266
μg/m³
0.08-0.90
nonspecific
repolarization
erythropoietin
anemic
epoetin
alfa
cancer-associated
40,000
SC
40K
120,000
120K
sixty-five
eighty-three
182
transfusions
.22
v
.58
g/dL
increment
held
end-of-study
Toxicities
thromboembolism
reasons
safely
sacrificing
Lack
blinding
confounded
Superior
Recent
perform
stems
discrimination
generalize
Experiments
like
searching
target-distractor
similarity
experiments
replicate
detection
stemming
stimulus
processing
disturbances
Amonafide
CALGB
8642
imide
derivative
naphthalic
preclinical
extensively
metabolized
Its
N-acetyl-amonafide
Leukemia
master
randomizes
cyclophosphamide-doxorubicin-5-fluorouracil
precedes
deals
amonafide
Comparisons
addressed
histologically
0-1
Prior
permitted
visceral
mg/m2/day
21-day
Escalation
mandated
hematotoxicity
thereof
Toxicity
bimodal
thrombocytopenia
35.7
3/4
8.3
0.08
steep
dose-response
curve
myelosuppression
Rates
incorporate
individualized
pretreatment
acetylator
phenotyping
itraconazole
fluconazole
fungal
myeloid
myelodysplastic
syndromes
forms
108
AML
MDS
probable
remission-induction
numbers
consolidation
/L
Vibrotactile
post-perceptual
stimuli
compelling
sensations
undetectable
judge
tones
noise
louder
vibrotactile
experiment
replicated
dB
loudness
2-interval
forced-choice
cross-modal
biased
vibrotaction
demonstrates
sometimes
ignored
judging
audition
appear
occur
perceptual
Recurrent
n't
first-line
assessable
platinum
bulky
474
239
235
intent-to-treat
=.095
19.7
=.390
56.7
platinum-sensitive
=.037
23.3
=.008
71.1
platinum-refractory
nonstatistically
=.455
Severe
convenient
valuable
option
clustered
randomize
clusters
errors
misleading
GEE
focusing
GEE-independent
within-cluster
binary
yields
robust
DARE
youth
substance
abuse
illustration
Eltrombopag
RAISE
6-month
thrombopoietin
eltrombopag
undertook
30,000
μL
matching
Randomisation
centrally
computer-generated
15,000
splenectomy
investigators
allocation
Dose
50,000-400,000
NCT00370331
Nov
2006
2007
197
62
responding
8·2
3·59-18·73
0·0001
59
concomitant
p=0·016
p=0·001
thromboembolic
Nine
eltrombopag-treated
bilirubin
balanced
GlaxoSmithKline
Role
antihypertensive
non-insulin
captopril
3-week
run-in/drug
placebo/wash-out
Captopril
154/90
5/2
144/86
4/3
postprandial
ACE-inhibition
a.m.
11.1
mmol/l
p.m.
11.0
8.9
kinin
40.0
pmol/l
doubled
108.8
23.5
Body
electrolyte
uric
hepatic
Antazoline/tetryzoline
eyedrops
levocabastine
allergic
conjunctivitis
Allergic
anterior
eye
segment
antiallergic
Antazolin/Tetryzolin
drops
Levocabastine
subjective
0.0395
drop
Therefore
outweigh
family
exaggerated
communicate
accurate
initiated
centers
comprehension
personal
first-degree
concordance
lifetime
1.3-9.5
thirds
substantially
Examination
produce
preoccupation
African-American
0.11-0.99
counsel
unless
anxieties
IMPLICATIONS
Attention
risk-counseling
cloned
susceptibility
gene
BRCA1
BRCA2
Sleep-anticipating
Melatonin
nocturnally
sleep-wake
task-related
rostro-medial
occipital
cortex
visual-search
music
parahippocampus
autobiographic
memory
modulates
resembling
actual
fully
awake
Furthermore
essentially
deprivation
revealing
fatigues
circadian
opposed
homeostatic
priming
sleep-associated
Local
house
dust
mite
Dermatophagoides
pteronyssinus
verify
LI
HDM
PI
lactose
premedication
disodium
cromoglycate
DSCG
-derived
bronchial
challenge
variation
methacholine
ultrasonically
distilled
water
UNDW
immunologic
humoral
cellular
locally
induce
Compensation
relations
strategic
foundations
stresses
dimensions
warmth
organize
compensation
dimension
Identity
Theory
extends
examining
boundary
underlying
correlational
conflict
asymmetrical
share
members
creativity
'noblesse
oblige
non-discriminatory
instrumentation
steel
non-tooth
plastic
supportive
SPT
cause-related
substantive
tooth
effort
non-root
Universal
Perio
Soft
Scaler
Hawe-Neos
Dental
Bioggio
TI
Switzerland
peridontal
BOP
PPD
17-42
periodontally
trauma
hard
liu
wei
di
huang
jin
gui
shen
qi
decoction
Eighty-three
Kidney-tonifying
Liu
Wei
Di
Huang
Jin
Gui
Shen
Qi
medicinal
courses
availble
well-matched
CR+PR
91.5
herb
46.9
Kaplan-meire
alive
Until
still
enjoying
disease-free
Hematologic
toxicities
frequently
0.01/WBC
BPC
decoctions
immuno-enhancement
non-specific
immunology
Paternal
RHD
zygosity
Tunisians
molecular
choice
paternal
entering
diagnostics
pregnancies
haemolytic
foetus
newborn
anti-RhD
RH:1
Tunisian
donors
sequence-specific
PCR-SSP
amplification
hybrid
Rhesus
box
RQ-PCR
exon
discordant
exons
boxes
amplified
PCR
sequenced
Molecular
comprise
193
dizygous
hemizygous
whose
Positive
Negative
83.24
87.27
polymorphisms
alleles
Trp185Stop
Ala176Thr
Ile342Ile
despite
heterogeneity
Sensory
Adapted
Environments
Enhance
Care
Pilot
adapted
dental
SADE
6-12
professional
cleanings
RDE
counterbalanced
3-4
apart
physiological
school-aged
galacto-oligosaccharides
bifidobacteria
LGG
GOS
microbiota
double-blinded
wash-out
ingested
milk-based
fruit
CFU
Symptom
diaries
filled
Fecal
ingestion
9.33
4.28
CFU/g
lactobacilli
defecation
consistency
stools
Ingestion
prebiotic
Subjective
cardiorespiratory
fitness
examine
Physical
Activity
IPAQ
accelerometry
GT3X
PA
VO2max
wore
Bland-Altman
plot
illustrate
Wilcoxon
employed
Steiger
Z
Sixty-eight
age=55±13
27.8±5.4
kg/m2
duration=5
yrs
Smaller
engaged
sedentary
Z=-6.80
Z=-6.89
Z=-6.26
objectively
rho=.35
rho=.34
P=.01
vigorous
MVPA
rho=.33
rho=-.27
P=.04
IPAQ-reported
maxV02
rho=.25
rho=.27
IPAQ-VO2
max
GT3X-VO2
Z=3.43
Via
Accelerometry
MPVA
interpreted
caution
complemented
ISRCTN04121489
Registered
September
middle
HDL2
HDL3
tendency
6-keto-prostaglandin
F1
alpha
B2
prostaglandin
E2
favourably
distribution
circulating
Rationale
RE-LY
anticoagulant
warfarin
dabigatran
Vitamin
K
antagonists
VKAs
difficult
Dabigatran
etexilate
prodrug
converted
thrombin
150
multinational
nonvalvular
Recruitment
18,113
VKA-naive
proportions
hemorrhagic
embolism
abnormalities
Adjudication
accrue
450
1-year
includes
VKA-experienced
naive
evaluates
dosages
worldwide
broad
applicability
2009
mediators
sustained-release
determinants
post-quit
withdrawal
cigarette
craving
cigarettes
smoked
lapse
exploratory
submitted
mediation
Tobacco
Madison
WI
PARTICIPANTS
403
contraindications
INTERVENTION
9-week
pill
momentary
equation
Bupropion
point-prevalence
mediated
partially
motivation
motivational
RESPECT-PTSD
re-engineering
PTSD
Posttraumatic
Component
Model
3CM
two-arm
clinics
Veterans
Affairs
healthcare
Blinded
assessors
195
Their
Iraq
Afghanistan
Vietnam
telephone
managers
supervision
psychiatrist
KEY
fill
adequate
refills
pharmacy
careful
way
supports
encourage
providers
manage
high-functioning
adversely
environments
yielded
randomizedto
treatment-as-usual
TAU
evaluators
interviews
Schedule
–
Version
ADIS-P
Forty-seven
Clinician
clinician
meaningful
Initial
agroup
normed
Feasibility
dose-dense
FEC
Central
CECOG
Addition
epirubicin
densification
proved
14-day
pegfilgrastim
=85
88
147
infusions
9.8
personal/logistical
Grade
incidences
enzymes
oedema
High-functioning
HFA
impairment
retardation
group-based
Skills
Group-based
SST-GP
Leisure
LA-GP
emotions
LA
error
labeling
DANVA2
Progress
justify
Anti-emetic
perphenazine
tonsillectomy
adenoidectomy
paediatric
4-10
antiemetic
0-3
87
0.204
corresponding
3-24
0.007
Measurement
exhalation
Transfer
carbon
monoxide
TLCO
inert
methane
solely
anomalies
inspiration
breath
holding
dyspnoeic
Exhalation
ex
Jones
Meade
bh
practise
manoeuvre
close
bias
deviation
precision
mmol/min/kPa
1.51
0.21
0.80
identical
pathophysiological
budesonide
Turbuhaler
aqua
seasonal
rhinitis
Rhinocort
microg/day
256
SAR
Secondarily
ascertain
preferences
double-
dummy
Private
practices
Ontario
Quebec
Manitoba
POPULATION
eighty-four
out-patients
symptomatic
ragweed
season
volunteered
enrolment
243
Most
non-nasal
epistaxis
headache
easier
unpleasant
irritation
Once
efficacious
indomethacin
phonophoresis
temporomandibular
pain-relieving
TMJ
massage
MHz
W/cm2
conducting
medium
cream
PPT
subgingival
controlled-release
chlorhexidine
microbiologic
serologic
CHX
chips
SRP
≥12
PD
≥5
placed
Ten
≥4
appointment
Immediately
inserted
Parameters
Periodontal
Aggregatibacter
Porphyromonas
gingivalis
Prevotella
intermedia
Tannerella
forsythia
Treponema
denticola
sensitive
lipopolysaccharide-binding
proteins
Mann-Whitney
CAL
1.17
microorganisms
sodium
pressurized
aerosol
Sodium
formulated
4-times
asthmatic
breathlessness
exertion
opinions
favoured
theophylline
beta-stimulants
Virtual
hypnosis
traumatic
injuries
impair
inadequately
nonpharmacologic
hospitalized
virtual
VRH
-hypnotic
suggestion
VR
hardware/software
technology
worthy
hypnotic
therapist-provided
Insulin
pump
glycemic
pancreatic
β-cell
preserving
secretory
T1D
starting
MDIs
MDI
8-18
Preservation
mixed-meal-stimulated
Between-group
sensor
anthropometric
Initiation
mixed-meal
test-stimulated
Nonetheless
pump-treated
normoglycemia
comparatively
contributed
Low
ketazolam
between-patient
evening
1-week
HAM-A
basal
kept
otherwise
Italian
4-point
Seventy-eight
Likewise
Tolerability
aspirin
Collaborative
Project
PPP
Nonsteroidal
antiinflammatory
scanty
SBP
DBP
hypertensives
factorial
Fifteen
units
142
automatic
Ambulatory
deltaSBP
-0.5
+2.9
deltaDBP
-1.1
+0.3
converting
exclude
posterior
tibial
refractory
monosymptomatic
enuresis
urodynamic
Another
46.4
detrusor
overactivity
bladder
78.6
0.002
wet
evident
Posterior
viable
Improving
xylometazoline
dexpanthenol
application-form
Xylometazoline
Dexpanthenol
Nasic
parallel-group-comparison
nasal-spray
inpatients
Rhinitis
nasal-breathing-resistance
target-parameter
Confirmatory
Wilcoxon-Mann-Whitney-U
MEASURE
superiority
Xylometazoline-Dexpanthenol
proven
Due
handling
underlines
confirms
enlargement
refrigerator-stable
Zostavax
=60
refrigerated
frozen
Enrollment
1:2
postvaccination
Varicella-zoster
titer
GMT
GMR
185
727.4
834.4
units/ml
formulation/frozen
0.71
1.07
GMRs
2.6-
2.9-fold
injection-site
35.6
freezer
Cuban
pneumococcal
conjugate
candidate
heptavalent
PCV7-TT
Cuba
μg
serotypes
18C
19F
23F
6B
conjugated
tetanus
toxoid
TT
IPD
4-5-year-old
Synflorix
single-dose
vaccination
IgG
OPA
pave
Public
Register
RPCEC00000173
cognitive-behavioral
modular
7-11
Raters
Gains
contributes
growing
literature
Spotty
calcification
spotty
calcified
quiescent
1,347
arc
90°
922
425
56
on-treatment
PAV
36.0
29.0
174.6
71.9
133.9
64.9
+0.43
0.07
+0.02
0.11
intensive
efficacies
attenuated
diffuse
oxytetracycline
cow
Staphylococcus
aureus
mastitis
supplemental
Holstein
intracisternal
commercial
cephapirin
benzathine
drying
Milk
calving
plated
isolation
storage
-20
degrees
Quarters
fresh
cured
29.4
quarters
27.5
25.0
21.2
22.5
intramammary
kinesthetic
locomotor
integrated
rhythm
post-stroke
hemiparesis
timed
up-and-go
electromyographic
kinematic
25.69
16.16
23.97
14.30
22.68
12.35
15.77
8.58
swing
muscles
angular
displacement
ankle
joints
hamstring
gastrocnemius
posttest
pregabalin
perioperative
laparatomy
mobilization
laparotomy
perioperatively
L
mg⁄kg
mg⁄kg⁄h
PL
nbsp
Hemodynamic
Morphine
Preoperative
hastened
motility
ondansetron
gynecologic
TAH
i.v.
Postoperatively
retching
emetic
sequelae
SES
deemed
43
Metoclopramide
ineffective
reactivity
nonsmokers
OCs
exact
mechanismsfor
Cardiovascular
nicotine
half
Approximately
12-hr
gum
videotaped
nonusers
nonsmoking
Young
specified
NOS
averaged
24.52
outperformed
visual-spatial
academics
though
physiotherapy
EDs
EECUs
review
mobility
EECU
re-presentation
ED
work/home/leisure
assessor
186
123
assessment/intervention
Referral
medical/nursing
-18
-6
non-significant
p≥0.45
ANZCTRN12609000106235
Neoton
thrombolytic
neoton
MI
arrhythmia
TLT
Q-MI
streptokinase
preparations
Left
analysed
Holter
dilation
volumes
Antiarrhythmic
manifested
establishment
unfavourable
prostatic
Urological
Stilboestrol
Cyproterone
Medroxyprogesterone
Estracyt
far
gynaecomastia
Adriamycin
Procarbazine
progressed
Inverse
Fluoxetine
Medial
Prefrontal
Cortex
Activation
Reward
Reversal
deficit
flexibility
Serotonin
reuptake
SSRIs
modulate
disorder-specific
dysfunctions
reward
reversal
SSRI
Age-matched
scanned
Repeated-measures
normalization
underactivated
medial
prefrontal
mPFC
precuneus
Under
up-regulated
down-regulated
learning
dissociated
skeletal
myoblast
transcatheter
intramyocardial
myoblasts
HF
MARVEL
image-guided
catheter-based
800
million
ejection
6-minute
Living
330
intended
MARVEL-1
financial
Ventricular
tachycardia
amiodarone
myoblast-treated
Δ6-minute
-3.6
+95.6
+85.5
m
.50
postinfarction
cardiomyopathy
provoked
treatable
problem
Adherence
lifestyle
sun
coadjuvant
wrist-watch-like
actimetry
note
explicitly
explicit
25.8
beta
2-agonist
oscillations
obstructive
random
ipratropium
bromide
fenoterol
hydrobromide
inhaler
Hz
Rrs
reactance
resonant
delta
34
qualitatively
capacitance
dependence
assuming
allopurinol
Allopurinol
protects
reperfusion
opening
cross-clamping
electron
spin
minute
spin-trapped
0.016
non-significantly
0.074
7.3
Myocardial
-0.94
1.21
+0.79
0.96
antioxidative
properties
neuroprotective
desflurane
neurosurgical
pre-conditioning
ischemia/reperfusion
cerebral
anesthesiology
Less
neurosurgery
regretful
considering
anesthetics
subtlety
oxygenation
retrospective
existing
volatile
anesthetics-induced
inpatient
surgeries
analyzing
haemodynamic
smoother
experiencing
vasodilation
Sevoflurane
afford
finasteride
androstenedione
prostate
high-
low-grade
androst-4-ene-3,17-dione
Prostate
Androstenedione
androgen
testosterone
5α-reductase
case-control
Adjusted
tertile
0.42
0.19-0.94
Gleason
high-grade
dihydrotestosterone
DHT
5α-androstanedione-3,17-dione
ozone
hepatitis
certain
complication
hepatorenal
renin
PRA
AII
ALD
Basic
autohemotherapy
milliliter
drawn
µg/ml
returned
1.31
ng·ml⁻¹·h⁻¹
111.25
17.35
251.31
22.60
0.13
155.18
19.13
405.31
29.88
4.67
14.23
2.02
162.21
15.32
401.20
35.02
4.97
15.61
175.15
28.20
ml/min
125.68
21.25
128.59
23.15
4.78
4.61
χ²
5.295
Thirty-three
survived
12.993
Event-related
amphetamine
attention-related
ERP
ERPs
SAT
detecting
infrequent
long-duration
short-duration
location
pitch
Amphetamine
Dependence
high-dependence
negativity
N1
location-relevant
nontarget
deficits
Memory
Attention/Concentration
severely
suffer
inability
selectively
preferential
attentional
Genotyping
CYP21
chromosome
6p
sex-specific
neonatal
adrenal
hyperplasia
utility
genotyping
mutations
dimorphic
X-Y
Blood-impregnated
filter
papers
Guthrie
neonates
genotyped
17-hydroxyprogesterone
17-OHP
Swiss
correlative
DNA
gene-specific
ligase
genes
heterozygote
classic
excluding
deletions
2.0
nonclassic
Zealanders
full-term
15-1400
nmol/L
Sick
genetically
Genetic
linkage
disequilibrium
accurately
Low-dose
magnesium
Pritchard
eclampsia
imminent
rTMS
dorsolateral
Stroop
Neuroimaging
DLPFC
executive
high-frequency
incongruent
congruent
interference
Mood
Such
implementing
top-down
Adhesion-prevention
fibrin
sealants
myomectomy
second-look
laparoscopy
adhesion
sealant
LM
Canadian
Task
Force
University-affiliated
myoma
pedunculated
myomas
sheet
adhesions
uterus
20/32
62.5
10/29
20/30
67.7
de
novo
adnexal
4/32
12.5
2/29
5/30
tumors
Skeletal
transporter
vegetarians
vegetarianism
TCr
CreaT
CrS
VEG
nonvegetarians
NVEG
supplements
wk
Muscle
Basal
staging
radiotherapeutic
RTOG
#
77-06
T1BN0M0
T2N0M0
Radiation
T18N0M0
lymphangiogram
LAG
SL
radiation
lymph
nodes
bed
449
7706
1978
1983
Lymph
node
mandatory
discretion
117
332
nodal
irradiation
Gy
megavoltage
portals
4.5-5
6.5-8
12-year
Disease-free
Bone
metastasis
prophylactically
surgically
staged
reflected
metastases
Anticholinergic
Premedication
VO2
EE
calculated
dioxide
VCO2
kcal/d
3.581
L/d
1.448
atropine
micrograms/kg
glycopyrrolate
scopolamine
indirect
calorimetry
Deltatrac
noninvasive
radioreceptor
Atropine
PRQ
Scopolamine
nervous
Barriers
urban
black
HBP
barriers
age/sex/race
highest
complicated
309
obstacles
alcoholism
illicit
unemployment
Having
7.20
.00
.56
employment
medication-taking
Men
2.64
counterparts
issues
salient
Pivotal
urgent
PRT
well-controlled
conduct
PRTG
psychoeducation
PEG
taught
NCT01881750
http
//www.clinicaltrials.gov
utterances
3.53
.038
format
84
met
Vineland-II
Mullen
group-delivered
skill
Oxytocin
caloric
Preclinical
oxytocin
anorexigenic
hypothesized
alter
appetite-regulating
Metabolic
intranasal
oxytocin/placebo
breakfast
menu
Caloric
Indirect
REE
cholecystokinin
carbohydrate
Intranasal
obesity
warrants
Pharmacokinetic
bilayer
matrix
fentalyl
patch
monolayer
Transdermal
transdermal
Fentalgon®
Durogesic
SMAT
reference
Fentalgon
reservoir
layer
maintains
gradient
donor
centre
patches
non-irritated
non-irradiated
intraclavicular
pectoral
post-removal
validated
LC/MS/MS
Bioequivalence
claimed
80-125
75-133
116.3
109.6
123.4
114.4
105.8
123.8
narrower
bounds
opioid-naïve
bioequivalent
Eudra/CT
2005-000046-36
In-season
sprint
elite
junior
soccer
players
in-season
vertical
countermovement
jump
Sprint-15m
agility
Agility-15m
0.6
71.4
skinfolds
11.4
academy
CONTRAST
SPRINT
supervised
alternating
heavy-light
15-50
soccer-specific
drills
small-sided
games
technical
30-m
sprints
2-4
sets
7.23
0.18
7.09
m.s
competitive
feiyanqing
rectum
condensed
liquid
syncytial
viral
pneumonia
Feiyangqin
Rectum
Condensed
Liquid
FRCL
Seventy-two
simply
Western
IgA
CD3
CD4
77.8
5.6
94.4
55.6
19.4
91.7
CD4/CD8
IgE
Reputation
propensity
reputation
purportedly
Izuma
Matsumoto
Camerer
Adolphs
explanations
donated
charity
manipulation
recipient
donations
told
opportunity
donate
expectation
reciprocal
tit-for-tat
motivate
watching
observing
Yet
think
vigilance
colonic
midazolam/fentanyl
67
colorectal
approved
ethics
committee
3-5
mg/kg.h
Mi/Fe
intubated
non-depolarising
relaxants
manually
ventilated
2:1.2
administrated
epidurally
arriving
Steward
Trieger
recall
column
KAI
symbol
counting
gases
Table
Figs
2-5
Fig
Comparing
pCO2
slightly
hypercapnia
advantage
concerned
Intraoperatively
Should
insertion
nails
fractures
reaming
3.8
exist
reamed
unreamed
nailing
shaft
Forty-five
displaced
closed
Gustilo
I-IIIA
tibia
Stabilization
slotted
stainless
nail
titanium
Nonunions
fracture
malunions
nonunions
healed
dynamization
static
interlocking
screws
nonunion
heal
exchange
fibular
osteotomy
Unreamed
hippocampal
Alzheimer
FIT-AD
accounts
dementias
highlighting
pressing
Aerobic
biologically
METHODS/DESIGN
moderate-intensity
cycling
community-dwelling
mild-to-moderate
slows
Ninety
low-intensity
stretching
Allocations
Cognition
Scale-Cognition
Hippocampal
detect
2.5-point
within-group
gap
curb
prohibitive
dementia
NCT01954550
2013
October
prepackaged
meals
4L
polyethylene
glycol
residue
one-day
lunch
dinner
options
214
54.1
TM-PEG
colon
cleansing
Ottawa
2.97
2.46
0.063
0.036
0.599
Self-Care
Rehabilitation
Asthma
SCRPA
self-management
Lung
Association
Utah
Curriculum
school-age
6-14
90-minute
keeping
worth
posttesting
Genital
sexual
arousal
remedying
vasculogenic
genitally
medically
Diagnostic
Statistical
Manual
Edition
DSM-IV
depicting
cunnilingus
intercourse
vaginal
VPA
photoplethysmography
latency
aroused
argue
revision
genital
metoprolol
hydrochlorothiazide
hydralazine
unselected
nineteen
Antihypertensive
smallest
beta-blocker
Tramadol
perineal
perineorrhaphy
Thailand
tramodol
birth
vaginally
episiotomy
second-
third-degree
tear
assign
oftramadol
ofplacebo
physically
10-cm
Side
opinion
significances
Inhibition
histamine-induced
wheal
flare
mizolastine
Mizolastine
nonsedating
antihistamine
urticaria
2-mu
intradermal
histamine
four-arm
5-day
Histamine
suppressing
10-
15-mg
trough
Continual
microalgal
biomass
laying
hens
14-wk
ssmetabolic
hen
Shaver
fed
defatted
green
DG
Desmodesmus
full-fatted
diatom
FD
Staurosira
11.7
protease
replicates
contained
individually
reared
cages
data/replicate
ADFI
BW
hen-day
egg
Feeding
glutamine
alkaline
phosphatase
3-methyhistine
tartrate-resistant
TRAP
ileal
digestibility
brush
border
mRNA
duodenal
transporters
Pept1
Lat1
Cat1
phosphorylation
key
S6
ribosomal
phospho-S6
weights
albumen
proteolytic
jejunal
digesta
Supplemental
feed
Mind
ToM
16-week
8-13
IQs
elementary
empathic
Home
popular
uncertainty
cost-effectiveness
multidisciplinary
definite
133
SF-36
minimisation
favouring
dimensions-general
bodily
role-emotional
822
euros/patient/year
admissions
interdisciplinary
cost-effective
thyroid
prognosis
inoperable
NSCLC
palliative
subset
non-small-cell
HRQOL
carboplatin
vinorelbine
Gy/15
compares
Except
temporary
gradual
esophagitis
hospitalizations
apparently
Growth
cortical
childhood-onset
endosteal
expansion
thickness
CO
GHD
Cortical
radiogrammetry
metacarpal
bones
6.43
3.34
9.61
MCI
6.14
3.95
8.38
-4.64
-7.15
-2.05
width
0.68
-1.17
promptly
reinstitution
fragility
extremity
comatose
ICU
vena
cava
unblinded
medical/surgical
Sixty-one
thrombotic
lower-extremity
phlebographic
jugular
Single
lumen
polyurethane
leg
phlebography
Leg
phlebographies
Fibrin
sleeves
6.6
nonobstructive
thromboses
superficial
extremities
Femoral
Given
attractive
critically
ill
Non-verbal
compassion
psychophysiologic
Calm
compassionate
comfort
non-verbal
NVCC
touch
autonomic
loving-kindness
meditation
LKM
10-point
peacefulness
physiologic
monitors
RR
10-minute
read
neutral
non-tactile-LKM
practiced
pretending
tactile-LKM
rested
lightly
touching
shoulders
hands
feet
legs
Post-Intervention
Rest
reading
something
else
43.6
Blinding
tactile
non-tactile
2.2
9.0
Extending
NCT01428674
Intermittent
theta-burst
Parkinson
iTBS
motor
Progression
eventually
dopaminergic
pose
Repetitive
sham-controlled
cortices
Class
1-month
bradykinesia
Unified
UPDRS
neuropsychological
neurophysiologic
EEG/EMG
excitability
epileptic
tinnitus
CLASSIFICATION
autologous
marrow
sequential
intermediate-grade
non-Hodgkin
lymphoma
464
Groupe
d'Etude
des
Lymphomes
l'Adulte
Intensive
autotransplantation
relapsed
aggressive
1987
carmustine
etoposide
CBV
consolidative
ifosfamide
asparaginase
cytarabine
intermediate-
younger
LNH84
anthracycline
3-year
.46
0.90
.60
1.11
parecoxib
thoracoscope-assisted
PCA
Parecoxib
mixture
4-5
ropivacaine
spaces
chest
coughing
start
button-pressing
/D
4-24
mifepristone
uterine
leiomyomata
leiomyoma
Uterine
bimonthly
sonography
follicle-stimulating
endometrial
Nineteen
shrank
5-mg
10-mg
nonsignificant
Leiomyoma-related
comparably
Amenorrhea
60-65
Hemoglobin
hot
flashes
Mifepristone
Nizatidine
ranitidine
peptic
nizatidine
230
159
ulcers
nocte
b.d
b.d.
Endoscopic
epithelialisation
mucosal
Endoscopy
Healing
habits
H2
tamsulosin
silodosin
benign
BPH
α
-blockers
patient-reported
T-S
S-T
continuation
70.3
59/84
70.2
18/84
21.4
'good
3/91
3.3
25/88
28.4
want
continue
Ankle
cryotherapy
soleus
2-factor
voluntary
60-minute
exists
torque
Hoffmann
reflex
H-reflex
Controversy
surrounds
cooling
deleterious
motoneuronal
pretested
Hmax
Mmax
plantar
crushed
ice
bag
Surface
temperatures
electrode
weak
0.38
existed
motoneuron
pool
30-minute
postcooling
lip
bite
Mallampati
endotracheal
intubation
possibility
replace
unaccomplished
tracheal
impending
hypoxic
oropharyngeal
criteria-class
incisors
vermilion
laryngeal
grading
Cormack
5.7
refrain
blinking
P3
amplitudes
Often
instructed
lest
EEG
potentials
distorted
high-pitched
blink
omitted
Target
P3s
non-targets
actually
blinked
rarely
harder
try
Omitting
off-line
subtraction
motivated
discrepant
preceding
sequence
discrepancies
largely
resolved
instructional
variable
conjunction
intensities
discouraged
arousing
Credé
justification
today
neighbourhood
Corynebacterium
parvum
operable
cervix
CP
uteri
confined
vagina
parametrial
malignancy
spread
malignancies
s.d
7.0
sensitized
DNCB
monocytes
transforming
macrophages
sequestration
tissues
adiposity
overweight
Latina
synergistic
CAST
adolescent
16-wk
stronger
glucose/insulin
15.2
repetition
7-d
3-d
records
dual-energy
absorptiometry
DEXA
Across
ANCOVA
pairwise
z-scores
pictorial
spoken
Presently
consensus
nonverbal
verbally-based
pictorially-based
Exchange
Communication
System
PECS
≤9
words
247
Dependent
vocabulary
exited
Bronchoscopic
bronchogenic
Fibre-optic
consisting
nodular
narrowing
bronchi
fibrous
strands
membranes
Microscopic
disappearance
nodules
Persistent
2-yr
scar
complicate
intrabronchial
Changing
Childbirth
initiative
continuity
midwives
maternity
Between-groups
cared
agreed
package
felt
compromise
FOR
PRACTICE
attempts
introduce
carer
Taking
provision
principles
agenda
situations
overarching
Caphosol
®
mouthwash
gives
mucositis
OM
toxic
≥16
allogeneic
HDCT
RESULT
Mucositis
WHO
imaginable
Start
hospitalisation
opioids
Augmented
soft
epicondylitis
augmented
ASTM
advice
evolution
ergonomics
Patient-rated
Patient-Rated
Tennis
Elbow
pain-free
grip
116
self-pressurised
air-QTM
intubating
LMA
Unique™
air-Q™
air-Q
LMA-Unique
leak
insufflation
5-18
12-17
6-22
p=0.05
14-18
10-29
15-20
10-30
cmH2
O
p=0.12
16-22
12-30
p=0.81
ventilation
Accumulated
brisk
Arterial
contributor
consequently
×
days/week
30-55
covariate
Anthropometry
NOx
surrogate
nitric
anthropometry
-0.65
meeting
psoriatic
REmoval
REmission
ArThritis
RETREAT
TNF
costly
willingness
MDA
phased
exit
36.1
29.8
18.4
43.4
withdrawals
Six
23.4
83.3
flares
Standardized
opioid-induced
multi-center
differentiation
CM
Totally
406
collaborating
Phenolphthalein
Tablet
Cleveland
CCS
numerical
Questionnaire-C30
V3.0
QLQ-C30
86.4
Benefits
morbidity
remain
WASA
patency
nonmasked
831
325
31.8
23.0
1.41
=.0001
=.02
prosthetic
8-mm
6-mm
femoral-popliteal
57.9
75.3
74.9
indications
dialysate
endothelial-derived
vasoregulators
hemodialysis
Intradialytic
∼15
intradialytic
endothelin
NO
imbalances
altering
2-arm
mEq/L
OUTCOMES
Endothelin
nitrite
NO2
Mixed
low-then-high
high-then-low
-6.4
-6.1
-9.0
-3.2
LIMITATIONS
Carryover
ameliorated
Longer
alfentanil
inventories
non-drug-abusing
Alfentanil
comparator
age-
weight-adjusted
STANPUMP
miosis
cold-pressor
Remifentanil
prototypic
micro-like
opioid
40:1
20:1
feeling
notion
pharmacodynamic
short-lived
Clofarabine
fludarabine
busulfan
pretransplant
Bu
Flu
reduced-toxicity
myelogenous
leukemia/myelodysplastic
AML/MDS
posttransplantation
antileukemic
decided
supplant
clofarabine
Clo
assayed
nucleoside
analogs
Bu-resistant
lines
pronounced
synergy
alkylator
cytotoxic
exposing
4-arm
allo-SCT
adaptively
Arm
I-Clo
10:30
II-20:20
III-30:10
IV-single-agent
were/was
pharmacokinetically
6000
μMol-min
exceeding
6-59
CML
BC
AP
tyrosine-kinase
Forty-two
chemotherapy-refractory
CR
CRp
CR1
Finally
Graft-versus-host
GVHD
tacrolimus
mini-methorexate
MTX
unrelated
antigen-mismatched
rabbit-ATG
Thymoglobulin™
engrafted
Forty-one
projected
Marrow
chimerism
+100
lower-dose
1+2
higher-dose
3+4
graft
died
sufficiently
immunosuppressive
single-blinded
fast-track
pragmatic
Breathlessness
carers
professionals
BIS
seeks
breathless
evidence-based
delivers
non-pharmacological
multi-professional
PreClinical
comprises
differing
non-malignant
sub-protocols
lay
sub-protocol
Qualitative
referring
non-referring
'patient
0-10
track
single-blinding
informing
nationally
adds
developments
sparse
NCT00678405ISRCTN
ISRCTN04119516
Pharmacokinetics
azithromycin
washing
pharmacokinetics
Samples
204
HPLC
Azithromycin
distributed
detectable
terminal
half-lives
132.86
74.32
133.32
70.5
Doubling
remarkable
1318
hx
2502
9.13+/-0.53
17.85+/-2.4
penetration
2.96
5.27
64.35
97.73
doubling
pharmacokinetic
reality-cognitive
contextual
VR-CR
objects
abstraction
multiple-baseline
single-subject
see
context
reinforcing
pivotal
context-related
Larger-scale
usability
Succinate
sumatriptan
migraine
circulation
echo-Doppler
36-39
echocardiographic
end-systolic
end-diastolic
diameters
succinate
pharmacist
threats
external
withdraw
sixty-three
usual-care
collaboratively
specialist
provider
463
191
272
multivariate
heightened
probability
between-group
preserved
exception
jeopardized
Unstuck
UOT
EF
insistence
sameness
goal-setting
self-regulatory
scripts
guided/faded
visual/verbal
cueing
contextually-based
contexts
SS
3rd-5th
graders
staff
Students
race
symptomotolgy
'dose
Measures
pre-post
classroom
parent/teacher
problem-solving
Schools
planning/organizing
make
background/training
Significance
quality-of-life
SSQ
external-beam
overall/global
seven-category
calculation
category
Spearman
rank
coefficient
Statistically
'a
12/16
ranging
0.24
producing
ceiling
concepts
assist
calibration
elucidated
Cholesterol-lowering
retard
hypercholesterolaemia
pathogenetic
cholesterol-lowering
non-insulin-dependent
lovastatin
HMG
CoA
reductase
30.0
Cr51-EDTA
Lovastatin
LDL-cholesterol
apo
Beneficial
HDL-cholesterol
A1
Lp
Glomerular
deteriorated
lovastatin-treated
normalisation
lean
long-chain
n-3
CHD
unstable
betablockers
meals/week
meat
+/-SD
4.3
eicosapentaenoic
docosahexaenoic
A-1
Coagulation
25-hydroxy
formoterol
beta2-receptor
applicable
methacholine-induced
bronchoconstriction
regularly
beta2-adrenoceptor
S-potassium
Q-T
Q-Tc
tremor
Formoterol
dose-dependently
protected
flatter
weaker
vivo
Evaluating
steady
Maximum
MLSS
excellent
endurance
designing
assesses
Minimum
LMT
lactic
VO2peak
eight-minute
incremental
running
28-minute
runs
sec-1
4-8
65.7
ml.kg-1.min-1
mmol
l-1
definition
LSS
mmol.l-1
signified
signifying
confirming
Intra-articular
hyaluronic
intra-articular
triamcinolone
hexacetonide
i/a
TH
HA
trail
rheumatology
effusion
recording
heat
synovial
thickening
joint-line
periarticular
tenderness
principal
self-selected
Vas
drop-out
Granulocyte-macrophage
colony-stimulating
GM-CSF
acceleration
CEF
granulocyte-macrophage
standard-dose
m-2
epidoxorubicin
s.c.
soon
haematopoietic
nadir
fourth
sixth
+28
+25
+20
suspended
Haematological
anaemia
0.088
moderately
dose-intensive
Family
empowerment
AIDS-affected
living
AIDS-impacted
communities
southwestern
Uganda
innovative
addresses
HIV/AIDS
cluster
n=179
n=118
hopelessness
savings
workshops
mentorship
find
Specifically
programmes
resource
5-fluorouracil
interferon-beta
5-FU
IFN-beta
unresectable
chemotherapy-naive
-2
intramuscularly
intolerable
IFN-3
33.3
0.021
0.0435
15.9
Cumulative
Fever
0.008
Expanding
perinatal
EXPONATE
mother
infant
Nigeria
low-
and-middle-income
LMIC
goes
maternal
mobile
phones
METHODS/STUDY
consenting
logistics
Consenting
pregnant
Edinburgh
Postnatal
EPDS
absent
bipolar
suicidal
686
Midwives
deliver
solving
parenting
childbirth
phone
psychiatrists
Automated
voice
appointments
'homework
comprehensively
Bayley
sub-Saharan
Africa
ISRTCN
isrtcn.com
ISRCTN60041127
Date
15/05/2013
Satisfactory
cytological
cervical
Inadequate
misdiagnosis
PapCone®
Ayre
spatula
cytobrush
collect
ectocervical
glandular
ecto-endocervical
Ultrastructure
features
overlap
sampled
metaplastic
highlighted
porous
spongy
responsible
Cervical
smears
conventionally
levofloxacin
omeprazole
nitazoxanide
triple
Helicobacter
pylori
Resistance
HP
HP-infected
four-drug
proton
PPI
treatment-naive
gastritis
endoscopy
LOAD
LOAD-7
LOAD-10
Alina
lansoprozole
clarithromycin
LAC
Intention-to-treat
88.9
80/90
81/90
89.4
161/180
73.3
66/90
contents
pH
26-40
diazepam
aspiration
Maternal
eating
Food
pairs
low-income
São
Leopoldo
Rio
Grande
Sul
Brazil
4-y-old
Mother-child
mothers
fieldworkers
counseled
Steps
Healthy
Birth
Years
Dietary
y
345
recalls
Eating
0.30
0.13-0.71
75th
percentile
vegetable
1.95
1.31-2.89
1.49
1.07-2.07
Chemotherapy-induced
CIPN
Pursuant
appearing
neurotoxic
utilizing
/placebo
2+
SN
Planned
Two-hundred
Cytotoxic
taxanes
-vitamin
-placebo
0.43
0.58
1.5-year
Internet-based
grief
psychotherapeutic
indicators
Event
SF-12
posttreatment
sport-tinted
lenses
enhancement
straylight
tinted
outdoor
sports
emmetropic
fitted
Nike
Maxsight
Bausch
Lomb
Rochester
NY
contralateral
lens
Optima
stabilization
0.09
0.95
Straylight
log
amber
grey-green
0.066
0.052
zero
0.736
photopic
wavelength
pupil
pigmentation
filters
Late
miscarriage
clindamycin
Zelen
vaginosis
BV
Southeast
Sweden
9025
819
Nugent
noniatrogenic
0.40-2.02
0.14
0.02-0.95
P=
0.024
birthweight
2,500
born
postnatally
extending
Clindamycin
saved
euro
woman
calculus
SofScale
split-mouth
Volpe-Manhold
quantify
deposition
lingual
mandibular
subgingivally
scaled
stain
Operator
questionnaires
paired
t-tests
2-minute
Intra-luminal
contractile
distal
Nicotine
ulcerative
colitis
UC
non-smokers
water-perfused
manometry
openings
tip
rigid
sigmoidoscopy
recto-sigmoid
instillation
Observations
low-frequency
abolition
contractions
Tone
0.000015
sign
normals
pulsed-dye
laser
acne
vulgaris
Acne
phototherapeutic
notably
PDL
fixed-combination
-benzoyl
peroxide
hydrating
C/BPO
585
nm
fluence
0.35
ms
spot
Investigator
Static
ISGA
lesion
Dermatology
DLQI
27.1
36.3
36.9
54.5
42.5
appreciable
sevelamer
hydrochloride
carbonate
hyperphosphatemia
Japan
CC
6.0
phosphorous
=5.5
mg/dL
Ca
9.0-10.0
finished
N=16
N=26
N=20
5.7+/-1.4
6.4+/-1.7
9.7+/-1.0
9.1+/-0.7
Side-effects
13/29
44.8
terfenadine
hay
substitution
non-responders
escape
envelope
Significantly
opened
Terfenadine
drowsiness
ionization
hyperactive
Twenty-one
exposed
ionized
ambient
atmospheres
rigorously
impulsivity
destructive/constructiveness
subgroups
hyperserotoninemic
PLACE
REMAXOL
HEPATOPROTECTOR
IN
INTENSIVE
THERAPY
PERVASIVE
PERITONITIS
PERPOSE
RESEARCH
Remaxol
peritonitis
agedfrom
devided
comporative
hemodinamics
asid
oxydation
background
experiensed
Noted
rudicators
suppot
ofparenteral
intreduction
ofperitonitis
ofparameters
contributing
Cyclosporin
somatomedin
insulin-like
anabolic
musculoskeletal
cyclosporin
CysA
attending
PsA
hydroxychloroquine
OH-Chlor
IGF-I
Gla
sulphate
DHEAS
OH-D
1-25
OH
2-D3
parathyroid
Allelic
imbalance
clonal
allelic
Twenty-five
pathology
files
Mayo
Clinic
retropubic
prostatectomy
lymphadenectomy
1987-1991
synchronous
microdissection
oligonucleotide
primer
microsatellite
D8S133
D8S136
D8S137
ANK1
8p12-21
LPLTET
8p22
D17S855
intragenic
17q21
informative
loci
retention
locus
allele
displayed
deletion
intrinsic
divergence
PCNL
Percutaneous
Nephrolithotomy
Cases
stone
configuration
pre-operative
coagulopathy
intra-operative
nephrostomy
tube
NT
ureteral
TU
indwelling
43.2
25-70
40.1
25-73
Procedures
lithotomy
plain
X-ray
abdomen
ultrasonography
IVP
leakage
haemorrhagic
collective
dilatation
Tubeless
So
Treatments
rupture
meta-analysis
overview
Oxford
MEDLINE
Excerpta
Medica
Medicus
Through
preset
judges
meta-analytically
0.286
endometritis
cesarean
section
Tocolysis
outside
temperature
transurethral
TURP
71.2
8.2
warmed
glycine
72.4
44.4
27.6
chewing
conduction
well-characterized
23-36
chewed
approximate
echocardiograms
signal-averaged
SAECG
again
Standard
two-dimensional
ESWS
shortening
SF
SVR
circumferential
fiber
Vcfc
QRS
LVET
LV
contractility
afterload
Cardiac
acutely
How
Cash
Counseling
consumer-directed
Medicaid
home-
community-based
waiver
HCBS
DATA
SOURCES/STUDY
claims
Demonstration
Arkansas
Jersey
Florida
1998
agency
Ordinary
squares
PCS/waiver
consumers
preenrollment
spending
Models
nonelderly
EXTRACTION
supplied
PRINCIPAL
Largely
authorized
paid
expenditures
care/waiver
Higher
offset
treatment-control
insignificant
shrink
time-to
entitled
flaw
reassessment
generous
keep
incurred
carefully
Intraoperative
pethidine
Anaesthesiologists
1-111
40-65
sub-arachnoid
institution
Monitoring
Complications
interviewed
ambulation
surgeon
Midazolam-tramadol
midazolam-pethidine
shuxuening
metalloproteinase-9
metalloproteinase-1
exacerbated
Shuxuening
SI
MMP-9
metalloproteinase
TIMP-1
Seventy-nine
Routine
dripping
Spirometer
FEV1/FVC
ELISA
MMP-9/TIMP-1
obvious
-0.677
-0.629
Obvious
-0.562
-0.661
MMP-9/
-0.732
-0.891
diathesis
fulminant
clotting
lesser
VIII
correction
rose
IX
X
potentiating
inadequate
deficiencies
Deep
cord
SCI
Medicine
SMS
College
Jaipur
India
297
166
131
docetaxel
GD
CD
GD→C
CD→G
predetermined
1-14
Upon
TtP
ORR
over-accrual
475
matured
324
385
epidermal
captured
18.0
0.009
1.101
0.885-1.370
0.387
1.031
0.830-1.280
0.785
0.239
207
34.8
40.8
hepatotoxicity
hand-foot
afatinib
cetuximab
squamous
head
Afatinib
irreversible
ErbB
EGFR
-mutated
antitumor
R/M
HNSCC
platinum-containing
/week
optional
shrinkage
IR
ICR
crossed
IR/ICR
10.4
/16.6
/10.1
0.46/0.30
16.1
/8.1
/9.7
≥3
DRAEs
rash/acne
14.8
stomatitis/mucositis
38.9
/33.3
/18.8
Sequential
EGFR/ErbB
cross-resistance
Gene
endothelin-1
broiler
chickens
-induced
ET
ET-1
rearing
semiquantitative
RT-PCR
immunometric
ventricles
-treated
broilers
mRNAs
normally
ET-1/ET
fibre
Intracapillary
nephrectomy
specimen
removed
intraglomerular
arose
dissemination
invasion
veins
Intraglomerular
indicator
turn
nephrectomies
RRR-alpha-tocopheryl
low-density-lipoprotein
oxidation
hormone-replacement
RRR-alpha-tocpheryl
alpha-tocopheryl
HRT
supplement
15-g
calculating
lag
propagation
dienes
Supplementation
shortened
lengthened
prevailed
Supplements
acetate/d
shearing
thermobiological
Blackhead
mutton
sheep
differentiate
shorn
unshorn
thermoregulative
temperate
environmental
coverage
thermoregulation
deuterium
dilution
Physiological
Fourteen
nonlactating
ewes
Individual
intakes
commenced
Water
Ambient
humidity
infrared
thermography
DMI
g·kg
-0.75
·d
165
134
breath/min
39.3
38.8
0.1°C
19.3
24.5
0.6°C
27.4
1.6°C
disappeared
isotope
Even
28°C
fleeced
empirical
St
George
SGRQ
CRQ
self-administered
forty
missing
0.54
Cronbach
coefficients
/=
0.76
Factor
domain
Correlations
FEV
PEFR
discriminate
Cross
sectionally
0.72
Longitudinally
0.17
instrument
considerations
acetaminophen
codeine
contribution
remedication
propranolol
rat
Propranolol
osteoblasts
orthotopic
endochondral
nonsurgical
rats
torsional
biomechanical
femora
plate
defects
mid-diaphysis
demineralized
defect
carrier
trabecular
metaphyseal
apposition
propranolol-treated
Densitometry
roentgenographic
callus
union
Modest
epanolol
1-selective
atenolol
Beta-blockers
cardiodepressive
nonselective
-blocking
Epanolol
1-receptor
sympathomimetic
intraarterial
sitting
bicycle
reverted
14-21
2-10
137/97
128/91
beta-receptor
blockade
angina
pectoris
oncologic
trans
institutional
distressing
undertreated
attitude
SCION-PAIN
multi
or=
3/10
wards
modules
pharmacologic
specially
nurses
booster
BQII
HRQoL
ClinicalTrials
NCT00779597
plans
individualised
AAPs
poorly-controlled
asthma-focused
seminar
n=13
6=intervention
7=control
beta2-agonist
Mini
AQLQ
ACQ
ANALYSISs
629
consented
returning
adjustment
p=0.03
Estimates
disappointing
underestimating
ADHD-RS
hyperactivity-impulsivity
34.9
27.0
14.5
16.5
diminish
tend
subside
Future
Carticaine
therapie
iterative
printed
middle-aged
materials
wider
Stages
Patterns
STEPs
mail
grain
cereal
post-test
TF
instalments
mail-delivered
re-tailored
self-adequacy
Tailoring
63-item
FFQ
GE
dietitian-led
wait-listed
socio-demographic
3-months
vegetables
cereals
wholegrain
Descriptive
serves/d
0.031
low-level
Bronchodilator
spacer
Twenty-eight
Exequiel
González
Cortes
AW
Fenoterol
FNT
IB
metered
inhalers
spacers
puffs
scorings
Student
Does
photodynamic
PDT
aminolevulinic
HCl
ALA
ongoing
mammography
outreach
reminder
scheduling
publicity
campaign
1908
group-model
HMO
mammogram
1994
administrative
chart
Bivariate
contacted
Mail
reminders
gynecologist
likelihood
Telephone
mailings
cautious
investing
member
efforts
athletic
sophisticated
Elite
middle-distance
swimmers
21-26
6-13
competition
Olympic-qualifying
specialty
diet-controlled
caffeine
knowingly
varying
log-transformed
swim
swims
Predictor
interacted
athlete
trends
owing
Performance
linearly
evenings
mornings
100-mg
squad
athletes
Immunotherapy
non-lymphocytic
leukaemia
1975
1977
264
Leukaemia
251
CROP
cytosine
arabinoside
daunorubicin
prednisolone
hydroxyurea
Remission
chemo-immunotherapy
BCG
leukaemic
blast
161
07
Institutions
04
Leucocytosis
/1
improvisational
TIME-A
generalisability
counselling
high-intensity
Generalised
standardised
Observation
ADOS
Responsiveness
SRS
look
Responding
generalisable
Addressing
ISRCTN78923965
Levitan
FPS
Scope™
pass
LFS
bougie
Macintosh
laryngoscope
in-line
MILS
simulate
Ninety-four
laryngoscopy
Cormack-Lehane
glottic
POGO
intubate
anesthesiologist
numeric
laryngoscopic
views
translate
intubations
sec
sore
Recovery
acoustic
neuroma
breathing
extubation
eye-opening
hand-squeezing
command
name
birthdate
sufentanil
349.1
19.1
349.2
22.9
haemodynamic/respiratory
14.9
29.2
Full
22.1
3.1
37.6
desirable
enabling
facilitating
neurological
High
Platelet
Reactivity
Syndromes
Undergoing
Prasugrel
Clopidogrel
clopidogrel
prasugrel
reloading
HRPR
loading
PCI
≥40
Multiplate
Analyzer
terminated
sharply
introduction
newer
P2Y12
0.49
identifies
suppression
translates
NCT01339026
Lithium
granulocytopenia
Twenty-seven
reinduction
lithium
t.i.d.
nadirs
100/cu
actuarial
1000/cu
16.0
no-lithium
0.013
granulocytes
500/cu
favored
approached
0.054
meq/liter
attributable
Chronology
panic
avoidance
Cross-National
Panic
chronology
cross-national
CNCPS
agoraphobia
alprazolam
imipramine
Enhancing
tDCS
anodal
first-ever
hrs
two-back
Accuracy
rate-commission
prestimulation
poststimulation
Regarding
indexed
GPs
specialists
guidebook
decision-making
recognised
mediate
doctor/patient
consultations
Semi-structured
postal
replies
clarification
Doctors
seldom
constrained
consultants
utilising
Interference
muzolimine
chlorthalidone
makes
diuretics
worsen
According
MZ
acts
loop
Henle
assumption
fairly
orthostatic
115
non-metabolic
clinostatic
20.7
micrograms/24
13.3
deviations
web-based
face-to-face
coaching
schools
Promoting
Competence
Success
Dalrymple
McGrew
2010
teacher-child
dyads
PBO
FF
WEB
consultant
1.12
videoconferencing
Videoconferencing
scalable
bridging
research-to-practice
Successful
distensible
scars
fibroblasts
multi-site
dermal
contour
deformities
wrinkle
appearance
fibroblast
vehicle
Skin
10-20
cells/mL
cheek
evaluator
photographic
viewer
IPR
Autologous
vs.18
permanent
Early-stage
oropharynx
trans-oral
robotic
ORATOR
OPSCC
decades
papillomavirus
HPV
decade
Transoral
TORS
non-randomized
susceptible
chemo
unlikely
post-resection
Tumor
T1-T2
margins
Nodal
N0-2
≤3
extranodal
N0
N1-2
chemoradiation
along
dissections
M.D
Anderson
Dysphagia
MDADI
swallowing
much-needed
definitive
eventual
NCT01590355
medroxyprogesterone
MPA
premenstrual
PMS
northern
28-day
sequentially
unwarranted
Adjuvant
L-arginine
in-vitro
follicular
gonadotrophin
assisted
reproduction
flare-up
gonadotrophin-releasing
GnRHa
pure
follicle
pFSH
oestradiol
ultrasonographic
perifollicular
arginine
citrulline
nitrite/nitrate
NO2-/NO3-
factor-1
IGF-1
cancellation
oocytes
embryos
transferred
receptivity
Aloe
vera
Failure
aloe
Amir-al-Momenin
Gerash
Iran
dressed
Wound
REEDA
Chi-square
t-test
27.56±4.20
26.62±4.88
P=0.003
P=0.283
41eight
Pethidine
labor
parturients
Analgesic
Apgar
obstetric
diclofenac
paracetamol
diclofenac-K
extraction
molar
2-day
double-dummy
parallel-group
2-tablet
1-tablet
ibuprofen
lot
double-dose
relieved
intense
parental
trauma-focused
interparental
violence
Interparental
harmful
lives
indirectly
refer
affective
parent-child
Trauma
Focused
traumatized
HORIZON
preparatory
multi-method
4-12
posttraumatic
internalizing
externalizing
completer
violence-related
IPV
illuminate
Netherlands
NTR4015
June
pentazocine
respiration
Cognitive-behavioural
HIV-positive
homosexual
CBSM
mildly
bisexual
era
antiretroviral
HAART
1992-1997
10-week
psychoeducational
battery
assistant
reframing
enhances
crucial
feline
chlamydophilosis
involves
antimicrobials
4-6
Not
surprisingly
owner
anecdotal
Chlamydia
trachomatis
chlamydia
Chlamydophila
felis
Whilst
re-isolated
chronically
clearing
here
unsuccessful
eliminating
carriage
strain
Increased
responsivity
m-chlorophenylpiperazine
neurodevelopmental
5-HT
m-CPP
Aspergers
know
repeating
ordering
tell/ask
six-month
chemoprevention
tea
Chemoprevention
attrition
Attrition
dropouts
25-week
biomarkers
premalignant
packets
caffeinated
Dropout
≥85
dropout
Throughout
Black
four-treatment
Multi-arm
ISRCTN70410203
Dynamic
EMG
stand
bend
forward
flexed
flexion-relaxation
flexing
Concentric
eccentric
Disability
concentric
symmetry
Active
Noradrenergic
yohimbine
comorbidity
Adrenergic
MDE
NE
3-methoxy-4-hydroxy-phenyl
MHPG
AUC0-90
dysregulated
predictably
bronchitis
emphysema
disabled
dyspnoea
Forty-three
COAD
psychodynamic
psychosomatic
liaison
Impaired
imaginative
gluten
gliadin
casein
TRANSCONJUNCTIVAL
NONVITRECTOMIZING
VITREOUS
SURGERY
VERSUS
25-GAUGE
VITRECTOMY
WITH
EPIRETINAL
MEMBRANE
27-gauge
transconjunctival
nonvitrectomizing
vitreous
NVS
25-gauge
sutureless
vitrectomy
idiopathic
epiretinal
phakic
NVS-group
Standard-group
Main
best-corrected
acuity
nuclear
0.039
Tukey
0.537
Epiretinal
Fisher
1.000
induces
Enhanced
inotropic
failing
modulation
signals
experimentally
myocardium
modulating
CCM
MVO
microembolizations-induced
generator
OPTIMIZER
257
micromol/min
+dP/dt
/min
unlike
cAMP-dependent
elicited
fondaparinux
enoxaparin
hip-replacement
Elective
carries
thromboprophylaxis
pentasaccharide
antithrombotic
2275
1584
thromboembolisms
787
797
-10.8
52.8
p=0.099
3-day
amoxycillin
non-severe
wheeze
multicentric
WHO-defined
pneumonias
over-prescribed
nebulisation
radiograph
METHODOLOGY
multi-centric
government
2-59
31-54
mg/Kg/day
day-
836
835
24.0
19.9
98.9
1.28
1.01
to1.62
excess
breaths
1.19
1.92
1.13
1.96
iv
broncho-dilators
1.71
1.30
2.24
non-adherence
8.06
4.36
14.92
Treating
NCT00407394
interdental
hygiene
RCTs
Univariate
re-analyze
pre-curved
brushes
flossing
brushing
compression
papillae
fractionated
total-body
TBI
preparative
8-mg
Administration
successive
fractions
receipt
4-day
relationships
Cmax
Thrombus
microvascular
substudy
REMEDIA
clarify
microembolization
genesis
MO
MCE
Mechanical
Distal
Embolization
Aspiration
Rescue
thrombus-aspirating
pretreated
thrombus
culprit
Sonovue
real-time
sequencing
motion
WMSI
CSI
endocardial
abnormality
WML
CDL
thrombus-aspiration
temporal
remodeling
occurs
influencing
strictly
correlates
post-infarct
phrenic
palsy
pneumonectomy
preservation
unanswered
proximal
paraphrenic
pericardial
diaphragmatic
paralysis
hemidiaphragm
mL/h
mg/h
above-mentioned
Temporary
accomplished
dislocation
Spirometry
paralyzed
Aortofemoral
bifurcation
NLA
peridural
Homeostasis
infrarenal
operated
neuroleptanaesthesia
NA
concentrates
Ringer
extracellular
35.3
spite
Stress
hypokalaemia
potassium
3.5-3.7
clamping
compensated
Declamping
paCO2
221
163
min-1
eventration
gut
162
184
Later
declamping
turned
considerably
artificial
hypnotics
analgesics
Eventration
exterioration
haemodynamics
sudden
paO2
intrapulmonary
right-to-left-shunt
edoxaban
Xa
non-valvular
1,146
qd
bid
dose-adjusted
normalised
2.0-3.0
non-major
64.4
warfarin-naïve
Whereas
p=0.029
30-mg
60-mg
Classification
Effective
sensorimotor
element
classify
performing
prerequisite
channels
spatial
filtering
CSP
discriminant
LDA
classifier
configurations
hemispheric
EEGs
execution
recordings
AU-ROC
≈
0.70
LDA+CSP
neuronal
extend
'most
hemisphere
train
SIGNIFICANCE
Including
Tetrahydrobiopterin
tetrahydrobiopterin
BH4
3-7
Impressions
CGI-I
CGI-S
Preschool
Scale-4
PLS-4
Vineland
Adaptive
mannerisms
Trials.gov
NCT00850070
Tight-fitting
underwear
sperm
Heparin-coated
interleukin-6
CPB
biocompatibility
heparin-coated
apply
HC
reactants
interleukins
granulocytic
C3a
851
791-959
quartiles
497
476-573
Terminal
Complement
Complex
114
71-130
AU/ml
35.5
28.9-51.4
570
203-743
168
111-206
Seventy-one
interview
anxiety-provoking
situation
endorsed
exhibiting
Budesonide
beclomethasone
dipropionate
93
Becotide
Nasal
birch
grass
pollen
prick
Symptoms
four-week
therapy-
isometric
thirty
QLQ-BM22
QLQ-FA13
FBK-R10
Psychosocial
0.010
0.081
Emotional
Cohen
paravertebral
thereby
6-months
NCT01409720
alertness
Chewing
alleviate
night
mediating
employing
tracking
grammatical
tasteless
odorless
square
R-R
RMSSD
preejection
PEP
Alertness
amongst
Similarly
Caffeine
Strong
parasympathetic
simpler
Lengthening
moment
patella
confers
extensor
postulated
conferred
212
incorporated
Extensor
pre-operatively
post-operatively
post-arthroplasty
Posthoc
modern
theoretically
confer
patencies
radial
saphenous
Radial
Artery
Patency
conduit
descending
10-year
single-center
198
196
112
Protocol-directed
weighted
Grafts
occlusion
string
237
Patencies
conduits
.54
minus
asymptomatic
surgeons
V1
second-order
cues
first-order
luminance
modulations
computational
spatially
firing
neurons
likewise
receptive
fields
orientation-
filter-rectify-filter
FRF
first-
f
MRI-adaptation
selectivity
orientation-defined
gratings
SFs
low-SF
grating
adapter
high-SF
incompatible
yielding
filter-rectify-normalize-filter
surround
Antifibrinolytic
hemorrhage
equals
antifibrinolytic
tranexemic
disease-modifying
antirheumatic
radiologic
11-year
Finnish
Rheumatoid
Combination
DMARDs
DMARD
sulfasalazine
FIN-RACo
SINGLE
drug-treatment
unrestricted
radiographs
Larsen
Sixty-five
P=0.037
erosive
Targeting
ISRCTN18445519
tube-S
Proseal
mask
Laryngeal
Tube
Sonda
LTS
ProSeal
Mask
Airway
PLMA
I-II
18-60
Ease
seal
fibre-optic
pharyngeal
First-time
second-time
tidal
28.8
10.3
s.
Fixation
54.9
73.2
H
24.1
10.8
morbidities
hoarseness
secure
insert
Better
7-year
hormone-deficient
Subnormal
eleven
U/kg
weight/week
und
sex-matched
ICTP
carboxyterminal
telopeptide
resorption
PICP
propeptide
procollagen
dual-photon
DPA
forearm
single-photon
SPA
Apparent
phalangeal
APU
plateau
Concerning
subnormal
stimulates
Thereby
triphasic
buildup
elasticity
plasma-derived
heat-inactivated
CLB
471
occupations
private
202
3-micrograms
HBsAg
one-month
anti-HBs
269
diminished
eight-month
vaccinees
anti-HBc
antibodies
autoimmune
Aftermath
sustainability
Ghana
CPAP
Ghanaian
district
equipment
Seven
machines
concentrators
electric
generators
non-functional
personnel
first-generation
second-generation
First-generation
trainees
Appropriate
ensured
Protocolization
future-generation
Folic
acid-based
non-ST
Homocysteinemia
vitamins
homocysteine
folic
non-ST-segment
non-ST-elevation
folate
=116
=124
composite
nonfatal
re-hospitalization
Advanced
ISRCTN30249553
impulse
oscillometry
Airways
reversible
steeper
slope
relating
Bronchodilators
0.53
0.19
anaerobic
VT
Borg/VE
+/-8
r=.40
Nebulized
TGMD-2
Gross
Motor
picture
card
within-subjects
repeated-measures
ANOVA
gross
Correlates
schizophrenia
observable
institutionalization
confound
307
haloperidol
psychopathology
two-thirds
antipsychotic
fluency
DUI
confounding
neurobiological
overlapping
5-Fluorouracil
adriamycin
FAC
Adequacy
diminutive
polyps
sigmoid
electrocautery
cautery
polyp
Sigmoidoscopy
adequacy
eradicated
distinctive
false
memories
impoverished
relational-encoding
distinctiveness
heuristic
why
pictures
Deese-Roediger-McDermott
J.
Deese
1959
H.
Roediger
K.
McDermott
interferes
encoding
relational
Alternatively
assumes
lures
withheld
retrieval
word
come
postrecall
sirolimus
azathioprine
one-haplotype
kidney
recipients-preliminary
buspirone
phobia
serotonin-1A
5-HT1A
phobic
Phobia
subscores
classified
Generally
speaking
6-day
simplified
alternatives
immunoblot
10-21
olds
tinidazole
lansoprasole
ATL-group
ATP-group
Urea
Breath
ATL-
powerful
elucidate
Epidural
TRAM
flap
reconstruction
hospitalization
transverse
rectus
abdominis
musculocutaneous
100-mm
126
.0498
tolerating
flatus
25-hour
adenomas
recurrence
Focusing
calls
translation
epidemiologic
steps
moderate/vigorous
Sixteen
minutes/day
pedometer
accelerometer
self-monitoring
pedometers
overcoming
steps/day
NCT01476631
Replacing
Non-Active
Video
Gaming
Prevent
Excessive
Weight
Gain
Adolescents
promotion
anthropometrics
sugar-sweetened
beverages
snacks
non-active
gaming
270
hours/week
encouragement
BMI-SDS
SDS
waist
circumference-SDS
circumference
Sedentary
self-reports
Multi-level-intention
treat-regression
β
3.22
6.17
-1.76
-3.20
-0.32
Exp
0.81
0.74
played
Move
hour/week
'excessive
gamers
~
ten-month-period
unexpected
direction
folds
desirability
NTR3228
dose-ranging
pramipexole
restless
polysomnographic
periodic
movements
polysomnographically
RLS
PLM
polysomnography
self-assessed
IRLS
0.50
0.75mg/d
107
asleep
PLMI
-26.55
-52.70
-3.00
Wilcoxon-Mann-Whitney
5PLM/h
delta-sleep
awakenings/arousals
-5.00
-11.75min
-2.00
0.25mg/d
25.75-66.75min
25.50
0.50mg/d
stages
2-4/rapid
REM
37.00-68.00min
26.75
dose-dependent
daytime
Pramipexole
p0.0023
ameliorates
hypoinsulinemia
hyperglycemia
field-exposed
SMF
-exposed
Rats
128
mT
h/day
plasmatic
-cholesterol
Interestingly
1,600
IU/100
restored
glycemia
insulinemia
SMF-exposed
salt
Fasting
pre-treatment
145/81
⩾140
7.5/3.3
7.5/2.7
8.5/3.6
3.9/1.6
Pulse
top
low-sodium
materially
non-and-low
revaccinated
immunization
HepB
Non-and-low
2005
Guangzhou
Beijing
Zhejiang
boosted
18.66
mIUml
88.82
mIU/ml
178.24
20.4
9.1
103
61.2
chi2
14.13
revaccination
HepB-Y
l0
HepB-CHO
HepB-HY
168.8
mJU/ml
174.7
184.9
182.9
Proportion
79.0
85.7
88.2
84.6
HepB-Y,10
L-ornithine-L-aspartate
TIPS
cirrhotic
awaiting
ammonia
L-Ornithine-L-aspartate
LOLA
encephalopathy
Child
transjugular
intrahepatic
portosystemic
shunts
Psychometric
connection
electroencephalography
non-TIPS
0.643
0.033
0.825
alteration
p=0.02
Glutamine
5-flurouracil
fifty-three
distant
taxol
Variables
thoroughly
substantiated
contention
regarded
documentation
statewide
group-randomized
abstracted
Generalized
GEEs
1,575
charts
653
noninjury
p-values
Evolution
stenoses
INTACT
Investigators
Nifedipine
Antiatherosclerotic
morphological
reviewed
348
1063
preexisting
-0.28
-0.14
progressing
occlusions
manifest
228
predominantly
angiographically
sealing
dentine
resin-based
sealers
maxillary
step-back
smear
ethylenediaminetetraacetic
Then
obturated
gutta-percha
condensation
EndoRez
varnish
sticky
wax
foramen
methylene
blue
sectioned
2.87
4.54
0.36
adpated
Concentrated
Standardised
concentrated
PN
overcome
macronutrient
macronutrients
SCAMP
Line
sepsis
CVC
900
158
884
183
n=74
n=76
use/type
positive/negative
with/without
Increasing
ISRCTN
76597892
carcinomas
DAHANCA
locoregional
heterogeneous
EGFr
overexpressed
repopulation
histopathological
fx/wk
visualized
immunohistochemistry
Tumors
stratifying
well/moderate
constructed
separation
0.37-0.78
0.51-1.25
multivariable
Moderately
Depiction
hypervascular
hepatocellular
64-MDCT
moderate-
flush
depiction
scans
149
I/mL
kilogram
516
Enhancement
portal
tumor-liver
multiphase
Aortic
Portal
Tumor-liver
eliminated
Roles
adapalene
pityriasis
versicolor
Ketoconazole
tretinoin
Adapalene
retinoid
ketoconazole
Vigorous
stereotypic
Examined
antecedent
non-exercise
community-integrated
vocational
flavin
monooxygenase
sulindac-mediated
familial
adenomatous
polyposis
Sulindac
nonsteroidal
NSAID
regressing
FAP
sulindac
genotypically
phenotypically
FMO3
microsomal
inactivates
relevance-M66I
P153L
E158K
V257M
E305X
E308G
R492W-in
heterozygous
homozygous
M66I
R492W
variant
sulindac-treated
nonresponders
homozygosity
prostanoid
Polymorphisms
catabolizing
hyperhomocysteinemia
renal-transplant
Thirty-six
hyperhomocysteinemic
mg/d
microg/d
Endothelial
high-resolution
micromol/L
endothelium
vasodilatation
Endothelium
Brain
differentially
initialisation
synchronisation
paced
tapping
correlate
sequences
limbs
moved
correlating
overlearned
initiation
cue
synchronise
pacer
neuroimaging
SMA
ganglia
supplementary
pre-supplementary
preSMA
rostral
dorsal
premotor
PMC
caudal
ventral
gyrus
centromedial
aprindine
digoxin
paroxysmal
21.5
freedom
prevalent
p=0.0414
Characterization
thermal
burns
hyperbaric
HBOT
TBSA
burn
Burn
LDI
WBC
cytokine
microbiology
-1β
IL-4
IL-6
IL-10
interferon-γ
Slower
antimicrobial
detail
tamoxifen
oophorectomy
.056
.18
suitable
Nuclear
fragments
holes
aspirates
Osteopontin
OPN
secreted
hematopoietic
regulate
myeloma
Dutch-Belgian
Hematology
IHC
ELISAs
blood/BM
sera
microarray
261
Expression
BM
blasts
expressing
.025
karyotype
prompted
summary
event-free
.0002
intermediate-risk
mesothelioma
Thoracic
Malignant
invariably
fatal
rising
BTS
ASC
nonrandomized
prolongs
worthwhile
mitomycin
vinblastine
MVP
Navelbine
Pierre
Fabre
Winchester
chose
recurrence/progression-free
acceptability
suitability
details
belatacept-based
immunosuppression
cyclosporine
BENEFIT
Belatacept
costimulation
calcineurin
Nephroprotection
First-line
Immunosuppression
belatacept
deceased
co-primary
patient/graft
mGFR
mL/min/1.73
Month
=10
3-Month
rejection
mL/min
posttransplant
lymphoproliferative
Evidence
multisensory
integration
exhibit
sound-induced
flash
illusion
typically-developing
Thirty-one
beep
illusory
beeps
implying
fusion
vision
perceive
directions
constraint-induced
mCIT
task-specific
poststroke
61.4+/-3.02
28.5
emphasizing
restraint
mCIT+mental
rehearsal
pre-existing
Action
+15.4-point
+8.4-point
Fugl-Meyer
+7.8-point
+4.1-point
P=0.01
gluconate
perirectal
enough
life-threatening
septicemia
scarce
CHG
skin-care
nonmedicated
cleanser
breakdown
fissures
hemorrhoids
irritating
hygienic
disinfectants
symptom-limited
40-74
61-94
Maximal
extra
Atenolol
anti-anginal
lentivirus-mediated
interleukin-10
constriction
injury-induced
high-mobility
Neuropathic
neuroinflammation
neuropathological
IL-1
TNF-α
HMGB1
lentivirus
delivering
LV/hIL-10
intrathecally
allodynia
hyperalgesia
CCI
Sprague-Dawley
weighting
260
320
Sham
CCI±Normal
Saline
CCI±LV/hIL-10
CCI±LV/control
vector
LV/control
recombinant
μl
Paw
thresholds
PWMT
paw
PWTL
Cerebrospinal
CSF
plane
IL-1β
Animals
sacrificed
L4-5
fluorescent
GFP
Immunohistochemical
anti
western
blot
reverses
inhibited
overexpression
hIL-10
RAGE
pAkt
CCI-induced
inhibits
HMGB1-RAGE
roles
IL-10-mediated
lentiviral-mediated
anti-thermal
anti-mechanical
Zoledronic
anastrozol
Austrian
Colorectal
ZOL
DFS
48-
62-month
ABCSG-12
I/II
estrogen-receptor-positive
progesterone-receptor-positive
goserelin
1803
mg/days
anastrozole
recurrence-free
94.4-month
0-114
0.60-0.99
0.042
0.66
0.43-1.02
0.064
predefined
Absolute
anastrozole-treated
1.63
1.05-1.45
0.030
osteonecrosis
jaw
ABCSG
twice-yearly
CLINICALTRIALSGOV
NCT00295646
//www.clinicaltrials.gov/ct2/results
term=00295646
witnesses
remember
shut
idea
instructing
witness
cued-recall
no-instructions
Eye-closure
incorrect
generality
variations
cued-
free-recall
recalled
eye-closure
accompanying
Collectively
convincingly
eyewitness
developmentally
year-old
CBT-group
delayed-treatment
negativity/lability
outbursts
vignettes
deal
Improved
mometasone
furoate
barrier
MF-DPI
mimic
or=12
counter
Self-reports
Health-related
missed
1233
93.3
97.2
95.3
Very
work/school
regimen.This
ISMJE
Take
park
self-timed
Glasgow
Scotland
Cadence
activPAL™
cadence
moderate-to-vigorous
bouts
breaks
convenience
119.3
110.9
steps/min
walks
25.5
9.6
interquartile
20.3
locations
interruptions
achievement
Anaphylactoid
substitutes
proceedings
naltrexone
opiate
self-injurious
idiosyncratic
accredited
practicing
dietitian
post-transplantation
anonymously
Thirty-seven
58.7
9.5
16.4-47.6
0.56
Extended
exploration
aprotinin
applications
hemostatic
November
1989
1990
Mill
Kallikrein
inactivator
KIU
OLT
0.1-0.4
KIU/hr
hyperfibrinolysis
thrombelastography
Tissue-type
t-PA
anhepatic
tendentiously
packed
retransplantation
host-versus-graft
perfusate
Atypical
uneven
spared
N=15
IQ-matched
N=18
whilst
Behaviourally
classical
generation
BOLD
signal
cerebellum
frontal
lobes
stimulus-oriented
stimulus-independent
signal-change
Brodmann
Area
organisation
underline
inhomogeneity
559
3/48
breasts
94/423
sized
34/88
distributions
three-level
tomographic
Cross-modal
attention-switching
9-13
alternated
Bioavailability
omega-3
perilla
seed
eicosapentanoic
docosohexanoic
alpha-linolenic
Enteric-coating
Entrox
coating
ALA-rich
Perilla
Entrox-coated
non-coated
6g
24h
terbinafine
bioequivalence
CAS
78628-80-5
+0.333
0.667
1.33
1.67
2.00
2.33
3.00
3.50
4.00
6.00
8.00
48.0
72.0
post-administration
Terbinafine
chromatography
tandem
HPLC-MS/MS
quantification
9.99
ng/mL
AUClast
AUCinf
non-compartmental
Classical
90CI
96.08-105.40
95.68-105.33
88.24-112.83
ranges
ginger
eicosanoids
mucosa
Inhibitors
COX
upregulation
PGE
CRC
Ginger
downregulation
incidence/multiplicity
g/d
13-hydroxy-octadecadienoic
5-
12-
15-hydroxyeicosatetraenoic
15-HETE
Flexible
spectrometry
eicosanoid
5-HETE
12-HETE
inhibiting
snowshoe
popularity
sport
snowshoeing
considerable
scientific
run
Vermont
surrounding
RTE
snowshoers
runners
75-85
6.3
Run
33.5
One-year
KeraVision
Intacs
myopia
inaccuracy
optical
zone
shortcomings
Drug
89
20/40
uncorrected
Ninety-two
Stability
Corneal
curvature
prolate
aspheric
shape
predictable
CD4+FOXP3+
condylomata
acuminata
Condylomata
CA
sexually
transmitted
China
Recurrence
FOXP3
Treg
warts
CY
Surprisingly
recur
re-administration
eliminates
depletes
HPV-specific
periphery
remnant
viruses
breakthrough
localizations
1985
lymphomas
IID
IIID
thirty-six
prednisone
Intermediate
p.
histologic
lymph-node
localization
Chemotherapy
Oscillatory
insulin-dependent
glucosylated
HbA1
neurosensory
OP-1
OP-2
OP-3
summed
OP-sum
oscillatory
OPs
electroretinography
7-years
0.0001-0.01
worsened
0.0002
11.2
Multiple
cross-sectional
0.0001-0.003
microaneurysms
differently
implanted
professionally
catheter-related
focuses
Eighty-two
tunneled
CVCs
semistructured
port
constantly
stigmatized
self-control
Assuming
ownership
Placement
Stigma
originating
necessity
statins
subclinical
infarct
Subclinical
SBI
epidemiological
post-hoc
Cerebral
Stenosis
ROCAS
stroke-free
227
infarcts
SBIs
6.27
2.4-16.5
0.01-0.82
Consistent
WHO/ISH
Guidelines
MONICA
CVD
indication
propose
stratification
organ
TOD
geographically
risk-classified
917
drug-treated
Three-quarters
737
1773
5997
medium-
very-high-risk
risk-group
48.3
35.2
shifted
130/85
278
12.2
low-risk
medium-risk
one-fifth
45-54
risen
Secretin
two-part
touted
GI
secretin
viability
IU/kg
Childhood
CARS
labeled
Pervasive
Otherwise
Specified
concurrently
Subsequently
alternatively
inquiries
Denosumab
zoledronic
denosumab
monoclonal
κ
RANK
ligand
delaying
skeletal-related
SREs
1,026
1,020
strongly
on-study
SRE
0.89
acute-phase
hypocalcemia
Osteonecrosis
infrequently
.39
Neck
cardiometabolic
2,318
18-64
Carotid
crPWV
cfPWV
dorsalis
pedis
cdPWV
0.049
0.034
modify
communication-focused
pre-school
life-time
families
decisions
parent-mediated
Pre-School
PACT
13-month
childcare
productivity
informal
Clinically
1.91
£4,489
£1,385
0.788
ISRCTN58133827
Pregnancy
CSII
Present
maternal-fetal
thirty-four
n=14
hypoglycemic
mode
abortion
0.46
1.58
trimester
1.74
baby
founded
hypoglycemia
Fifty-two
CSA
AZA
observers
inefficacy
prematurely
anti-hypertensive
citalopram
CONTEXT
Selective
Health-sponsored
Mount
Sinai
Shore-Long
Island
Jewish
Carolina
Chapel
Hill
California
Los
Angeles
Yale
Dartmouth
forty-nine
9.4
Illness
compulsive
mg/5
Uniform
citalopram-treated
32.9
34.2
0.61-1.51
.99
-2.0
.81
Citalopram
impulsiveness
stereotypy
Registration
NCT00086645
conjunctiva
map
conjunctival
regions
noncontact
wearers
27.7
adnexa
cornea
bulbar
tarsal
Cochet-Bonnet
esthesiometer
0.12-mm
filament
eyelids
Bonferroni
adenocarcinoma
infusional
FU
CDDP
1,000
mg/m2/d
CDDP/FU
mg/m2
dominant
iliac
crest-donor
orthopaedic
crest
harvest
-loaded
microspheres
964
ng
638
366
lasts
dangerous
Experimentally
anaesthetic-loaded
interesting
Laparoscopic
Open
Hysterectomy
Without
Lymphadenectomy
Presumed
Early-Stage
Endometrial
ASTEC
increasingly
obese
1998-2005
presumed
1408
1309
60-150
60-95
harvested
10-16
11-13
0.67
0.31-1.43
requires
Deliberate
hypothermia
craniotomy
enthusiasm
deliberate
rewarming
normothermic
hypothermic
Tympanic
isoflurane-fentanyl-N2O-O2
Normothermic
36.5-37.0
cooled
drift
blankets
convective
heating
cool
rewarm
34.3
Cooling
C/h
Rewarming
0.1-1.8
Hypothermia
normothermia
.45
35.8
37.1
shivering
37.3
.029
intraoperatively
attain
valociclovir
Opioid-immune
chemical
messengers
neuroimmune
axis
infantile
determinations
performances
NAL
DSM-III-R
BSE
subsets
T-helper-inducers
CD4+CD8-
T-cytotoxic-suppressor
CD4-CD8+
inversely
beta-endorphin
opioid-immune
Fondaparinux
pneumatic
5-9
6-8
all-cause
842
64.3
7/424
fondaparinux-treated
22/418
69.8
27.9-87.3
7/417
1/424
0.037
bleeds
10/635
1/650
equipotency
etidocaine
Ropivacaine
congenerate
mepivacaine
long-acting
statement
varicose
stripping
18-70
50-100
space
midline
L-3/4
interspace
Injections
remainder
positioned
supine
Analgesia
pin-prick
Bromage
blocked
L-1
dermatome
dermatomal
two-segment
174
340
428
12/20
Bupivacaine
...
checklists
ethological
playroom
15-minute
Skeletal-related
hypercalcemia
312
12-month
Prognostic
p53
node-negative
IBCSG
uncertain
poorer
Estrogen
ER
microarrays
TMAs
pathological
1113
chemo-endocrine
nuclei
immunohistochemical
80.1
880/1092
125/212
171/880
qualitative
express
allowance
luminal
non-luminal
subtypes
Interpretation
ACTRN12607000037404
ACTRN12607000029493
stem-cell
Sargramostim
Immunex
Corporation
Seattle
WA
12.8
cytotoxicity
progenitors
490
310/microL
550
350/microL
=.2
1030
580/microL
690
370/microL
=.004
500/microL
=.04
166,000
51,000/microL
151,000
45,000/microL
=.007
150,000/microL
=.0025
Episodes
antagonizes
actions
GH-deficient
crossing
IU/day
leucine
dependently
Postprandial
Protein
aggravate
attenuate
nonoral
Prostaglandin
E1
hypotensive
PGE1
100-150
ng/kg/minute
operative
pre-administration
pre-ejection
Noninfiltrative
transrectal
lidocaine-prilocaine
lidocaine-ketorolac
Periprostatic
PPNB
TPB
periprostatic
constitutes
neglected
perianal-intrarectal
PILP
US-guided
1:1:1
0-to-10
probe
VAS-1
VAS-2
MPP
unbearable
leaving
PSA
probe-related
sampling-related
1.47
0.39
0.65
0.94
1.54
1.02
1.82
probably
Lidocaine-prilocaine
noninfiltrative
administer
deserves
well-designed
telehealth
precipitates
myriad
socially
Participatory
electronically
algorithms
addressing
programmed
easy-to-use
Buddy
participatory
electronic
tele-messaging
affordable
Tension-free
inguinal
hernia
tension-free
esthetic
mini-invasive
Anyway
controversy
persists
recurrences
repairs
well-informed
monolateral
transabdominal
preperitoneal
TAPP
47+/-7
mesh
herniorrhaphy
45+/-6
Complication
5.26
4.68
Post-operative
post-hospital
convalescence
9.3+/-7.2
12.1+/-7
compromises
busy
job/sport
quantity
low-birth-weight
tyrosine
phenylalanine
Well
appropriate-for-gestational
gm/dl
bovine
caseins
F2
60:40
F3
18:82
F4
catabolize
Guatemalan
investment
1424
25-42
2002
2392
0-7
1969-77
villages
nutritious
atole
fresco
wages
0.16-1.17
meant
incomes
wage
investments
drivers
Altered
releasing
GHRH
microgram/kg
TRH
GHRH-induced
uremics
22.7
micrograms/l
uremic
habitual
post-peak
till
Uremic
PRL
TRH-induced
26.5
Again
abnormally
uremia
GHRH-
Unlike
GHRH-stimulated
TRH-stimulated
PRL/GH
dispersed
15-30
dispersion
impression
flattened
curves
hypersecretion
Leucine-enriched
mTOR
signaling
EAA+CHO
stimulate
mammalian
rapamycin
Providing
postexercise
leucine-enriched
EAA+CHOs
nutrient
immunoblotting
FSR
4E-BP1
Postexercise
S6K1
Akt
eEF2
playing
Cardiology/European
Cardiology
Angiographic
Compression
lossy
Photographic
Experts
JPEG
playback
angiographers
25-sequence
CRs
6:1
10:1
16:1
Lossy
degradation
Caution
B-type
unmet
BNP
coordinated
Basel
323
Assignment
point-of-care
end-points
certainty
adjudicated
1655
850-3331
1541
859-2827
work-up
receiver-operating
0.81-0.93
volar
splints
hypertonus
hypertonic
wrist
flexors
spring-weighted
splint
intervening
Cefprozil
tonsillopharyngitis
cefprozil
409
V.
88.1
0.023
serotype
streptococci
91.3
87.4
68.4
beta-Lactamase-producing
phosphorus-restricted
phosphate-binding
Phosphorus
CKD
phosphorus-dependent
phosphorus
attenuating
CAC
non-dialysis
binder
End-points
36-month
confounders
appropriateness
non-dialyzed
concreteness
prose
depend
respects
importantly
clarified
contradictory
imageability
manipulated
between-subjects
depends
moving
listened
Potential
theories
enteral
fecal
elastase
Enteral
exocrine
feedings
low-birthweight
VLBW
Extremely
Heparin
hemolytic-uremic
1976
anuria
Protective
HD-MPA
MPA-Hematology
b.i.d
PR
23/46
13/47
antithrombin
Ag
alpha-2
macroglobulin
anti-thrombin
impede
tumor-induced
thrombophilia
antiviral
Lessons
HALT-C
fibrosis
virologic
IFN
peginterferon
alfa-2a
ribavirin
RBV
Ishak
1,046
Hepatitis
Antiviral
Cirrhosis
125,000/mm3
=125,000/mm3
HCV
determinant
optimize
difficult-to-cure
immature
puts
part-blinded
Preterm
12h
necrotising
NEC
31.9
25.4
P=0.392
P=0.002
Sertraline
sertraline
Adult
N=204
Impression
CGI
Marks
203
N=71
32.6
18.6
sertraline-treated
clonidine
Clobass
fifty-nine
'responders
checked
4-weekly
Non-responders
41.5
69.0
34.7
Withdrawals
Dry
clonidine-treated
Clonidine-related
qualities
disinhibition
prosocial
weaken
pleasure
getting
you
deserve
surprised
happening
topic
psychology
deserved
authority
coworker
push
accepting
unfair
rejecting
displeased
advantageous
indeed
reminding
past
inhibitions
fairness
unfairly
adopted
mindset
proself
orientations
mindsets
hookworm
Trichuris
oxibendazole
ascariasis
178
trichuriasis
anthelmintic
15mg/kg.d
3d
pyrantel
10mg/kg.d
Re-examinations
70.3-80.6
92.5-97.8
67.0-71.0
98.1-98.6
larval
Ancylostoma
duodenale
Necator
americanus
77.7
83.2
mentioned
parasites
73.5
90.0
98.8
29.7
7.9
Compare
Ethics
g.
Spinal
5-minute
cold
pinprick
T4
Levobupivacaine
olanzapine
2-year
LAI
Outpatients
psychotic
Syndrome
405
mg/4
Dosing
150-405
5-20
psychiatrically
nonadherent
645
678
0.61
53.8
51.2
0.60
20.1
18.5
Postbaseline
post-injection
delirium/sedation
3-hour
precautionary
taping
verbally
movie
DAS
Spielberger
STAI
SPSS
multimedia
ATX
Slopes
2004-2005
=.043
hyperactive/impulsive
=.005
1.27
inattentive
=.053
d=
Impressions-Improvement
1-2
rehospitalized
multisite
methylphenidate
Continuous
pralidoxime
organophosphorus
pesticide
poisoning
oximes
pesticides
single-centre
anticholinesterase
Controls
Thereafter
weaned
ventilators
NCT00333944
drop-outs
24-26
risk=0.72
0.62-0.86
p=0.0001
ventilatory
g/h
organophosphorus-pesticide
mucociliary
chloride
sinusitis
Mucociliary
saccharine
132
Irrigation
prochlorperazine
headaches
migraines
Restlessness
akathisia
PC
.1
Prochlorperazine
restlessness
cytokines
proinflammatory
Sixty-seven
brevis
CD2
salivarius
subsp
salicinius
plantarum
tablet
Cervico-vaginal
TNFα
Neutral
sphingomyelinase
quantified
nearly
restore
Vaginal
eccentric-exercise-induced
bout
hamstring-stretching
strenuous
jogging
warm-up
SAS
CON
contraction
PHS
myoglobin
prestretching
poststretching
5°
10.8°
-4.1°
-5.7
-6.7
muscle-damage
lessened
helpful
GnRH
obstetrics/gynecological
specializing
PATIENT
S
Premenstrual
laparoscopically
21-item
HRSD
Hotellings
P=.02
manifesting
stop
Approaches
Stop
DASH
high-normal
Adults
120-159
80-95
higher=142
mmol/d
intermediate=107
lower=65
two-fold
1.4-2.9
Reducing
2.3-fold
1.7-3.2
DASH/lower
control/lower
Relationships
PROP
Taste
Phenotype
Receptor
Genotype
Replacement
Recommended
NRT
n-6-propylthiouracil
bitter
phenotype
supply
lozenges
non-tasters
cartridges
Unexpectedly
taster
Menthol
nonmenthol
Kendall
τ
.591
under-dosing
aversive
impacting
off-pump
IP
CABG
Thirty-two
LAD
two-vessel
occluding
2-min
3-min
vessel
troponin
CTnI
isoenzyme
MB
CK-MB
SVI
prohibited
inactivated
whole-cell
sonnei
Orally
vaccines
grown
BHI
broth
deoxycholate
SsWC
formalin
inactivation
pre-clinical
sonnei-induced
keratoconjunctivitis
guinea
pig
LPS
IpaC
4-fold
vaccinated
Antibody
antigens
rises
immunogens
trended
one-tailed
Equivalence
pennsaid
OA
622
radiological
McMaster
Universities
WOMAC
VA
PGA
-8.6
71.0
144.5
1700
-1.2
255
dryness
83/311
dyspepsia
Application
diclofenac-related
complaints
ball
volleyball
lighter
Tachikara
Volley
Lite
seventh-grade
tournament
pretest-to-posttest
16-day
intact
balls
pretest
underhand
serve
alleviates
restores
self-esteem
seek
mammaplasty
consideration
macromastia
conservative
RBDI
Raitasalo
Beck
p=0.04
electroacupuncture
Baihui
GV
Sishencong
EX-HN
Shenting
Benshen
GB
Yintang
Naohu
Naokong
Neiguan
scalp
Areas
86.7
three-year
sirolimus-versus
paclitaxel-eluting
stents
Three-year
MACE
MACEs
sirolimus-eluting
PES
169
190
0.374
0.368
8.60
3.25-22.76
TVR
9.50
3.07-29.44
saxagliptin
sub-maximal
metformin
uptitration
PROMPT
intensification
uptitrating
T2D
glycaemic
metformin-tolerant
add-on
SAXA-MET
two-step
MET-UP
NCT01006590
1c
HbA
Week
Exploratory
patient-related
5-dimension
Digestive
Status
DHSI
286
7.71
7.80
-0.47
-0.38
-0.10
-0.26
0.260
43.8
49.6
35.0
diarrhoea-predominant
+0.8
+7.9
dysmotility
+1.9
40-55-year-old
AGE
21-35-year-old
CTL
21-35-year-olds
afternoon
AFT
l-amphetamine
color-coded
Profile
POMS
Addiction
ARCI
stimulant
Opiate
constitutionally
aloofness
Panksepp
1979
arguments
vocalization
blocking
description
Naltrexone
crying
salty
spicy
foods
aggressiveness
smiling
Leboyer
Bouvard
Dugas
1988
Campbell
tranquilizing
ISOLDE
exacerbations
Double
751
P=0.16
0.99
P=0.026
P=0.0043
P=0.034
Fluticasone
489
6,890
non-black
Important
racial
0.93
pyridostigmine
myasthenia
gravis
Continuing
omitting
regards
Myographic
Medically
posted
thymectomy
Neostigmine
Vecuronium
trans-sternal
neostigmine
belonging
sexes
quicker
155
approx
T1
3/7
effect-97
approx.
Omission
predisposed
Determinants
Atherosclerosis
estrogen-induced
intima-media
IMT
enrolling
222
3.37
mmol/L
unopposed
micronized
17beta-estradiol
B-mode
on-trial
A1C
On-trial
jointly
explaining
Unopposed
RU
486
non-pregnant
42633-monodemethyl
42848-didemethyl
42698-hydroxymetabolite
Peak
ten-fold
42633
42848
42698
48-72
methyl
slowly
olmesartan
medoxomil
VIOS
Vascular
Olmesartan
renin-angiotensin
RAS
sympathetic
drive
beta-adrenoceptor
Remodeling
vessels
earliest
predate
JNC
-7
gluteal
define
biologic
morphologic
uncomplicated
ubiquitous
glomeruli
affording
end-organ
amphotericin
kala-azar
288
parasitologically
AMB
bw
bw/day
afebrile
parasitological
Ultimate
ultimate
rigor
GIT
Indian
minimise
unresponsiveness
Yohimbine
neurally
syncope
Pathophysiological
NMS
manipulating
outflow
tilt-induced
34+/-2
Vanderbilt
Syncope
CLO
YHO
EKG
MSNA
upright
tilt
tilts
NorEpi
prevented
Yohimbine-induced
raises
systemically
alpha-2a
utilised
ablation
2-tailed
Exact
Interferon
What
gonadotropin
microdose
rFSH
119
GnRH-agonist
retrieved
M2
Grade-1
embryo
13.1
15.3
money
Investigations
pharmacodynamics
racemic
Ketorolac
-warfarin
template
1.35
ketorolac-warfarin
levocarnitine
L-carnitine
mitochondrial
MATERIAL/METHODS
L-carnitine/kg
bodyweight/day
n=19
n=11
ATEC
TAM
FISER
/global
GRSEB
/patient
PRISE
-2.03
CI=-3.7
-0.31
-0.69
CI=-1.1
-0.06
free-carnitine
R2=0.23
P=0.046
R2=0.27
P=0.019
R2=0.20
P=0.047
protocol-compliant
mg/kilogram-bodyweight/day
imitation
subliminally
primed
pro-
non-
pro-socially
non-socially
speculate
TEACCHing
TEACCH
waitlist
formal
frame
reach
Hysteroscopic
morcellation
hysteroscopic
electrosurgical
polypectomy
1.5-100.6
35.9
52.0
-24.7
-7.6
unacceptable
NCT01509313
antiplatelet
amputation
gangrene
opposite
21.8
19.0
20.0
opposite-side
amputations
infarctions
noteworthy
cerebrovascular
strokes
attacks
regimen-related
pentoxifylline
transplant-related
BMT
PTX
xanthine
downregulating
-8
post-BMT
MSO4
15.7
mumol/L
82.4
103.9
graft-versus-host
11/25
12/26
Humoral
Controlling
alloimmune
tacrolimus/mycophenolate
mofetil
Tac/MMF
cyclosporine/azathioprine
CsA/AZA
antithymocyte
steroids
D0
D15
M12
IgM
–35
–26
B-cell
–5.9
–14.6
–34
Hypogammaglobulinemia
HLA-sensitized
6.7
p=0.5
non-sensitized
May
698
cytogenetics
translocations
11q23
French-American-British
FAB
M5
M7
=.03
M1
M3
youngest
=.01
Younger
=.002
=.5
=.003
=.06
complicating
PRoject
Ex-vivo
Vein
ENgineering
Transfection
PREVENT-IV
post-CABG
geographic
663
2,131
Post-CABG
.41
.08
catheter-tip
PO2
fabrication
Fabrication
intra-arterial
mechanically
138
laser-cut
non-reading
37.5
kPa
Drift
recalibration
calibrations
Scanning
micrographs
hole
purposes
Delayed
genomic
nongenomic
glucocorticosteroids
Glucocorticosteroids
rhinorrhea
itching
discriminations
affection
allergen
three-period
betamethasone
methylprednisolone
provocation
airflow
rhinomanometry
Itching
P=0.07
rsp
beneficially
pathophysiologically
detailed
ROMEO
rethink
Scarcity
expertise
patient-centred
everyday
reproducibility
Multicentre
=1
dietitians
videos
PRIMARY
3-monthly
waist-hip
bi-yearly
SECONDARY
QT
hypoglycaemic
clinico-pedagogic
competencies
hypoxemia
distressed
meperidine
suction
transcutaneous
O2
Newborns
sunitinib
castration-resistant
angiogenesis-targeted
mCRPC
docetaxel-based
PFS
873
584
289
futility
11.8
0.914
0.762
1.097
.168
0.725
0.591
0.890
asthenia
Frequent
treatment-emergent
lymphopenia
docetaxel-refractory
antiangiogenic
bacillus
Calmette-Guérin
Cree
sensitization
purified
Lymphocyte
Candida
PPD-SI
24.9
52.9
Can
menopause
2-group
menopausal
flushes
designated
tonic
Ch'i
site-specific
Sleep
Acupuncture
menopausal-specific
nonhormonal
educate
cystic
demand
CF
steadily
priori
counselors
making
asking
basics
peculiarities
IC
one-on-one
Starting
answers
multiple-choice
counselor
toe-brachial
TBPI
PTA
relate
restenosis
administering
glyceryl
trinitrate
GTN
technically
claudication
non-healing
balloon
arteriography
corresponded
Restenosis
Haemodynamic
Measuring
underestimates
reassurance
Overlay
Ref
resynchronization
implanting
deploying
Forty-four
advance
skin-to-skin
80.7
98.5
32.2
0.029
16.2
36.4
p=0.004
p=0.007
p=0.003
shortens
Ultracision
dramatically
Nevertheless
big
tumours
diathermy
cut
coagulate
dissector
cutting
coagulating
ultracision
looking
seroma
Pusat
Perubatan
Universiti
Kebangsaan
Malaysia
PPUKM
31st
EC
unpaired
χ2
Malay
axilla
489.5
188.1
mls
169.3
58.8
663.7
247.0
enable
Transcutaneous
appendicectomy
TENS
Consecutive
postappendicectomy
'placebo
Atrial
Mitral
auricular
dilated
atrium
homogeneous
restarted
remark
-21.5
+16.8
+8.4
depended
fruits
preschoolers
socio-economic
Porto
Alegre
RS
non-recommended
candy
chocolate
drinks
Poisson
p=0.024
p=0.033
high-sugar
p=0.014
acetazolamide
cystoid
macular
Behcet
CMO
uveitis
reverse
fundus
13-50
33.6
P=0.99
Acetazolamide
P=0.53
seemingly
14.1
12-23
0.0006
fimasartan/hydrochlorothiazide
fimasartan
-lowering
HCTZ
siDBP
≥90
mg/HCTZ
263
fimasartan/HCTZ
6.88±8.10
3.38±7.33
P=0.0008
8.67±9.39
5.02±8.27
P=0.0023
10.50±13.76
5.75±12.18
P=0.0069
13.45±15.15
6.84±13.57
P=0.0007
≥10
53.6
39.8
P=0.0359
11.79
antagonism
antagonistic
agonistic
saralasin
Pre-saralasin
290
Na+/day
Antagonist
Decreases
sarcalasin
antagonist/agonist
BEACOPP
dose-escalated
COPP/ABVD
advanced-stage
Hodgkin
Lymphoma
HD9
escalation
polychemotherapy
HD
variants
bleomycin
procarbazine
escalated
COPP
/doxorubicin
dacarbazine
ABVD
three-arm
IIIA
IIIB
rearranged
Escalated
G-CSF
irradiated
505
inferiority
FFTF
.034
resembled
'Senokot
soiling
laxative
Senokot
dual-axis
rotational
XPERSWING
gold
orthogonal
projections
Rotational
pre-set
rotation
visualization
93.1
41.7
50.9
mGycm
operators
Contrast
335.1
192.1
238.5
Environmental
enrichment
Enriched
rodents
compensate
attempted
3-12
olfactory/tactile
stimulated
Indeed
Sensorimotor
Leiter-R
Visualization
Reasoning
ameliorating
intent
5-19
ICD-10
Interview-Revised
Schedule-Generic
Checklist-Community
ABC-CV
parent-rated
amantadine-treated
clinician-rated
ABC-CVs
-2.1
.046
.076
Amantadine
acting
glutamatergic
Excimer
trabeculotomy
trabeculoplasty
open-angle
excimer
ELT
ab
interno
SLT
POAG
XeCl
Laser
emission
308
microm
trabeculum
frequency-doubled
q-switched
neodymium
yytrium-aluminum-garnet
532
adjacent
meshwork
mJ
53.3
P=0.35
qualified
26.6
P=0.5
.Mean
25.0+/-1.9
17.6+/-2.2
-29.6
23.9+/-0.9
19.1+/-1.8
-21
Perioperative
leucocytes
transfused
Packed
buffy
coat
filtered
leucoreduced
LD
697
Five-year
emphasis
63.6
65.3
27.8
27.9
non-transfused
59.6
72.9
24.3
Leucocyte
NSAIDs
pKa
acidic
inflamed
Anesthesiology
Jackson-Pratt
character
break-through
ultrasound-guided
photocoagulation
-guided
PLP
compressive
68+/-3
mean+/-SEM
71+/-2
nodule
2.8-26.9
Nodules
2.4-16.7
0.69-14.2
Energy
cosmetic
7/13
6/13
sub
hyperthyroidism
claim
belief
post-exercise
exercise-sleep
emphasising
25.2
Vdot
35.4
ml·
·
no-exercise
0.067
oxprenolol
disopyramide
beta-blockade
'serious
arrhythmias
473
dysrhythmic
beta-blockers
ventriicular
pharmocodynamics
porphobilinogen
deaminase
carriers
porphyria
porphyrin
autosomal
haem
biosynthetic
precipitated
reproductive
precursors
5-aminolevulinic
accumulate
excreted
replenishment
mouse
phenobarbital
phenobarbitone
biosynthesis
mimics
porphyric
9808
deaminase-deficient
=4
Part
Parts
titres
chromatography-tandem
concentration-time
instantaneously
transitory
proportionality
half-life
grounds
overt
sphygmomanometrically
pulsatile
modifiers
6,781
Dysfunction
beta-adrenergic
Over
61-month
1,582
1,397
covariates
1.10
JIA
Cross-sectional
Sociodemographic
1-day
Screen
Related
SCARED
CDI
CHAQ
12.13
2.92
11.27
1.59
0.000
0.29
0.37
0.41
sclerotherapy
staple
transection
esophagus
esophageal
varices
vasoactive
0.51
uncemented
press-fit
cups
cement
DXA
hips
THA
aseptic
loosening
cup
periprosthetic
osteolysis
socket
cementless
acetabular
acrylic
fluoride
Cemex-F
porous-coated
ceramic
Trilogy
gentamicin
Palacos
Spectron
Acetabular
ROIs
sockets
proximally
medially
Stepwise
high-pressure
Contrary
osteolytic
shielding
substantiate
amlodipine
besylate
SiDBP
eighteen
Fifty-seven
49.0
51.6
152.0
98.1
153.4
2-sided
-4
42/49
91.8
45/49
Compliance
97.4
97.1
flushing
edema
paresthesia
initiating
ART
LBM
A5224s
sub-study
A5202
1857
ART-naive
abacavir-lamivudine
ABC/3TC
tenofovir
DF-emtricitabine
TDF/FTC
efavirenz
EFV
atazanavir-ritonavir
ATV/r
two-sample
non-Hispanic
RNA
log10
copies/ml
233
cells/μl
post-randomization
3.35
P=0.02
P=0.15
P≥0.10
interventional
Concurrent
adaptations
college
CE
equilibrated
discernibly
HR/aerobic
-10.7
-9.1
-14.0
latin
capital
dot
o2max
-4.9
Integrated
-13.2
-12.6
60.0
discernible
compatible
complimenting
Zambian
cryptosporidiosis
Cryptosporidiosis
malnutrition
nitazoxanide-a
antiparasitic
drug-on
Cryptosporidium
cryptosporidial
Lusaka
Zambia
HIV
co-infected
serology
HIV-seropositive
HIV-seronegative
7-59
p=0.037
14-63
-34
p=0.041
Nitazoxanide
stratum
hematogenous
50-75
intra-
extrahepatic
haematogenous
answer
add
disadvantages
ISRCTN45066244
Probiotics
IgE-associated
cesarean-delivered
microbial
microflora
allergies
1223
propionibacteria
galacto-oligosaccharide
eczema
1018
891
Frequencies
52.6
29.5
41.3
43.3
atopic
25.1
probiotics
40.5
0.47
0.23
.035
allergy-preventive
bacteria
zeaxanthin
wolfberry
Gou
Zi
Fructus
barbarum
carotenoid
macula
degeneration
berry
Kei
Tze
richest
food-based
Berries
homogenised
skimmed
freeze
powdered
zeaxanthin-standardised
3-5-week
cannula
post-ingestion
Zeaxanthin
triacylglycerol-rich
peaked
9.73
sem
2.45
3.24
3.14
nmol
h/l
homogenisation
3-fold
'classical
berries
high-protein
energy-restricted
hyperinsulinemic
replacing
TEE
RQ
thermic
TEF
hyperinsulinemia
Parallel
MJ/day
lower-protein
LP
males/26
34-65
28-43
12-45
meal
7.9+/-0.6
6.8+/-0.5
719+/-106
kJ/day
energy-restrictive
protein-to-carbohydrate
platelets
CPB-platelets
/platelets
arterial-venous
PCO2
CA19-9
SPan-1
confirmation
TMs
carcinoembryonic
DUPAN-2
2006-October
fluctuation
TM
TM-PD
2007-October
TTP
RECIST
≥25
35/49
STARS
signalling
striated
Rho
link
transcriptional
ECC
CONC
myocardian-related
transcription
factor-A
MRTF-A
SRF
single-bout
exclusively
pSRF
Prolonged
Multiorgan
perconditioning
RIPerc
organs
ischemia-5-min
thigh
kidneys
one-way
128.68
102.56
172.33
184.38
96.4
73.8
121.5
89.6
0.032
458.2
264.2
545.1
349.0
0.048
36.6
hyperbilirubinemia
quitline
2010-2013
quitlines
Memphis
Tennessee
n=427
Caucasian
Proactive
counselor-initiated
Reactive
participant-initiated
biochemically-verified
salivary
cotinine
falsification
NCT00827866
JobTIPS
transition
Mind-based
guidance
job
16-19
Content
Delivery
non-nucleoside
transcriptase
CPCRA
058
FIRST
NNRTI
virological
1397
antiretroviral-treatment-naive
NRTI
n=470
n=463
three-class
n=464
AIDS-defining
mm3
two-class
NCT00000922
302
AIDS
HRs
0.79-1.31
0.80-1.41
0.66-1.37
0.56-0.78
1196
+234
+227
p=0.62
1.15
0.91-1.45
0.75-1.00
p=0.38
000
copies
100,000
p=0.26
discontinue
NNRTI-based
PI-based
Entomological
insecticide-treated
net
Myanmar
nets
ITN
coincident
entomological
abundance
biting
sleeping
surveys
catching
characterise
glands
dissected
anophelines
caught
sporozoites
4,824
anopheline
mosquitoes
916
3,009
pm
am
Anopheles
annularis
epiroticus
subpictus
maculatus
aconitus
vagus
1447/2837
bites
mosquito
outdoors
vectors
VLDL
apolipoproteins
CIII
Cholesterol
CARE
inconsistent
pravastatin
4159
VLDL-apolipoprotein
particle
apoCIII
apoE
VLDL+LDL
n=418
n=370
VLDL-cholesterol
VLDL-triglyceride
VLDL-apoB
interrelated
quintiles
=0.04
=0.02
=0.03
=0.6
Adjustment
LDL-
cisapride
transit
dysphagia
myenteric
plexus
67.3
Webster
Parkinsonian
Butorphanol
colic
butorphanol
analgesically
hallucinations
narcotic
narcotics
Relation
regurgitation
GISSI-3
echo
757
24-48
S1
S2
S3
S4
693
64.6
59.8
asynergy
40.9
ml/m
colour
10.2
stepwise
akinetic-dyskinetic
Matched-pair
all-polyethylene
metal-backed
osteoarthritic
knees
round-on-round
Apollo
cruciate
sacrifice
38.4
self-assessment
pending
Maintenance
wear
advocate
versatility
Montelukast
HSCT
constitution
EG
living-training
P=0.022
P=0.028
posing
cefuroxime
axetil
cefaclor
amoxicillin-clavulanate
suspensions
otitis
377
AOM
10-day
CAE
CEC
AMX-CL
otoscopy
tympanometric
Paired
diaper
rash
demand-control
caregivers
D-C
gathered
caregiver/patient
out-patient
Demand
patient-
caregiver-derived
linking
Principal
follicular-fluid
meiosis-activating
sterol
cumulus-enclosed
FF-MAS
bicenter
Third-level
referral
biology
genetics
laboratories
Endocrinologically
intracytoplasmic
FSH
IVO
oocyte
IVM
Retrieved
cumulus
complexes
0.1-20
Polar
body-extruded
processed
chromosomal
metaphase
spectral
karyotyping
situ
hybridization
probes
Giemsa
Oocyte
germinal-vesicle
aneuploidy
20-muM
1-10
30-hour
Variance
hyperbilirubinemic
gm/kg
salt-poor
exchanges
reserve
albumin-binding
r=0.87
RABC
sephadex
question-asking
robot
human-trainer
ABA
ABA-based
trainer
self-initiated
incisions
3M
Steri-Strip
Closure
subcuticular
Technological
innovations
coaptive
Wise-pattern
Key
signed
nonviable
mismatched
edges
Operative
Comfort
closures
0.142
0.903
2.6
0.014
permits
wounds
bicarbonate
N-acetylcysteine
radiocontrast-induced
protecting
contrast-induced
CIN
NAC
Contrast-induced
.007
.036
.059
Mehran
.043
Hydration
hydration
Single-use
toothbrushes
oscillating/rotating/pulsating
Oral-B
ProfessionalCare
7000
3D
Excel
3DE
toothbrush
Sonicare
Advance
Philips
Healthcare
single-use
examiner-blind
refraining
23-25
pre-brushing
Rustogi
Navy
Plaque
commercially
dentifrice
re-examined
post-brushing
examiner
59.0
59.7
51.8
surfaces
67.5
67.8
59.4
approximal
Utilization
Viozan
sibenadet
smoking-related
52-week
establishing
pre-trial
COPD-related
Subsequent
Voice
IVRS
30-day
minimized
year-long
Physicians
utilize
expensive
irrespective
trip
ninefold
gathering
advent
Bronchodilatory
obstuctive
within-patient
Atrovent
micrograms/puff
fumarate
Foradil
D.
puff
F.
spirometric
335.2
home-based
Low-intensity
back-strengthening
HYPOTHESIS
Back-strengthening
vertebral
lift
prone
antigravity
Isometric
Back
0.012
phlebectomy
amounted
blisters
teleangiectatic
matting
bruising
bandaging
persist
argued
Long
colonoscope
colonoscopes
cecal
scope
Asymptomatic
check-up
Buddhist
Dalin
Tzu
Chi
endoscopist
colonoscopic
CF-240I
PCF-240L
cecum
February
918
3.66
PCF
240L
96.9
71.7
73.4
5.75
3.18
6.26
3.30
Subgroup
5.50
2.93
2.90
6.25
3.68
Cecal
inspiratory
IES
mmax
duty
loaded
Borg
Either
34.4
22.2
electromyogram
EMGdi
transdiaphragmatic
Pdi
superimposed
twitch
relaxed
diaphragm
1-superimposed
twitch/Pdi
Biological
magnesium-vitamin
Nepafenac
Covariance
summarize
errors-in-variables
instances
multiplicative
examples
recourse
ignoring
wrong
true
unobserved
outlined
Antihistaminics
dystonia
non-diabetic
hypertriglyceridaemia
BIGPRO
re-evaluate
n=168
=1.7
=6.5
=140
=180
=90
=105
waist-to-hip
=0.95
850
Metformin
Apo
Tissue
electro-acupuncture
Electro-acupuncture
Tests
leukogenic
auxiliary
Deleterious
oestrogen
orchidectomy
ECG-testing
Oestrogen
polyestradiol
i.m
ethinylestradiol
p.o
inter-group
CH2
0.0005
CH5
depressions
oestrogens
argues
Big
cisplatin-based
'best
381
NoC
3-weekly
cisplatin/vindesine
mitomycin/ifosfamide/cisplatin
mitomycin/vinblastine/cisplatin
vinorelbine/cisplatin
PS
Complete
0.77-1.35
Non-adherence
MEMS
Medication
Aprex
Fremont
container
client
Frequency
self-report
forgetfulness
stringent
percentages
80-90
Electronic
aspirations
CB
pain-related
Hypnosis
preparing
CYBOCS
PDDs
Units
Psychopharmacology
RUPP
CYBOCS-PDD
Compulsion
0-20
medication-free
PDD
Reliability
intraclass
ICC
disruptive
3.86
.85
0.28
five-item
distinct
N-acetyl-beta-glucosaminidase
Tubulointerstitial
feature
DM
NAG
tubular
PTF
Proteinuria
NAG-creatinine
920
522
U/g
803
523
10.5
9.3
Conversely
progresses
tubulointerstitial
Lead-exposed
TLC
chelation
impairs
Lead-Exposed
lead-exposed
succimer
Baltimore
Cincinnati
Columbus
Newark
Philadelphia
micrograms/dL
lived
residence
26-day
three-point
1854
780
August
residences
Diverting
mesorectal
controversially
pilot-study
diverting
ileostomy
NCT00457327
sphincter-saving
termination
nonstoma
anastomotic
reoperations
ostomy
Sociopsychological
disparities
sociopsychological
multiethnic
IMCP
readiness
nontailored
informational
record-documented
postvisit
discussion
recommendation
1,164
ethnicity
49.3
27.2
Hispanic/English
Hispanic/Spanish
offices
Sacramento
Bronx
Denver
San
Antonio
Texas
Adjusting
ethnicity/language
previsit
-4.3
Hypoxic
senescent
T-lymphocyte
trafficking
T-lymphocytes
elucidates
hypoxia
phenotypic
n=10
normoxic
O₂
N-C
H-C
N-T
hypoxic-relative
H-RT
hypoxic-absolute
H-AT
min/day
CD8
bright
CD11a
KLRG1
molecules
compartment
co-stimulatory
molecule
CD28
Simultaneously
interleukin-4
myeloperoxidase
MPO
mobilizations
productions
pro-inflammatory
retarding
senescence
Ceftriaxone
ampicillin
chloramphenicol
meningitis
single-drug
cerebrospinal
Haemophilus
influenzae
meningococci
falls
colony-forming
bactericidal
antisecretory
gastroesophageal
reflux
extraesophageal
multichannel
intraluminal
MII/pH
PPIs
-receptor
RAs
symptom-free
85.4
n:19
n:16
11/19
PPI-treated
6/8
Nissen
fundoplication
5/16
31.2
1/11
10/11
7/10
Antisecretory
suburethral
microvessel
hematuria
MVD
angiogenesis
candidates
cystoscopy
hyperplastic
histopathologic
9.08
13.94
5.90
14.21
7.10
19.75
suppressive
Parenteral
Aggressive
acid-base
cysteine
Premature
or=32
or=1850
g/kg/d
Acidosis
ductus
arteriosus
PDA
urea
Gestational
Low-birth-weight
Careful
fluids
comorbidities
accretion
masks
PPV
round
Paykel
Laerdal
Royal
Alexandra
T-piece
resuscitator
resuscitators
mean±s.d
28±3
1210±448
5±3
7±2
25-38
24-46
P=0.40
4.9-8.9
5.2-8.9
P=0.69
flecainide
verapamil
flutter
mg/kg/10
mg/1
AFI
convert
Conversion
Transient
Verapamil
breast-feeding
Belarus
summarizes
exclusive
Promotion
Breastfeeding
PROBIT
cluster-randomized
WHO/UNICEF
Baby-Friendly
Initiative
17,046
breast-fed
Belarussian
affiliated
13,889
duplicate
triceps
subscapular
skinfold
thicknesses
clustering
hospitals/clinics
permit
inferences
mo
infancy
exclusivity
uncontrolled
Antibiotic
group-B
labour
Urine
4122
27-31
Group-B
recolonisation
formats
Bordetella
pertussis
DTaP
DTP
DT
kinetic
PT
filamentous
hemagglutinin
FHA
pertactin
fimbriae-2
imputed
non-cases
tree
EU
ml-1
18/27
15/49
Logistic
historical
agglutinating
multicomponent
fimbriae
PT/FHA
oftentimes
placing
uncooperative
Boston
peer
goggles
favorite
sunglass-style
eyewear
unable
handheld
portable
player
Venham
technologies
nondental
Stepping
Stones
Triple
Interims
Stepping-Stones-SPC-Multicentric
handicapped
Centers
SPCs
clinics/institutions
dysfunctional
stepping
stones
flavonoid
FLAVURS
validate
flavonoid-rich
flavonoid-poor
high-flavonoid
low-flavonoid
18-week
broadly
portions/day
0.015
flavonoids
0.035
non-starch
polysaccharides
carotenoids
implies
hands-on
cholecystokininA
sphincter
relaxations
distension
TLESRs
loxiglumide
CCKA
10-lumen
sleeve
assembly
LESP
swallow-induced
Loxiglumide
5.8-18.3
3.3-14.3
4.25-7.5
0.5-6.8
cavities
4.0-20.0
2.0-7.8
interfering
swallow-related
NO-aspirin
NCX-4016
proof
oxide-releasing
equimolar
Upper
endoscopies
gastroduodenal
TX
AA-stimulated
TXB
Mucosal
0.63
virtually
devoid
1.38
AA-induced
NO-donating
moiety
entity
cyclooxygenase-1
inhibitory
avoiding
multi-media
Le
Fort
graphic
efficiencies
15.48
268
Pathological
neoadjuvant
bevacizumab
MRI-defined
T3
resectable
noncomparative
RC
5-FU-RT
leucovorin
Folfox-4
bevacizumab-5-FU-RT
TME
pCR
Forty-six
39.5
0.906
fistulas
fistula
bevacizumab-Folfox-4
TRIALSGOV
IDENTIFIER
00865189
parotid
MZBCL
4500
cGy
TTF
sildenafil
Asian
erectile
Assess
co-morbidities
six-week
Singapore
fifty
Sildenafil
sildenafil-treated
Erectile
Function
IIEF
Thai
Malaysian
Singaporean
Placebo-Controlled
Killed
Bivalent
Whole-Cell
Cholera
Vaccine
Ethiopia
cholera
OCV
sanitation
epidemics
two-dose
Bangladesh
216
Vibrio
cholerae
O1
Asia
Haloperidol
schizoaffective
exacerbating
schizophrenic
HAL
2-13
13.1-24
24.1-35
Psychiatric
BPRS
111
REVIVE
Retrograde
Cell
end-stage
IHF
nonischemic
NIHF
aspirate
BMAC
31.1
p=.007
p=.035
p=.020
translatable
Infant
gm
sociodemographic
280
INT
surveillance
center-based
Stanford-Binet
Achebach
0.0003
heavier
conivaptan
1A
vasopressin
Arginine
Inhibiting
1a
/V
-2.6+/-0.7
-5.4+/-0.7
-4.6+/-0.7
-2.0+/-0.4
-3.7+/-0.4
-3.5+/-0.4
6-hour
Conivaptan
-11+/-17
68+/-17
152+/-19
176+/-18
mL/hour
functionally
Management
calcium-antagonist
vasospasm
48-hour
480
alternately
thin
endoscope
Attempts
thinner
endoscopes
routes
prototype
she
gagging
6/9
1/9
Thin-diameter
gastroscopes
Modifications
passage
Moist
Exposed
Ointment
MEBO
mono-center
dermaheal
ointment
Flammazine
partial-thickness
Wounds
alleviation
transepidermal
gr/m2/h
p=0.78
splinting
reconstructive
BRG
Natural
coral
33-patient
presplint
splinted
postsplint
nonsplint
DEBR
CPAL
desmodontometry
DDM
periotest
PTV
reproducible
afterwards
DDM-horizontal
microns
undisturbed
parecoxib/valdecoxib
scleral
buckling
valdecoxib
buckle
pro-drug
analyzer
scan
subretinal
Interim
achievable
LNH-84
1984
ML
vindesine
ACVB
teniposide
AraCVmB
forty-two
highgrade
unclassified
IIE
disseminated
tumoral
went
fibronecrotic
dying
septic
0.500
Exhaled
Nitric
exhaled
tension
inhale
mixtures
inspired
FiO2
chemiluminescence
detector
0.0012
ppb
Hyperoxia
behind
bond
dentin
etch-and-rinse
two-
three-step
self-etching
canines
instrumented
burs
posts
luting
resin
Duo-link
Aestheti
molds
All-Bond
TE3
rcp
Dl
One-Step
TE2
Tyrian/One-Step
Afterwards
CEJ
apex
push-out
universal
machine
EMIC
mm/min
Bond
two-way
adhesives
5.22
1.70
2.60
1.68
1.85
bonding
needing
restorations
beta-sitosterol
Beta-sitosterol
alpha-receptor
5-alpha-reductase
Drugs
plants
precise
Europe
phytosterols
Boyarsky
IPSS
beta-sitosterol-treated
-7.4
mL/s
30.4
39.9
65.8
pretreatment-elicited
Alone
Sign
Simultaneous
Presentation
Alternating
child-initiated
Regardless
frusemide
Diuretic
cor
pulmonale
ANG
pressor
vasoconstriction
hypoxaemic
N2/O2
SaO2
85-90
75-80
Pulsed
doppler
hence
PVR
dyn
cm-5
291
356
delta-PVR
hypoxaemia
vasculature
hypothesised
mesalamine
granules
Ulcerative
relapsing
remitting
mesalazine
MG
n=209
n=96
revised
Sutherland
SDAI
bleeding=0
6/end
Relapse
≥1
≥2
78.9
58.3
impairing
preteens
BIACA
Wood
al.
irrational
numerous
posttreatment/postwaitlist
PARS
28.6
valerate
Betamethasone
scrub-wash
enumerated
perioral
intravenous-intra-articular
tranexamic
TXA
tourniquet
grams
3h
drained
BT
allogenic
500.00
900.00
-525.00
-300.00
2.10
3.10
-1.60
-0.60
p=0.109
0.101
0.117
negligible
carbenicillin
purulent
AMP
Streptococcus
pneumoniae
Neisseria
meningitidis
incuding
1.60
mug/ml
0.45
/=75
mg/100
residua
punctures
sterilization
CB-treated
persistence
hemophilus
organisms
fermented
casei
Shirota
constipation-related
haemorrhoids
puerperium
Constipation
LcS
bottle/day
6.5×109
cfu
answered
PAC-SYM
PAC-QOL
P=0.013
P=0.043
P=0.031
habit
Residual
bleedings
real-world
298
Indications
drug-eluting
≥75
≤60
Minimal
Thrombolysis
Infarction
15.1
permanently
temporarily
cardiogenic
shock
Etanercept
longterm
etanercept
modifying
714
581
longest
3139
patient-years
rate=14.8
events/100
patient-yrs
rate=4.2
rate=1.0
rate=0.7
ACR20=73
ACR50=52
ACR70=27
DAS28
CRP
response=52
remission=37
167
Year
Doses
Durable
benefit-to-risk
horses
NaAcetate
alkalinizing
horse
physicochemical
NaAcetate/acetic
NAA
Jugular
exercise-conditioned
CET
CETs
ad
libitum
nasogastric
hay/grain
alkalosis
H+
TCO2
HCO3-
SID
Na+
Cl-
Atot
acidifying
Egg
alters
yolk
bioactive
PBMC
ATP-binding
cassette
ABCA1
leukocytes
carbohydrate-restricted
-30
eggs
EGG
yolk-free
substitute
SUB
lipopolysaccharide-induced
toll-like
TLR4
3-hydroxy-3-methyl-glutaryl
-CoA
raft
Together
-cyanidanol-3
Web-based
print-delivered
Internet
disappointingly
user
choosing
audience
mailing
Municipal
P=.001
P=.03
modes
NTR
2297
//www.trialregister.nl/trialreg/admin/rctview.asp
TC=2297
Archived
WebCite
//www.webcitation.org/65TkwoESp
esmolol
lidocaine-esmolol
blunting
rocuronium
Anesthesiologists
LE
116.1
121.9
4.4
92.9
P=0.465
SCHEDULE
totalling
3,760
rads
22-23
3,440
10-11
3,568
Selaginella
herbal
Selaginella-induced
radiosensitization
mucous
milder
imiquimod
reflectance-mode
confocal
Mohs
micrographic
Imiquimod
modifier
up-regulates
biopsy-confirmed
x/week
vehicle-controlled
Confocal
cleared
under-treated
Opiates
Non-steroidal
anti-platelet
Cyclo-oxygenase
welcome
dural
craniotomies
post-anaesthetic
Bedside
celiac
neurolysis
paramedian
needle-insertion
economical
comfortable
bedside
Paucity
single-site
double-site
USCPN
needle
20-mL
ethanol
unilaterally
mL×1
bilaterally
mL×2
bearing
Incidences
Ultrasound-guided
post-myocardial
Montreal
Attack
Readjustment
M-HART
Gender
433
=5
GHQ
mid-term
readmission
marginally
die
.087
readmitted
Post-myocardial
Panax
quinquefolius
ginseng
cancer-related
dose-finding
NCCTG
N03CA
2,000
Fatigue
vitality
Short
Form-36
Benefit
ninety
accrued
Nonsignificant
1,000-
2,000-mg/day
460-467
480-551
7.3-7.8
750-mg/day
10.5-14.6
1,000-2,000
Atherosclerotic
Warfarin
1300
569
0.40
0.91
nonvascular
P=0.05
1.04
1.48
P=0.83
Aspirin
Mar
1981
Sep.
1982
histopathology
histology
COF
Vincristine
Pingyangmycin
Bleomycin
A5
IM
ending
merely
5/25
keratinization
cancerous
epithelium
chemoprophylaxis
599
urological
160/800
trimethoprimsulfamethoxazole
infectious
21.6
Single-dose
determines
office-based
Third
Revised
Conners
abbreviated
Buspirone
helping
his
lone
PTCA
contraindication
10,000
radionuclide
ventriculography
repeat
restudy
Hospitalization
0.046
25,191
15,368
19,643
7,250
streptokinase-treated
Adjunctive
cast
loco
classico
positions
plaster
Colles
AO
immobilized
flexion-extension
dorsiflexed
carpus
pushed
2-7
accidents
ulnar
abduction
clenching
sagittal
inclination
zonisamide
epilepsy
Zonisamide
subanalysis
179
6-18
370.6
zonisamide-treated
overweight/obese
0.0007
48.4
65.6
underweight
one-third
Relief
opiates
appreciably
Nausea
Vancomycin
granulocytopenic
Antimicrobial
Canada-Clinical
747
ceftazidime
amikacin
vancomycin
gram-positive
bacteremias
CAV
gram-negative
.17
.009
.16
.82
.93
Antibiotic-associated
nephrotoxicity
Final
UKLG
LY02
CHOP
BEAM
NHL
457
Randomization
melphalan
attained
0.0008
Computer-navigated
lacks
computer-navigated
’
durability
survivorship
520
navigation
452
904
sixty-eight
eighty-eight
radiographically
Osteoarthritis
annually
Alignment
computernavigated
99.2
Sotalol-Amiodarone
Fibrillation
SAFE-T
fifty-five
sotalol
cardioversion
short-
beat/min
Cardioversion
nonobese
computer-tailored
youngsters
non-smoking
out-of-school
10-13
'Fun
Smokes
transformation
prompts
c-RCT
prompt
Information
pupils
letters
e-mail
Attitudes
expectations
Pupils
prompting
revisit
website
utilisation
Expectations
NTR3116
Stage
ovary
FIGO
intraperitoneal
radioactive
forty-five
expired
forty-eight
reexploration
Metastatic
june
december
continually
350
X2
1,05
0,01
Peripheral
phlebitis
heparin/hydrocortisone
hep/hc
infusate
hydrocortisone
mg/L
Infusion
hep/hc-related
Ultrasonography-guided
sheath
umbilical
BRSB
postanesthesia
PACU
ultrasonography-guided
observer-blinded
Tertiary-referral
FACES
Fewer
nonopioid
nonopioids
longer-acting
NCT01015053
subchronic
levocetirizine
diphenhydramine
accompany
antihistamines
interfere
Levocetirizine
sedative
word-learning
Sternberg
1,90
25.9
Mass
inoculation
situation-specific
group-administered
nonclient
rubella
no-practice
cope
encouraged
helminthosis
partial-budget
profitability
Debre
Berhan
station
highlands
anthelmintic-treatment
non-treated
protein-energy
yes/no
indigenous
Menz
n=40
Awassi
crosses
n=38
n=31
sub-clinical
Supplemented
mix
Anthelmintic-treated
drenched
fenbendazole
nematodes
triclabendazole
trematodes
gram
EPG
faeces
packed-cell
PCV
adult-worm
Actual
market
input
prices
profit
MP
non-supplemented
ETB
contemporaries
MP=ETB
profitable
fluoxetine
serotonin-receptive
examines
9.9+/-4.35
CY-BOCS
compulsion
532-nm
multispot
collateral
panretinal
nonproliferative
solid-state
GLX
PASCAL
symmetrical
sittings
200-mum
Pattern
40.33
J/cm
Average
1.43
4.53
0.33
Heidelberg
430
310
zones
25.08
22.08
23.16
17.14
tilmicosin
drying-off
IMI
Cows
dairy
herds
geographical
Canada
248
938
bacteriologically
summarized
coagulase-negative
staphylococci
housed
tie-stall
barns
parity
somatic
SCC
DHI
blanket
managing
Icosapent
Ethyl
Eicosapentaenoic
Acid
Ester
High-Sensitivity
C-Reactive
Lipid
icosapent
ethyl
IPE
high-sensitivity
hsCRP
grams/day
MARINE
≥500
≤2000
ANCHOR
≥200
n=204
n=645
P=0.0003
78.0
statin-treated
P=0.0035
n=16
non-high-density
non-HDL-C
ApoB
P=0.0015
raising
21.7
P=0.0236
P=0.0053
Relationship
sCD44v6
TCM
weitai
CD44v6
Weitai
WTC
typing
Pi-deficiency
damp-heat
anti-metastasis
integrate
DCCT
succeeding
EDIC
begun
narrow
=.09
aiming
practicable
cerivastatin
podocytes
glomerulonephritis
podocyte
CGN
hypercholesterolemic
40.8+/-14.4
non-IgA
1.8+/-0.6
0.8+/-0.4
1.6+/-0.6
0.9+/-0.4
cells/ml
Statins
lamivudine
stavudine
134678-17-4
3056-17-5
analytes
test/reference
In-transformed
0-t
0-infinity
Past
memorizing
picture-pitch
melodies
musical
savants
fine-grained
psychoacoustic
devised
musically
same-different
high-low
categorization
Mottron
Burack
outperform
Administered
Computer-assisted
computer-assisted
CAI
lecture-based
immunodeficiency
Sexuality
Lecture
lecture
constructs
MANCOVA
Hoc
utilized
disclosed
self-evaluative
CAI-based
moderators
rerun
Situations
HSQ
Hyperactivity/Noncompliance
Candidate
moderated
Antipsychotic
once-a-day
t.i.d
serotoninergic
indiscriminately
Intraocular
'Diprivan
thiopentone
non-barbiturate
Apnoea
SPAF-I
SPAF-II
1.3-1.8
2.0-4.5
715
CI-0.4
CI-1.7
inherent
Ongoing
Telmisartan
Endpoint
ONTARGET
angiotensin-receptor
blockers
ARBs
ACEIs
telmisartan
non-inferior
ACEI
high-quality
noninferiority
Tromethamine
buffer
modifies
depressant
permissive
ARDS
ventilator-induced
THAM
Pa
pH-corrected
pH-uncorrected
transesophageal
Permissive
buffering
realized
hypercapnic
MMX
Lialda
Shire
Pharmaceuticals
LLC
Wayne
delayed-release
Asacol
Warner
Chilcott
Dublin
Ireland
active-control
826
83.7
-3.9
-5.0
P=0.5116
P=0.5455
FDA
panitumumab
Vectibix
U.S.
granted
approval
Amgen
Inc.
Thousand
Oaks
receptor-expressing
fluoropyrimidine-
oxaliplatin-
irinotecan-containing
submission
panitumumab-treated
rash/acneiform
hypokalemia
curative
fixed-point
vertigo
spasm
RI
atlantoaxial
ADI
dialectical
2.75
neck-shoulder
nausea-vomiting
noises
0.48
0.32
0.59
5.68
3.12
1.86
3.25
1.64
1.79
0.52
4.50
Fixed-point
oppression
ischemia
vestibular
labyrinth
eliminate
peptidase
minocycline
enzymatic
ANIMALS
Beagles
PROCEDURE
dog
Peptidase
Bleeding
gums
noticeably
thiopentone-vecuronium-isoflurane
nitroprusside
trimetaphan
camsylate
obtunded
Mebendazole
enterobiasis
Amiprilose
amiprilose
immunomodulatory
flared
propoxyphene
napsylate
swollen
erythrocyte
sedimentation
sole
Synthetic
carbohydrates
less-affected
MTLA
Poststroke
less-severe
ipsilesional
occupational
28.76
neurophysiological-based
Affected
Brunnstrom
BRS
FMA
dexterity
MMDT
Purdue
peg
board
PPBT
Testing
MMT
Postintervention
Intraperitoneal
8-year
55875
pathologically
debulking
153
violations
P.S
serous
residuum
Port-a-Cath
Tenckhoff
neurotoxicity
0.59-1.33
0.52-1.29
suggestive
cholinomimetic
SDZ
ENS-163
scopolamine-induced
Scopolamine-induced
placebo/intravenous
ENS-163/intravenous
placebo/0.4
ENS-163/0.4
Computerized
Neuropsychological
Battery
CNTB
salivation
indistinguishable
placebo/scopolamine
ENS-163/scopolamine
muscarinic
cicloxilic
bile
gallstones
gallstone
endowed
choleretic
Bile
siphonage
caerulein
salts
biliary
lithogenic
Cicloxilic
litholytic
low-dosage
all-norgestrel
Latin
dl-norgestrel
0.075
estradiol-17
242
246
fifth
spotting
inactive
re-biopsied
pyruvate
vasomotor
clinical-biological
mg/die
TAM/MPA
post-menopausal
antiestrogen
Metrorrhagia
thrombophlebitis
PgR
8/11
N-desmethyl
TAM-MPA
n3
FAEE
12-wk
WL
Omacor
DHA
WL+FAEE
Large
C1
C2
-3
-25
HOMA
-12
+9
adiponectin
+18
-5
-36
+3
+6
+22
TGs
FAEEs
parasuicide
POPMACT
cognitive-behaviour
MACT
personality
Variation
policies
seeing
self-harm
Parasuicide
latest
allopurinol-controlled
febuxostat
TMX-67
non-purine-selective
oxidase
hyperuricemia
gout
Febuxostat
12-day
-40.75
-34.41
closing
82.0
70.0
0.019
213
11.6
ruled
hypouricemic
lactating
fortification
flour
reproducing
dramatic
NTD
-affected
RBC
NTDs
well-educated
university-educated
cut-off
NTD-risk
906
correctly
quartile
151-410
410
Folate
maximizing
small-cell
whole-brain
SCLC
Whole-brain
WBRT
becomes
questionable
Teniposide
combined-modality
teniposide-alone
P=.005
P=.087
Abnormal
synaptic
connectivity
etiologies
PAF
checklist
mA
postsession
health/behavior
Novel
noncompartmental
Iron-containing
non-linear
SFGC
sucrose
GeneraMedix
Ferrlecit
Watson
Laboratories
n=240
n=29
transferrin-bound
post-dose
PK
PPK
ADAPT
5®
area-under-the-curve
AUCpred
Cmaxpred
ln-transformed
Ratios
baseline-corrected
AUC0-36
100.4
96.5
104.5
99.7
94.2
105.5
82.7
91.1
92.4
85.6
multi-compartmental
89.9
85.9
94.0
89.7
93.9
BE
Anaerobic
cefoxitin
clindamycine
eradicating
offending
anaerobes
tramadol-ropivacaine
fentanyl-ropivacaine
mg/mL
g/mL
ug/mL
Hemodynamics
instrument-assisted
Umbilical
PCO
0.026
Birth-weight
PO
Complaints
enflurane
enflurane/alfentanil
flunitrazepam
N2O/30
Balanced
caesarean
exteriorisation
exteriorization
obstetricians
Havana
Specialist
Lagos
chi
Fischer
exteriorized
0.009,0.048
0.028
inexperience
Dose-related
cytomegalovirus
foscarnet
Protocol
915
Team
reflects
retina
destroyed
weight/day
FOS-90
FOS-120
photographs
pre-established
definitions
foveal
proximity
enlarged
43.5
microns/day
.002
fovea
42.8
.010
32.3
.031
gastrin
pentagastrin
0.062
microgram/kg/h
surmounted
Oxo
Zollinger-Ellison
transmembrane
flux
ions
radiofrequency
ligation
RFA
GSV
incompetence
saphenofemoral
disconnection
patient-based
obliteration
above-knee
67-84
39-54
4-21
0.50-4.30
2.35-6.05
HBI
postdischarge
0.80-1.35
unplanned
0.86-1.24
677
readmissions
824
1.20
readmissions/patient
readmission/patient
surviving
0.64
1.26
1.61
823
dollars
1642
960
1376
.045
dezocine
fentanyl-induced
μg/kg
1-1.5
suxamethonium
tetanus-diphtheria
chloroquine
primaquine
Immune
drug-vaccine
Td
Prophylaxis
Anti-tetanus
anti-diphtheria
Immunization
anti-tetanus
pre-Td
unvaccinated
Geometric
delavirdine
mesylate
didanosine
Delavirdine
nonnucleoside
pH-dependent
HIV-infected
CD4+
304
213/mm3
three-way
Didanosine
buffered
7.22
3.51
infinity
AUC0
microM.h
N-dealkylation
N-dealkylated
0.708
Reductions
4.65
7.93
6.54
10-month-old
no-intervention
experimenter
talked
attenders
interacts
Pre-operative
evenly
Normal
220.0
12.9
324.3
84.3
218.0
260.5
844.0
147.4
1100.0
158.1
830.0
117.4
1090
etoposide-based
lymphoblastic
ALL
R15
epipodophyllotoxins
frontline
L-asparaginase
Etoposide
single-agent
P=0.016
84.4
P=0.025
+/-se
52.0+/-9.6
20.0+/-8.0
cytoreductive
Overexpression
VEGF
KDR
VEGFR-2
neovascularization
VEGF/VEGFR-2
VEGFR-1
staining
=0.024
=0.040
=0.566
0.609
leukemic
constitute
Tetracaine
ametop
palivizumab
synagis
immunizations
tetracaine
Topical
pain-reduction
Pentraxin-3
CORONA
GISSI-HF
PTX3
innate
debated
1457
Rosuvastatin
Multinational
GISSI-Heart
N-terminal
pro
NT-proBNP
Q1-Q3
5.34
3.55-7.64
2690
759
1.12-1.30
587
1.17-1.38
Three-month
call
NCT00336336
NCT00206310
-hyoscine
amylobarbitone
post-rotational
turning
nystagmus
Kirschner
wires
locking
dorsally
DRAFFT
Radius
Fracture
wire
K-wire
locking-plate
dorsally-displaced
assessor-blind
Kingdom
460
implants
K-wires
£714
588
ICER
£89,322
Sensitivity
£30,000
'cost
saving
Methylprednisolone
Markers
carcinogenesis
white-cell
pre-treated
RCC
416
362
neutrophil-lymphocyte
discriminatory
C-statistic
0.673
0.654
appropriately
Cyclosporine
P-glycoprotein
CML-BP
multidrug
Pgp
Southwest
modulator
CsA
Seventy-three
CR/CP
Blast
LRP
=.025
rhinosinusitis
CRS
longer-term
Short-Form
post-functional
visitfrom
Eighty-nine
59.3
40.7
norms
categories
normative
Intramedullary
plating
extra-articular
articular
Sonoma
Wrx
Orthopedic
Products
Santa
Rosa
A2.2
A2.3
A3.1
C2.1
C2.2
Radiographic
36.81
7.11
48.97
5.45
5.70
Device
reveals
TOF
RV
M-mode
semisupine
isovolumic
force-frequency
mL/m
Detailed
long-axis
postsurgical
pathophysiology
begins
subtle
interlinked
excitation-contractile
coupling
EICESS-92
Ewing
sarcoma
standard-risk
Sarcoma
dactinomycin
VAIA
VACA
or=100
EVAIA
EFS
647
252
1.53
1.08
2.03
-35
.12
.84
Cyclophosphamide
Sulfasalazine
Radiation-induced
Eicosanoids
OBJECTlVE
radiation-induced
500-mg
Tissue-Subjective
Analytic
LENT-SOMA
table
histopathologically
3/15
10/16
aging
GABA-mediated
intracortical
GABAA-mediated
underlie
lifespan
interdependence
motorcortical
network
Double-pulse
dpTMS
short-interval
SICI
right-handed
covering
20-88
47.6
visually
dexterous
Weak
resting-state
demanding
Declining
weakened
modulatory
reflecting
malfunctioning
GABAAergic
neurotransmission
consequence
inevitable
lipotoxicity
{
}
-cell
ketosis-prone
Americans
ketoacidosis
DKA
go
near-normoglycemia
KPDM
beta-cell
ketosis
ketosis-resistant
intralipid
ml/h
beta-Cell
AIR
arg
microU/ml
fourfold
FFA
48-h
Near-normoglycemia
decompensation
670
adjusted-dose
venograms
417
211
51.7
206
Cl
-7.2
334
336
Prenatal
security
ethnic
minority
217
Mothers
Attachment
unwanted
fills
shaping
urokinase
thrombolysis
rt-PA
alteplase
Intra-arterial
IAF
pro-urokinase
PROACT
fulfilling
900,000
monocentre
Rankin
haemorrhage
SIH
Authorities
oedematous
IA
4:16
5:24
conclusive
p16
INK4a
intraepithelial
neoplasia
Spontaneous
CIN2
recognized
1955
Brazilian
paraffin-embedded
CIN3
CIN1
ASCUS
undetermined
signifiance
68.9
-negative
-positive
0.6-2.0
compliant
sarpogrelate
monocyte
chemoattractant
protein-1
Sarpogrelate
thiazolidinedione
arteriosclerosis
obliterans
albumin-to-creatinine
advertisement
Norway
PE
PE+SE
16-month
P=0.011
-0.64
-0.35
-0.77
-0.30
-0.29
-0.67
-0.48
-0.91
-0.02
-0.93
three-session
NCT00319423
moreover
cardioplegia
Surgery
post-ischaemic
ultrastructure
carnitine
ATP
papillary
Glycogen
septal
weaning
extracorporeal
nucleus
sarcoplasmic
reticulum
mitochondria
ultrastructural
well-compensated
haemodynamically
chlorambucil
alfa-2b
Non-Hodgkin
Alpha
MU
/m2
62.1
64.7
thoracoscopy
talc
poudrage
pleurodesis
slurry
TAPPS
pleural
effusions
MPE
Various
Talc
conflicting
methodologically
flawed
suitably
ANALYSIS
bore
Fr
Seldinger
sterile
Pleurodesis
ETHICS
DISSEMINATION
ethical
West-Preston
12/NW/0467
steering
peer-reviewed
journal
conferences
charities
wish
publication
ISRCTN47845793
obsessive
6-
follow-ups
1.06-1.24
ds=
-0.13
-0.12
sparing
rule
empagliflozin
78-week
insulin-treated
≤10
≤86
mmol/mol
glargine
detemir
NPH
170
-0.1
-6.2
-0.7
-7.8
35-36
Empagliflozin
accommodate
remediate
Therapists
parent-training
78.5
3,583
Pravastatin
Minor
conferring
post-MI
Risperidone
destructive
longer-duration
8-56
mean=22
22-week
57.5
Irritability
87.5
antiseizure
MR.
Flutamide-metformin
ethinylestradiol-drospirenone
lipolysis
antiatherogenesis
hyperandrogenism
flutamide
flutamide-metformin
dysadipocytokinemia
polycystic
drospirenone
progestin
antiandrogen
fourth-generation
d/month
pulsatility
normalizing
ovaries
herewith
hypoadiponectinemia
hyperresistance
DUP
First
Episode
Psychosis
FEP
drug-naïve
1month
6months
Underlying
prodrome
disorganisation
Onset
SOS
inventory
mixed-effect
dichotomised
DUNS
DUPS
pre-attentional
shorten
11betaHSD
11beta
hydroxysteroid
48-66
11betaHSD1
11betaHSD2
Abdominal
adipose
Glucose
disposal
GDR
euglycaemic-hyperinsulinaemic
clamp
GH-treated
transiently
exemestane
Tamoxifen
Exemestane
1,614
receptor-positive
repeatedly
7,286
bone/muscle
aches
.0004
Iloprost
iloprost
vocal
actors
Randomly
ringing
overtones
kHz
Fundamental
F0
SPL
long-term-average
LTAS
trainers
Sound
1.5-14.5
BF
tighter
adduction
danger
hyperfunctional
PIN
suspicious
LSPC
rounds
ERSPC
56,653
Finland
Italy
database
re-biopsy
33.8
inter-observer
screening-related
a.o
ageing
abstain
re-biopsies
reassuring
GH-binding
2-phase
Recombinant
sc
bedtime
GHBP
ligand-mediated
immunofunctional
RIA
acid-ethanol
truncated
radioligand
Lean
TBW
bioelectrical
-12.5
-4.5
GH-induced
Psoriasis
Grenz
rays
ray
psoriasis
followed-up
reactogenicity
diphtheria-tetanus-acellular
pertussis-hepatitis
B-inactivated
polio
poliovirus-Haemophilus
DTPa-HBV-IPV-Hib
One-half
DTPa
HBV-IPV-Hib
1/2
DTPa-IPV-Hib
HBV
seroprotected
diphtheria
Hib
poliovirus
vaccinee
HBV-HPV-
92-97
post-vaccination
=37.5
HBV-
IPV-Hib
Raw
age-equivalents
norm
age-equivalent
thrombi
platelet-inhibitory
111Indium-labelled
Dacron
grafts
DPM
labelled
re-injected
thrombogenicity
emissions
femoro-popliteal
labelling
aorto-femoral
quantitated
Caregiver-mediated
low-resourced
preschool-aged
Housing
Urban
caregiver-mediated
CMM
blepharitis
eyelid
etiologic
AzaSite
Inspire
Inc
compresses
compress
debris
redness
meibomian
plugging
secretions
biomicroscopic
Dexamethasone
bony
types/sizes
Periotest
Osstell
peri-apical
dehiscence
dehiscences
Periotest/Osstell
enlarge
Osstell/Periotest
6-mm-long
perimeter
3-mm-wide
peri-implant
destruction
hyperintensities
geriatric
periventricular
subcortical
hyperintensity
gray
early-onset
late-onset
implicating
MDM2
Ki-67
92-02
regulates
apoptosis
STAD
Adequate
478
PSP
per-sample
MIS
Fine
Gray
cause-specific
CSM
.0007
P53
cell-derived
microparticles
retransfusion
Pericardial
retransfused
discarded
Microparticles
T2
cytometry
bound
C1q
C4
C3
amyloid
P-component
SAP
immunoglobulin
Ig
Fluid-phase
C4b/c
C3b/c
microparticle-bound
Concentrations
fluid-phase
Retransfusion
nefazodone
antidepressants
Nefazodone
17-item
HAM-D-17
-12.2
-7.7
nefazodone-treated
.021
.017
.004
Montgomery-Asberg
HAM-D
dysthymia
491
503
discontinuing
synbiotic
paracasei
B21060
arabinogalactan
xilooligosaccharides
3-36
outputs
Resolution
90.5
78.1-102.9
109.8
96.0-123.5
0.040
2.8-3.8
1.9-2.8
0.9-1.6
0.4-0.9
Rate
41.8
15.4
10.9
ACTRN12611000641998
anaplastic
semustine
Gradual
phenomena
pseudo-withdrawal
passive-dependent
traits
chemistries
month-long
NTX
contrasted
PLC
conjoint
Massively
C-terminal
adrenocorticotropic
arginine-vasopressin
clearest
C-terminal-beta-endorphin
carry-over
pro-opiomelanocortin
Kasari
8-10
pointing
cross-lagged
panel
causal
Optimization
adenotonsillectomy
mannitol
YM17E
acyl
coenzyme
transferase
acyltransferase
3-300
Unchanged
M2-a
M2-b
M4
fasted
post-prandial
Cmin
48.6
ng.ml-1
166.6
Diphtheria
antitoxin
ago
I.U./ml
unprotected
serological
flying
VRE
FOF
wait
list
Seventy-five
Twenty-three
airplane
airport
fly
flight
self-ratings
world
Blockade
hormone-releasing
dissociates
slow-wave
non-rapid
NREM
SWS
inducer
corollary
whereby
antagonized
20-33
N-Ac-Tyr
D-Arg
GHRH-29
NH
12-h
2100
0900
0700
montage
2300
chemiluminometric
93+/-1.8
P=0.012
Polysomnography
P=0.607
quantifiable
indispensable
4-month
Week-8
22-month
immunoradiometric
dopamine
type-2
DRD2
39.0
19.2
Prolactin
17.8
25.3
Taq1A
-141C
Ins/Del
C957T
risperidone-induced
four-fold
emesis-free
Granisetron
postsurgery
Disruptive
Emory
Indiana
Ohio
Pittsburgh
267
2014
boosters
Checklist-Irritability
0-45
Questionnaire-Autism
0-9
1-7
23.7
16.3
-1.7
0.62
prespecified
Impression-Improvement
68.5
NCT01233414
flourishing
appraisal
exploiting
noisy
forcing
speeded
guess
traced
capability
saccades
emerges
mature
MT
phenomenic
sense
Retroinfusion-supported
myoprotect
retroinfusion-supported
main-stem
main-stem-equivalent
angioplasty/stent
pressure-regulated
retroinfusion
Parsonnet
Twenty-eight-day
Event-free
52.3
9,346
807
26,874
3,985
stored
Latanoprost
Xalatan
dark
Slit-lamp
biomicroscopy
intra
vice
versa
Eyes
IOPs
subtracted
bottle
ROS
-independent
80-mg
LVMI
Formation
gated
BP-independent
ofloxacin
otic
neomycin-polymyxin
B-hydrocortisone
suppurative
poses
discharging
ears
quinolones
revived
sensitivities
Gram
eardrops
two-week
ototoxicity
Pathology
Subgroups
positivity
subdivided
histological
effecting
MATERIALS/METHODS
564
Proliferation
ductal
lobular
mirror
Grandin
Hug
Machine
self-administration
disengaged
Arousal
behaviorally
physiologically
galvanic
GSR
calming
distraction
chemotherapy-related
endure
head-mounted
Sony
Glasstron
S700
encompassing
Distress
Piper
SAI
pre-test
mounted
cybersickness
pindolol
labetalol
Considerable
+/-2
dreaming
multiplane
biplane
Images
three-grade
oesophageal
LOSP
transducers
predominated
Midazolam
gynaecological
hysteroscopy
ureteroscopy
fibrates
atherogenesis
PAI-1
vonWillebrand
E-selectin
glutathione
Fenofibrate
malondialdehyde
P-selectin
interact
prescriptions
aids
Assistance
Publique-Hôpitaux
Paris
prescribing
1,469
over-prescriptions
guideline
0.1-0.8
under-prescription
anticoagulants
Multitargeted
expenses
Cariprazine
mania
flexibly-dosed
cariprazine
manic
3-12mg/day
n=158
n=154
Mania
YMRS
Impressions-Severity
P=0.0004
postbaseline
≥50
58.9
44.1
P=0.0097
score≤12
51.9
P=0.0025
P=0.0027
cariprazine-related
TEAEs
SEEDS
categorical
64+/-17
presumptive
patient-hospital
Actuarial
P=0.30
P=0.72
benchmark
irritable
IBS
biweekly
audiotapes
Rectal
barostat
conductance
forehead
Somatization
sweat
somatization
describing
precancer
Squamous
Cells
Undetermined
Low-Grade
Intraepithelial
Lesion
LSIL
Triage
ALTS
equivocal
Pap
608
PCR-based
ranked
hierarchically
HPV16
carcinogenic
noncarcinogenic
601
95.4
59.9
HPV31
18.1
HPV52
HPV51
HPV18
multiparity
HPV16-positive
Kruskal-Wallis
disagreement
reviewers
multiparous
IMPACT
permitting
anaesthetics
venepuncture
EMLA
Ametop
IGOH
840
2-17
rigorous
casts
doubt
exert
etiological
Dose-response
intermediate-stage
nonbulky
IF/BF
noninvolved
extended-field
EF/IF
mediastinal
massive
spleen
HD1
HD5
146
Bulky
Freedom-from-treatment-failure
SV
20-
30-
40-Gy
destined
Lidocaine
warning
beta-blocking
asystole
culture-specific
breastfeeding
Vietnamese
Sydney
immigrant
counteract
prenatal
sustain
gastrectomy
pouch
Longmire
interposition
BACKGROUND/AIMS
Longmire-Interposition
Roux-en-Y-reconstruction
Roux-en-Y
connected
atrioventricular
BiV
intraventricular
post-atrioventricular
AV
Node
Ablation
CLS
Pacing
Therapies
AVAIL
CLS/CRT
Closed
Loop
Stimulation
BIOTRONIK
Berlin
2:2:1
Echocardiography
Ejection
insignificantly
Interventricular
dyssynchrony
post-AV
Coronary-artery
five-year
914
in-hospital
Q-wave
89.3
86.3
80.4
80.6
Stockholm
SWITCHD
thirty-seven
Initiated
restructuring
P=0.007
Introducing
calcium-channel
unadjusted
P=0.009
Osteocalcin
osteocalcin
3.45
4.42
1.39
ESR
26.4
mm/h
CRP-
-0.44
-0.45
Disopyramide
coumarin
1,2-benzopyrone
4-hydroxycoumarin
macrophage-dependent
50-mg
thick
TNM
coumarin-treated
actinic
keratosis
Actinic
Diclofenac
easy-to-apply
versions
0,001
17.4
3.15
non-blinded
p=0.09
p=0.827
Erythema
crusts
GAI-E
Ability
GAI
Tulsky
Saklofske
Wilkins
Weiss
6-subtest
premorbid
subtest
N=2,401
n=1,200
formulas
n=1,201
Validation
Subtest
GAI-Estimate
6.44
9.57
r=.76
r=.90
AMADEUS
Obesity
SR34006
Acenocoumarol
1588
18.5-25
n=515
25-30
n=711
BMI≥30
n=362
22.8
stroke/systemic
trend=0.01
0.11-0.77
n=814
1.21-2.80
anticoagulated
dose-intensity
lenogastrim
translocation
Consolidation
R3
COPADM
105-day
non-G-CSF
post-R3
post-COPADM
myelosuppressive
inappropriately
Myelosuppressive
erythropoiesis
recover
rHuEPO
zidovudine
AZT
cyclic
-40
Quality-of-life
rHuEPO-treated
1.65
diaphoresis
reversing
waited
SBIRT
Polish
drinkers
Sosnowiec
Poland
23-week
4:00
midnight
446
two-stage
blindly
reassessed
brief-intervention
furosemide
cotransporter
basolateral
1-9
seventy
Siena
instrumental
Multi-institutional
epothilone
ixabepilone
BMS-247550
estramustine
castrate
EMP
Grades
Post-treatment
declines
prostate-specific
ixabepilone-alone
Ixabepilone
Angiotensin
Suppression
up-regulation
AT1
enalapril
Forearm
plethysmography
fmol
replete
Patterning
Martha
Rogers
unitary
beings
Guided
sufferers
MET
sensitizer
NGT
40.3
insulin-resistant
WBISI
15.0
cardio-metabolic
Diode
prematurity
unfavorable
ROP
apnea
bradycardia
lid
Argon
ophthalmoscope
Retinal
diode
lasers
argon
ablative
symmetric
814/815
asymmetric
485
863
Postconceptional
transported
Apneic
cryotherapy-treated
skip
laser-treated
detachment
keratoses
AKs
precancerous
licensed
AK
dermatology
state-funded
comply
notice
Lesions
Clearance
vehicle-treated
erythema
induration
vesicles
erosion
excoriation
scabbing
aromatase
unresponsive
estrogens
androgens
regulators
estrogen-responsive
estrogen-unresponsive
androgenic
intratumoral
17β-hydroxysteroid
17βHSD5
5αRed1
5αRed2
AR
Ki67
CAAN
increments
whole-body
mild-cold
AIx
brachial
°C
Supine
climate
chamber
+2
0.36-4.36
1.24-10.1
in-flow
-15.4
+0.04
+0.36
-0.41
appliance
myofascial
TMD
creating
tender
masticatory
needlescopic
EBM
postnatal
babies
DW
Neonatal
Facial
Coding
NFCS
38.5
9.5-57.5
28-210
70.7
36.6-104.9
sooner
Befriending
inner
city
fresh-start
Volunteer
befriending
promoted
'fresh-start
Fresh-start
style
chances
stressors
liable
volunteer
artefact
profitably
lighting
discordance
2005-2009
Glaucoma
Eye
Clinics
Missouri
EXPOSURE
certified
examiners
binocular
DVA
nonbacklit
near
NVA
glare
matched-pair
triplets
Lighting
Vision
Knowledge
clinician-patient
discussions
homes
spiritually
non-spiritually
church-attending
modestly
Church-based
attend
church
Churches
non-spiritual
Trained
advisors
print
disproportionate
PLI
SCD
speech-language
SCIP
PROCEDURES
11-10
assistants
narrative
blind-rated
conversational
teacher-reported
parent/teacher-reported
6-11-year-old
Vertebral
Risedronate
VERT
1226
elemental
amendment
Lateral
nonvertebral
adverse-event
modulated
co-emitted
prepare
gaze
gesture
170ms
limbic
irrelevant
caries
topography
carious
Carious
excavation
bur
air-abrasion
chemomechanical
sono-abrasion
gold-coated
hand-excavated
bur-excavated
air-abraded
dentinal
tubules
orifices
chemo-mechanical
augmentations
22-36
Caregiver-child
regulation-JASPER
parent-only
PEI
researcher-parent
JASPER
f²
.69
diversity
NCT00999778
Fludarabine
graduated
stockings
LMWH
GCS
VTE
institute
LMWH+GCS
Altogether
Vs.
Dual
low-tube-voltage
detectability
HCCs
kVp
voltage
ASIR
HIPAA-compliant
9-month
40-85
iodine-load
tube-voltage
milligram
kilovolt
600-120
500-80
400mg/kg
400-80
signal-to-noise
SNR
HCC-to-liver
contrast-to-noise
CNR
figure
FOM
receiver-operating-characteristic
3.3-4.1
mSv
Iodine
quinolone
antiseptic
arrhythmogenic
P-wave
durations
Signal-averaged
Electrocardiograms
averaging
bandpass
0.8+/-0.3
1.1+/-0.2
saliva
6.6+/-1.6
microg/dL
bexarotene
psoralen-ultraviolet
PUVA
IB-IIA
mycosis
fungoides
Cutaneous
NCT00056056
Psoralen
ultraviolet
21011
00056056
Targretin
IIA
MF
CCR
accrual
UVA
1·4-489·9
101·7
0·2-529·9
PUVA-alone
0·57
9·7
5·8
0·33
0·45
27·5
0·11
55·8
117·5
0·5
periorbital
botulinum
BoNT-A
intractable
AACG
VARS
EQ-5D
0.299
2.61
VDI
Sun
VIDSUN
25-hydrocyvitamin
nmol/l
Wisconsin-Madison
609
sd
33.0
tan
sunscreen
2.15
5.24
μg/d
IU/d
4.55
8.48
344
suntan
2.25
≥89
≤35
Existing
TAG
occlusive
retarded
prooxidation
admit
pleiotropic
obstinate
supplementing
activating
Afala
domestic
afala
irritative
uroflowmetry
Absence
sort
1d
serotonergic
SQ
YBOCS-compulsion
parallels
selenium
sulfide
tinea
Selenium
lotion
irritant
detergent
dose-escalation
subconjunctival
intravitreal
SCJ
IVT
DME
dose-escalating
BCVA
20/200
440
880
1320
1760
352
dose-limiting
Conjunctival
hyperemia
iritis
nonocular
-23.7
-52.0
Locally
advancing
FINANCIAL
DISCLOSURE
Proprietary
disclosure
references
population-based
PSA-D
PSA-T
Rotterdam
10,865
1202
Planimetric
ellipsoid
receiver
ROC
361
ng/mL/cc
diagnosing
planimetrically
Hevac
yeast-derived
Engerix-B
365
395
kinetics
slow/non-responders
titre
HBsAg-specific
lymphoproliferation
interassay
dichotomous
non-proliferation
castor
thirteen
Fleet
Phospho-Soda
lemon-flavored
Purge
glycol-based
GoLYTELY
endoscopists
cathartic
left-colon
glycol-electrolyte
Thalidomide
apthous
canker
sores
venlafaxine
XR
summation
complementing
benzodiazepine
temazepam
non-benzodiazepine
zolpidem
well-known
precompetition
stressed
inducers
marrow-derived
Cellular
Sclerosis
ACTiMuS
MS
neurophysiological
stepped
Bristol
SPMS
PPMS
unfractionated
multimodal
EDSS
MSFC
MSIS-29
OCT
non-myeloablative
pathways
ISRCTN27232902
11/09/2012
NCT01815632
19/03/2013
conservation
conserve
c
waveforms
accidental
workers
located
Exclusion
inspected
dampening
deformation
88.5
47.4
103.5
99.9
high-priority
wasting
preanalytic
Iron
iron-fortified
beikost
meat-containing
fortified
ferrous
Fe/100
Fe-fortified
kcal
nonfortified
Fe
75-86
mg.kg-1.d-1
80-85
Hct
g/L
Do
leuprolide
depot
3.75
kilograms
46-
64-
72-
89-159
pounds-102-
140-
159-
196-350
0.044
suppressed
Heavier
thymopentin
200-500
cells/mm3
Thymopentin
-infected
prestratified
p24
ICD
strata
treatment-by-stratum
AIDS-related
ARC
AZT-experienced
milliliters
intrapleural
intrapleurally
elicits
20-40
Relaxation
adjuncts
transplants
'booster
0.103
helpfulness
encephalopathic
melarsoprol
trypanosomiasis
Encephalopathies
feared
sickness
existence
encephalopathies
coma
convulsion
convulsions
post-ictal
Febrile
progredient
bullous
14/16
3/38
n=34
eruptions
dietetic
undernourished
Undernutrition
Aim
non-institutionalized
≥65
handgrip
fat-free
-0.15-1.12
-0.33-0.64
-0.62-1.60
Predefined
0.70-2.11
-1.16-0.75
notification
STI
gonorrhoeae
standard-of-care
gonorrhea
chlamydial
nucleic
AOR
Gonorrhea
STIs
postinjection
palatal-anterior
Wand
1:100,000
P-ASA
incisive
Heft-Parker
moderate/severe
Postinjection
numbness/paresthesia
papilla
soreness
Benzodiazepine
fiberoptic
fiber-optic
FOB
anatagonist
10mg
midazolam-alfentanil
systolic/diastolic
SBP/DBP
rate-pressure
RPP=
HRxSBP
/100
One-hundred
RPP
p=0.06
NCT00394537
Desmopressin
nocturia
desmopressin
=18
=2
voids/night
3-wk
dose-titration
=20
diuresis
=80
n=61
desmopressin-treated
voids
p=0.0014
-0.84
voiding
spironolactone
bulimia
nervosa
mention
Spironolactone
corticoid
binging
binges
executed
Symptom-Check-List
SCL-90R
EDI-2
gravity
robot-assisted
ICAE
stroke-related
upper-extremity
UE
horizontal
N=62
planar
1.40-4.47
n=41
2.29
0.85-3.72
robots
Zinc
copper
balances
zinc
quantities
nutrients
bioavailable
whey-predominant
utero
Seventy-two-hour
postconceptual
1,549
34-week
fetus
0.432
Immunoenhanced
Malnutrition
immunosupression
immunoenhanced
nutritions
arginine-enhanced
polymeric
isonitrogenous
14,5
19,8
8,5
Fistula
CPR
TNFalpha
fourteenth
immunonutrition
overestimated
Autism-Spectrum
Quotient-Japanese
intelligent
Quotient
AQ
AQ-J
HPDD
215
129
test-retest
29.6
AQ-J-21
AQ-J-10
cut-offs
distinguished
non-PDD
cangrelor
rapid-acting
adenosine
diphosphate
5362
ischemia-driven
2654
2641
P=0.17
0.31
0.83
P=0.13
groin
hematomas
periprocedural
NCT00385138
Neurodevelopmental
=.051
artesunate
amodiaquine
falciparum
Artesunate
coblistered
ACT
divide
Senegal
Cameroon
three-day
paroxysm
parasitaemia
1,000/microl
biologist
D14
Three-hundred
sixteen
PCR-corrected
99,4
one-daily
99,3
artesunate/amodiaquine
Variations
discharges
Smith-Lemli-Opitz
SLOS
interictal
epileptiform
IEDs
within-subject
repeated-measure
cognitive/behavioral
4-17
readers
Within-subject
IED
Schedule-2
Epileptiform
Fluctuations
fluctuations
Laser-aided
draining
transchoroidally
rhegmatogenous
endolaser
laser-aided
transchoroidal
incarceration
laser-assisted
undernutrition
undecanoate
Nutritional
no-treatment
testosterone-treated
supplement-treated
combined-treatment
0.041
Larger
confirmatory
commencement
trials.gov
NCT00117000
abrasion
enamel
toothpastes
abrasivity
synergistically
interplay
five-treatment
removable
polished
Drinking
toothpaste
orange
1100
Drinks
profilometer
directional
paste
abrasive
truncation
Erosion
Dentine
RDA
Magnesium
ideal
fits
eclamptic
Maiduguri
ibopamine
arrhythmic
Ibopamine
adrenergic
31-83
NYHA
aetiology
couplets
R'-R
msec
117.7
20.9
118.1
71.8
72.6
55.3
number/hr
ectopic
supraventricular
beats
61.9
ns
52.5
57.8
Lown
17.9
sub-divided
dilatative
aetiologies
Divalproex
multi-faceted
orofacial
SSc
multifaceted
rechargeable
Oral-B®
oscillating-rotating-pulsating
Reach®
Access™
Flosser
toothbrush-like
handle
aperture
floss
ps
p=0.0007
toothbrushing
finger-held
Recommending
educating
clean
looks
Partial
Occlusion
Oxidative
PVO
resistance-trained
LIRE
1RM
MIRE
carbonyls
absorbance
ORAC
XO
ROS-induced
MDpsy
STOPD-PD
hierarchy
emphasize
cinnarizine
non-nephrotic
Shenyanning
SYN
IgAN
Seventy
Decoction
Losartan
77.1
54.3
red-cell
Beside
Omeprazole
aspirin-induced
prostaglandins
prostaglandin-depleted
H2-receptor
650
cotherapy
signed-rank
erosions
'preschoolers
cognitive/language
rural
low-functioning
sibutramine
thermogenesis
immersion
sibutramine-induced
groups-the
thermogenic
31.5+/-2.05
30.4+/-2.94
P=.07
33.5+/-4.1
30.9+/-4.8
1.27+/-0.29
kcal/kg/h
1.44+/-0.13
1.56+/-0.27
1.33+/-0.36
Calorimetry
Anti-IgG
extracts
hyposensitization
timothy
allergens
anti-IgG
dithiothreitol
Reactions
rabbit
allergen-specific
multiallergy
hyposensitized
multiallergic
purification
anti-
Nonspecific
Toronto
bacille
intraperitoneally
NED
rational
immunisation
HBs-Ag
anti-HBsAg
mUI/ml
One-trial
item-difficulty
Gabapentin
nociceptive
gabapentin
oxazepam
0-100
gabapentin-treated
vomiting/retching
pamphlet
actigraphy
Actigraphy
gather
Habits
sleep-onset
commented
put
Tacrolimus
LT
methylprednisolon
End
88.8
0.572
48.2
0.116
0.257
CMV
0.336
post-transplant
0.248
hypercholesterolemia
interferon-
ribavirin-free
ombitasvir/paritaprevir/ritonavir
treatment-experienced
virus-infected
/ribavirin
IFN-
RBV-free
ombitasvir
ABT-267
NS5A
paritaprevir
ABT-450
NS3/4A
ritonavir
paritaprevir/ritonavir
IFN/RBV
1b
18-75
100/100
150/100
Sustained
SVR24
-100
72.2
2a
Concordance
SVR12
difficult-to-treat
Cimetidine
mononucleosis
double-blinding
7.89
13.25
cellulose
microbicide
microbicides
Sexually
urogenital
intermenstrual
abdominal/pelvic
REMADHE
cardiologists
Education
ADherence
seventeen
2.47+/-1.75
P=0.008
driven
Number
1.3+/-1.7
0.8+/-1.3
19.9+/-51
11.1+/-24
4.5+/-10.6
1.6+/-2.4
cardiologist
prehospital
resuscitation
multiorgan
dextran
HSD
blunt
land
Coma
accident
protocol-related
logistical
neurocognitive
paramedic
forgot
109/113
penetrating
interstitial
32.7
Organ
Apache
Marshall
Zero
Alive
35/50
42/56
34/50
41/56
37/77
33/37
12/12
15/21
neurofunctional
problematic
threatens
empirically
oliguria
micrograms/kg/min
renal-protective
CHF
74.3
bumetanide
remitted
48.9
32.1
1.97
48.8
ml/kg/h
impulse-oscillometric
rhinometry
aR
IOS
weather
resistance-measurement
anamnestic
rhinokonjunktivitis
pricktest
0,38
0,14
kPa/l/s
0,11
0,39
allergenic
0,69
0,27
0,77
0,42
0,65
0,29
0,6
0,63
0,67
unspecific
hyperreactivity
correspondence
announcing
symptomscore
testings
Levamisole
laryngopharyngeal
epidermoid
biopsy-proven
hypopharyngeal
fortnight
control-group
disturbed
laryngo-pharyngeal
aquatics
pre-test-post-test
randomized-groups
post-programme
Increases
losartan
forced-titration
seated
SeDBP
P=.031
equivalently
Hydrogen
rinse
post-tonsillectomy
hydrogen
H2O2
Double-blinded
bone-marrow
marrow-mononuclear
progenitor
blood-mononuclear
ankle-brachial
ABI
0.06-0.11
9-17
-0.85
-1.6
p=0.025
0.7-1.7
secrete
angiogenic
Q10
hormonally
coenzyme-Q10
tegafur
uracil
UFT
apoptotic
deoxynucleotidyl
transferase-mediated
deoxyuridine
triphosphate
biotin
nick
end-labeling
TUNEL
UFT-treated
Gonadotropin-releasing
raloxifene
nationwide
Circulating
25-hydroxyvitamin
D3
1,25
dihydroxyvitamin
2D
VDR
intriguing
14,916
1,066
incident
496
7-10
1,618
cancer-free
smoking-matched
prediagnostic
FokI
conditional
spring
summer
summer/fall
winter/spring
1.2-3.4
pinteraction
Ff
ff
1.1-3.3
1.1-5.8
European-descent
Potentiation
non-depolarizing
acylaminopenicillins
nondepolarizing
electromyographically
apalcillin
azlocillin
mezlocillin
piperacillin
relaxant
intra-individual
+26
+46
+38
+55
EMG-response
metaplasia
bulb
pylori-positive
DBU
stomach
duodenum
urease
Jatrox-HP
Rohm
Pharma
ureC
Helicopol
Lytech
Russia
Regions
acid-Schiff
alcian
Serva
Duodenal
DU
Estimation
non-complicated
perforation
pyloroduodenal
87.7
83.6
92.8
88.7
ration
65.4
HP-positive
carvedilol
thiazide
Twenty-four-hour
Diastolic
illustrates
economy
reading-writing
syndrome/high-functioning
AS/HFA
writing
RD/WD
Every
underscore
reevaluations
Midlife
online
internet-based
unintended
underserved
midlife
164
40-55
hirsutism
Ferriman-Gallwey
ethinyl
estradiol/desogestrel
estradiol/levonorgestrel
Hormones
radioimmunoassay
desogestrel-containing
levonorgestrel-containing
levonorgestrel
desogestrel
3alpha-androstanediol
glucuronide
33.4
hirsute
social-interaction-based
MEHRIT
Casenhiser
:220-241
re-analysis
Reanalysis
MLUm
underscores
Alcohol
ADS
purported
Fourth
Treatment-seeking
alcohol-dependent
Combining
Pharmacotherapies
COMBINE
1,372
alcohol-
AUROC
Linear
alcohol-related
DSMIV
.75
.70-.79
.67
.60-.74
.77
.74-.80
.74
.69-.79
.30
psychoperceptual
psychophysical
treatment-seeking
Labetalol
seventh
exerted
retentive
antiarrhythmic-drug
implantable
defibrillators
resuscitated
near-fatal
Antiarrhythmics
Implantable
Defibrillators
AVID
survive
cardioverter-defibrillator
antiarrhythmic
1016
507
cardioverter-defibrillators
1013
defibrillator
82.3
81.6
74.7
75.4
64.1
39+/-20
27+/-21
31+/-21
causing
A.
reinforcement
Polysomnographic
postcessation
iatrogenic
Valid
substance-abusing
suicidality
ideation
Consequently
1990s
ideations
suicide
totally
marijuana
cannabis
cocaine
refute
pharmacotherapeutic
psychotherapies
Angiotensin-converting
reninangiotensin
ergometric
ANF
GFR
MA
incomplete
ml/mn-1
nonathletic
imatinib
476
319
157
MMR
cytogenetic
CCyR
.2035
.3470
400-mg/d
.0035
800-mg/d
.0146
Goodstart
mother-to-child
township
MDG4
PMTCT
necessitates
post-natal
peri-urban
Umlazi
Durban
post-natally
HIV-free
1.59-2.33
length-for-age
0.00-0.18
0.03-0.19
1.04-1.18
ARVs
diluted
pro-poor
visiting
reengineering
notable
naloxone
starvation
Starvation
blunted
thyrotropin-releasing
mIU/L
hypothalamic
somatostatinergic
starving
urinary-free
27-35
overnight
placebos
naloxone-sensitive
cholinergic
stimulatory
submucosal
ESD
adenoma
UMIN
000001497
KDOG
0801
underpowered
prove
Biochemical
Crosslaps
CTx
D-Pyr
B-ALP
6th
12th
-1.73
hydroxyproline
resumption
PTH
Dual-task-related
transitionally
frail
walking-associated
matters
falling
fall-prone
82.6
arithmetic
Walking
stepping-over
stops
Speechley
Tinetti
frailty
dual-task
0.131
0.407
transitional
walking-
interfered
attention-splitting
gangrenous
cholecystitis
LC
sick
leave
Suspected
bile-duct
cholangiography
empyema
gallbladder
Calot
triangle
p=0.0048
5-8
p=0.0063
30.1
10.9-21.7
Alcoholism
MAST
companion
recanalisation
meta
small-sized
invalidity
Intestinal
Fat
Beta-carotene
malabsorption
methyldopa
dose-tritrated
lying
BPs
28/15
23/15
29/14
29/15
High-dose
salutary
HDPM
638.9
216.3
CPRS
NIMH
doubts
Mitigation
sociocommunicational
oxytocin-induced
Sociocommunicational
prospects
slowing
neuropeptide
Tokyo
within-subject-crossover
information-based
NVJs
enabled
mitigated
originally
umin.ac.jp/ctr
UMIN000002241
UMIN000004393
Iomeprol
Iopamidol
densitometric
Ninety-eight
Intra-uterine
insemination
hyperstimulation
expectant
subfertility
Intrauterine
IUI
COH
realistic
253
ISRCTN72675518
conceived
0.63-1.1
twin
twins
triplet
Expectant
Sorafenib
uniformly
sorafenib
0.053
BP-elevating
placebo-
active-controlled
1,214
loratadine
171
521
-0.09
-0.03
nighttime
rhinoconjunctivitis
Loratadine
validating
LBW
synthesize
HbF
285
2,000-2,500
mg/kg/d
iron-supplemented
81.2
16.8
37.0
13.8
postconceptional
rejected
Instead
insensitive
staffs
joined
Official
unformed
philosophy
harmony
atmosphere
'hard
'soft
incorporates
welcomed
impressions
GISSI-2
Quantifying
social-emotional
predominately
Chicago
Growth-curve
structural-equation
youths
-.14
-.26
mounting
offsetting
formidable
Niacin
revisited
wax-matrix
niacin
95th
percentiles
Enduracin
employs
1250
diet-treated
-26
-19.3
-18.4
cholesterol-high-density
-20.4
-19.4
diet-
chemistry
niacin-treated
coupled
hormone-escaped
VBL
unexpectedly
refusal
30.8
EMP/VBL
EULAR
Sjogren
ESSDAI
rituximab
phase-related
Emerging
quitting
men-possibly
luteal
intending
Cigarettes/day
Phase-related
=2.82
p=0.0650
urge
=4.85
p=0.0186
inference
breast-cancer
Aromatase
Gail
1.66
Toxic
menopause-specific
4560
Funded
Pfizer
NCIC
CTG
MAP.3
NCT00083174
Potentials
monocular
automobile
enrich
optimising
operator
context-sensitive
semi-transparent
works
drawbacks
paper-based
documents
BMS
d2
Aufmerksamkeits-Belastungs-Test
concentration-test
Around
noticed
blurred
ergonomic
hardware
ophthalmological
non-ophthalmological
cable
optimisation
Available
firm
665
gluconolactate
ispaghula
husk
552
29.3
20.2
0.38-1.17
p=0.16
1.01-2.76
p=0.042
p=0.028
+0.9
+71
-15
-77
+0.4
ACTRN12612000574842
mesothelial
neutral-pH
Acid-base
longevity
utmost
biocompatible
APD
7.43
7.38
Peritoneal
equilibration
solute
carcinogen
antigen-125
twofold
U/ml
Effluent
bicarbonate-buffered
lactate-based
c-erbB-2/neu
oncoprotein
cathepsin
glycoprotein-72
neu/c-erbB-2
catD
tumor-associated
TAG-72
Neu
CatD
IRMA
0.00001
adenocarcinomas
neu
titanyl
tonsillitis
Intra-operative
cm3
reactionary
conservatively
Potassium
tonsillar
minimising
fentanyl-bupivacaine
clonidine-bupivacaine
Alpha-adrenergic
agonists
five-point
FHR
bupivacaine-clonidine
139.4
bupivacaine-fentanyl
127.9
30.9
first-stage
mitomycin-C
methyl-CCNU
SWOG
pancreas
Mitomycin-C
FU-mitomycin
FU-METHYL-CCNU
Leukopenia
dismal
neoplasms
mini-extracorporeal
ECC.O
Cardiopulmonary
coated
circuit
unit-stay
p=0.0069
5BX
workout
Isotonic
thrice
2025
1044
4925
1238
4125
1276mg
Hemostatic
newest
monophasic
gestodene
thrombin-antithrombin-III-complexes
Qigong
Cignolini
PDE5
geometry
defective
second-messenger
guanosine
monophosphate
II-III
velocities
4.62
5.20
5.19
4.71
5.23
annuli
transmitral
32.0
29.1
148.0
130.0
128.0
g/m
Vo
Hip
protectors
Aged-care
Falls
readministered
aware
2.58
protector
2.44
2.08
confident
Diason
313.8
kJ/100
Venous
day-7
OGTT
1673.6
kJ
HOMA-IS
hyperglycemic
Misoprostol
mug
misoprostol
tertiary
shoulder
placenta
or=38
P=0.98
Shivering
self-limiting
arginate
repeated-dose
descriptor
stopwatches
498
219
279
Meaningful
77.6
61.0
Adverse-event
Ibuprofen
VLED
36.3+/-5.1
94.6+/-13.9
30.8+/-3.0
well-trained
36.2+/-7.2
72.2+/-5.9
22.3+/-1.7
Substrate
high-fat
Hi.F
En
reduced-fat
Red.F
CHO
+31
-98
shortage
-103
-185
reliance
case-management
Caregivers
Transition
Reported
Replications
extensions
PACT-type
broader
Set
coordinator
femur
piriformis
fossa
trochanteric
Fifty-four
chair
Analog
2.49
trochanter
interferon-alpha
n=136
n=131
'Profile
'Everyday
TW
TW24
TW48
TW8
vigor
Especially
zest
EEG-biofeedback
succeeded
pretest-posttest
Thirty-eight
-biofeedback
EEG-
SC-biofeedback
19-channel
theta
EEG-regulators
SMAS
lifts
rhytidectomies
Presented
SMASectomy
rhytidectomy
Manhattan
Ear
Throat
well-defined
Photographs
buccal
midfacial
ptosis
flattening
nasolabial
commissure
reactivated
noticeable
midface
halves
sides
plasty
Responders
taper
judgment
.049
nematode
ruminants
breeding
farms
Sabah
East
Government-owned
small-ruminant
goats
smallholder
farmers
high-level
stock
pathogenic
Haemonchus
contortus
FECRT
benzimidazole
imidothiazole
macrocyclic
lactone
salicylanilide
anthelmintics
Drastic
bringing
Impulsivity/Hyperactivity
Learning
Profile-Language
paired-associate
Administering
SE-Restlessness
lighted
stylet
GlideScope
trachea
-spine
unresolved
C-spine
blade
Intubating
Lighted
Stylet
popularly
Lightwand
Trachlight
Occiput-C1
C1-2
C2-5
C5-thoracic
bag-mask
segments
Laryngoscopy
QUESTIONS/PURPOSES
timings
10-mg/kg
IO
POIO
IOPO
POIOPO
688
three-dose
SGA
puberty
postponement
uncensored
GH/GnRHa
pubertal
-2.9
0.795
technetium-99m
methoxyisobutylisonitrile
photon
18-fluoro-2-deoxyglucose
positron
Tc-MIBI
SPECT
differentiating
PET
FDG
FDG-PET
Histopathologic
foci
differentiated
NPCs
bronchopulmonary
dysplasia
BPD
Pulmonary
chlorothiazide
mg/kg/dose
H2O/L/s
0.095
1/L/s/cm
H2O
mL/cm
Fluid
osmolal
intrauterine
FlexiT
NovaT
first-trimester
Flexi-T380
IUD
expulsion
NovaT-200
device-type
post-abortion
Nova-T200
brand
non-intervention
government-linked
databases
provincial
single-payer
IUDs
NCT01174225
inspires
RPE
VO
Listening
499.4
220.1
413.2
150.6
28.1
73.1
listening
nonstructured
Decompressive
craniectomy
RESCUEicp
www.RESCUEicp.com
Craniectomy
Uncontrollable
Elevation
decompressive
colonization
2-g
cephalosporin
cefazolin
cefotetan
cefoperazone
43.7
zeta
haemodialysis
times/week
10.5-12.5
test-reference
dose/kg
neutralizing
anti-erythro
poietin
313
11.35
8.96-14.22
11.54
8.74-13.84
0.09-0.28
+/-0.6
92.68
12.74-398.41
IU/kg/wk
92.58
10.53-393.07
-4.67
4.29
+/-45.00
nominal
23.6
anti-erythropoietin
Epoetin
Dipyrone
endovascular
ruptured
aneurysms
clipping
aneurysmal
SAH
n=57
n=52
43/41
surgical/endovascular
5/4
vegetative
9/7
Symptomatic
1.45
4.19
Hunt
Hess
2.50
4.75
8.90
44.15
aneurysm
P=0.032
retraction
territory
mean+/-SD
39+/-18
rebleedings
rebleeding
quasi-experimental
118
left-heart
postcatheterization
IVF-ET
chorionic
5940
4370
follicles
66.1
cleavage
rate/embryo
OHSS
livebirth
diagnose
Methylphenidate
baseball
7.8-9.9
on-task
Judgment
batting
Influenza
F1+2
CRP-levels
D-dimer
nontraumatic
thromboprophylactic
down-regulate
Lanoxin
absorbed
dissolution
second-line
squamous-cell
LUX-Head
ERBB
cytologically
amenable
ECOG
EGFR-targeted
Clinicians
NCT01345682
Jan
Dec
483
322
6·7
3·1-9·0
2·6
2·0-2·7
1·7
1·5-2·4
0·80
0·65-0·98
p=0·030
stomatitis
afatinib-treated
methotrexate-treated
Boehringer
Ingelheim
Se-enriched
yeast
p34
cdc2
CyclinB1
germ
offspring
MPF
regulating
herd
Taihang
Goats
Se
174d
mgkg⁻¹
Testis
30d
testis
Se-deficient
Se-excess
Se-induced
post-hypnotic
proactive
hypnotized
Concurrently
aforementioned
discerned
scholastic
aptitude
Coordination
DCD
Provision
paediatrician
helped
SAMPLE
swapped
Movement
comments
40-week
Epstein-Barr
EBV
HL
ISH
EBER
EBV-DNA
EBER-ISH
Specimens
E2496
copies/100
µL
Pretreatment
failure-free
FFS
274
NCT00003389
phenylbutazone
shutdown
calculous
vehicle-containing
Fibrinogen
euglobulins
Phenylbutazone
Fibrinolytic
plausible
speculated
plasmin
conserving
22881-10882
BCT
policy
77.4
50Gy
16Gy
N=5318
P=0.97
threshold-age
Applying
1/3
Pre-bent
single-port
single-incision
SILS
restrictions
triangulation
SILS-specific
novices
SPLS
pre-bent
SPLS-pp
straight
SPLS-ps
participants`
experts
SILS-designed
needlescopically
robotically
ICS
dissociate
Methacholine
PD20
micro
FEF25-75
diurnal
1.6-fold
exhibits
ICS/long-acting
primrose
gamma
linolenic
docahexaenoic
pre-eclampsia
Oxide
Placebo
Pre-Eclampsia
primiparous
histories
Maternity
Luanda
Gamma-linolenic
GLA
Docosahexaenoic
1:50,000
1:80,000
premolar
incisor
Technology
pulp
tester
Retrospective
Resistive
Underwater
Exercises
Interferential
Juvenile
Idiopathic
resistive
underwater
interferential
quadriceps
hamstrings
polyarticular
mos
HUMAC
NORM
CSMI
Isokinetic
Pivampicillin
uro-genital
dried
purple
QUENCH
predisposing
Anthocyanins
phenolic
53.1
118.5
anthocyanins
259.2
Aspartate
Intramuscular
megestrol
Hot
Progestins
progestins
offering
hydraulic
HCT
CV
42.2
cardiography
nonexercising
d.wk-1
circuits.d-1
HCTmax
repetitions
RM
HCTsub
70-85
ml.kg-1
SVmax
COmax
Prevalence
Kerman
Province
Scale-Up
Method
scale-up
NSU
southeastern
multi-stage
Interviewees
estimator
Monte
Carlo
upper/lower
One-yr
5-yr
Reactivation
479
reactivation
reactivations
coronary-bypass
Reactivations
Concomitant
Junctional
junctional
JET
JET-related
rare
tertiary-care
matched-cohort
Whenever
CICU
historically
parent-delivered
trainer-delivered
qigong
estrogen-progestin
BCPT
194
1048
Fatal
tabulated
6074
6072
8.13
2.28
1.57
0.00
5.18
2.26
6.55
9.47
Affordable
Act
mandates
cover
smoking-cessation
cost-sharing
spike
premiums
1346
1338
requisite
quitters
541
community-
dwelling
p=0.01
Making
classrooms
peer-mediated
PEER
child-assisted
CHILD
playground
friendship
nominations
connections
yoga
Yoga
Self-care
YES
afflicting
CAM
mind-body
book
Interviewers
back-related
bothersomeness
relieve
in-depth
camel
thymus
activation-regulated
chemokine
boiled
TARC
Famotidine
famotidine
3.8-8.1
reciting
Checklists
Aman
meaningless
etidronate
Progressive
173
EHDP
diphosphonate
osteoclastic
intolerance
deformity
.98
.07
Topiramate
topiramate
TPM
26-week
Migraine
Migraine-Specific
MSQ
functionality
study-completer
frustration
helplessness
mixed-effects
piecewise
372
Third-
sixth-grade
Autism/Information
attributing
classmates
ascribed
LIFE-study
1195
ECG-verified
177/96
146/79
148/79
losartan-treated
atenolol-treated
586
Tensile
lithium-disilicate
pressed
glass
desensitizer
disinfectant
tensile
7x3
discs
IPS
e.max
fabricated
Representative
fractured
trandolapril
205
Morning
predosing
-10.6
-10.9
-15.1
Trandolapril
FFB
168.7
167.3
sedation-related
CO2
82.5
Ambu
Brice
Traumatic
injury-related
lisdexamfetamine
dimesylate
Vyvanse
debilitating
moderate-to-severe
16-42
6-34
post-injury
6-weeks
12-weeks
moderating
Avenues
conductivity
Relatively
Cndi
Excess
mS/cm
postplasma
R2
Interdialytic
2.34
Predialysis
144
diffusive
cf
IMB
interdialytic
Design
Dolphinarium
optimistic
Dolphin-assisted
emulating
swimming
dolphins
dolphin
poolside
gestures
Immersive
gesture-based
immersive
equipped
curved
spanning
°
high-end
five-panel
endangered
arsenic
acid-supplementation
Populations
arsenic-contaminated
inorganic
InAs
methylated
monomethylarsonic
MMA
dimethylarsinic
DMA
folate-dependent
one-carbon
methylation
arsenic-exposed
/=9
arsenic-related
tetracycline
symptomatically
nonintensive
Drew
Eur
Adolesc
Psychiatr
11:266-272
PDD-NOS
'Focus
Emotion
reappraisal
Six-
13-year-olds
sad
reappraise
ruminate
Reappraisal
Rumination
Specific
pregnancy-related
stabilizing
Tygerberg
Paarl
Hospitals
Cape
P=0.76
P=0.29
P=0.06
P=0.89
P=0.70
girdle
bifidobacterium
breve
defense
Bifidobacterium
1489
commencing
Bifidobacterium-predominant
Enterobacteriaceae
Empiric
Particularly
post-empiric
1951
761
shifts
explanation
soft-tissue
Glycopeptides
antifungals
inexperienced
emphasizes
genuine
MDSL
MSL
ADL
74.8±5.6
Intra-class
ICCs
ICC=0.95
ICC=0.81-0.82
r=-0.32-0.41
r=0.28-0.48
r=-0.19
r=0.15
relates
CGM
intensively
or=25
-0.4
or=7.0
71-180
Branch
atheromatous
SPS3
spare
Travasol
Baxter
mL.kg
.min
mg.kg
tracer
l-
1-
6,6-
glucagon
-16+/-4
micromol.kg
.h
16+/-3
-17+/-7
7+/-5
Hyperglycemia
10.1+/-1.9
protein-sparing
avoids
ready-to-eat
fourth-
non-ready-to-eat
RTEC
breakfasts
SUBJECTS/SETTING
625
Bienestar
multiple-pass
fourth-grade
fifth-
calculate
STATISTICAL
ANALYSES
PERFORMED
inferential
6×4
cross-tabulation
nutrition-related
Antiasthmatic
PWEs
PWE
tobacco-exposed
Earlier
anti-panic
anti-agoraphobic
potentiates
agoraphobics
'associative
framed
associative
associate
trait
self-rated
potentiate
case-controlled
imparting
squared
inferring
prosody
Sally-Anne
infer
distinctively
demographically-matched
insula
sulcus
dorsomedial
voxels
one-tail
originally-diminished
0.858
Nicotinic
hypolipidemic
dyslipidemic
very-low-density
glycosuria
vortioxetine
2010-May
MDD
DSM-IV-TR
MADRS
Columbia-Suicide
C-SSRS
Arizona
Sexual
Experience
ASEX
1,111
469
flatulence
Discontinuation
NCT01179516
anovulation
evidences
FSH/human
Helath
hypogonadotropic
hypogonadism
HH
hypothalamic/pituitary
r-hFSH
r-hLH
hMG-HP
LH-like
25-36
150IU
r-hFSH/75IU
rhLH
Ovulation
hCG
r-hFSH/r-hLH
≥17
pre-ovulatory
≥400
mid-luteal
levels/follicle
mid-cycle
p=0.11
FSH-induced
7.58
4.49
0.844
occlusal
repeatability
predilection
0-5
disclosing
deposits
rescored
60-90
drawing
outline
onto
grids
suspending
toothcleaning
Highly
fissure
repeatable
atherothrombotic
610
anastomoses
occluded
0.0037
Offering
personalized
laterality
lateralization
lateralized
implication
Practical
thin-ideal
dissatisfaction
disclaimer
Retouched
photograph
Warning
Trying
your
thin/attractive
undergraduate
n=342
car
post-exposure
advocacy
minerals
Reference
Intakes
DRIs
inter-participant
DRI
pantothenic
FFQs
Orlistat
losing
orlistat-assisted
=40
45.8
5.2-86.4
p=0.031
-0.6+/-0.5
-8.55
-13.0
-4.1
p=0.017
p=0.036
orlistat
alpha1A-adrenoceptor
923
466
-1.4
-4.2
-2.3
ejaculation
Proportions
Silodosin
urethral
Urethral
skilled
urethra
vulvar
vestibule
Researchers
inserting
Comments
Cobedding
cobedding
heel
lancing
incubator
incubators
cried
42.6
19.8
7.4
comforting
comparation
thoracoscopic
Netilmicin
tobramycin
West
netilmicin-ticarcillin
tobramycin-ticarcillin
netilmicin
Ototoxicity
netilmicin-treated
254
social-communication
far-transfer
symbols
object
small-dose
ketamine
preemptive
5-mL
Patient-controlled
nightmares
Ketamine
Rett
Eight-week
parents/caregivers
Hand
Apraxia
Identification
Neurophysiological
neurotoxin
complexing
Xeomin
Merz
GmbH
Frankfurt
Electroneurographic
digitorum
EDB
Botox
Allergan
Ltd.
Westport
BTXCo
M-wave
0.195-1.370
0.309-1.167
abductor
digiti
quinti
hallucis
diffusion-induced
desired
AMI
=12
SK
bpm
335
TIMI
=.001
predischarge
angiogram
=.4
appreciation
anxiolysis
dentistry
hundred-fifty
appreciated
anxiolytic
loco-regional
complicances
permanence
extraordinary
96.6
98.6
tranquillity
wished
diffused
enthusiastically
astonishment
Methotrexate/nitrous-oxide
See
non-residential
replications
involve
parent-assisted
Friendship
CFT
DTC
Targeted
sportsmanship
dates
teasing
post-testing
loneliness
Post-hoc
66.7
nelfinavir-based
antiretrovirals
-experienced
nelfinavir
NFV
RTV
ddI
50-55
nevirapine
NVP
d4T
=400
copies/mL
M8
NRTI-experienced
native
Stenting
Occluded
Native
Arteries
PRISON
intracoronary
stented
1.93
=.009
44.7
=.036
Binary
=.137
reocclusion
canalith
repositioning
positional
neurotological
Fifty-eight
mastoid
oscillator
maneuver
anti-vertiginous
passed
75.9
canalithiasis
fainting
insofar
stories
7-14
directive
eliciting
generalizing
Verbal
VCI
WISC-IV
Preliminary
palatal
sleep-disordered
SDB
board-approved
palate
RFAP
3-stage
uvulopalatoplasty
LAUP
snoring
SNAP
Epworth
Sleepiness
trihexyphenidyl
remit
volumetrics
relied
ROI
MRIs
nortriptyline
late-life
MRIcro
MRI-hyperintensity
DWMH
PVH
24-item
7.14
OR=4.17
OR=5.00
Importantly
White
CMFVP
L-phenylalanine
mustard
L-PAM
68-month
estrogen-receptor
Xuezhikang
cholestin
rice
CSX
n=18
log-CRP
A-fortified
coconut
cooking
Filipino
542
Control-1
unfortified
Control-2
coming
A-rich
households
purchasing
vigorously
Tactile
expanding
haptic
believe
force
haptics
simulators
interpret
texture
identity
Inspection
palpation
Statistic
amplify
defining
gemfibrozil
HGM-CoA
fibric
od
APO-A1
APO-B
Gemfibrozil
tipifarnib
farnesyltransferase
Zarnestra
R115777
Johnson
Pharmaceutical
Beerse
Belgium
Tipifarnib
=.75
Neutropenia
nonhematologic
vitamin/mineral
Vitamin/mineral
5-16
improved/increased
+17
S-adenosylmethionine
oxidized
GSSG
GSH
-27
nitrotyrosine
-29
0.000001
NADH
NADPH
+30
near-normal
levels.The
Parental
Impressions-Revised
PGI-R
Tantrumming
Receptive
significant.Regression
adj
sulfation
NCT01225198
indobufen
aortocoronary
antiaggregation
ACB
DSA
dipyridamole-treated
reconstructions
28.2
45.2
Ranibizumab
verteporfin
neovascular
ranibizumab
exudative
'as
vision/anatomical
Retreatment
defibrillation
biphasic
VF
DFT
shocks
9.5+/-6.0
10.8+/-7.0
p=0.4
10.9+/-6.1
12.6+/-5.6
7.0+/-3.5
10.5+/-6.3
Defibrillation
Ultrasonographic
characterisation
Achilles
tendons
tendon
UTC
Case-control
Sports
Hague
Centre
midportion
tendinopathy
researcher
custom-designed
quantifies
qua
contiguous
categorises
echotypes
echo-types
pixels
51.5
76.6
Intraclass
Coefficient
interobserver
I+II
HES
130/0.4
200/0.5
Hydroxyethyl
starch
on-pump
N.=37
N.=39
Equivalent
1577
1540
-150
sertindole
pharmacopsychometric
Renewed
dose-related
re-analysing
wellbeing
Selected
Simpson-Angus
LOCF
proxy
Relaxing
retinotomy
silicone
vitreoretinopathy
Silicone
404
C-3
full-thickness
quadrants
relaxing
tamponade
hypotony
Retinotomy
perflouropropane
Adjvant
floor
1974
citrovorum
mg/week
signigicantly
peri-procedural
contemporary
PMI
Resolute
'All-Comers
CK
CK-myoband
cTn
PMIs
type-4a
2121/2292
analysable
dataset
890/2121
267/890
Type-4a
208/2121
93/2121
CK-based
65/2121
p=0.6
MI-definition
recruit
//www.ClinicalTrials.gov
NCT00617084
Calmette-Guerin
intravesical
18/21
17/21
health-promotion
Ageing
activity-based
28-month
n=62
disablement
Carboplatin
CALYPSO
platinum-
paclitaxel-based
carboplatin-pegylated
carboplatin-paclitaxel
treatment-free
TFI
259
n=128
HR=1.05
0.79-1.40
P=0.73
40.2
43.9
HR=1.18
0.85-1.63
P=0.33
P=0.46
P=0.47
P=0.082
P=0.27
alopecia
P=0.089
risk-benefit
carboplatin-PLD
nurse-administered
citrate
undue
request
n=37
n=43
requesting
oversedation
neuroadaptive
Differential
K1
AFP
DCP
HCC
27-patient
100-fold
mg/infusion
PRs
Mechanism
JNK
c-Jun
caspase-mediated
non-toxic
weakly
Shorter
candidosis
miconazole
Fluconazole
pessaries
Cure
lactation
circuitry
detailing
balance/gait/falls
Imaging
lobe
brainstem
posture/locomotor
postural
partaking
cognitively
Balance
Agility
Boot
Camp
MiniBESTest
NCT02231073
AHA
prerecorded
pulseless
PEA
anaesthesiology
residents
omission
specification
commission
-10.1
Users
-5.3
redundant
Δ=-3.2
-9.3
p=0.286
Δ=-4.4
-9.4
p=0.075
-6.3
person-centred
agitation
neuropsychiatric
10-month
Dementia
Mapping
DCM
VIPS
VPM
three-armed
624
Agitation
BARS
10-item
Neuropsychiatric
NPI-Q
Cornell
CSDD
Late-Stage
QUALID
automation
array
distractor
40-min
vigil
EI
beta/
yoked
haemangioma
interlaminar
intervertebral
herniation
degenerative
spondylolisthesis
Numerous
fusions
paucity
ASSESSMENT
Oswestry
ODI
37.7
77.9
30.2
Lumbar
NCT00681447
allotted
dermatological
six-monthly
psychophysiological
circumferences
WC
bean
hypocaloric
48.7
45.00
2.41
lymphocytic
Eighty-seven
CNS
ITC
cranial
craniospinal
CSpRT
arabinosylcytosine
2400
rad
Craniospinal
1400
Stratum
testes
ordinarily
uncommunicative
children/adolescents
inappropriateness
anchors
informant
questioning
exams
neuropsychologically
noncompliant
selection/adaptation
low-end
developers
autism-adapted
cross-site
in-person
teleconference
Definition
attainable
imperfect
McDougle
elsewhere
Scahill
Case-controll
arthroscopic
53.62
6.53
10.35
6.42
54.34
7.67
11.94
5.13
debridment
femoris
Lysholm
limp
stair
squat
Electroacupuncture
MYSTAR
bone-marrow-derived
-3.5
-5.5
-1.5
1.3-5.6
0.7-6.1
9-12
200.3
68.7
194.8
60.4
1.29
caring
Hampshire
towns
SunSafe
recreation
DESIGN/INTERVENTION
Pediatricians
town
single-focus
Field
bivalent
swine
outbreak
porcine
circovirus
Swine
industry
H1N1/H3N2
accomplish
cohorts
finisher
pigs
PCVAD
Cohort
numerically
Examine
co-occurring
11-16
Amphotericin
dextrose
emulsion
AmB
rigors
high-performance
liter
024
distributes
Contin
XL
OAD
12-hourly
multi-centered
n=25
238
q24h
q12h
P=0.0108
P=0.015
100.3
Fluctuation
179.3
P=0.0001
Critically
breathe
resistor
mouthpiece
pressure-flow
tubes
breaths/min
VE
progressively
equivalents
VE/VCO2
VE/VO2
Chemoradiotherapy
gemcitabine/cisplatin
LAPC
RT-5-FU
RT-GC
full-dose
RT-GC+GC
Corresponding
P=0.61
P=0.21
GC-containing
neutropaenia
non-variceal
Forrest
somatostatin-UCB
mcg
2.56
3.05
5.17
4.96
11.25
11.63
0.0383
mathematical
simulation
simulations
dilution-time
nomograms
curettage
electrodesiccation
Curettage
BCC
Toll-like
atrophic
hypopigmented
flat
pink
ppm
compressed
carboxyhemoglobin
4.08
1.52
1.34
218.5
146.6
219.9
221.3
Breathing
stayed
intensified
night-time
2.6/2.6
0.6/1.7
1.0/1.4
0.6/1.5
57.7
Scandinavian
4S
CAD
4,444
213-310
5.5-8.0
mmol/liter
+8
Noncardiovascular
431
Impression-Severity
Adolescent
Scale-Revised
Caregiver
Strain
autism/mood
anticipating
mitigating
extremely-low-birth-weight
770
769
postmenstrual
402
deciliter
micromol
Bevacizumab
grid
GLP
perfused
ophthalmologic
logarithm
logMAR
CMT
tomography-3
0.22
59.5
60.3
Intravitreal
inequality
lesson
mathematics
Extinction
over-selected
under-selected
higher-functioning
over-selectivity
post-acquisition
trial-and-error
two-element
extinguished
extinction
fruitful
CEA
UICC
Marker
truly
biochemical/clinical
cytotoxics
move
lengthening
trimethoprim-sulfamethoxazole
aerosolized
pentamidine
Pneumocystis
carinii
021
PCP
treatment-limiting
sulfamethoxazole
trimethoprim
jet
nebulizer
extrapulmonary
aerosolized-pentamidine
156
1.72
Crossovers
pneumocystis
Isradipine
Weekly
paclitaxel-pretreated
Hellenic
Co-Operative
paclitaxel-containing
0.413
Ethanol-induced
electroencephalographic
blood-alcohol
breathalyzer
10/20
Fast
Fourier
Transform
bands
19.5
P4
band
Kay
crowded
uncrowded
amblyopia
strabismic
n=17
anisometropic
n=24
severe/moderate
0.250
uniocularly
orders
0.343+/-0.150
P=0.084
0.402+/-0.188
0.074+/-0.036
P=0.0382
0.088+/-0.008
crowding
acuities
Ten-year
/yr
striking
believed
β-adrenergic
Fifteen-year
hyperfractionated
noninflammatory
1.2-Gy
q.d
2-Gy
supraclavicular
15-year
p=0.36
moist
desquamation
b.i.d.
p=0.54
hyperfractionation
postmastectomy
3,4-dihydroxyphenylethyleneglycol
3-methoxy-4-hydroxyphenylethyleneglycol
noradrenergic
Animal
interspecies
DOPEG
MOPEG
DSM-III
desipramine
metapramine
anesthesia/opioid
fentanyl/bupivacaine
micrograms/mL
micrograms/h
54.4
0.86
reinforcers
12-year-old
tradic
confederate
touchscreen
dinosaur
spoke
human-robot
embedding
motivators
chestnut
tannins
welfare
carcass
rabbits
Rabbits
20°C
33°C
CT5
CT10
CT/kg
reacting
preaching
Financing
demonstrations
1,900
beneficiaries
fee-for-service
hundred-seventy-three
lengthy
973
letter
free-of-charge
Medicare-provided
everyone
pollutant
unvented
combustion
appliances
Epidemiological
0.5-2.0
Bronchoalveolar
BL
BAL
polymorphonuclear
neutrophils
PMNs
alpha1-antitrypsin
NO2-induced
phagocytose
unopsonized
albicans
superoxide
NO2-
air-exposed
contributions
alcoholics
erratically
Attendance
Alcoholics
Anonymous
meetings
explains
positive-outcome
Placebo-controlled
mecamylamine
acetylcholine
nAChR
postmortem
α4β2
nAChRs
α7
brains
Mecamylamine
n=8
n=12
0.13-0.15
≥0.18
Graphed
verbalization
expense
varenicline
acetylsalicylic
B-thromboglobulin
B-TG
ADP-induced
TIA
fourteen
14th
alpha-granule
meal-stimulated
neurotensin
jejunoileal
3:1
1:3
jejunum
ileum
NH2-terminal
immunoreactivity
end-to-side
intestine
unoperated
Meal-stimulated
Endotracheal
cuffs
overinflated
cuffed
Portex
Searle
Sensiv
Mallinkrodt
Hi-Lo
Lanz
Tracheal
overpressurised
specify
carotene
22071
statistic
non-parametric
0.80-1.65
0.68-1.10
.09
.96
Enamel
gaseous
shear
microtensile
bonded
1E
Clearfil
Protect
2E
3E
Xeno
4E
Ozone
Shear
noncarious
Middle/deep
1D
ozone+Clearfil
ozone+Xeno
4D
Four-mm-thick
buildups
built
nontrimming
disinfect
cavity
gastrostomy
OG
Sachs-Vine
Stamm
1675
979
1574
stapled
hemorrhoidectomy
circular
stapler
quick
well-accepted
Milligan
Morgan
46.02
12.33
48.64
14.57
80.9
24.28
4.25
45.21
5.36
Milligan-Morgan
1.24
2.76
8.12
2.48
17.62
5.59
97.6
2-19
Stapled
day-care
ensures
perianal
deny
heterotopic
ossification
HO
orthopedic
organizational
16-20
Voltaren
resinat
Heterotopic
Brooker
Grading
47.8
Analyzing
Referring
Irradiation
Double-Blind
Olprinone
Phosphodiesterase
Inhibitor
Preventing
Resection
phosphodiesterase
olprinone
pg/mL
Registries
JPRN-UMIN2404
//www.umin.ac.jp/ctr/
Finasteride
Urodynamics
urodynamically
BOO
twenty-one
BPE
LUTS
tracings
reader
unaware
Abrams-Griffiths
Detrusor
PdetQmax
76.2
J-EDIT
thioquanine
remissions
diflunisal/naproxen
diflunisal
diflunisal-naproxen
FDC
marketed
laboratory-blinded
Way
Cross-Over
Egyptian
co-administration
72-h
UV
AUC0-t
AUC0-∞
tmax
t1/2
transformed
AUCt-∞
0.8-1.25
perspectives
-reference
Tinzaparin
dalteparin
periprocedure
Low-molecular-weight
tinzaparin
Open-label
predialysis
anti-Xa
IU/mL
20-24
canceled
bleed
puncture
Small
Dalteparin
Bridging
LMWHs
interruption
n=766
inclusive
n=152
n=148
n=83
558
283
Z-test
0.0198
unweighted
1.98
Treatment-emergent
Responder-enriched
extrapolation
stabilized
norethisterone
enanthate
Testosterone
progestogens
oligo-azoospermia
NETE
NETE-8
NETE-12
NETE-6/12
NETE-6/12/0
NETE-0/0
MAMC
AMA
isovolemic
hemodilution
twelve-month
investigator-initiated
IH
deferred
IVI
CRVO
+28.1
±19.3
+25.2
±20.9
0.326
heatwrap
LBP
n=95
unheated
wrap
0-
5-point
101-point
fingertip-floor
Roland-Morris
Heatwrap
1.76+/-.10
1.05+/-.11
43.1+/-1.21
47.6+/-1.21
P=.008
18.6+/-.44
16.5+/-.45
P=.0002
Nateglinide
strict
nateglinide
drug-naive
-0.017+/-0.054
mm/year
0.024+/-0.066
P=0.0064
highly-sensitive
no-training
songs
semantics
phonology
pragmatics
linguistic
organized
FC
vaporization
IFA
C.A
F.C
1986
1372
peoscopy
thousand
74.27
penile
98.27
93.93
87.23
or/plus
D-myo-inositol-1,2,6-trisphosphate
1,2,6-IP3
possesses
inflammation-induced
ketobemidon
inositol-1,2,6-trisphosphate
cholecystectomized
Optimal
lignocaine
Need
thumb
immobilised
scaphoid
Immobilisation
carpal
392
gauntlet
'scaphoid
interphalangeal
292
Er
YSGG
GaAlAs
hypersensitivity
DH
desensitizing
erbium
chromium-doped
yttrium
scandium
gallium
garnet
galium-aluminium-arsenide
8.5J/cm
none-contact
0.25W
20Hz
60s
30s
aqueous
acne-specific
Acne-QoL
self-perception
role-social
HRQL
clindamycin-BPO
2813
study-by-treatment
pooling
participant-reported
ingredients
balance-based
torso
Torso
BBTW
weight-placement
TUG
sharpened
Romberg
360-degree
turns
25-foot
platform
posturography
membership
nonweighted
Parent-based
Mode
P.T.P
devoted
semantic
Nursing
role-playing
T.S
C.S.
C.S
consolidate
Educational
water-sanitation
5.89
nonintervention
7.55
NCHS
necessarily
low-pass
LPFST
LPFSTs
monaural
low-redundancy
richness
redundancy
listener
1kHz
corner
computer-based
normal-hearing
8-11
Canterbury
UCAST
four-alternative
LPF
Test-Filtered
Words
UCAST-FW
maturational
faropenem
daloxate
89.0
88.4
-95
CI=-5.2
+6.4
7-16
post-therapy
28-35
92.6
94.9
-6.8
+1.2
148
causative
47.1
Moraxella
catarrhalis
90.8
CI=-9.2
+9.5
97.3
96.3
85.0
90.9
100.0
M.
daloxate-treated
Absorption
mg.kg-1
Karen
unconscious
anticonvulsant
deepen
sleepy
Phenobarbitone
29.3-42.6
mumol.l-1
2.5-12
antiretroviral-naive
554
or=400
cells/mm
300-mg
3TC
150-mg
48-week
276
-7.1
-9.7
+144
+146
HIV-associated
Disability-Child
-.388
.407
.032
.449
.013
.414
.040
.499
Bitewing
holder
bitewing
apprised
overlaps
cone
2.11
2.16
2.18
97.8
improper
Locomoting-to-reach
perception/action
locomotion-to-reach
locomote
lit
vision/target
vision/point-light
brought
outstretched
walk-to-reach
centric
τ.
Dynamical
fit
hand-centric
τ-based
ABP
WCE
Hypertensive
CBP
reactors
discrepancy
0.64/0.59
Agreement
GH-releasing
incidentaloma
hypercortisolemic
incidentally
discovered
Cushingoid
48-63
serendipitously
Briefly
scintigraphy
hypothalamic-pituitary-adrenal
UFC
0800
ACTH
microg/L
33.7
531
incidental
autonomous
S-phase
kinase-associated
F-box
Skp2
G1-S
G1
p27kip1
LSCC
p=0.026
p=0.0051
p=0.0002
poorest
p=0.0017
p=0.0234
p=0.2055
30°
CPM
hidden
ecchymosis
ROM
FFD
straight-leg
mitigate
Placebos
estrogen-treated
Reasons
Non-Participation
Family-Coping-Orientated
Palliative
FamCope
existential
trajectory
problem-solvers
nurse-led
family-coping-orientated
non-participation
impedes
oncological
non-participants
65.9
declining
Timing
impeded
construct
hydroxide
Solid
filling
cleansed
shaped
lateral-vertical
Roth
AH26
Sealapex
CRCS
Nogenol
VI
amalgam
capped
vial
inch
gauze
pads
humidor
layers
polish
stained
india
ink
decalcified
dehydrated
methylsalicylate
filar
micrometer
eyepiece
dissecting
0.277
0.343
0.263
2.310
cholesterol-raising
Long-chain
triacylglycerol
DHA/d
Values
lathosterol
plant
down-regulates
disclose
Theorists
wisdom
self-disclosure
self-disclosures
clients
liked
Home-based
hospital-based
High-intensity
HIT
men/10
TE
HE
85-95
ml/kg/min
37.2
CI-0.5
-1.0
efficiently
Obstetrical
Tramal
deliveries
medicaments
excerted
analgetic
obstetrical
excert
eptifibatide
ESPRIT
IIb/IIIa
CrCl
Integrilin
1,755
Gault
0.109
Cluster
live-born
ninety-six
retinyl
palmitate
all-trans
Married
125,257
ascertained
amenorrhea
All-cause
stillbirth
140-273
166-309
177-323
0.75-1.76
0.81-1.81
47.9
44.3-51.5
45.6
42.1-49.2
48.0-55.6
births
63.7-72.5
65.0
60.7-69.4
65.4-72.3
1.46
1.42-1.50
μmol/L
1.09-1.17
1.18
1.14-1.22
blindness
NCT00198822
paroxetine
methamphetamine
Methamphetamine
pharmocologic
OCDS
Quest
Lava
Mountain
Computer
Game
Behaviors
Elementary
Group-Randomized
Computer-based
QTLM
ethnically
diverse
Quasi-experimental
2012-2013
PARTICIPANTS/SETTING
Process
back-end
server
in-school
afterschool
min/wk
274±110
sugar
P=0.021
nutrition/physical
P=0.041
Commentary
cytoreduction
8949
Dose-effect
isosorbide
dinitrate
ISDN
dialy
anginal
mononitrates
protracted
substance.U
mammographic
MBD
618
non-threatening
norgestimate
ORTHO
TRI-CYCLEN
Ortho-McNeil
Raritan
N.J.
norgestimate/ethinyl
fifty-seven
0.180
0.215
color-matched
within-cycle
62.0
38.6
93.7
comedones
papules
pustules
Ebeltoft
Danish
political
profession
checks
Denmark
check
hearing
1370
905
Almost
456
discussing
undertake
doctor
talk
willing
talks
Motion
aftereffects
horizontally
anechoic
500-Hz
6300-Hz
high-pass
traversed
semicircular
front
hemifield
10-sec
adaptor
750-msec
-200
+200
degrees/sec
-10
+10
Observers
headphones
Grantham
Wightman
aftereffect
MAE
spectrally
subject-dependent
spectra
multi-modal
stimulus-response
neurogenic
hand-eye
or=18
detections
multiplicity
Equivocal
Pegboard
Classroom
math
pathophysiologic
ADs
ABC-C
hyperactivity/noncompliance
Strategies
Structured
educators
kindergarten-through-second-grade
District
9.2-point
8-month
UKALL
XI
0-14
/l
0.46-0.87
peri-implantitis
Vector
screw
threads
curette
Vector-treated
chromatic
silver
nanoparticles
gantrez
S-97
copolymer
Silver
NNPs
bioadhesive
Gantrez
mutans
color
Gantrez-NNP
brushed
rinsed
thymol
Color
Minolta
colorimeter
CR300
2.10.1
nonlinear
NLME
luminosity
esthetics
dipeptidyl
peptidase-4
PHX1149
DPP4
glitazone
+0.11
-2.08
-1.88
glucagon-like
peptide-1
mediator
3.90
2.83
2.86
16.42
2.72
15.75
2.71
placebo-corrected
PHX1149-treated
transbronchial
jumbo
bronchoscope
Transbronchial
TBLB
parenchymal
infiltrates
gastroenterological
Jumbo
'normal
DPLD
solitary
Fogarty
aspirator
lobar
bronchus
operate
forcep
infiltrative
H.pylori
Du
methods-microscopy
staining-were
cometidine
colloidal
bismuth
subcitrate
CBS
metronidazole
gastroscopy
cimetidine
group-one
57.1
group-the
Improve
UCLA
PEERS
caregiver-assisted
18-24
antianginal
amlodipine/day
nitroglycerin
NTG
consumed/week
98.4
63/64
attacks/week
58/64
2/week
self-assessments
55/58
53/58
Amlodipine
Antifungal
onychomycosis
foetal
mink
Neovison
vison
post-partum
adulthood
metabolically
Eighty-six
ME
crude
~20
30-42
post-weaning
Being
attaining
lipidosis
alleviated
Encephalopathy
acupoint
ETTAA
Eighty-four
42.39
6.86
32.15
5.12
44.58
6.76
39.72
38/42
28/42
Secondly
non-metastatic
28.3
11.4-139.0
80.3
32.6-250.6
21.1-98.3
62.9
161.7
0.289
0.0-62.2
0.057
52.1
0.0-162.7
0.592
0.604
hallmark
commensurate
vagotomy
pyloroplasty
Caudal
dromedary
camels
Camelus
dromedarius
12-18-month-old
LK
intercoccygeal
Co1-Co2
ataxia
lt
tail
anus
perineum
lidocaine-ketamine
alert
Ataxia
Academy
Pediatrics
Population-based
2003-2004
495
6716
11,403
Exposures
family-centered
culturally
accessible
0.30-0.66
1.06-1.30
Pressure
ABCD
NIDDM
nisoldipine
80.0-89.0
950
470
choroidal
COMS
Ocular
Melanoma
enucleation
large-size
melanomas
1993-1994
1995-1996
-20.2
senile
release-controlling
almitrine
l/d
oryzanol
3/d
ABPM
remarkably
ith
brt
tha
ere
HAMD
untoward
perspiration
antianxiety
neurosis
MRI-detected
skull-base
intensity-modulated
advances
-detected
IMRT
749
nondisseminated
metastasis-free
DMFS
LRFS
Skull-base
pharyngobasilar
fascia
clivus
vs.75
subclassifications
myelocytic
Transluminal
Balloon
pTBA
dichotomized
DIND
Transcranial
TCD
P=0.03
P=0.54
Good
Length
procedure-related
oxidant-inflammatory
flow-mediated
FMD
-mediated
ISDN-mediated
56.1
Xanthine
oxidoreductase
Perceptual
lexical
Norris
McQueen
Cutler
lexically
enables
talker-specific
dialect
3a
loads
4a
4b
/s/
/f/
nonlearning
trimegestone
dydrogesterone
estradiol/trimegestone
estradiol/dydrogesterone
2mg
+trimegestone
0.5mg
T-group
+dydrogesterone
DYDR
VIIc
VIIa
Plasminogen
Trigemestone
Trimegestone
procoagulant
tuberculosis
fluoroquinolone-containing
smear-positive
TB
Cross-protocol
anti-tuberculosis
non-infected
non-HIV-infected
thrice-weekly
larynx
scintigraphic
self-rating
hungry
.11
nurse-based
disease-related
Rome
multidisciplinary-based
Ganciclovir
oestroprogestins
hyper-responsiveness
pilo-sebaceous
acneic
PCOS
estroprogestins
EPs
ethinyl-estradiol
mcg/drospirenone
DRSP
mcg/chlormadinone
CMA
EE/DRSP
EE/CMA
Pillsbury
TEWL
homogeneity
seborrhea
Estroprogestins
mcg/DRSP
Setting
room/outpatient
5-15
MPIS
=9
5-12
63.2
p=0.37
glucocorticoids
//clinicaltrials.gov
NCT00565955
Fusidic
cataract
patient-administered
fusidic
viscous
commonest
pseudophakic
endophthalmitis
epidermidis
lids
conjunctivae
Fellow
fornix
margin
'clinically
0-49
organisms/swab
non-Staphylococcus
Whole-body
contrast-enhanced
A-scan
B-105
C-145
Homogenous
assuredly
decompression
collapse
radiography
ON
core-decompression
conservatively-treated
weight-bearing
necrotic
mid-coronal
mid-sagittal
A/180
B/180
electrothermal
EBVS
adrenalectomy
manoeuvres
pts
UltraSonic
Shears
USS
pt
OpT
mins
40-90
68.6
50-130
55-100
65-140
monoamines
fenfluramine
attention-demanding
ACRT
HVA/DA
press
button
ignore
pitched
latencies
maxima
rostrally
Fz
Pz
non-target
Subtraction
halved
Nd
pulsed
decubitus
microA
Seventy-four
epidermis
keratinocytes
Households
freely
bednets
Madagascar
Malaria
Insecticide-treated
bednet
2007-2008
Interviews
wealth
Coverage
owned
Univariable
Bednet
560
1.56
9.10
Household
adoption
cranberry
bacteriuria
pyuria
SCAPE
Honolulu
HI
596
sun-protection
hats
sunglasses
recency
communications
low-cost
donepezil
cholinesterase
8-17
amiloride
concomitantly
3/16
3/14
hyperkalaemia
Fixed-dose
manidipine/delapril
losartan/hydrochlorothiazide
antihypertensives
85-105
doubleblind
n=54
n=56
-22.2/-14.6
-19.5/-14.3
mg/mmol
-2.7
-4.0
-1.3
losartan/HCTZ
P=0.199
Glycemia
P=0.064
simulator-based
OSCE
first-year
lead-in
statements
manikin
simulator
hypothetical
likelihoods
normality
unpredictability
Miotics
Piperacillin/tazobactam
tazobactam
g+0.5
piperacillin/tazobactam
decontamination
antibacterial
apyrexia
piperacillin/
glycopeptide
dependency
OTHER
Smokers
INDEPENDENT
VARIABLE
marital
cohabitation
supranuclear
Neurotransmitter
degenerated
cortico-striato-pallidal
idazoxan
IDA
Uncomplicated
CFVR
DEBATE
Dissections
A-B
6.603
1.197
Moderate
Reversible
Ischaemia
60-80
Argatroban
ARG-E04
arginine-derived
argatroban
heparin-induced
non-HIT
multiple-dose
ARG250
ARG300
ARG350
μg/kg/min
UFH
70-100
96.8
45.5
Composite
ropivacaine/fentanyl
ropivacaine-fentanyl
ropivacaine-4
ropivacaine-2
ropivacaine-1
orthostasis
Lesser
interleukin-2
IL-2
T3-4
MIU/m2
1-4
17-20
Interleukin-2
1-5
constitutional
2/4
Subcutaneous
multitargeted
Oesophageal
auscultation
Prompt
oesophagus
Auscultation
epigastrium
anaesthetist
he
squeezes
beachgoers
England
avoidable
2,324
Southeastern
midday
beach
Subset
PointBreak
Pemetrexed-Carboplatin-Bevacizumab
Followed
Pemetrexed-Bevacizumab
Versus
Paclitaxel-Carboplatin-Bevacizumab
Nonsquamous
Non-Small-Cell
whites
underrepresented
pemetrexed-carboplatin-bevacizumab
pemetrexed-bevacizumab
PemCBev
paclitaxel-carboplatin-bevacizumab
PacCBev
Hazard
939
805
uniform
1.125
.525
1.229
.251
.607
1.375
.209
0.902
.670
0.661
.191
0.969
.915
Cranberry
UTI
V1A/V2
euvolemic
hypervolemic
hyponatremia
Hyponatremia
Na
mEq/liter
5-d
least-squares
2.0-fold
2.5-fold
46.5
/=135
Headache
visibility
phobics
veridical
sit
loudspeakers
audible
habituation
worried
broadcast
Rituximab
HD2002
375
CD20
Out
321
295
Estimated
logrank
0·047
DLBCL
0·35
0·05
0·006
0·02
0·00-1·03
0·27
0·05-0·97
Indicators
Twin
Pregnancies
PTB
1,447
±8.9
mm/y
-1.42
-2.6
-0.25
2.39
Cappra®
Alternative
Cappra
4.87
3.44
numbness
Sodium-potassium
Odense
Schoolchild
sodium-potassium
86rubidium
3H
-ouabain
9-11
cross-sectionally
cation
EDTA
Procalcitonin
pancreatitis
procalcitonin
PCT
Critical
Huizhou
Guangdong
semi-quantitative
immunoassay
PCT-guided
0.5ng/ml
10.89+/-2.85
16.06+/-2.48
16.66+/-4.02
23.81+/-7.56
Multicomponent
fibromyalgia
mixed-methods
PASSAGE
FMS
T0
PGIC
Waitlist
capture
ISRCTN14526380
Leptin
hormone-secretagogues
feeding-resistant
reesterification
stores
low-activity
somatotropic
thyrotropic
unravel
paradoxical
leptin
somatomedins
GH-secretagogues
normocaloric
GHRP
GHRP-2
Peptide
1-microgram/kg
microgram/kg.h
0600
IGF
-I
IGF-binding
protein-3
acid-labile
subunit
ALS
micrograms/L
microIU/mL
504
+87
+157
GH/IGF-I
Stimulating
GH-secretagogue
Untoward
compiled
notes
listlessness
upset
rebound
thorough
Albendazole
cysticercosis
albendazole
cyst
sulfoxide
giant
cysts
analyser
PFA-100
collagen-
epinephrine-coated
pore
aggregating
flowing
Naproxen
anti-aggregatory
104+/-16
212+/-69
109+/-19
148+/-56
168+/-66
Acetaminophen
Interceed
TC7
absorbable
reformation
Obstetrics
Adhesion
fabric
composed
regenerated
Sixty-three
sidewall
uncovered
deperitonealized
sidewalls
mm2
100-1000
10-98
Hearing
hearing-aid
worn
emotionally
anhedonia
hearing-impaired
surprising
Literacy
CwPLI
literacy
non-word
CwSLI
n=
SDs
illustrating
houses
inversion
electrophysiological
P100
Walker-McConnell
WMS
MGH
YouthCare
30-week
non-ASD
flexibility/transitions
intrasplenic
IS-IL-2
tried
chronometric
hepatoma
JRU/day
25-40
eosinophilia
12/18
thrombocythemia
LAK
Leu11
CD16
OKM1
CD11
OKIa1
HLA-DR
micrometastases
Calcitriol
Osteoporosis
calcitriol
1alpha,25-dihydroxyvitamin
vertebrae
12-57
25th
-1.8
-3.8
vasodepressor
prostacyclin
bradykinin
bradykinin-mediated
quinapril
2,3-dinor-6-keto-PGF1
salt-replete
normal-to-high
pg/mg
potentiated
50-fold
ACEI-treated
ng/kg/min
567
Indomethacin
abolished
vasodepression
prostaglandin-independent
bradykinin-independent
fenretinide
Retinoids
pTa
pT1
Cystoscopy
aneuploid
histograms
hyperdiploid
41.9
0.44-3.07
Recurrence-free
adaptability
morphology
urothelial
washings
hampered
predictivity
dermoid
Operating
93.6
chiropractic
eighteen-month
681
managed-care
facility
18-month
0.80-2.07
1.69
1.08-2.66
0.98
0.62-1.55
zero-balanced
ultrafiltration
Z+M
Oxygenation
OI
alveoli-arterial
A-α
Cstat
caridopulmonary
T5
Zero-balanced
brackets
resin-modified
glass-ionomer
RMGIC
premolars
cylinders
crowns
etching
Scotchbond
Multipurpose
one-step
MPa
8.34
7.05
7.00
4.79
10.61
4.58
orthodontic
Epimedium
brevicornum
neuroendocrino-immunological
EB
hypothalamus-pituitary-adrenal-thymus
HPAT
adrenocorticotrophin
Fufang
corticosterone
CORT
monoaminic
transmitters
hypothalamus
pituitary
CRH
paraventricular
neurofibrilin
eminence
fasciculate
atrophies
gamma-IFN
CORT-rats
temafloxacin
enoxacin
pefloxacin
pipemidic
methylxanthines
3-way
183mg
600mg
750mg
mg/L.h
terminal-phase
4.5h
intertrial
Coadministration
methylxanthine
leisure
fish-oil
vegetable-oil
ethanolamine-containing
lysophospholipid
oleic
42-d
collagen-induced
washed
omega-6
20:5n-3
ether-containing
plasmenylethanolamine
mol
moles
phosphatidylethanolamine
agonist-induced
lysoplasmenylethanolamine
phospholipase
hydrolysis
A23187-stimulated
acid-derived
5-hydroxyeicosatetraenoic
EPA-derived
LTB5
5-HEPE
5-hydroxyeicosapentaenoic
lipoxygenase
idarubicin
Memorial
Sloan-Kettering
MSKCC
SEG
stated
Epileptogenic
SLE
acid-containing
multivitamin
epilepsy-related
periconception
12225
periconceptional
-containing
cleft
22-year-old
carbamazepine
20th
She
lupus
erythematodes
Her
ended
drug-induced
blood-brain
UGIE
dufing
SpO2
non-sedated
0.0027
MST
dress
Marsden
anterior-posterior
FPEs
treatment-simulator
right-left
ARL
superior-inferior
ASI
LAP
LSI
S.D
sigma
0.06-0.09
cm2
Hypofractionated
Systematic
hypofractionation
customised
immobilisation
RL
ideally
coexisting
patellofemoral
PF
tibiofemoral
compartments
knee-specific
ADLS
Moderate/severe
PFOA
Nm/body
Nm/BW
120.8°
14.4°
133.5°
10.7°
125.8°
13.0°
0.1-0.7
0.1-0.6
going
downstairs
1.0-8.1
TFOA
zilpaterol
finishing
steers
4,178
403.9
16.04
R25C
ZH
Steers
yard
genotype-specific
pens
steers/pen
slaughtered
132.1
ZH-fed
ADG
9.67
9.53
9.28
kg/d
9.68
9.90
ZH-feeding
USDA
YG
carcasses
17.7
Marbling
Choice
Prime
marbling
HCW
fatness
ME-609
patient-initiated
simplex
labialis
HSL
Xerese
Xerclear
acyclovir
2437
self-initiate
Cream
times/d
1443
232
.014
contain
atracurium
Regurgitation
ingesting
hyper
cetrorelix
buserelin
infertile
Follicle
HCG
unsettled
high-flow
PaO2
alveolar-arterial
AaDO2
Insular
cingulate
SZ
rsFC
dACC
striatum
addiction
insular
weakening
anatomically
insula-dACC-striatal
non-psychiatrically
Decreased
insula-dACC
scrutinized
7184
4151
resin-dentin
neutralizes
ascorbate
μTBS
Bonded
beams
stereomicroscopy
40×
dentin-composite
interface
RATIONALE
English-speaking
brochure
conversation
technologist
clarifying
semi-Fowler
Phonophoresis
ketoprofen
arthroscopy
Just
Fastum
10-cm2
Biopsies
phonopheresis
noninduction
tacrolimus-based
globulins
ATG
France
n=151
Steroid
tapered
Azathioprine
rejections
P=0.001
steroid-sensitive
Steroid-resistant
Histologic
1971
NLPD
Stanford
lymphoid
alkylating
CVP
C-MOPP
22/78
histiocytic
Documented
FAM
BCNU
unmeasurable
ways
SOURCES
PubMed
searches
cross-referencing
English
1970
SELECTION
Relevant
abstracts
articles
Included
chronicity
emerge
centralized
lends
hopefully
reshaping
translational
mechanistic
osmotic
calorific
glycerol-based
Equilibration
Solutions
80-fold
eightfold
haemolysis
glucose-based
non-esterified
ketone
bodies
chromic
P-32
IDI
43-65
mCi
Tc-99m
loculation
pseudoloculation
Autosomal
ADPKD
pravastatin-treated
indeterminate
Monkeys
primacy
let
hint
conspecifics
sharper
duller
monkeys
traces
probed
escaping
mirrored
Signal-detection
Optimality
sophistication
gamma-linolenic
antioxidants
influx
Previously
EPA+GLA
Oxepa
alveolar-capillary
permeability
injury/acute
isocaloric
BALF
ceruloplasmin
Pao2/Fio2
facilely
eight-week
step-count
Mobility
Therapy-General
Therapy-Fatigue
P=0.28
silence
piglet
atrophy
weanling
piglets
Expt
28-d-old
suckling
L-glutamine
wt
L-alanine
Operon
Porcine
Genome
Oligo
52-346
35-77
120-124
oxidants
34-75
Functionally
oxidative-defense
+12
+19
coordinate
mammals
Infliximab
ankylosing
spondylitis
Methotrexate
infliximab
0-18
Bath
Ankylosing
Spondylitis
BASDAI
NCT00507403
workloads
pedalling
cycles/min
fR
VT/TI
canopy-computer-spirometer
TI/TTOT
CX516
AMPA-modulating
fragile
Ampakine
FXS
attention/executive
CX516-treated
Problems
AMPA-mediated
IMVAMUNE
smallpox
MVA-BN
clone
Vaccinia
Virus
Ankara
571
pre-immunized
seroconverted
TCID50
vaccinations
Lister-Elstree
Dryvax
attributes
render
contraindicated
pulpitis
Novafen
anhydrous
pulpectomy
omega
peroxidation
ethane
pentane
PPMD
N=56
MDD/PPMD
PSQI
Estradiol
scores≥15
=0.98
p=.32
post-delivery
Antisaccade
pursuit
lorazepam
saccadic
distractibility
carrying
antisaccade
arise
psychopharmacology
interpreting
no-saccade
saccade
Lorazepam
Practice
worsens
psychotropic
chlorpromazine
leadership
biometric
organizations
Interceptor®
insecticidal
polyester
denier
bursting
alpha-cypermethrin
@
mg/m²
tribal
dominated
Chhattisgarh
Kanker
viz
Interceptor
LN
undertaking
fortnightly
Mosquito
collections
catch
pyrethrum
dwellings
Slide
SPR
wash
bioassays
LNs
post-net
destructively
culicifacies
24.8
44.2
737/936
possession
31.7
holed
Availability
usable
Outpatient
optimizing
disciplines
eighty-six
registrants
'mental
MAC
'psychological
BSI
ZUF-8
complete-cases
lacked
fighting
spirit
otoplasty
TTS-scopolamine
scopolamine-treated
peroperative
8/25
atropine-treated
1/25
TTS-scopolamine-treated
0.8+/-0.9
0.3+/-0.6
auriculoemetic
auriculocardiac
Cutting
undesirable
monoethylglycinexylidide
MEG-X
lidocaine-induced
MEG-X30min
dose-independent
.0013
Child-Pugh
manipulative
cLBP
lumbopelvic
Questionnaires
inquired
15D
Instrument
Pearson
Incremental
one-point
512
Physician
absenteeism
Smoking
smokeless
Smokeless
cigarettes/day
pack-years
Point-prevalence
2.52
31.5
1.94
.023
23.1
Ambulation
ambulant
recumbent
oxytocic
budding
AJCC/UICC
Jass
Cancer/Union
infiltrating
scattered
Progression-free
cancer-specific
survivals
lymphovascular
High-grade
univariable
3.91
1.3-11.77
1.62-21.51
prognostication
reactivities
cryptococcal
culture-proved
silent
shortly
meningeal
cryptococcal-antigen
flucytosine
maintenance-treatment
practice-based
SNAC
Staged
Nutrition
behaviourally-based
prescriptive
Guides
ISRCTN:42921300
out-perform
uncluttered
luggage
target-absent
bags
opportunities
1-29
NH2
longstanding
post-irradiation
supramaximal
re-evaluated
18.4-26.7
13.7
11.4-15.7
post-radiotherapy
30Gy
2min
5min
Irradiated
5mU/l
37.4mU/l
4.8mU/l
15.2mU/l
05
122mU/l.min
179mU/l.min
268mU/l.min
tropic
late-occurring
competing-risk
ninety-four
-13
.14
threefold
phenytoin
polyglutamate
pteroyltriglutamate
polyglutamates
Movement-related
Presence
predictability
inferred
movement-related
MRPs
internally
Supplementary
disrupted
non-cued
externally
cued
unpredictable
bypassed
reliant
programming
90-min
psychoactive
Vitrectomy
vitreoretinal
perfluoropropane
attached
maculas
multicentered
Community-
university-based
sulfur
hexafluoride
265
218
48-month
60-month
72-month
oil-treated
gas-treated
reattachment
5/200
oil-retained
oil-removed
keratopathy
detachments
paramount
obtaining
amorphous
fluorescence
phosphoprotein-amorphous
CPP-ACP
mouthwashes
WSL
debonding
bracket
0-4
remineralising
Topacal
fluoridated
registrations
WSL-scores
regime
aesthetically
CHOP-levamisole
CHOP-levamisole-BCG
large-cell
Chemoimmunotherapy
levamisole-BCG
MCID
elicitation
ping-ponging
university-affiliated
Sixty-four
MCIDs
flip
2.01
1.60-2.42
afterward
1.015
implied
patient-physician
In-hospital
self-expanding
nitinol
femoropopliteal
VascuCoil
Intracoil
Femoropopliteal
stenotic
popliteal
IntraCoil
3,500
8,435
4,980
provisional
bitolterol
isoproterenol
nonsteroid-dependent
bronchodilation
Tachycardia
palpitations
Bitolterol
olopatadine
provocative
Olopatadine
H1
mast
stabilizer
non-steroidal
ciliary
episcleral
beds
Implementing
protocol-helping
HBB
Nepal
asphyxia
Helping
Babies
Breathe
Perinatal
attendants
intrapartum-related
cohort-study
CCD
cameras
oximeters
Along
intrapartum
policymaking
ISRCTN97846009
Aims
RelyX
Unicem
PCCs
RXU
RXU+E
PCC
CAD/CAM
Cerec
USPHS
24-59
25-75
PBI
3-9
debonded
USHPS
discoloration
reobserved
metipranolol
butizide
torrat
Kenyan
Africans
interviewer
underreporting
Eighty-eight
telephone-administered
MP24R
rEI
BMR
Deltrac
EEPA
Caltrac
estTEE
misreporting
In-person
Underreporting
widespread
Handwarming
warm-relax
WR
cool-relax
hand-warming
-cooling
1/2-hour
directionality
expectancies
Esomeprazole
resolves
heartburn
oesophagitis
esomeprazole
241
heartburn-free
6-7
21-22
Systems
parent-adolescent
BFST-D
Families
BFST-D.
fathers
Acipimox
hyperlipidaemia
Fredrickson
IIb
acipimox
triple-drug
Lokmanya
Tilak
Mumbai
thirty-one
pantoprazole
Per-protocol
85.8-96.1
81.8
73.9-87.8
0.027
80.9-93.0
79.1
71.1-85.4
Follow
lithotripsy
ESWL
Extracorporeal
Shock
Wave
Lithotripsy
anaesthesiologists
publications
tell
procedure7
0,05
mcg/kg/min
GROUP
N.=114
µg/kg/min
requests
deepness
Obsever
O/ASS
Likert
11-points
P=0.20
1.61±0.19
2.987±0.20
granting
vulvovaginal
candidiasis
VVC
mycologic
Candidas
56.0
44.0
29/300
271/300
glabrata
tropicalis
krusei
parapsilosis
Mycologic
96.0
98.0
93.8
89.8
prioritizing
hazardous
manufacturing
columns
rows
high/moderate/low
Reflecting
industrial
hygienist
walk-through
inspection
processes/areas
6-point
roughly
urgently
inter-rater
kappa
inexpensive
complements
upstream
STAT
shortness
LVIDd
echocardiogram
cardiothoracic
necessitate
674
ventriculograms
diet-exercise
IGT
receives
-4.6
-0.9
figures
posture
Cheyne-Stokes
respirations
Orthopnea
cardinal
cardiographic
Sleeping
slept
apneas
5/h
hypopneas
hypopnea
non-supine
wakefulness
congestion
IFN-α
MMP-8
Matrix
metalloproteinases
MMPs
Pre-treatment
IIB-IIIC
36.8
0.55-0.99
0.88-1.55
0.86-1.56
1.00-1.02
0.81-1.46
1.36
1.17-1.58
CPX
EFs
62.6
67.4
ventilation/carbon
VE/VCO
Echocardiographic
E/A
34.0
CRPS1
MIP
Possibilities
RecImMir
ImRecIm
RecMirRec
imparted
Imagined
Mirror
13-cis
retinoic
13-CRA
Determination
CBC
reticulocyte
.66
Greater
exerts
posttransfusion
irrigated
n=30
20cc
installed
P=.018
choices
40-year-old
DA
harms
38-45
worksheet
knowledgeable
7.35
p=0.24
indecision
DAs
Single-needle
gag
single-needle
gag-reflex
Settings/locations
cardioembolic
Johann
Wolfgang
Goethe-University
Frankfurt/Main
Subjects/Study
disposable
Suzhou
Appliances
10-mm
Chengjiang
chin
superficially
visual-analogue
nonacupuncture
CV24
tribulations
egg-yolk
lutein
pigment
buttermilk
Naturally
xanthophylls
Macular
heterochromatic
flicker
photometry
yolk-based
yolks
NCT00527553
ergometry
widely-cited
overestimation
ramp-incremental
20-80
randomly-selected
isokinetic
dynamometry
bone-free
formerly
ramp
statin-based
SHARP
ezetimibe
2353
355
simvastatin/ezetimibe
AURORA
Evaluate
Hemodialysis
337
1.23
P=0.44
707
LDL-C-lowering
725
Taken
Converting
Enzyme
11weeks
Class=2.3±0.5
28±7
64±12years
32:5
V˙O
2peak
non-exercising
genotype-dependent
Pretests
posttests
Attainment
Scaling
discusses
neoplastic
uricosuric
BUN
mg/24
azotemia
ml/min/1.73
day-to-day
interferometry
pulsations
mechanocardiography
a/b
oxymetric
fingerplethysmography
phenylephrine
isoprenaline
isoprenaline-effects
isoprenaline-induced
QS2c-measurements
Fingerplethysmography
vasodilating
-change
characterization
Prognosis
Okuda
Liver
CLIP
Barcelona
BCLC
Fédération
Francophone
Cancerologie
Performances
Akaike
Harrell
Royston
monotonicity
gradients
Schemper
Vs
classifications
538
4.6-6.2
alpha-fetoprotein
associating
aberrant
AD
genders
time×treatment
lethargy/social
P=0.04
hyperactivity/non-compliance
Vomiting
Proposed
Lipid-lowering
undoubtedly
CCB
CCBs
unequivocal
conceivable
anti-atherosclerotic
REGRESS
cotreated
cotreatment
unrealistic
anticipate
HMG-CoA
merits
Currently
underway
Immunoglobulin
LAIV
6-36
strain-specific
fold-rises
GMFRs
2-fold
0.5-2.2
seronegative
seropositive
hemagglutination
3.1-fold
culture-confirmed
type/subtype
vaccine-induced
hinders
LAIV-induced
T-cell
wild-type
breast-conserving
forty-four
radiotherapy-first
chemotherapy-first
ar
Age-Related
cupric
2,166
'traceback
interscalene
zidovudine-induced
/AIDS-related
intolerant
Zidovudine
instituting
ANC
1,000/microL
/microL
microgram/kg/d
Neutrophils
Viral
malaise
Escort
spirometer
Micromed
turbine
mini-Wright
meter
pragmatically
Fleisch
pneumotachograph
Pocket
Aldermoor
Southampton
5-88
6-82
Ninety-five
Graphical
plots
over-reading
Readings
interchanged
acustimulation
ReliefBand
0.625
Postdischarge
vs.40
Acustimulation
FK
506-
A-treated
endomyocardial
2.28-2.93
1.78-2.03
0.98-1.13
Wakings
0.18-0.53
0.20-0.34
0.04-0.12
8.05
7.65-8.44
8.75
8.56-8.98
9.84
9.68-9.99
Processing
familiar
propofol-sufentanil
day-case
Stimuli
names
fictitious
GRoup
attribute
fame
famous
elaboration
brachytherapy
metal
SEMS
incurable
Gy×3
n=21
FU1
FU2
patient-number
n=35
Difference
hope
Kawasaki
IVGG
Chemoradiation
locoregionally
as-treated
3-74.6
leucopenia
60.9
p=0.9613
0.50-0.98
79.2
p=0.9884
0.63-1.010
Menstrual
re-evaluation
elders
294
cool-down
tracked
.51
recovering
genito-urinary
hypospadias
II-IV
microg.kg
-16.6
17.2
697.6
240.7
248.0
178.4
270.2
180.8
-230.6
166.9
16-17
PGE2
PGE-2
Arm-cranking
arm-cranking
Community-based
N=17
sessions/wk
warming-up
10-15min
arm-crank
20-30min
3wk
cooling-down
5-10min
Plasmatic
peroxidase
carbonyl
P=.014
P=.027
P=.022
finally
Acceleration
warming
Subcutaneously
excursions
InsuPatch
accelerate
unit/kg
aspart
euglycemic
GIRmax
GIR
0-90
glucodynamic
accelerates
open-loop
coingestion
abusers
disrupt
MS-sNT
sequestered
pellet
Sequestered
tampering
crushing
morphine-induced
4-way
opioid-naive
sequestering
coadministration
Zocor
lipostabil
forte
prime
micronutrients
Christchurch
earthquakes
22nd
earthquake
post-traumatic
end-of-trial
ES=0.69-1.31
Disaster
disaster
ACTRN
12611000460909
isoglycemic/hyperinsulinemic
50-min
15-d
1-wk
heptic
refers
error-prone
casebook
conscious-processing-condition
consciously
unconscious-processing
distracter
occupation
1,504
police
ups
Loss
zidovudine/lamivudine
lopinavir/ritonavir
LPV/r
sTNFR
simplification
EFV-based
LPV/r-based
SQ-standardized
trigger
Graza
Phleum
pratense
75,000
SQ-T/2800
BAU
ALK
moderate-severe
RQLQ
opioid-spare
unquantified
analgesic/sedative
Neonates
≥32
mg·kg
6-hourly
postthoracoabdominal
mcg·kg
·h
seizure
extubated
-28
5/20
ultrasounds
electroencephalographically
intraabdominal
end-tidal
N2O
Intraabdominal
demographically
Bisphosphonate
GOALS
WORK
bisphosphonate
pamidronate
Enrolled
Where
disruption
16/138
13/14
uropathy
infusions-and
save
childhood/adolescent
antipsychotics
Impressions-
Olanzapine
lbs
2597
qdRT
HART
0/1
time-concentration
225
Gy/d
57.6
tid
.28
Two-
pneumonitis
let-7
miRNA-complementary
untranslated
KRAS
N0147
microRNA-complementary
LCS6
upregulate
mutation
clinicopathologic
2,834
977
Log-rank
432
G-allele
2,402
84.8
834
T-allele
Caucasians
races
0.929
0.76-1.14
germline
Endeavor
zotarolimus-eluting
TAXUS
ENDEAVOR
Zotarolimus-Eluting
Paclitaxel-Eluting
Stents
ZES
zotarolimus
antiproliferative
phosphorylcholine
polymer
cobalt
alloy
thin-strut
1,548
773
775
noninferior
in-segment
0.284
0.228
0.756
NCT00217269
TeachTown
Basics
Instruction
between-subject
K-1
off-computer
possibilities
remediating
funds
ischaemic/reperfusion
FR
Free
spectroscopy
16.6
RVEF
stunning
LACC
WP-CRT
WP-IMRT
Federation
IIB-IIIB
50.4
10.7-37.4
7.7-34.4
79.4
P=.651
P=.645
P=.034
P=.047
P=.011
anti-cancer
Pleural
neoplasm
Nocardia
rubra
skeleton
N-CWS
thoracostomy
46.1
immunopotentiator
pleurisy
intrapericardial
Carbazilquinone
ACNU
3-365
reaccumulation
pericarditis
incontinence
incontinent
gone
corroborated
PROCLAIM
atherothrombosis
CD40
pro-brain
model-adjusted
CD40-ligand
-186.5
-342.3
-30.8
fluke
worm
beef
cattle
housing
livestock
farm
batches
clorsulon
closantel
drench
parasiticide
2D1
Monoclonal
KwaZulu-Natal
phenotypes
Non-pharmacological
Enforcement
Nasotracheal
curve-tipped
NTI
orotracheal
CTSC
nasotracheal
advancement
under-went
ventrally
nasopharynx
pharynx
62/62
57/69
21/62
33.9
37/69
wks
Sixty-two
triptorelin
conversions
Triptorelin
IFN-alpha-2b
PEG-IFN-alpha-2b
1,256
627
micrograms/kg/wk
DOSAGE
ERROR
CORRECTED
C30
-11.6
-8.2
-15.0
-10.5
-6.6
-14.4
incompensation
retrospect
Peritoneovenous
shunting
ascites
Alcoholic
Ascites
1/2-year
299
peritoneovenous
LeVeen
liver-function
prerenal
1093
disabling
nonacute
promyelocytic
genotypic
NPM1
FLT3
CEBPA
ATRA
1075
daunorubicin/Ara-C/thioguanine
Ara-C
duplications
592
423
MN1
FLT3/internal
prizidilol
Prizidilol
92657
arteriolar
Isoprenaline
beta-adrenoceptors
hyperkinetic
Immunologic
antiinflammation
Hydrocortisone
interleukin-8
CD11b
CD64
antigen-DR
phagocytosis
monocyte-activating
interleukin-12
non-fatal
non-processed
peanut
re-challenge
Peanut-allergic
re-challenged
recipes
RAST
reacted
epitope
p.p.m
990
p.p.m.
food-allergic
Older
CML-Study
five-arm
BCR-ABL-positive
IM400
IM800
828
382
630
NCT00055874
respondent
becoming
minorities
Respondents
fall/winter
home-visit
invitation
Samliem
Khon
Kaen
quasi-randomized
in-home
inner-city
Northeast
visited
culturally-sensitive
screening-coverage
p=0.339
p=0.119
p=0.070
Paclitaxel
414
cisplatin-only
paclitaxel/cisplatin
P=.028
P=.026
P=.862
arthralgia/myalgia
Angina
RITA
register
arteriographically
agree
revascularisation
satisfy
2x2
43-103
guessed
incorrectly
saw
condyle
orthognathic
mandible
condylar
retrognathism
osteotomies
condyles
15/28
TMJs
derangement
Fixing
well-established
cardiology
Republic
90-
=140/
Trough
SiSBP
perprotocol
violation
146.7
/96.6
/83.4
146.8
/96.7
/83.8
SiSBP/SiDBP
56/69
83/92
90.2
28.7
3/94
1/94
Pupillary
Dilation
Anterior
Segment
Morphology
Pseudoexfoliation
post-dilation
pseudoexfoliation
tropicamide
PXS
PXG
fellow
Pentacam
ACD
ACV
ACA
CCT
pupillary
mydriatic
mmhg
-1.06
1.59mmHg
Post-dilation
pre-dilation
Anti-glaucoma
tongbu
Tongbu
TB1
Kidney
Spleen
viscera
send
Turbid
downward
leaf
cistanche
fleeceflower
rhubarb
etc
endocrinal
scavenging
TB2
overdentures
5-y
edentulous
prosthodontic
overdenture
opposing
denture
Satisfaction
dentures
single-implant
NCT02117856
6-hr-period
1-hr
+5
+15
18±3
33±3
ventilation+15
area/left
High-frequency
ventilation+10
eccentricity
ventilation+5
whatever
redistribution
Wavefront-guided
LASIK
refractive
higher-order
aberrations
HOAs
wavefront-guided
spherical
-2.01+/-1.36
diopters
Zyoptix
Refinement
ZAR
-1.81+/-1.21
Planoscan
Uncorrected
UCVA
refraction
Acuity
Zywave
aberrometry
20/25
0.5-D
HOA
RMS
1.5-18
retreatments
Moderate-intensity
aerobics
9yrs
2.9mL/kg/min
watts
.000
Teenagers
RESPECT
friends
n=120
Danish-speaking
ambassador-facilitated
schoolteachers
ambassadors
file
NCT01772849
NCT01772862
Academic
Spatiotemporal
0.364
nonparetic
deg
0.177
dorsiflexion
-0.222
push-off
W/kg
-0.142
.026
hiking
BMIs
edrophonium
neuromuscular
pancuronium
tubocurarine
Edrophonium
antagonize
pancuronium-
tubocurarine-induced
Antagonism
train-of-four
Neuromuscular
interosseous
Humour-related
humour-related
mentally
comedy
post-percutaneous
n=49
n=50
post-PCI
Repeated
2-week-longer
contingently
walked
furnished
sofa
chairs
toys
statue
still-face
imitated
sat
attempting
contingency
imitative
Parietal
antacids
antacid
gastroscope
corpus
parietal
H-2
gastritic
d-cycloserine
d-Cycloserine
N-methyl-d-aspartic
weight-loss
watchers
Watchers
-8.0
Watchers-only
contacts
temper
placebo-substitution
N=5
N=1
intermediate-length
device-guided
advocated
helps
Resperate
-12.4
/-2.6
-8.4
non-compliant
Anti-tumor
Crohn
missile
Diet
GL
12-mo
GL-level
decrements
Decrements
regain
provided-food
deter
bench
Work
Bench
anywhere
warehousing
absences
Dunaliella
bardawil
beta-carotene-rich
algae
9-cis
PLT
MN
four-
one-tenth
three-
1.5-fold
LEAP
non-model-specific
CTMs
CTM
non-urgent
referrals
'fast
'ordinary
Lothian
Borders
SF12
T-scores
EuroQol
+/-16
+/-51
15-month
Rationing
wasteful
Slotted
non-slotted
locked
Grosse-Kempf
AO/ASIF
cadaver
stiffnesses
strengths
torsion
implant-bone
deformed
Gross-Kempf
splinterings
osteosynthesis
Osteosynthesis
high-stiffness
globally
neurologic
Cord
Injury
post-SCI
edition
12-Item
differs
assistive
Practicing
Lanthanum
Fosrenol
hyperphosphatemic
non-aluminum
non-calcium
ESRD
lanthanum
one-
three-week
=1.8
titration
pre-randomization
carbonate-treated
EUROSCAN
Steering
Mexiletine
mexiletine
HIV-related
PPN
crossed-over
Crossover
Dose-limiting
first-drug
Colon
curable
cell-BCG
7-66
p=0.011
18-81
0-68
p=0.032
clomiphene
day-1
metformin/placebo
menses
resumed
P=0.63
ovulated
P=0.59
equipotent
micrograms.kg-1
pancuronium-metocurine
ml/10
post-induction
Intubation
tachycardic
Atracurium
PCWP
Al
evaluation/academic
evaluation/social
Hypothesis
high-BP
low-BP
stressor
shame-
anger-related
shame
Thromboprophylaxis
low-molecular-weight
125I-fibrinogen
Verification
mexicor
thrombocyte
viscosity
Russian
cytoprotector
50patients
cytoprotective
mexidor
lowers
thrombocytes
hemorheological
retards
hydrocodone
Hydrocodone
active-comparator
HI1
HI2
51.1
Types
arthritic
neuralgic
351
74.8
opioid-nonopioid
2.25+/-0.89
1.98+/-0.87
1.85+/-0.96
2.94+/-0.99
3.23+/-0.76
3.26+/-0.75
0.24+/-0.49
0.34+/-0.58
0.49+/-0.85
79.5
decision-theoretic
0.0053
0.383
-0.015
-0.127
0.091
Phenytoin
Sunlight
D-deficient
non-western
immigrants
IU/3
Non-western
18-65
March-September
50.5
sunshine
Controversies
Challenges
successes
institutions
infrastructure
committed
logs
3547
prescreened
n=3092
ineligible
n=113
assure
Recording
standards
P3b
deterministic
context-dependent
multi-institutional
imidafenacin
fesoterodine
overactive
OAB
fesoterodine-controlled
DMVF
vi
-3.38
3.63
-2.45
3.73
Imidafenacin
-0.53
teleconferencing
interviewing
Teleconferencing
Supervision
Motivational
Interviewing
post-workshop
Integrity
proficient
ml/kg
emulsions
10.0
min.
Mini-Mental
Neoadjuvant
LARC
II/III
825
weekends
TMN
T4N2
T3N2
T2N2
T3N1
T2N1
T3N0
acneiform
radiodermatitis
Overall-
T-
N-downstaging
anal
verge
Non-fatal
downstaging
Catheter-related
VACs
nosocomial
catheterizations
subclavian
lengths
0.1371
bloodstream
0.5967
Two-week
Intravesical
Adriamycin/Farumorubicin
465
Ta
Flurbiprofen
cryo
Conservative
fasciitis
accommodative
orthoses
proving
anthracyclines
cardiosclerosis
PICS
diaphorase
eNOS
iNOS
peroxinitrite
ONOO
plazma
Reliable
NT-pro
demands
Biotin
teratogenic
3-hydroxyisovaleric
3-HIA
biotin-dependent
methylcrotonyl-CoA
carboxylase
organic
21-37
biotin/d
early-pregnancy
late-pregnancy
teratogenicity
lymphocysts
retroperitoneal
glue
paraaortic
thin-walled
water-equivalent
demarcated
surroundings
Botulinum
antinociceptive
cystitis
BTX-A
Intriguing
Dysport
cystoscope
submucosally
trigone
O'Leary-Sant
Interstitial
Cystitis
Problem
Daytime
desire
void
cystometric
afferent
3333
olive
gamma-glutamyltranspeptidase
free-EPA
onwards
free-arachidonic
BACKGROUND/AIM
YAG
unfit
cardia
extrinsic
'intention-to-treat
post-Resources
REACH
bother
cities
ninety-five
Hispanic
CGs
check-in
CG-rated
racially
18F-FDG
PET/CT
lapatinib
trastuzumab
HER2-positive
Neo-ALTTO
selecting
Lapatinib
Trastuzumab
Optimisation
455
HER2
anti-HER2
F-FDG
SUVmax
pCRs
non-pCR
61.5
34.1
micronutrient
aneurysmectomy
ischemia-reperfusion
augment
Handgrip
Self-rated
sled
towing
Weighted
excessively
heavy-
light-load
10-m
5-m
posttraining
hyperthyroid
speckle
2D-STE
TSH-suppressive
levothyroxine
l-T
low-TSH
euthyroidism
euthyroid
PROPOSAL
N-Acetylcysteine
+risperidone
placebo+risperidone
effervescent
NAC+risperidone
nervousness
Meanwhile
//www.irct.ir
IRCT201106103930N6
multiphasic
0.1-1.9
.49
0.5-3.6
0.0-8.9
intragastric
anticholinergics
MAO
mmol/h
radiotelemetric
tenfold
binds
leaves
Ascorbic
0.5-5.5
Diazepam
digit
visuomotor
Playtime
FPI
Siller
Dev
Disord
43:540-555
2013a
bigger
attachment-related
separation-reunion
undergraduates
submerging
medicinal-smelling
non-dominant
no-expectation
McGill
immunomodulator
immunoregulatory
H2-histamine
H2-blocker
mitogen
phytohemagglutinin
CFS
myalgic
encephalomyelitis
syndrome/myalgic
CFS/ME
UK-Chalder
UK-SF-36
Netherlands-CHQ-CF87
UK-Hospital
Spence
Netherlands-Spielberger
time-to-assessment
multinomial
12-18
1.42
1.90
81.1
Paediatricians
recognise
aetiopathology
NUMBERS
FITNET
ISRCTN59878666
NCT00893438
post-results
2-D
160/90
pharmacogenomic
70-90
2-gene
signature
RASGRP1
aprataxin
APTX
AMLs
RASGRP1/APTX
chemotherapies
T-based
NCT00602771
FLT3ITD
mutated
unmutated
FLT3-internal
duplication
648
FLT3ITD/wtFLT3
FLT3ITD/wtFLT3+1
329
NPM1+
wtNPM1
3.1-11.2
3.4-16.5
postremission
NPM1-mutated
Course
clinician-guided
Internet-delivered
iCBT
iCBT-based
lessons
Psychologist
e-mails
30/31
29/31
.88
.38
.64
81.54
30.91
contacting
gamblers
gambling
post-treatment/post-waiting
Gambling
Money
Spent
Last
Gamblers
Consequences
Mouth
chinstrap
complicates
diminishing
complaining
polysomnographies
Cephalometry
42.9+/-23.5
23.8+/-13.3
TST
33.4+/-18.6
23.6+/-9.3/sleep
6.7+/-14.3
24.0+/-13.2
Cephalometric
unacceptably
Consideration
Onset/offset
rapacuronium
assessor-blinded
Datex
Relaxograph
good-to-excellent
39.1
attracted
unpremedicated
18-59
gynecological
propofol/kg
N2O/O2
FIO2
ED50
0.102
0.202
20/10-15
postinduction
dreams
pleasant
I.
Predisposition
methotrexate-induced
Quadratus
lumborum
quadratus
QLB
fascial
path
singleton
kg⁻¹
NCT02328378
attendees
Wales
pre-consultation
61-91
0-33
3-25
pre-counselling
worry
GP
moderately/very
dissatisfied
thyrotropin-stimulated
radioiodine
goiter
rhTSH
131I
augments
GVR
setup
22-83
nontoxic
25-379
n=60
35+/-3
P=0.81
131I-activity
MBq
45-1269
245-3530
official
goiter-related
myxedema
131I-therapy
posttherapeutic
Carbon
open-chamber
deairing
left-sided
maneuvers
twenty-five
Neurocognitive
z
intracardiac
chambers
crossclamp
declaration
Deairing
9-18
250-mg
Naprosyn
Astra-Syntex
50-60
1.5-3
Capsaicin
jelly
extracranial
perivascular
afferents
migraineurs
Perivascular
fibres
calcitonin
gene-related
CGRP
vanilloid
depolarisation
capsaicin
periarterial
vaseline
17/23
mild-
11/17
capsacinoids
MgSO4
1-12
dispensed
containers
Decoding
aminophylline
hospitalisations
Community-dwelling
expert
386
hospitalised
screen-detected
COMB
MED
three-site
parallel-groups
3:2
aripiprazole
60.5
.006
4.31
4.16
0.071
three-year-old
early-life
MEE
6350
town/rural
suburban
tympanometry
otoscopic
tympanostomy
socioeconomically
advantaged
disadvantaged
circumscribed
unidentified
causality
findings.language
Minimally
cytokine-induced
Adoptive
chemoembolization
CIK
CD3+
CD56+
CD3+CD56+
CD4+/CD8+
68.6+/-11.0
31.1+/-9.0
15.6+/-7.9
5.2+/-3.1
1.1+/-0.5
70.7+/-10.1
33.5+/-8.0
18.4+/-9.4
5.9+/-2.8
1.3+/-0.7
31.1+/-7.8
28.6+/-8.3
ranolazine
antidiabetic
FPG
MERLIN-TIMI-36
MERLIN
Ranolazine
first-in-class
antidiabetes
Spotfire
or=8-10
placebo-adjusted
-0.99
150-400
-43.3
-8.1
slopes
Diphereline
Cabergoline
Dostinex
cabergoline
Tabriz
Sciences
46-53
21-97
p=0.881
0.701
hold
Synthesis
interleukin-1
colchicine
PBC
cholestatic
Interleukin-1
Colchicine
PHA
lipopolysaccharide
constitutively
immune-mediated
stimulants
IL-2-induced
epidermidis-induced
colchicine-treated
TEN
ATI
Vivonex
Freamine
HBC
Trophamine
branched
calorie
150:1
jejunostomy
Jejunal
unconditionally
gm/day
Traditional
Infections
abscess
Behavioral/psychoeducational
overtaxed
bendrofluazide
xipamide
Russell
tentative
clarifies
AAAs
2-dimensional
AAA
CT.
Limits
+/-5
Custom
tray
non-surgical
trays
custom-tray
Tray
Gel
acclimation
standardize
BI
post-SRP
1.40
1.50
cited
GC
IC-IV
doses/schedules
636
820
919
P=.199
censoring
57.3
P=.013
HR=1.22
CI=0.99-1.52
P=.067
asystolic
Femoral-artery
out-of-hospital
six-hour
early-phase
pollutants
NAR
cationic
ECP
tryptase
MCT
Allergen
curbside
traffic
Conduit
lowlanders
highlanders
sympathoexcitation
adaptions
altitude
mountain
high-altitude
natives
5050
Sherpa
endothelium-dependent
endothelium-independent
CIMT
Cephalic
radical-mediated
hydroperoxides
LOOH
sea
12-14
m.
Highlanders
GTN-induced
allometrically
∼19
normobaric
±1.3
α1-adrenoreceptor
intensifies
remodelling
Post-stroke
58.5
40-83
6-913
Crying
HDS
UKU
McNemar
triage
high-volume
unscheduled
rooms
398
midsize
3600
in-stent
Sirolimus
Inhibit
In-stent
OSIRIS
ISR
neointimal
halt
allograft
vasculopathy
usual-dose
P=0.08
Abecedarian
1972
Frank
Porter
Graham
heath
risky
thiopentone/guaifenesin
ketamine/guaifenesin
ketamine/midazolam
anaesthetised
acepromazine
xylazine
guaifenesin
KG
KM
2.07
75.6
81.0
ECV
anthracycline-treated
DHEA
61-89
strains
non-vaccinated
1:40
A/Texas
non-protective
Post-immunization
A/Johannesburg
anti-B/Harbin
antibodies-repeated
practolol
Practolol
2-adrenoceptor
oxandrolone
burned
wondered
postburn
constitutive
transaminases
Constitutive
retinol-binding
1-acid
2-macroglobulin
Albumin
Hepatic
oximetry
erythrocytes
18-28
hydroxyethyl
956
l
-24.9
l.
NCT01195025
synthase
-monomethyl-L-arginine
L-NMMA
alpha-adrenergic
phentolamine
Phentolamine
isolate
resistances
postsham
108.0+/-2.4
102.1+/-3.3
sessile
tubulovillous
Funen
Adenoma
wanted
cumulated
28.7-41.4
28.4-42.7
44.9
36.0-53.9
60.1
48.5-71.7
villous
2.3-8.1
3.8-13.3
4.2-13.0
7.6-27.2
3.43
0.2-2.6
Clinilal
biochemistry
virology
Departments
orthopedics
N=126
STG
n=65
Million
=.016
squat-test
training-induced
Ameliorating
intrusive
appraisals
Could
reappraisals
stressful
proof-of-principle
nonexplicit
adopt
poststressor
scripted
clips
cognitions
implicit
TKR
blacks
543
recommending
cooperativeness
stereotypes
liking
believing
.10
subconscious
biases
.439
.960
possessed
ARIX
xerostomia
Patient-reported
PROs
sip
swallow
waking
unstimulated
Trans
Tasman
TROG
03.07
I-IIIB
unsuitable
PET-detected
groups-arm
Gy/20
fractions/4
fractions/3
0.147
tocainide
prajmalium
bitartrate
dose-effect
11-
15-year-old
Janeiro
painted
dentition
106.6
107.7
0,1
2,3
Lofexidine
impulsive
correspondingly
equol
daidzein
equol-producing
EP
non-EP
Menopausal
Kupperman
sweating
Isoflavone
flexibility-training
8-12
WM
non-adaptive
mock-training
Braingame
Brian
EF-training
game-elements
pretraining
6-week-follow-up
near-transfer
-behavior
Attrition-rate
ADHD-behavior
Substituted
H+/K+ATPase
coadministered
beta-acetyldigoxin
confirmative
-confidence
AUC-
Cmax-ratios
Pantoprazole
T-wave
S-1+paclitaxel
S-1+cisplatin
far-advanced
1-21
RRs
P=0.74
P=0.50
P=0.84
non-haematological
17.1
non-platinum-based
III-controlled
Ciprofloxacin
lomefloxacin
osteomyelitis
fluoroquinolones
quinolone-sensitive
Levofloxacin
Lomefloxacin
60.6
Gram-positive
first-time
mother-infant
unwed
well-baby
her
Polyunsaturated
ARA
transduction
dismutase
Checklist-Community-measured
Scale-measured
up-regulating
Hyperbaric
4.92
atm
0.0473
0.0102
9/30
2/26
0.0471
24/30
10/26
0.0024
0.0336
0.0168
0.0322
0.0311
sensory/cognitive
0.0367
NCT00335790
peribulbar
phacoemulsification
dexmedetomidine
midazolam+fentanyl
Ramsay
ophthalmologist
Sabgh
Formulation
Vitiligo
vitiligo
Iranian
Pharmacy
.436
eyelash
liquids
low-fat
CLD
ready
LFSD
LOH
resume
Decisions
post-refeeding
re-admission
refeeding
calories
Initiating
Collagen
cross-linking
photoactivated
riboflavin
PACK-CXL
keratitis
melting
CXL
chromophore
PACK
-CXL
slit-lamp
39.76
18.22
46.05
27.44
Psychophysiological
Proprioceptive
Facilitation
latent
PNF
Myofascial
Trigger
Point
MTrP
innervated
lumbosacral
sciatic
peroneal
nerves
stretch
0.9-1.0
MTrPs
never-treated
sleep-deprivation
workday
sleep-insufficient
Ropinirole
levodopa
Restless
uncomfortable
14-week
ropinirole
6-item
Legs
carryover
reversion
0.25-2
1:200,000
nonparametric
Pruritus
moxibustion
gastroparesis
PGS
sticking
7.24
3.87
9.83
4.60
75.0
15.25
3.81
Observational
dictated
belonged
superordinate
Stimulus
understudied
BPT
3.5years
nonsleep-related
5-session
Physician-pharmacist
randomized-controlled
40-79
140-179
90-99
Equal
physician-pharmacist
2.9/3.3
96-week
antiretroviral-naïve
MONARK
MONotherapy
AntiRetroviral
Kaletra
cells/microL
PI-associated
viraemia
50-500
Self-management
SMILE
summarised
inferentially
non-compliance
ISRCTN57937389
gynecology
opioid-sparing
4.13
16.20
19.60
26.29
32.49
2.42
41.72
2.70
49.97
60.06
65.68
3.23
Persons
hyporesponsive
CPG
7909
TLR9
7-valent
7vPnC
1b/2a
randomizing
Prevnar
23-valent
polysaccharide
PPV-23
Pneumo
Novum
phosphate-buffered
microg/mL
Ninety-seven
77.3
56.3
87.8
non-7vPnC
NCT00562939
climacteric
Hormone
Anecdotal
tolerate
camazepam
separating
Spectral
all-night
1-min
epochs
awakenings
Camazepam
slowest
paralleled
periodicity
distort
acceptance-
control-based
cravings
theorized
Hershey
Kisses
chocolates
eat
acceptance-based
experiential
defusion
Power
surreptitiously
Migration
pressurization
radiolucency
radiostereometry
Cementing
fingerpacking
THAs
anchorage
RSA
radiolucent
HHS
migratory
Pressurization
Disorder-dissociated
N-back
underactivation
deactivation
Within-patient
task-positive
task-negative
default
DMN
ritualized
endophenotype
recognizing
facially
Asperger-syndrome
rtt=.91-.95
retest
rtt=.89-.92
prepost
social-communicative
trophic
1750
0.5-1
Nutritive
CRIB
41.4
73.7
kcal/kg
-11.5
feeds
ml/kg/day
-11.2
-19
-22.4
CI-41.5
-3.3
-22.1
-42.1
-2.2
Trophic
-agonist
3-14-day
four-hour
electrocardiography
proarrhythmic
80+/-8.6
80+/-10.6
732+/-2685.4
650+/-2090.6
35+/-131.0
30+/-101.3
0.4+/-1.70
1.0+/-9.23
0.02+/-0.082
0.05+/-0.479
504+/-1844.1
823+/-2961.8
22+/-80.6
37+/-129.6
Vital
Bazett
Fridericia
n=26
n=33
Raichs
memorial
diltiazem
microg/min
onsets
Removal
veno-venous
CRRT
Veno-venous
HCQ
0.072
0.957
MTX-HCQ
diminution
Extra
L-type
thalassaemia
Sideroblastic
cornerstone
Blocking
thalassaemics
amlodipine+chelation
T2*
Value
Aga
Khan
Karachi
Pakistan
regulations
ClinicalTrials.Gov
NCT02065492
Pharmacist
reviews
post-discharge
46.7
3.97
0.514
IRR
0.85-3.60
1.80-3.05
Post-discharge
multi-disciplinary
rubber
hemorrhoidal
banding
postbanding
Associated
0.000002
0.000005
shaking
lightheadedness
disposition
triazolam
four-way
0.25-mg
Ranitidine
Consecutively
listed
asimadoline
kappa-opioid
Arginine-vasopressin
AVP
alpha-hANP
cAMP
r.i.a
GC-MS
1.1-1.4
3.3+/-1.3
5.6+/-1.4
+/-1.6
5.5+/-2.2
CH2O
0.2+/-1.5
2.0+/-1.6
0.6+/-1.6
3.0+/-1.6
46+/-23
25+/-15
410+/-206
181+/-125
Asimadoline
SNRI
unawareness
alexithymia
depressive-like
PSD
75-150
Alexithymia
TAS-20
Antidepressants
422
n=257
NNT
=13
NNT=10
NNT=9
n=165
ratio=1.15
1.01-1.31
Community
immunoresponse
anti-HBV
W24
HBeAg
IFN-gamma
P=0.0446
6/24
HBeAg/Anti-HBe
7/24
24W
Pentoxifylline
cachexia
suppressor
plasma-TNF-alpha
lymphokine
suprapharmacological
BMNC
thyroxine
3,5,3'-triiodothyronine
closer
fT4
fT3
rT
Questionnaire-12
GHQ-12
Thyroid
fT
0.663
0.318
0.275
71.83
0.3-4.0
mIU/liter
hypothyroid
hyperinsulinaemia
5-hydroxyindoleacetic
5HIAA
Genotypes
promoter
5HTTLPR
s/s
health-damaging
biobehavioral
renoprotection
liver-type
acid-binding
L-FABP
eGFR
CAtholic
CATOS
DESs
CTO
Sprint®
n=80
Cypher®
2.5mm
TVF
Consortium-defined
definite/probable
6.0-22.2
5.8-21.6
P=0.168
P=0.316
Just-in-time
354
nonprofit
one-time
HF-specific
COLLECTION
45-day
magnitudes
just-in-time
SSS
globulin-enriched
HSA
retain
expanders
Plasmatein
Therapeutics
Plasmanate
Cutter
Miles
Elkhart
Pronuclear-stage
tubal
HTF
v/v
alpha-
beta-globulins
embryonic
formulate
lots
four-cell
postinsemination
Lot
Excyte
Diagnostics
Kankakee
Illinois
murine
hatched
blastocyst
36-40
microprecipitate
ultimately
Murine
postthaw
hatching
convient
Asymmetric
regimes
circumvent
nitrate
invasively
asymmetrically
PAWP
31.4
5.56
Memantine
ritualistic
stereotypical
hyper-and
hypoglutamatergic
ideologies
memantine
10-wk
IRCT1138901151556N10
www.irct.ir
choral
student-to-student
Thirty-minute
criterion-referenced
Herpes
herpetic
antiherpetic
1-related
keratitis/keratouveitis
shock-inactivated
0.050
0.051
zinc-treated
mumol/l
practically
1.89
1.83
35-48
stations
one-repetition
Endurance
risperidone-treated
risperidone-associated
Age-
gender-standardized
mean=5.6
SD=3.9
mean=0.6
SD=0.5
mean=-0.3
SD=6.2
N=48
curvilinear
decelerates
lisinopril
Lisinopril
slow-release
Sitting
Cough
paclitaxel-induced
PIPN
Neuropathy
RR=0.3
=0.1-0.9
2.25+/-5.1
0-15
11+/-11.63
0-32
supraspinal
M-ANNHEIM
dermatomes
C5
T10
L1
L4
T10BACK
conditioned
nociception
NIH-sponsored
evolutional
Orientation
Vocal
SVB
psychiatry
Random
cross
17/33
9/33
multivendor
regadenoson
CTP
CTA
platforms
128-
256-
320-slice
interpretable
Regadenoson
0.77-0.97
0.71-1.00
0.77-0.91
0.74-0.98
accuracies
0.78-0.91
0.60-0.77
establishes
Antiinflammatory
Phytotherapeutics
ultraviolet-
-erythema
fold
UV-B
Formulations
Chamomilla
recutita
Hamamelis
virginiana
Melissa
officinalis
Mentha
arvensis
Melaleuca
alternifolia
Coriandrum
sativum
unguentum
leniens
Photometric
t0
t1
t2
UV-control
UV-induced
erythemas
GERD
Antireflux
gastro-esophageal
pH-impedance
Heartburn
GERD-HRQL
1498
951-2472
2393
1353-3027
Ω
2983
2335-3810
non-acid
INFERENCES
care-based
detoxification
AOD
CMU
freestanding
staffed
IDUs
addicted
heroin
cramps
Successfully
detoxified
opioid-addicted
clonidine/naltrexone
45/100
49/100
19/72
18/72
88/125
AODs
24/57
64/68
internists
Liposome-entrapped
hyperresponsiveness
mite-allergic
Liposomes
adjuvants
liposome-entrapped
monosensitive
Der
T12
Mth
Mth-PD20
Mth-DRS
intercellular
molecule-1
ICAM-1
TI2
Pteronyssinus
2197
AC
Doxorubicin
2,882
1.22
.78
ER/PR-negative
roxithromycin
lansoprazole
3.0-5.0
0.3-0.4
antrum
3.8-4.0
microg/g
5.9-7.4
4.2-4.4
Proton
synergic
hypoxemic
Oxymizer®
assumed
Oxymizer
CNC
pred
LTOT
858
754
766
652
32-152
isotime
90.4
0.427
liters/min
mammary
sentinel
node-positive
Hungarian
Axilla-Surgery
Radiotherapy
OTOASOR
cALND
RNI
SLN+
SLN
.095
pT2-3
ALND
.066
190/244
159/230
.020
Endocrine
213/244
204/230
.372
niguldipine
TPR
rate-corrected
electromechanical
systole
QS2c
PEPc
noninvasively
TRP
dihydropyridines
rhTPO
PBPCs
PBPC
microg/kg/day
pheresis
n=27
n=22
+4
microg/m
CD34+
yield/pheresis
/kg
P=.006
P=.050
.041
rhTPO-treated
phereses
.011
.015
leukapheresis
Oxaprozin
NSAID-refractory
periarthritis
oxaprozin
unsuccessfully
patient-assessed
investigator-assessed
Short-Form-36
-5.85
-5.54
4.41
Investigator-assessed
diclofenac-treated
0.0202
0.0067
0.0235
0.0272
20-54
Mechanomyographic
pollicis
0.4-0.5
Corticosteroids
prejunctional
postjunctional
immobilization-induced
hemiplegic
herbal-based
gingivitis
crevicular
subtotal
thyroidectomy
strumectomy
hypoparathyroidism
Subtotal
strumectomies
Rothmund
ligated
branches
Unstable
cinoxacin
Cinobac
nitrofurantoin
Furadantine
oxolinic
Uritrate
Ursodeoxycholic
restorative
proctocolectomy
aggravated
12-point
ursodeoxycholic
U.C
externa
polymyxin
7500
IU/neomycin
3500
IU/dexamethasone
PN+Dx
PN-Dx
AOE
338
18-76
Visit
'very
B/neomycin
chaos
Enrichment
Relational
IT
neurotoxicities
CCG
1952
psychologist
Speed
below-average
attention/concentration
EBUS-TBNA
CDS
EUS-FNA
recruiting
permuted
masking
time-to-treatment
intention-to-diagnose
NCT00652769
14-15
23-35
1·39-2·82
pneumothorax
CT-guided
Anxiolytics
combines
Mi
+Morphine
Mo
suspicion
ENDPOINT
890
Mi+Mo
Drowsiness
drowsy
anxiolytics
arzoxifene
LY353381
hormone-sensitive
choose
CBR
NCI-CTC
NONMEM
GloboMax
Hanover
MD
61.4
Arzoxifene
3.62
7.48
Four-year
waves
Diego
12-step
detraining
rotator
Imbalance
well-documented
land-based
torques
rotators
preseason
midseason
postseason
60°·s-1
180°·s-1
dynamometer
ER/IR
coaches
dry-land
Beverage
veracity
property
Energy-matched
interspersed
1.77
2.22
acetonide
intermittently
hub
88.0
unmasked
Masking
Anti-inflammatory
anti-oxidant
capacities
100-125
ex-smoking
post-bronchodilator
/forced
h.day
carboxyhaemoglobin
mg.mL
Inhalation
bezafibrate
guar
HLP
IIa
Guar
cholesterols
apoprotein
meteorism
stanol
318
margarine-like
spreads
8-g
reformulation
233+/-20
153+21
mg+/-dL
Triglyceride
Stanol
mid
50-54
beam
Sphincter-preserving
0.020
13.63
11.57
theatre
insertions
Skill
manikin-only
commonplace
Fadrozole
HCL
CGS-16949A
multiinstitutional
fadrozole
683
wiht
perimenopausal
1.39+/-1.06
2.36+/-1.50
2.31+/-1.25
mg/l
postmenopause
premenopause
1.93+/-1.33
3.42+/-1.35
r=0.243
r=-0.273
Spatial
postures
Kowloon
prism
slanted
erect
Adjustments
OPG
sRANKL
vWF
osteoprotegerin
Weibel-Palade
κB
Ligand
RANKL
T180
over-HD
behave
expressly
31.13
.016
8.26
heparins
-.51
OPG/RANK/RANKL
reinforces
presumption
mineralization
Drawtex
dressings
exuding
rebranded
Vibriant
RCD
Services
deconvolution
novelty
miss
finer
nuances
lies
somewhere
cardiovascular/thromboembolic
tPA
18-55
skiing
tour
mountains
pack
self-dug
igloos
temp
Citrated
Already
receded
vagal
INOVATE-HF
METHODS/RESULTS
CardioFit
BioControl
Yehud
Up
milliseconds
Vagal
'controlled
'controlled-release
check-list
gastro-intestinal
Homocysteine
Metabolism
MTHFR
C677T
A1298C
MTR
A2756G
MTRR
A66G
Jointly
Elevate
Deficiency
methylenetetrahydrofolate
methionine
28-75
2005-December
Known
677TT
2756AG
AG
elevating
multifactor
dimensionality
0.0107
resp
ergometer
20:121
And
cavitron
coagulator-A
Cavitron
CUSA
coagulator
TissueLink
TL
195.2
343.3
198.4
/minute
ties
15.8
hepatectomy
trichloroacetic
peel
TCA
rejuvenation
gaining
oculoplastic
dermatologists
cicatricial
ectropion
phenol-peeled
reportedly
blepharoplasty
1,2
peeling
upper-eyelid
lower-eyelid
hypertrophic
resurfacing
preseptal
frost
dermatopathologist
peels
lowest-concentration
deepest
dermis
Dader
EMDADER-CV
BP/TC
pharmacies
Spain
pharmacists
dispensing
130/80
dL
358
62.8
43.0
P=0.017
Intratunnel
extratunnel
double-bundle
ligament
Anatomic
ACL
restoring
kinematics
cross-pin
buttons
ACL-deficient
bioabsorbable
Rigidfix
pins
bundle
secured
EndoButton
tunnels
anteromedial
Biointrafix
laxity
KT-1000
arthrometer
imidapril
PAI
IU/L
IU/ml
49.1
retapamulin
wt/wt
cephalexin
Retapamulin
Microbiologic
87.2
hydrolysate
CHO+PRO
421
/S
424
389
-48
+78
Concentration
ICU-acquired
ICU-AW
immobility
IIT
polyneuropathy
units/kg/d
duel
euglycemia
pharmacogenomics
concentration-effect
SirT1
selisistat
Selisistat
SEN0014196
Huntington
first-in-human
5-300
Steady-state
QTc
Transcriptional
Corticosteroid-induced
osteopenia
D2
'triple-treatment
45000
iu
prednisone-
triple-treatment
BMC
25OHD2
25OHD3
enormously
hydroxylation
ferrule
crown
dowel-and-core
crown-lengthening
endodontically-treated
dowel-core
cementoenamel
Ni-Cr
prefabricated
fiber-reinforced
dowel-resin
self-cured
crosshead
mm/minute
kN
dowel-cores
ferrules
dowel
Crown
50-79
26,321
hysterectomies
10,272
equine
5,076
5,196
16,049
8,240
7,809
arthroplasties
Arthroplasties
estrogen-alone
0.70-1.00
0.52-1.03
0.71-1.07
estrogen-plus-progestin
0.82-1.20
0.92
0.83-1.57
0.72-1.15
Delays
Freeman
Paparella
generalizability
clomipramine
5.62
Live
Employing
conversations
linguistically
converge
interlocutor
posited
syntactic
goal-directed
Ex
WHR
METs
conducive
potentiation
teicoplanin
transposition
myocutaneous
TRAMF
Teicoplanin
contamination
15/18
2/20
adenoassociated
rAAV2-TNFR
Fc
cDNA
factor-immunoglobulin
tgAAC94
DNase
four-point
Synovial
TNFR
two-point
2/11
proceed
incentives
undermine
lottery
tickets
municipality
incentive
promised
ticket
reply
69.3
Incentives
reinforcer
single-item
varies
categorizing
operants
High-preference
functioned
Middle-preference
low-preference
Low-preference
middle-preference
Trace
trace
regrafting
autonomy
non-financial
reinfection
Mycobacterium
1,075
twice-weekly
rifabutin-containing
Isolates
IS6110
false-positive
88.8-99.2
0.8-11.2
rabeprazole
2-way
pharmacology
'washout
Intragastric
14-24
P=0.0002
P=0.0005
0-24
Hepatoprotective
remaxol
milticentre
hepatoprotective
494
staying
anticholestatic
cetamolol
dose-titrated
5-10-15
15-25-50
-18.1
2.3/-9.2
-17.3
2.3/-8.3
2.5/-3.5
sublingual
buprenorphine
herein
opiodes
T6
consequent
pseudorabies
isotype-specific
passively
Pigs
inoculated
intranasally
virulent
NIA-3
avirulent
Bartha
Phylaxia
challenge-exposed
IgG1
IgG2
Challenge
Pharmacokinetic-pharmacodynamic
antihistaminic
bilastine
single-
7-
modelled
two-compartment
preselected
72-96
Bilastine
two-compartmental
rapid-absorption
parentheses
zero-order
k
ng/mL/h
14.60
15.14
5.15
11.10
8.35
14.56
inter-dose
running/jogging
correct/incorrect
Anastrozole
oligo-
anovulatory
ovulatory
Infertile
18-35
midluteal
41.0
52.4
42.3
Cryotherapy
musculature
injurious
forces
vulnerable
trap
door
perturbation
BIDS
recommends
physician-diagnosed
Bronchiolitis
Infancy
clipped
ISRCTN28405428
Oct
15·0
high-dependency
Recorded
nations
thiabendazole
Faux
pas
faux
Baron-Cohen
Journal
407-418
non-intentional
involuntary
over-detected
justifications
speaker
mistaken
theory-of-mind
compensatory
abstract
Hemolytic
streptococcus
OK-432
hemolytic
Intradermal
Accompanying
Su-strain
Su-PS
Needle
NETZ
LLETZ
London
demostrate
forty-seven
739
pieces
'difficult
3.17
peri-operative
piece
PBSC
mobilized
impotence
Sepulveda
Convenience
coital
penile-brachial
PBPI
impotent
steal
reestablish
professed
erections
fantasy
masturbation
inertia
grogginess
88-hour
2-hour
naps
polysomnographical
abrupt
N/A
nap
caffeine-containing
α-Smooth
actin
desmoplastic
stromal
CONKO-001
α-smooth
α-SMA
peritumoural
stroma
curatively
putty
bovine-derived
xenograft
ridge
ridges
nonmolar
PUT
BDX
Horizontal
caliper
postextraction
trephine
midbuccal
0.3+/-0.7
0.7+/-1.2
+/-9
+/-20
Allograft
Ridge
proprioception
angles
Penny
Giles
electrogoniometer
19-27
60-86
laterally
active-fold
sedentary-old
active-old
Ro
15-1788
benzodiazepines
typified
incoordination
imidazodiazepine
hereditary
nonpolyposis
HNPCC
postdecisional
regret
decisional
8.97
4.37
.037
charcoal
supranormal
two-tailed
victims
overdose
Theory-driven
south
counties
Assigned
theory-driven
Occupational
extractor
purpose-built
Gases
Mapleson
pressure-limiting
noticing
smell
P=.003
P=.05
P=.009
Gas
lofexidine
assurance
22921
inconsistency
phase-III
calculations
three-field
four-field
accelerators
MeV
photon-beam
fair
44.7+/-a
complied
specifying
ICRU
CTV
cranio-caudal
inter-institutional
stretched
lower-limb
DPT
SLR
20-second
180-
300-second
Straight
60-second
preadmission
adapt
Tiotropium
Respimat
TIOSPIR
trial-design
tiotropium
Mist
HandiHaler
NCT01126437
μ
event-driven
encompasses
17,000
dose-dependence
epidemiology
computer-mediated
web-tools
10-s
patient-centered
problems/concerns
rapport
Computer-mediated
needle-knife
ultra-short
65.76
15.11
4.59
53.74
15.13
ketanserin
2-month
electrocoagulation
IS
POF
Wah
Cantt
proctoscopic
Lottery
Wieda
pile
phenol
almond
satisfying
Mexican
sulfonylurea
secretagogue
=7
HOMA-S
Check
QUICKI
FSI
Glycemic
glimepirede
-0.78
-0.68
8.66
7.46
7.77
-7.9
-0.007
-21.1
pmol/L
35/121
17/123
antihyperglycemic
nonhandicapped
non-comparative
erlotinib
GFPC
10.02
2-16
+docetaxel
d1
Simon
33/66
60±8
0/1/2
44/83/20
PFS15
Hyperfractionated
70.6
5-FU/Mitomycin
ARO
95-06
C/5-fluorouracil
C-HART
LRC
Gy/2
C/5-FU
7.8-9.7
38.0
26.0
P=.002
P=.042
P=.049
0.5-0.8
P=.264
s-enantiomers
Ninety-nine
sub-umbilical
wake-up
Dexmedetomidine
anesthetized
Isoflurane
ng.kg-1
abolish
pour-on
feedlot
heifers
endectocides
1,862
yearling
SG+IVPO
IVPO
doramectin
DMX
retreated
Heifers
slaughter
IVPO-treated
Cooperia
Trichostrongylus
DMX-treated
SG+IVPO-treated
endectocide
beta-Carotene
immunostimulatory
B-lymphocytes
pharmacogenetic
irinotecan
semisolid
maximum-tolerated
DLT
Irinotecan
high-calorie
Dosages
1-15
DLTs
SN-38
stabilizations
UGT1A1*28
irinotecan-induced
pseudorandomised
Vincent
Melbourne
Victoria
Aged
Coordinated
currents
workdays
Clinicaltrials.gov
NCT01434836
MSLT
insomniacs
32-64
polysomnograms
NPSG
nightly
NPSGs
MSLTs
hyperarousal
wake
father
neighborhood
Incompatibility
visitors
obstacle
chorea
Allogeneic
leucocyte-depleted
Induced
TACTIC
non-LD
89.2
79.7
50.8
0.191
0.482
0.864
atorvastatin
Targets
TNT
accompanies
10,001
9,376
year-1
6.90
0.0015
5-ml/min/1.73
Validity
Siriraj
GINA
29-73
5-items
6-items
2,15
0.829
chemotherapy-radiotherapy
IA-IIB
1980
II2A
II3+A
mechlorethamine
Oncovin
MOPP
supradiaphragmatic
CCNU
CVPP
lumboaortic
nonirradiated
subdiaphragmatic
probabilities
91.6
87.6
Azoospermia
prethrombolytic
cyclosporine-A
Reperfusion
STEMI
Cyclosporine-A
Infarct
LVEF
TLT-related
38.3
FAST
2-center
Catheter
drug-refractory
twenty-four
antral
ganglionated
plexi
appendage
P=0.0022
P=0.027
NCT00662701
Aneurysm
Neurological
Surgeons
C-37
C-33.5
=38.5
neuropsychologic
fever-related
hydrocephalus
Barthel
destination
workplace
workplace-based
WRPE
42.0
5×10
HOME
-0.8
Within-group
bisphosphonates
DTCs
concealment
NCT00242203
signing
p=0.054
antimetastatic
Novartis
Deficits
Reading
amygdala
Accruing
activations
rACC
orbitofrontal
OFC
Altering
upcoming
Multiplex
biogenesis
vastus
lateralis
PGC-1alpha
COX5B
MT-CO2
mtDNA
MHCI
aspired
physiology
underling
3-8
Behaviour
Rescorla
Sentence
Complexity
Abacavir
Ziagen
Antiretroviral
intracellular
abacavir
simplify
384
4.89
262
infrequency
ABC-related
endosseous
2,641
transoral
implantology
Implant
osseointegration
uncovering
amprenavir
indinavir
saquinavir
1-infected
ss
Nelfinavir
CYP3A4
parasitologic
malaria-suspected
artemisinin-based
RDTs
endemicity
prescribers
RDT
local/regional
neuromonitoring
EBSLN
mini-incision
Handicap
Index-10
VHI-10
Reflux
RSI
handicap
Nerve
medication-overuse
Medication-overuse
MOH
overuse
Norwegian
transcripts
trying
convince
guilt
emphasised
alliance
relies
misconceptions
Singing
foreign
singing
phrase
listen-and-repeat
rhythmic
15-min
phrases
phonological
listen-and-sing
verbatim
Practitioners
identifiable
telephoned
booklets
Contractubex
Scar
Co.
D-Frankfurt/Main
50/U
allantoin
Contractubex-treated
skin-coloured
Hypertrophic
keloidal
Sudden
trend=0.001
2.78-fold
5.72
2.65
8.83
trend=0.03
exemplified
657
FUDR
non-resectable
chemoembolisation
granulocyte/colony-stimulating
4.21
0.100
GS-9620
TLR7
conserved
plasmacytoid
dendritic
ascending-dose
6:2
well-absorbed
-α
flu-like
agonism
chemokines/cytokines
IFN-stimulated
Pharmacodynamic
laryngectomy
sound-producing
laryngectomees
hypotonic
pharyngoesophageal
tracheoesophageal
performs
outward-striking
phonation
read-aloud
intelligibility
acoustical
necessitating
Pitch
alaryngeal
postlaryngectomy
melodic
interferon-based
pegIFNalpha
IFNalpha
412
2b/RBV
PegIFNalpha
1000-1200
HQLQ
-specific
between-treatment
CCQ
abstainers
121.8
37.9
0.0069
Weeks
-1.04
narrowed
NCT00285012
soy-based
nucleotides
isolate-based
soy-fed
Nucleotides
Newborn
milk/formula-fed
three-color
CD57
milk/formula
nucleotide-supplemented
formula-fed
helper
memory/effector
pH-metry
Second
6.1-6.2
acidity
alleged
haemostasis
.117
Teacher-implemented
vast
preschools
prelinguistic
Play/Engagement
Regulation
JASP/ER
taped
Modafinil
OSA
modafinil
Driving
AusEd
driving
Karolinska
lapses
1/reaction
www.anzctr.org.au
ACTRN12606000027516
Preserved
Aldosterone
TOPCAT
3400
Kansas
City
Cardiomyopathy
3395
5D
1431
Questionnaire-9
54.8
NCT00094302
357
sCsA
reduced-dose
rCsA
BCAR
±SEM
Nankivell
1.78
nephrotoxic
troxerutin
carbazochrome
post-hemorrhoidectomy
Flavonoids
Fleboside
ampoules
camera
post-surgical
Tapentadol
Release
Pregabalin
3b
tapentadol
PR/pregabalin
painDETECT
11-point
NRS-3
1-point
/pregabalin
LSMD
-0.066
-0.57
anticonvulsants
0.0302
mg/pregabalin
mobilisation
autografts
closed-envelope
24th
Alpha-tocopherol
subtype-specific
Alpha-Tocopherol
Beta-Carotene
ATBC
metrics
GCC
noncardia
GNCC
341
nonspecified
unsaturated
iron-binding
TIBC
-shaped
0.060
u
subsite
elucidation
muscle-invasive
T4b
cT3b
cT4
precystectomy
pelvis
cisplatin-treated
leukocytosis
diclofensine
Diclofensine
Maprotiline
maprotiline
Depending
dissipation
psycho-energizing
self-stimulation
hypervigilance
Clonidine
2-adrenergic
placebo-crossover
Glucosamine
glucosamine
overall-conditioning
immunoreactive
125I-insulin
Obtained
insulinaemia
semicurative
3000
4200
mediastinum
succinylcholine
electromyography
adductor
acceleromyography
AMG
chlorpheniramine
Plasmodium
CQ
0.6-12
livers
CQCP
P-values
0.00000
0.00002
HR50
HR90
plotting
hp
1/2hp
'hepatic
Bhp
hpFr148
hpFr96
hpFr196
Bhl
P.
randomise
chi-squared
analysing
anti-phospholipase
backgrounding
fermentation
calves
70-d
GrowSafe
Airdrie
AB
Feed
Efficiency
Facility
FEF
Calves
low-concentrate
aPLA2
FE
trailer
km
relocated
calf
transportation
haptoglobin
242.0
313.0
9.18
8.53
0.389
0.110
-0.272
339.0
0.164
high-concentrate
substrates
mg/body
Appetite
thenar
cavum
concha
23-48
SESSION
Seirin
emptyv
0.20x15
earpoint
Lu
hemi-conchae
Hwato
0.30x30
Hegu
overlying
post-stimulation
overlaying
acupunctura
Update
0·1
Tretinoin
ninety-seven
photodamage
0·15
0·04-0·54
0·46
0·27-0·77
1·88
1·15-3·08
Carpal
tunnel
palmar
CTR
n=36
crease
transillumination
palm
zigzag
Intervals
2-15
2-21
5-45
10-60
Scar/pillar
hemoperfusion
microporous
N=24
HA330
hematology
SOFA
Hemoperfusion
cartridge
hematinic
hematinic-supplemented
nursing-led
driver
Resource
multiprofessional
pounds
sterling
turner
stature
Turner
debate
FH
Girls
IU/m
.d
centimeters
157.6
162.9
163.6
HV
age/change
ref
Pre-medication
pronase
artefacts
mucus
pre-medication
Out-patients
anti-foam
dimethylpolysiloxane
high-echo
Aspirin-associated
Aspirin-induced
free-radical
radiolabeled
FeAST
continual
microbleeding
Supporting
CAPEDP
home-visiting
suburbs
fluent
vulnerability
birthday
home-visits
adapting
particularities
psychologists
methadone
beagle
breeds
Methadone
Chromatography-Electrospray
Ionization-Tandem
Spectrometry
Behavioural
82.1
licking
whining
misinterpreted
Cortisol
tomography-negative
preplanned
EORTC/LYSA/FIL
H10
Combined-modality
involved-node
IN-RT
PET-negative
corresponds
one-sided
1,137
85.8
Immunological
esophagectomy
OE
MIE
esophagectomies
imply
ALPHA
Eliciting
intimate
couple
Providers
vs.1.8
-1.96
5.243
df
witnessed
12.488
Carbohydrate
fructose
sorbitol
xylitol
provoke
sugars
H2-exhalation
H2-test
malabsorbers
BRAF
V600E/K
HGF-MET
vemurafenib
Formalin-fixed
BRIM2
BRIM3
Immunohistochemistry
SP44
vemurafenib-treated
bromocriptine
L-dopa-induced
peak-dose
dyskinesia
Automatic
Spencer
Frame
pixel
Spencer-Frame
k-nearest
neighbor
achieves
Isolation
Easterners
holistically
Westerners
Kim
Markman
Psychol
:350-364
rooted
FOI
furthermore
within-Western
styles
milrinone
transthoracic
phosphokinase
CPK
intra-aortic
LVEFs
Short-course
Evidence-based
uropathogens
double-strength
trimethoprim-sulfamethoxazole-treated
uropathogen
trimethoprim-sulfamethoxazole-nonsusceptible
trimethoprim-sulfamethoxazole-susceptible
fluoroquinolone-sparing
Dactylis
glomerata
nasal-sinus
EVR
ninety-one
1000/1200
Ribavirin
or=75
microg/week
0-12
modifiable
vacuum
Midlands
hundred-seven
311
0.4-1.04
0.38-0.97
0.49-0.99
0.04-0.76
cephalhaematomata
1.4-7.4
economics
grounded
addictive
reward-processing
buprenorphine-naloxone
N=353
screens
Obtaining
dealers/patients
OR=1.30
OR=1.31
remediated
Itch
ISS
tofacitinib
Janus
CID
CIR
anchor
≥30
GUSTO-III
Streptokinase
TPA
GUSTO
-III
inhospital
1121
13,921
Killip
=48
CMAX
bivariate
inter-
intrasubject
unbiased
estimators
happen
sleeplessness
58.2
workup
tentatively
undiagnosed
Cow
arousals
hydrolyzed
hypoallergenic
reappearance
agitated
1,213
752
966
Ovarian
multivariable-adjusted
normal-weight
2.30
screenings
variceal
heparinized
cyanoacrylate
tetradecyl
ethanolamine
morrhuate
polidocanol
1:10,000
Cyanoacrylate
Epinephrine
intravariceal
HIP
Methodologically
theory-based
club
clubs
municipal
Tehran
15.93
5.57
45.53
Prehydration
day-only
oxygen-free
0.16+/-0.03
2/19
2/21
4/20
Considering
dollar
26,637
annum
day-stay
5Fu
derivatives
contraindicate
disqualified
enjoy
hoped
Consumption
iTFA
CLA
Diets
TNF-RI
-RII
chemotactic
8-iso-PGF
2α
nmol/mmol
trocar
Verres
2.32
omental
high-fiber
Polyp
large-bowel
2079
servings
1905
958
947
39.7
+/-SE
1.85+/-0.08
1.84+/-0.07
Adopting
Fluorouracil
Filtering
trabeculectomy
prognoses
reoperation
Mantel-Cox
bleb
leaks
gliomas
glioma
CCG-945
institutionally
lomustine
8-drugs-in-1-day
nonrandomly
neuropathologists
reclassification
fibrillary
astrocytoma
chemotherapy-alone
front-line
clozapine
physicians'-choice
Connecticut
Long-stay
parametric
create
Clozapine
disruptiveness
payer
unwilling
incur
Albumin-glutaraldehyde
Bioglue
hemorrhoidopexy
Hemorrhoidopexy
prolapsing
anastomosis
intrapelvic
albumin-glutaraldehyde
eye-drop
meniscus
spectral-domain
tomographer
-2.50
+0.75
-1.34
Tear
Copernicus
Optopol
Tech
Zawiercie
Volume
tomograms
Blink
Abbot
Optics
hypromellose
Artific
Farma-Lepori
0.638
0.098
eye-drops
Post-laparoscopic
Lignocaine
Gamma
aminobutyric
GABA
synapses
orchestrate
GABA-acting
epilepsies
excites
chloride-importer
GABAergic
3-11
D90
Bumetanide
D90-D0
P-value=0.031
P-value=0.017
occasional
3.0-3.5
Hadjikhani
suited
intolerance-like
Histamine-rich
cheese
sausages
sauerkraut
tuna
tomatoes
peppermint
equaling
dihydrochloride
dissolved
histamine-free
histamine-degrading
diamine
DAO
sneezing
4x
3x
2x
1x
non-reactors
gluten-free
GFCF
Abstinence
stand-alone
abstinence-contingent
voucher
contingent
noncontingently
Wednesday
Friday
Monday
contingent-voucher
noncontingent
12-13
vouchers
premedicants
psychotomimetic
self-test
non-attendees
RACOMIP
well-run
8,800
30-62
1:5:5
4,000
self-testing
1.19-1.57
2.00-2.71
colposcopy
health-care
sector
Neuroendocrine
neuroendocrine
5-HT-receptor
5-HT1D
5-HT1B
NHS
non-Q-wave
diltiazem-placebo-controlled
kinase-MB
544
376
666
726
IU/liter
aldose
tolrestat
DAN
Valsalva
expiration-inspiration
resultant
Zolmitriptan
311C90
Zomig
5-hydroxytryptamine
1B/1D-receptor
zolmitriptan
circumstances
descent
AB/BA
Seychelles
included.Main
LIS
1.2-8.6
/3.6
1.0-6.2
9.2-16.6
/6.3
3.7-8.8
15.0-22.5
/14.6
12.0-17.1
8.7-16.2
/7.7
5.1-10.2
0.6-9.4
/2.7
7.1-16.0
/5.7
2.6-8.8
14.2-22.1
/15.4
12.4-18.5
/2.3
-5.4
xenogenic
acellular
second-degree
SIRS
betadine
gauzes
immunodiffusion
descended
Sivelestat
hydrate
sivelestat
PMN-E
ALI
SP-D
PER
Hi-receptor
cetirizine
seriousness
-regulation
TACE
HIFU
grade-matched
TACE+HIFU
9.3+/-3.2
5.0-14.5
13+/-7
90.6
29/32
70.8
28/38
minification
21.1
Are
everolimus
RECORD-1
mRCC
TKI
TKI-everolimus
RAD001
TKI-everolimus-TKI
dovitinib
TKI258
disease-control
1.8-28.5
1.7-34.6
5.2-11.9
DREW
inactivity
373
45-75
NIH
Consensus
KKW
parasympathetically
rMSSD
23.19+/-1.0
4-KKW
25.98+/-0.8
8-KKW
27.66+/-1.0
12-KKW
27.40+/-0.0
00011193
beta-sympathomimetic
NEFA
3-hydroxybutyrate
3-HB
glycogenolysis
non-measureable
beta-receptors
Biomedical
weekday
20-s
inter-train
pulses
HAUT-Coil
coil
encased
helmet
self-oriented
socially-related
employ
PSK
immunochemotherapy
protein-bound
tegafur/uracil
supposed
Th1/Th2
Th1
IFN-gamma-positive
Th2
IL-4-positive
NKT
CD56
CD25
62.2
0.0486
CD57-high
CD57-low
51.4
Omega-3
head-to-head
medicines
triglycerides/HDL
triglycerides/HDL-cholesterol
non-HDL
P=0.023
CIGTS
Longitudinal
607
aggressively
eye-specific
Humphrey
24-2
full-threshold
=3
proprietary
Dark-phase
disrupts
chronobiologic
entrained
photobiologic
light-exposure
configured
12:12-h
dark-phase
μW/cm
lights
low-volume
draws
4-h
0400
Circadian
5-aminosalicylic
enemas
5-ASA
intravaginal
well-dated
Bishop
postdates
Hyperstimulation
E2-treated
Aztreonam
aztreonam
Enterobacter
Pseudomonas
aeruginosa
Klebsiella
Enterococcus
faecalis
Aeromonas
hydrophila
FCP
SCP
pathologists
graduate
pathologist
pointed
ezetimibe/simvastatin
aspirin-naive
CD141
thrombomodulin
CD51/61
vitronectin
Ezetimibe
await
IMPROVE-IT
Vytorin
inhibitor-containing
anti-Helicobacter
debates
PPI-containing
pylori-infected
PAC7
PAC14
anti-ulcer
598
75.5
86.6
anti-H.
Teriparatide
parathyreoid
1-34
nonoperated
teriparatide
Linköping
Callus
arbitrarily
Bridge
DCS
supracondylar
RIMSN
bridge
24-36
p=0.000
p=0.855
p=0.727
p=0.925
p=0.927
delayed-released
DR
102625-70-7
LC-MS-MS
ion
electrospray
MRM
104.6540
90.8616
-120.5401
99.9708
90.9987
-109.8275
95.6634
85.2675
-107.3267
89.3500
83.6630
-95.4237
Who
1984-1986
N=3300
1988-1989
N=3331
1992-1993
N=3133
2003-2006
N=6170
35-75
5.9-7.1
9.0-10.5
Irrespective
3.1-4.5
6.1-7.3
5.1-6.8
double-injection
infero-temporal
supero-medial
medial-percaruncular
Combinations
supero-nasal
'inferior-superior
percaruncular
'inferior-medial
akinesia
inferior-superior
inferior-medial
injectate
0-8
2.66
capabilities
pressure-
volume-limited
positive-pressure
NPPV
expiration
Ventilation
pneumotachy-graphically
fitting
pressure-limited
ventilator
726+/-129
1104+/-164
1257+/-166
Leak
leakage-induced
/87
additionally-delivered
Expiratory
clinically-important
www.uniklinik-freiburg.de/zks/live/uklregister/Oeffentlich.html
UKF001272
medical-surgical
15-bed
Dedicated
glucometer
Physiology
APACHE
pre-ICU
682
42.4
1607
7-mmol/L
38.7
660
8-
10-mmol/L
.35
refined
Examining
presentations
spaced
identifications
scalar
CMF-chemotherapy
Zoladex
ZIPP
CMF-
menstruating
amenorrheic
CMF
complementary/alternative
578
2-
neurogenetic
unsafe
disproven
Underimmunized
Neridronate
Today
Androgen-deprivation
ADT
neridronate
osteoporotic
triptorelina
cholecalciferol
bicalutamide
DPD
BALP
midway
d/week
expending
1255
2max
min/kg
CI-1.9
CI-2.7
CI-2.3
Spectra-System
Core-Vent
Las
Vegas
NV
crestal
1,705
593
.092
multidetector
MDCT-CA
nonivasive
radiologists
trainee
per-segment
pervessel
per-patient
73-90
morbidly
Hypoxemia
anesthesiologists
multifactorial
index-BMI
Reverse
Trendelenburg
Supine-Horizontal
Fowler
oxygen/50
disconnected
oximeter
re-established
hip-waist
Horizontal-Supine
ventilate
preclude
self-physiotherapy
MPD
subthreshold
4.80
Subthreshold
atraumatic
non-carious
ground
mesio-distally
hemi-sections
reassembled
ball-shaped
diamonds
excavated
caries-detection
Smales
Fang
Demineralized
Miller
U.K.
antifungal
Aspergillus
Itraconazole
erratic
itra
flu
293
nil
aspergillosis
5/6
candidal
affords
EPOCH
immunocompetent
-85
-68
50/microL
trauma-related
fared
Person
non-asthmatic
interleukin-5
Seasonal
IL-5
open-labelled
skin-prick
function/bronchial
asthma/wheezing
Sputum
supernatant
sICAM
diluent
immediate-type
myometrium
gnRH
analogue-treated
isoforms
blotting
inter-relationship
durable
cilazapril
Cilazapril
Correspondingly
Navajo
868
beta-hemolytic
subsurface
remineralized
sugar-free
phosphopeptide-amorphous
nanocomplexes
Recaldent
insets
slabs
remineralization
microradiography
16-hour
deposited
CPP-ACP-remineralized
CPP-ACP-treated
demineralization
underneath
atovaquone-proguanil
chloroquine-proguanil
mefloquine
nonimmune
tourists
travel
moods
547
confusion
departure
reanalyzed
T1-T4
p=
Scent
lavender
rosemary
scent
18-30
anxiety-eliciting
scents
pleasantness
covaried
tension-anxiety
confusion-bewilderment
vigor-activity
fatigue-inertia
conization
knife
scalpel
155.4
1,570.9
cet
Conization
40-mg
actometers
tungiasis
niridazole
Ambilhar
pulpless
reinforced
FRC
Fiber
Reinforced
glass-fiber
Artglass
Charisma
hot-press
polycarbonate
505.4
564.1
411.3
315.3
358.4
423.4
47.5
fragmentation
periarthropathies
5-HT3-receptor-antagonist
tropisetron
Finding
5-HT3
Navoban
corticosteriods
tension-type
galea
tendon-muscle
CTTH
needling
Fengchi
Taiyang
Touwei
2.38
2.54
146/150
122/138
cyclical
clodronate
60-day
clodronate-treated
3.32
cyclically
chimpanzee
adenovirus-vectored
Ebola
1/2a
monovalent
adenovirus
type-3
vector-based
Zaire
ChAd3-EBO-Z
Hospitalier
Universitaire
Vaudois
Lausanne
lists
deployed
2·5
Deployed
non-deployed
NCT02289027
2015
n=51
μg/mL
41·1-63·3
44·9
25·8-56·3
5·2
3·5-7·6
85·7-99·5
86·5-99·5
0·1-24·9
25·5
20·6-31·5
22·1
19·3-28·6
3·2
2·4-4·9
glycoprotein-specific
Secretariat
Innovation
SERI
Horizon
2020
1H
resonance-based
metabolomic
Qingrehuatan
abundant
phlegm-heat
QRHT
YEH
squares-discriminate
loadings
endog-
enous
citric
glycerophosphate
choline
hydroxybutyrate
glutamate
lipoprotein/very
N-acetyl
O-acetyl
NMR-based
guanethidine
Ganda
3.0/0.5
1.0/0.2
Timolol
Timoptol
phasing
8.87
8.24
Chorea
unified
UHDRS
judgement
Voluntary
Neuroleptic
aggravation
pain-specific
noxious
lance
time-locked
PIPP
ISRCTN78390996
sterilised
Nociceptive
0·10
0·04-0·16
0·08
0·04-0·12
p=0·46
biceps
3·7-7·8
8·5
7·3-9·8
neutrophilia
pups
rhu
1,500
rhuGM-CSF
Neutrophil
C3bi
sandwich
AMC
Tibial
NSP
T1/2
dronedarone
ATHENA
parallel-arm
patiENTs
fibrillation/atrial
4628
paroxysmal/persistent
Dronedarone
non-CV
AF-related
0.626
0.546-0.719
0.0105
AF/atrial
hospitalization/death
0.0048
00174785
erythromycin-neomycin
metronidazole-neomycin
Bacteriologic
feces
erythromycin
contributors
Twice-a-day
four-times-a-day
twice-a-day
QID
conjuctivitis
blepharoconjunctivitis
Signs
2.6-3.0
4.3-5.0
Ligaclip
lymphocele
Ethicon
Endo-Surgery
lymphoceles
lymphatic
Lymphocele
perfomed
N=296
age=10.21
e
Fifth-graders
extra-familial
Mother
persuasive
third-graders
Persuasion
prescribe
routines
acknowledged
GWU
strength-trained
SDLI
Dot
Above
O2max
LDLI
SDMI
LDMI
CTRL
no-GWU
367.8
70.1
345.6
359.4
69.2
359.1
70.4
multi-dimensional
50-87
1-28
0.229
head-down
countermeasure
Taikong
Yangxin
micro-
macrovascular
macrovasculature
EMPs
Bed
ACh
unmodified
marine
laxatives
Cod-liver
anti-bacterial
anti-viral
administrating
defecate
defecated
Mitoxantrone
MMC
mitoxantrone
Ta-T1
TUR
instillations
8th
NR
dilutions
3-question
CIS-R
11/16
5/13
ISRCTN44902048
dysphoria
dysphoric
termed
PME
Penn
Dally
DSR
DSRs
HAM-D17
premenstrually
Leuprolide
pirprofen
gonarthrosis
coxarthrosis
MEAL
Plan
aversions
disseminate
randomized-control
0-120
Co-administration
telemetry
benefit/disadvantage
PBSCT
accelerating
neuroblastoma
miscellaneous
chemotherapy-responsive
unit-granulocyte-macrophage
CFU-GM
CD34
cells/kg
microg/m2
disease-oriented
MCVAC
ranimustine
MCNU
Hi-MEC
carboplatinum
MNC
=.046
=.126
transfusion-dependent
engraftment
seriously
reconsidered
Bipolar
monopolar
Surgmaster
TURis
Olympus
Storz
Tübingen
photometer
radicality
472
855
VAST-D
next-step
bupropion-SR
augmenting
efficacy/effectiveness
efficacy-effectiveness
β-Blockers
nebivolol
β-receptor
β-blocker
NO-releasing
N=65
N=63
85.2
P=0.12
≈1
provokes
anti-shivering
triggering
18-40
Lactated
tympanic
anova
437
P=0.344
unimportant
danazol
Decapeptyl
Ferring
Kiel
Fertility
AFS
Kwong
postmedical
posttherapy
hypoestrogenic
flexor
muscle-tendon
surae
Achilles-medial
8-s
MVICs
21.0
60-s
stretches
retested
interrupts
stretch-induced
attention-matched
N=35
66.9±12.7y
≥30min
thigh-worn
inclinometer
7d
24h/d
triaxial
Multimedia
Recall
640.7±99.6min/d
30±50.6min/d
5.8-54.6
40.4±92.5min/d
13.0-93.8
recanalize
transradial
RAO
homolateral
recanalization
very-low-dose
5,000
TR
plethysmography-guided
duplex
Hematomas
2,000-IU
5,000-IU
hematoma
2,000-
recanalized
very-low-
intra-peritoneal
vancomycin/gentamicin
Staphylococcal
coagulase
Epithelial
defects-namely
STATA
re-epithelialisation
2011,157
non-laparoscopic
Qassim
Saudi
Arabia
50mg/m
β-hCG
88.6
P=0.1
Receiver
3600-5500
mIU/mL
whooping
toxin-induced
immunoglobulins
monocomponent
two-component
haemagglutinin
Diagnosis
whoops
0.0041
0.0196
buflomedil
dihydrogenated
ergot
alkaloids
Seventy-six
Infrared
LED
phototherapy
HRmax
mW/cm
Tlim
Bruce
12-months
whitening
strips
Strips
Tooth
strip
Ultrasonically
transvaginal
Timed
urination
oxitropium
inhalations
flow-rate
non-trial
RV/TLC
valproate
abomasal
Commonly
Holstein-Friesian
8-15
NaCl
Abomasal
periodically
Erythromycin
.62
urapidil
VR-JIT
didactic
laboratory-based
enjoyable
role-play
self-confidence
vildagliptin
islet-cell
Dipeptidyl
DPP-4
T2DM
prolonging
incretins
glucose-dependent
insulinotropic
polypeptide
GIP
GLP-1
postabsorptive
islet
6.2-7.5
2-wk
Vildagliptin
meal-induced
allografts
cadaveric
Aza
CsA-specific
vacuolation
tubuli
Histological
3.2-4.3
cyclosporine-related
meningococcal
A+C
observer-blind
MenC
MenPS
n=92
n=90
Hypercholesterolemic
pitavastatin
163.4
159.7
25.6
-0.070
-0.067
r=-0.24
liquid-polish
biofilm
Biofilm
polymethyl
methacrylate
PMMA
light-cured
CLSM
Mum
Bonding
coatings
palatability
Omega-3/omega-6
3/6
q
Investigator-rated
Scale-IV
instituted
lidocaine-bupivacaine
fastest
kJ/d
gamma-tocopherol
redox
cystine
GSH-glutathione
disulfide
cysteine-cystine
parent-implemented
imitate
Reciprocal
RIT
Generalization
commissurotomy
Inoue
metallic
Metallic
cheaper
PTMC
IBMC
PMMC
valvotomy
Procedural
90.18
=.29
14C-labeled
dose-linear
reaches
Vz
590
radioactivity
consist
ring-hydroxylated
demethylated
TGF-beta
pre-menopausal
Transforming
factor-beta
TGF-β
TGFBR2
ligand-binding
Tgfbr2
n=252
downstream
SMAD2
pSMAD2
n=319
CAFs
links
clinicopathological
treatment-predictive
CAF-specific
CAF-TGFBR2
0.534
0.360-0.793
lentiviral
hairpin
RNA-mediated
TGFBR2-specific
knockdown
fibroblastic
contact-dependent
clonogenicity
clonogenic
transfected
co-injected
MCF7
fibroblast-related
tumour-stromal
cross-talk
microenvironment
Anabolic
athelics
weightlifters
methandienone
seeif
improvemments
Methandienone
deprecate
athletics
L-carnosine
L-Carnosine
dipeptide
gamma-aminobutyric
-homocarnosine
anticonvulsive
Gilliam
Expressive
One-Word
Socialization
enterorhinal
Long-Term
517
427
Vitality
rebounded
NCT00006164
PNU-142633
anti-migraine
thrombocytopenic
1463
Ordinal
Central/South
heritage
ALP
HCV-related
expedites
Bronchial
clinicoanatomical
vitagram
Chocolate
frogs
frog
faded
chocolate-based
posting
packs
phoning
UDCA
biochemistries
enriches
AST
antiresorptive
ipriflavone
isoflavone
elcatonin
eel
carbocalcitonin
Katsuragi
Asu1-7
diaphysis
bone-specific
pyridinoline
calcium/creatinine
Ca/Cr
gainers
losers
Gruppo
Oncologico
Italia
Meridionale
Docetaxel
DCT
doublet
VNR
VNR/CDDP
chemo-related
prospectically
EPO
EORTC-QLQ-C30
LC13
NCI-NCCN
CTC
Recist
DCT/CDDP
module
24-40
TGCR
time-to-progression
1-26+
1-28+
G3-4
p=0.005
G-CSF/EPO
p=0.019
biologics
life-limiting
Statin
nonstatin
74.1
P=.36
6.85
716
Thoughtful
patient-provider
NCT01415934
CATIE
K-means
discrete
groupings
1,049
LS
LSE
Ob
HS
Dp
Ak
HSE
Six-month
quetiapine
mere
Ipratropium
laryngectomized
unrelenting
sprays
micrograms/spray
mohs
marks
gentian
violet
MMS
marking
mark
markings
confines
outset
SD=16.1
SD=10.8
n=31.72
SD=7.0
cryoablation
EBRT
disease-specific
QLQ
exceptions
cryoablation=69.4
EBRT=90.7
arising
cryoablation=7.2
EBRT=32.9
sexuality
retaining
Consumer-directed
CCDE
arrangements
outlook
N=109
N=119
nine-month
agency-directed
IU/hour
000-50
heparin-treated
chi2-test
ganciclovir
GCV
140-age
25-50
10-24
ml/
=70
0.78+/-0.46
1.42+/-0.37
24-hr
AUC0-24
24.7+/-7.8
hr/ml
50-69
1.93+/-0.48
2.57+/-0.39
52.1+/-10.1
0.41+/-0.27
1.17+/-0.32
14.6+/-7.4
0.75+/-0.42
1.59+/-0.55
64.6+/-18.8
7.2+/-2.4
1.47+/-0.48
0.69+/-0.38
pancreas-kidney
Nitrous
Fentanyl
air-O2
N2O-O2
laparotomies
Nonnucleoside
Tachocomb
Ganitumab
fulvestrant
hormone-receptor-positive
Insulin-like
IGF-2
bind
IGF-1R
ganitumab
sponsor
NCT00626106
3·9
3·6-5·3
5·7
4·4-7·4
1·17
0·91-1·50
p=0·44
1·78
1·27-2·50
p=0·025
hyperglycaemia
neutropenia-reported
Hyperglycaemia
Serious
reconstitution
filgrastim-mobilized
CD45RA
low/-
herpesvirus
antigen-stimulated
1.7-fold
2.4-fold
Death
lymphocyte-subset
97:3380-3389
Syphacia
muris
Fourty-eight
muris-positive
necropsied
40.7-63.3
35.14-58.88
48.39
Dramatic
graphs
A-V
Impulse
deep-vein
hemiarthroplasty
subcapital
Calf
1.55
dapsone
clinically-effective
3010
identically-designed
Dapsone
gel-treated
glucose-6-phosphate
dehydrogenase-deficient
Quincke
24-gauge
Gertie
Marx
needles
Benin
Parturients
pre-eclampsia/eclampsia
postdural
PDPH
non-postdural
NPDPH
backache
Non-postdural
anaesthetists
residential
Substance
aftercare
sedatives
non-thermal
SkBF
Tsk
thermostatic
20-minute
microvessels
time-course
pre-core
mutant
Pre-core
proceeds
Wild-type
osteopenic
Raloxifene
PINP
Continuation
Unexpected
results-limitations
pyrocatechol
violet-dye
PrCr
Vitros
analysers
Maternal/perinatal
91/233
94.1
47/160
17/160
'detected
deionised
Re-analysis
dilute
pyrogallol
dye-based
False
benazepril
20-45
SDBP
SSBP
-21.6
progestogen-only
depot-medroxyprogesterone
DMPA
subdermal
Norplant
BMDprox
depot-medroxy-progesterone
BMDdist
0.077
minimally-invasive
rtPA
intracerebral
evacuation
MISTIE
ICH
ICH-mediated
clot
avenues
stereotactic
clot-reduction
flushed
clots
re-bleeding
ventriculitis
Location
-80
ascent
8-ft
sit-to-stand
five-times
6MWT
MH
Bacille
C+I
enter
central-nervous-system
CSN
innocuous
mallard
ducks
Anas
platyrhynchos
regenerative
Wisconsin
Phlebotomy
Ducks
mL/kg
hetastarch
hemoglobin-based
oxygen-carrying
HBOCS
birds
polychromasia
post-phlebotomy
regeneration
cements
STATEMENT
PROBLEMS
cementation
scientifically
dentin/composite
dual-polymerizing
phosphoric
single-bottle
light-activated
primer/resin-based
hypersensitive
Linkmax
etched
Dentin
Untreated
P=.066
Tertiary
abort
induction-to-abortion
FES
FES-assisted
paraplegic
tibialis
force-time
FTI
pulsewidth
micros
stochastically
+/-15
stochastic
centered
10-min
Pseudoephedrine
preexercise
pseudoephedrine
PSE
Anti-Doping
Agency
WADA
cyclists
triathletes
30.6
V˙O2max
64.8
mL·kg·min
kJ·kg
nonfed
PLA
pre-warm-up
μg·mL
Capsular
contracture
saline-filled
textured
7.5-year
Biocell
pores
hardness
subglandularly
Siltex
Baker
contracted
one-half
patents
hardened
softened.The
hetero-thermal
microcirculation
vaginoscopic
Hysteroscopy
eighty-nine
vasovagal
TFPI
released
releasable
depleted
APTT
anti-factor
pre-injection
aphakic
encirclement
Simplicity
repairing
loteprednol
etabonate
Bulbar
LE-treated
Loteprednol
sensory-adapted
Dentists
43/chemotherapy
40/control
27/chemotherapy
33/control
III/IV
hypopharynx
paranasal
Cytoxan
exceptional
venipuncture
Noncompliance
ramifications
Draw
draw
∼
elected
Completion
20.59
Erlotinib
Gemcitabine
NCT01608841
sitaxsentan
PAH
Sitaxsentan
endothelin-A
manufacturer
6-min
6MWD
TTCW
0.090
Government
funded
PoCT
PoC
A1c
DCA
Cholestech
LDX
CoaguChek
QC
colour-coded
Result
Sheet
on-site
Within-practice
imprecision
within-practice
lipoprotein-cholesterol
centrifugation
hemoconcentration
MPH
cardiopulmonary-bypass
Conducted
Consisted
12-hour
12-hours
chest-tube
turnaround
Open-Label
Long-Acting
Injectable
RLAI
SGAs
n=44
n=77
that-within
design-RLAI
haemostatic
type-1
P=.024
P=.048
Separately
P=.083
P=.069
P=.038
P=.046
profibrinolytic
oats
rye
bran
beet
20-28
ingest
oat
Meals
Oat
glucose-lowering
fibre-rich
cefotiam
trepanations
contaminated
Excluded
transnasal-transsphenoidal
shunt-operations
711
te
trepanation
steroidal
metastasised
intratumoural
thymidylate
mCRC
TS
Tumour
quantitation
5-FU/folinic
FA
FUFA
5-fluorouracil/folinic
FOLFIRI
parties
Analysing
n=119
un-blinding
9/19
5/23
p=0.077
n=91
9/17
3/17
p=0.035
foot
posteromedial
bibrocathol
Posiformin®
Bibrocathol
intention-to-treat-group
97:100
preferring
Blepharitis
butyrate
Butyrate
SCFA
nonstarch
fibers
supplying
RS/d
31-66
3.5-32.6
mmol/kg
excretions
0.3-18.2
mmol/48
moisture
infraction
Diltiazem
mg.kg-1.h-1
Nitroglycerin
microg.kg.h-1
microg.kg-1.min-1
Pelvic
no-closure
lymphocyst
Lymphocysts
23/61
16/31
7/30
13/31
Retroperitoneal
methodologies
object-oriented
social-communicatively
unintentional
ketotifen
SML
TK
mg+K
success/failure
symptoms/awakening
SML-treated
Peritonsillar
peritonsillar
Photodynamic
5-aminolaevulinic
recalcitrant
incoherent
ALA-PDT
placeboPDT
Recalcitrant
placebo-PDT
paring
keratolytic
Verucid
wart
p=0.0006
vanishing
levosimendan
dobutamine
low-output
LIDO
Levosimendan
sensitiser
extrapolated
Enalapril
Costs
157+/-52
139+/-64
1108
entirely
life-year
LYS
3205
3091
3331
hyperemic
Phenobarbital
Seizures
Seizure
P=1.00
P=0.67
reflectance
spectrophotometry
non-treatment
spectrophotometric
radio-induced
object-based
Object-based
excitatory
replicating
Dihydroergocryptine
psycho-organic
alkaloid
dihydroergocryptine
Venographic
Enoxaparin
range-of-motion
1,009
-108.1
m/second
stentless
Stentless
Freestyle
valves
Carpentier-Edwards
Preoperatively
annulus
13.55
13.46
213+/-77
202+/-72
141+/-41
170+/-43
bioprostheses
aerosols
betalactam
Aerosolized
Theophylline
microcrystalline
Nuelin
Retard
mcg/ml
narratives
SIB
nonaggressive
CoAct
Cocreating
web
employees
company
employer
registers
NCT00994565
affirmation
race-discordant
race-concordant
stereotype
values-affirmation
Roter
Interaction
trust
66.3
Patient-provider
interested
friendly
respectful
.29
Multichannel
Bladder
distention
±114
±150
±171
±172
326
±183
±180
Bismuth
subsalicylate
investigator-blind
ethylsuccinate
Gastritis
colonized
rhamnosus
ATCC
53103
Gut
FISH
qPCR
secretor
neurologist
6/35
cells/g
Probiotic
Multimodal
nonmetastatic
1973
ADR
VAC
nonpelvic
primaries
pessimism
typhoid
Viatim
Vi
181
Seroconversion
seroprotection
Immediate
98.7
99.1
84.9
HA/Vi
hyporesponsiveness
4h
identical-appearing
Ulcers
Mitomycin
HCFU
noncuratively
Kyushu
Chugoku
carmofur
Macroscopic
Definitive
metachronous
69-month
disseminating
60-min
three-minute
montages
Cz-T5
Cz-T6
Cz-F7
Cz-F8
Self-reported
533
589
I.U
Duplex
Scan
Hemorrhagic
Haematomas
LEGO
SULP
6-11
h/week
autism-specific
Maladaptive
socialisation
anthracycline-pretreated
tumor-activated
fluoropyrimidine
capecitabine/docetaxel
1,250
Capecitabine/docetaxel
0.652
0.545
0.780
0.775
0.634
0.947
=.0126
=.006
myalgia
arthralgia
fever/sepsis
Docetaxel/capecitabine
Aminoglycosides
aminoglycoside
aminoglycosides
Gentamicin
OD
dose-reduction
32/35
25/32
+26.9
superinfection
1590
1672
trough/peak
0.6/10.2
1.4/5.2
Nephrotoxicity
2/40
11/45
High-tone
audiometry
3/12
3/11
5/12
4/11
information-only
2862
Kaiser
Permanente
0.0004
personally
Notably
saliency
colinear
contours
segregate
backgrounds
grouping
governing
extents
match
nonoverlapping
Salient
nearby
Contour
2-interval-forced-choice
spacing
subtending
cascade
distances
resections
suck-and-ligate
submucosa
cap
mm/185
mm/168
mm/314
mm/260
artifact
Villalta-Prandoni
Post-thrombotic
PTS
hyperpigmentation
VPS
VCSS
Sixty-nine
30-40
≥8
0.71-0.98
0.5-0.98
triangular
flaps
trismus
symmetrically
Trismus
interincisal
tape
pills
Envelope
Osteosarcoma
muramyl
tripeptide
three-drug
osteosarcoma
MTP
sixty-two
EEN
EN
IL-11
EEN/rhubarb
intensive-care
stays
SAP-related
damages
B-vitamins
tHcy
A-beta
1-40
25mg
B12
S.E
dentifrices
Belgian
Crest
Whitestrips
anticavity
Cavity
NaF
Mentadent
Whitening
Toothpaste
monofluorophosphate
MFP
Rembrandt
Abrasion
Strip
Deltab*
DeltaL*
-0.96
Deltaa*
yellowness
brightness
timepoints
plexopathy
sixty-one
13-99
paraesthesia
hypaesthesia
reflexes
Fractions
advisable
damaging
microneedle-based
wearability
microneedle
multi-day
T1DM
basal/bolus
NovoRapid®
U-100
Tmax
intra-subject
0-1.5
nadolol
thyrotoxicosis
thyrotoxic
nonmetabolized
Letter
Begg
family-level
FDR
approaching
FDRs
1380
331
OR=1.6
CI=1.01-2.51
OR=2.15
CI=1.11-4.13
OR=1.77
CI=1.1-.85
OR=3.3
CI=1.9-5.93
partnered
OR=4.37
CI=1.86-10.26
OR=2.88
CI=1.08-7.68
1-20
Anemia
HFREF
HF-ACTION
2331
quintile
1763
515/1763
1.01-1.32
1.10-1.42
0.87-1.42
1.01-1.33
1.06-1.51
CV/HF
propofol-nitrous
enflurane-N2O
thiopental-enflurane-N2O
propofol-propofol-N2O
commands
Acidform
acid-buffering
microbicidal
spermicidal
nonoxynol-9
N-9
messiness
Colposcopic
Acidform/N-9
Vulvar
exulceration
de-epithelialization
vulva
titan
clip
ETHICONR
laproclipR
Davis
Geck
duct
Bdp
removals
time-intervals
transperitoneal
TLA
RLA
quadrant
5.96
126.5
electively
Averaged
Temporal
microL
sacs
timolol-induced
374
hernias
teams
overlook
malnourished
zofenopril
governed
sympathetically
derives
laparoscopy-assisted
IA/IB
JCOG0912
T1N0
T1N1
JCOG0703
credentialed
Auditory
Evoked
stimulations
single-trial
Electrophysiological
amphetamine-like
Ventilatory
urography
iothalamate
Forced
non-atopic
Bronchospasm
realtime
teledermatology
Northern
kbit/s
telemedicine
dermatologist
52.85
Pounds
59.93
47.13
48.77
isobaric
pethidine-clonidine
bupivacaine-morphine
rhGM-CSF
infection-related
citrate-resistant
Infertility
Clomiphene
clomiphene-induced
LH/FSH
thicker
dysomnias
wakenings
bepotastine
besilate
perennial
Bepotastine
BBOS
dual-acting
instilled
reflective
subject-assessed
Subject-reported
NCT01174823
Penang
Quit
urn
13.78
0.669
0.395-1.133
bio-chemically
0.375
0.217-0.645
TCTR20140504001
Rivaroxaban
14,264
rivaroxaban
306
nonmajor
1475
1449
Bayer
ROCKET
NCT00403767
Weight-adjusted
serum-mediated
serum-induced
APC
76464767
thromboprevention
WAD
circulating-tissue
Circulating-tissue
282-347
319-431
dalteparin-treated
281-346
274-339
Serum-induced
MIA-Paca-2
Boyden
+54.9
-21.9
BB-tissue
0.384
low-molecular
dose-intensified
MEC
M-VAC
Urothelial
T3b
S-MEC
I-MEC
15/29
22/29
14/30
cell-mediated
G.
g/kg/month
psychologic
patient-rated
Cell-mediated
delayed-type
recommencement
Immunomodulatory
GTR
OFD
GTR-group
OFD-group
CAL-h
recession
GR
CAL-v
2.51
2.27
etoricoxib
active-comparator-controlled
548
q.d.
Subscale
WOMAC-PS
WOMAC-PFS
PGADS
utilizes
+/-10
62.52
70.14
=0.002
-11.66
-16.31
-7.01
-7.62
-12.30
-2.94
-10.15
-14.74
-5.57
-7.23
-11.85
-2.61
-11.65
-16.81
-6.50
-8.11
-13.30
-2.92
interferons
IFNs
immunomostimulatory
costimulatory
IFN-mediated
sheathed
Tru-Cut
Menghini
commoner
Cytology
reusable
Papanicolaou
overdiagnosis
12,527
persistently
colposcopies
mid-30s
NCT00479375
lornoxicam
Lornoxicam
definitely
Aripiprazole
PAE
316
naïve
AN
Aripiprazole-treated
drooling
aripiprazole-treated
z-score
Identifiers
NCT00332241
NCT00337571
Chlorhexidine
swabbing
Peridex
Procter
Gamble
Toothette
Sage
subjects/caregivers
Subjects/caregivers
smile
1-h
mug/h
annulled
recreational
Sense
Coherence
Rosenberg
Self-Esteem
beta-lactamase-producing
beta-lactamase
inactivate
throats
midazolam-bupivacaine
genitourinary
Lowest
bupivacaine-midazolam
drug-containing
porcine-cornea
Fifty-five
transplanted
acetyl
rescued
43.59
prazosin
gelatin
0.4-mg
burst
vitro-in
AUC0-infinity
mycophenolate
Astellas
TacMR
nonadherence
mycophenolic
Tac
2-by-2
Pawinski
42.24
16.98
37.18
13.75
40.09
16.69
mg·h·L
0.1327
0.1109
Cephamandole
cephamandole
'tourniquet-release
Assurance
ROSEL
uniformity
oncologists
physicists
non-academic
Plans
optimised
conformity
Exploring
tanezumab
humanized
DPN
PHN
limiting
landmark
Inventory-short
Tanezumab
Riluzole
hyperglutamatergic
glutamate-modulating
riluzole
optimally
riluzole-treated
3.750
acupoints
JiaJi
T10-13
Ciliao
Han
Acupoint
Stimulator
DC
HANS
PCIA
PCEA
T10-L3
battery-powered
Ondansetron
dripped
BaxterAP
lockout
L2-3
Sufentanil
ug
uroschesis
artery-radial
Y-graft
EuroSCORE
grafted
crossclamping
euglycaemic
30.3
mumol/kg
non-oxidative
-0.71
dealing
bio-psycho-social
return-to-work
full-time
Cytokine
diarrhea-dominant
IBS-D
factor-α
IL-10/IL-12
Bowel-related
mitosis
P=0.024
well-powered
DIR/Floortime™
Individual-Difference
Relationship-Based
DIR
/Floortime™
FEAS
Solomon
intermuscular
elbow
0.130
44.6
EMG-EMG
β-band
13-25
muscle-specific
antimony-unresponsive
isethionate
abatement
up-and-down
staircase
volume50
7.3-17.1
23.2-27.5
timolol/pilocarpine
pilocarpine
Fotil
Leiras
Timpilo
MSD
optic
Schirmer
6.31
burning
blurring
accumulating
CLAS
preintrusive
40-
59-year-old
colestipol/niacin
Alendronate
Bisphosphonates
vanguard
Frequently
gastro-oesophageal
alendronate
45-58
T-score
10mg/day
C-telopeptide
pyrosis
enteric-coated
Enteric
Pre-Operative
Arimidex
locally-advanced
whichever
4/48
25/49
0.05-0.41
0.05-0.96
0.0436
2/48
10/49
pre-operative/post-operative
baroreceptor
Fatty
PUFA
baroreflexes
baroreflex
beat-to-beat
Finapres
Ohmeda
Englewood
bradycardic
depressor
computation
g/die
1.76
8.99
powers
to12
Revision
impression-improvement
at2
checkpoints
Informed
consentwas
pemoline
MS.
Digit
Span
Trail
Symbol
Modalities
Reminding
Benton
Retention
Finger
Tapping
tibiofibular
fibularis
longus
arthrokinematics
H/M
P=.48
ponezumab
Ponezumab
antiamyloid
Aβ
single-dose-escalation
drug-attributed
midbrain
Electrocardiography
unremarkable
microhemorrhage
vasogenic
meningoencephalitis
proportionally
infinite
inf
~0.5
1-x
'leaky
lactulose
L/M
gluten/dairy
gluten/milk
glycogen
IL-6R
ubiquitously
gp130
tightly
low-glycogen
normal-glycogen
ABC-I
1.37
-13.4
ES=-0.7
Competitive
COMET
Self-esteem
psychopathological
rumination
trans-diagnostic
monohydrate
Time-concentration
1-sided
MIC
pyogenes
CL/F
Suboptimal
Delay
acid-suppressive
pathogen
Neurobiological
serotonin2A-dopamine
28.1+/-7.3
2.9+/-1.4
wind-up
sensitisation
non-cardiac
FGD
or=0.3
Wind-up
UO
p=0.3
disordered
row
Trainees
CPRS-R-DSM-IV-ADHD
sleep-related
lability
PDD/ID
lymphokine-activated
lymphocytosis
CD45RO
T-memory
folded
unfolded
frontotemporal
migraine-induction
antimigraine
aura
Mindfulness
Meditation
mindfulness
MM
IMMI
health-and-wellness
65-90
Portland
Acceptability
above-average
0-6
604
506
home-practice
0-1432
0-46
2-6
327-1524
11-35
credibility
avascular
ARCO
IIc
STIR
FATSAT
T1-weighted
Sucralfate
overcomes
unicenter
site-protective
sucralfate
reluctance
24-mo
2-mo
4-mo
cimetidine-
sucralfate-healed
spell
hastens
colectomy
Concern
872
open-colectomy
P=0.32
laparoscopic-surgery
P=0.51
briefer
psychobiological
social-evaluative
N=123
individual-threat
group-threat
no-threat
baseline-adjusted
individual-
Therapist
supportive-expressive
Profound
patient-therapist
.32
early-in-treatment
Alliance
.65
purity
.44
therapist-related
self-evaluated
emphases
NZ
Middle-aged
amide
digits
digital-brachial
quickest
IPPB
croup
Racemic
stridor
Rate-modulated
ventilation-sensing
rate-modulating
Treadmill
fixed-rate
VVI
VVIR
cc/kg
beats/min
134.9
anti-tumor
Anti-Tumor
Necrosis
Rheumatology
ACR20
28-joint
ACR
Sharp/van
der
Heijde
MTX-treated
Usual
blood-letting
cupping
gouty
eachgroup
Probenecid
ob
96.7
Vinegar
HUVECs
acetic
phosphorylated
PKA
AMP-activated
AMPK
acetate-induced
FBF
vinegar
acid-induced
acupressure
Acupressure
frequency/high
myxomatous
Pres
chordae
tendineae
rm
recruitable
Preserving
chordal
attachments
nanocrystalline
hydroxyapatite
intrabony
nano-HA
Probing
PBL
uneventful
RAB-plate
sliding
blade-plate
buttress
rod
displacements
postreduction
neck-shaft
varus
angulation
screw/neck
ripening
1000-microgram
resectoscopy
Premenopausal
Occurrence
isthmus
tracheostomy
division
Impacts
dually
LifeMasters
Supported
SelfCare
telephonic
33,000
resided
high-cost
nuts
Multicentric
thirty-eight
virgin
densitometry
PRAL
NEAP
2.63
=-1.01-6.35
nonsignificantly
CI=-0.13-0.74
P=.14
deoxypyridoxine
Medium
19-50
27-33
Oils
muffins
0.0177
0.0386
0.0413
time-by-diet
Distinction
comes
Adenosine
Rolofylline
Hospitalized
Decompensated
Overload
Congestion
PROTECT
rolofylline
2033
Prespecified
rehospitalization
c-index
c-indices
identifiers
NCT00328692
NCT00354458
concrete
nouns
categorize
nonliving
MTG
semantically
integrating
episodic
High-calcium
Sixth
high-calcium
low-calcium
Anthropometric
.018
long-standing
adductor-related
Groin
multiple-logistic-regression
3.4-47.2
p=0.006
Nurse-led
Blackwell
Publishing
Joanna
Briggs
JBI
Synergy
www.blackwell-synergy.com
www.joannabriggs.edu.au
covers
self-help
Audit
PEBM
group-comparison
manual-based
justifying
appearances
SUBJECTS/METHOD
meals/day
snacks/day
3+3M
dieticians
3+3M=-4.1+/-6.1
-5.9+/-9.4
P=0.31
glucocorticoid-induced
Introduction
subgrouped
25-OH
65-74
subpopulation
Osteoporotic
P=0.0189
P=0.0305
Conclusions
anti-IgE-induced
alcohol/onion
anti-human-IgE
intradermally
atopics
non-atopics
Diameters
wheals
anti-IgE
epidermally
Oedema
calliper
onion-treated
Obviously
onions
frontoparietal
after-school
WMI
tensor
DTI
BMI≥85th
11-year-old
instructor-led
Tractography
fasciculus
blend
krill
salmon
Krill
premium
krill-oil
KS
1-g
canola
8-wk
Matsuda
oral-glucose-tolerance
intimamedia
KS-oil
ACTRN12611000602921
Ga-Al-As
uni-
joule
demonstrable
RIVM
CIS
bacilli
Drug-induced
BCG-treated
MMC-treated
0.560
plasmakinetic
vaporesection
Plasmakinetic
PKVP
vaporized
Peri-
sharp
0.192
0.757
0.888
0.862
0.169
potassium-
thiazide-induced
isrctn41456865
Pathways
Latium
cluster-RCT
EMS
non-trained
SU
Intention
2656
2239
78.3
106/434
43/328
0.79-4.00
105/243
43/311
3.21
1.62-4.98
15/175
2/115
15/99
2/107
potenti
ERs
organised
ISRCTN41456865
MR
reduced-calorie
Travis
Shenandoah
Iowa
iowa
Nebraska
4.90
4.30
Tinidazole
amoebiasis
2g
Bupivacaine-CO2
bupivacaine-HCl
carbonated
1965
bupivacaine-CO2
urologic
18-gauge
Tuohy
Spread
-HCl
Co-A
maculopathy
ARMSS
Age-related
AMD
outlines
Maculopathy
diethylstilbestrol
orimethen
glutethymide
T1-2N0M0
57.4
pyrimethamine
toxoplasmic
encephalitis
Terry
Beirn
Programs
Pyrimethamine
200/microL
opportunistic
Toxoplasma
gondii
Leucovorin
1.3-4.8
0.01-1.79
dan
shao
tang
yin
Dan
Shao
Tang
DST
Yin
70.00
37.50
proapoptotic
End-systolic
N-terminal-pro-B-type
Fas
1,378
68.2
Levosimendan-induced
0.671
0.586
0.441
0.614
antiapoptotic
6-mercaptopurine
6-thioguanine
veno-occlusive
CCG-1952
IT-MTX
2027
1010
1017
1009
thiopurine
84.1
91.9
91.2
.6
VOD
RHR
NCT00002744
'high
1970s
CMF-type
679
fennel
mefenamic
dysmenorrhoea
Islamic
high-school
postbypass
high-frequency/low-volume
Pao
Accumulating
documenting
utterance
untargeted
PTK2
CLL
genome-wide
R-FC
CLL8
treatment-naïve
Genes
treatment-gene
messenger
R-dependent
NCT00090051
NCT00281918
esteem
visual-motor
kindergarten
first-grade
VMI
DVMI
non-directive
NDSI
work-related
WR-LBD
Qingre
granule
stabilizes
plaques
tenascin-C
Granule
QQG
Ninety-six
n=48
numbered
endarterectomy
Plaques
CD68
metalloprotease-9
CD40L
polarized
MMP9
stabilize
pro-inflammation
restraining
breast-milk
compositional
inoculum
elusive
Bifidobacteria
30-35
adolescentis
bifidum
48.7-3.8
longum
non-allergic
22.4-3.0
Breast-milk
deranges
bifidobacterial
mRS
END
65.2
non-statin-withdrawal
14.91
-fold
8.67
24.63
37.63
10.01
19.01
184.09
43.51
21.91
CARESS-in-AMI
Breaking
decomposition
guidance-based
breaking
tennis
backhand
exoskeleton
unimpaired
broken
flexion/extension
anatomical
motions
Euler
coordinates
decomposed
Varying
anatomically-isolated
Administrative
Feedback
AFFECT
2533
3142
confidential
0.82-1.37
0.90-1.52
0.86-1.50
0.84-1.33
candesartan
mitral-valve
Port-Access
Heartport
Redwood
disadvantage
pyoderma
Bamako
Mali
Pyoderma
tropical
Apart
poststreptococcal
benzathine-penicillin
povidone
openly
Amoxicillin
Owing
parent-coaching
P-ESDM
parenting-related
Remaking
Recess
wait-list-controlled
recess
ADDITION-Cambridge
Anglia
unbalanced
1:3:3
40-69
target-led
audit
alongside
timely
ISRCTN86769081
unilocular
echoes
lumiracoxib
celecoxib
cyclooxygenase-2
COX-2
o.d
1:2:1
755
1,519
758
o.d.
45.3
NCT00145301
radio
BCG-therapy
curing
DTkid
tutors
Discrete-trial
DTT
SIMon
novice
declarative
Transthoracic
Electrical
Sinus
29/30
cardioverted
renders
CYP17a
Alexandria
IVF/ICSI
monofollicular
insulin/glucose
antiestrogenic
responsivenss
DD-CGAS
disabilities-relevant
descriptors
rater
Inter-rater
.79
.86
Checklist-I
-.71
Scale-I
-.52
.72
convergent
eclectic
educated
defaulted
Disopyramide-pyridostigmine
245
101.9
104.6
DSM
IV-TR
chief
complaint
pentoxifylline+risperidone
Lethargy/Social
Withdrawal
initiations
bids
seeding
nephroureterectomy
THPMG
Pirarubicin
Monotherapy
pirarubicin
voided
5.54
1.12-27.5
0.00-0.53
cystotomy
seeded
urothelium
reach-to-grasp
RTG
upper-limb
therapy-provider
minimization
physiotherapist
hour/day
ARAT
Wolf
WMFT
Log
Carer
ISRCTN56716589
cocaine-dependent
sociodemographics
unemployed
suppertime
postponing
imperfectly
glyburide
Premixed
NPH/30
supper
insulin-only
units/d
Fidelity
Simulation
Resuscitation
Scenarios
ACLS
high-fidelity
superfluous
video-based
outlining
Megacode
low-fidelity
Video-based
simulation-based
lectures
Tradeoffs
double-mediation
tradeoffs
tradeoff
sacrifices
argumentation
U-shaped
upward
conversely
predictions
Commonalities
Interfering
Baddeley
Hitch
supra-span
span
forward-memory-span
articulatory
slave
single-task
random-interval
1559
seniors
635
Computer-Assisted
Face
Improves
Recognition
Mentalizing
FaceSay
mentalizing
face-processing
social-skills
cost-
time-efficient
cartoons
intra-class
0.915
0.745
0.940
exam
ebrotidine
Ebrotidine
N-
diaminomethylene
-thiazoly
thio
-4-bromo-benzenesulfon
100981-43-9
FI-3542
affinity
gastroprotective
blood/
90-95
ulcer-related
ulcerated
Matching
Distraction
Distress-Revised
Oucher
574
coach
synovia
intra-articularly
intraarticular
impingement
subacromial
periarticularly
1,2,4
Numeric
piritramide
Piritramide
reagibility
bursa
Financial
agreeing
DUB
50,000/quality-adjusted
tampons
pad
tampon
263-
2,291
1847-
2752
costing
co-designed
someone
HCPs
unproblematic
Carers
'Take
HCP
Short-
neurodegenerative
HPA
RTM
Salivary
eighth
time-point
anti-parkinson
Diurnal
ClinicalTrial.gov
NCT01734876
FoU
108881
immunoactivation
neopterin
22.6
monocytic
ONO-5334
15-
multiple-dosing
15-day
5b
TRAP5b
osteoclast
inducements
thank
postcard
tide
49,605
subsample
4,968
postcards
familiarity
scrutiny
Preservative-free
PVP
preservative-free
ABAK
polyvinylpyrrolidone
frequent-replacement
fluorescein-staining
punctuations
Lens
wettability
lubrication
ondansetron-
Predicting
foreign-born
County
LTBI
clinic-related
Foreign-born
US-born
1.15-1.39
1.02-2.97
0.36-1.19
0.15-1.03
extracoporeal
shockwave
ESWT
3,800
approximated
1,300
mJ/mm
ED+
Maudsley
Dornier
Epos
Ultra
end-of-treatment
1,524
649
875
45.1
point-prevalent
Mtx
non-T
6-MP
maximally
Pars
plana
delamination
hyaloid
CME
fundametal
ILM
vitreomacular
traction
focal
PVD
detached
Examinations
ETDRS
FLA
MAR
-208.95
-78.05
-80.90
+59.17
affirm
arrow
eye-gaze
paradigms
eye-movement
distractors
orienting
schematic
ovale
ketoacid
branched-chain
KA
1-14C
hyperaminoacidemia
ELF
mumol.kg-1.min-1
LOX
NOLD
Ps
mumol/kg.min
AA/branched-chain
ketoanalogs
enteropathy
5-fluorouracil/leucovorin
NSABP
C-07
FL
Roswell
Park
Regimen
FLOX
BWI
Female
antidiarrheals
mapping
psychopharmacological
denbufylline
SDAT
MID
Computed
electroencephalograms
demented
61-96
subdiagnosed
Marshall-Hachinski
multiinfarct
Sandoz
Geriatric
SCAG
score/factors
Substitution
DSST
Trail-Making
TMT
DS
delta/theta
centroid
asymmetry
Denbufylline
interdrug
objectified
Approval
fulfill
postmarketing
commitment
Gleevec
NJ
CD117
GISTs
946
746
400-mg/day
800-mg/day
neodymium-doped
aluminum
strictures
Sachse
urethrotomy
61.8
VLASU
YAGlaser
low-invasive
Char
urethrotome
stricture
MUFA-diet
PUFA-diet
hemin
s.d.
0.073
0.408
+4.0
PUFA-rich
MUFA
paddle
TTI
transmyocardial
Minimising
paddles
rectangular
end-expiration
sternal
Transverse
amifostine
cytoprotection
ASCT
n=47
910
pre-ASCT
Amifostine
post-ASCT
P=0.09
therapy-induced
CML-study
HU
Ph/BCR-ABL
n=194
534
IFN/HU
nontransplanted
IFN/HU-treated
n=59
HU-treated
P=0.0063
IFN-based
Anti-angiogenic
VEGF-A
VEGFR2
neo-vascularization
coexpressed
Sex
T2-4
N0-1
Epirubicin
Decrease
synergism
V-325
AGGEC
V325
445
DCF
Karnofsky
KPS
Pain-free
protocol-specific
abstinence-specific
LAAM
operationalized
Demoralization
productive
brown-egg
19-wk-old
HyLine
Brown
1,700
3,400
6,800
corn-soybean
meal-based
FCR
quadratically
shell
Haugh
choline/kg
micronuclei
Micronucleus
Ferric
antioxidant-supplemented
0.979
0.922
Mandibular
MAS
OSAS
Indices
RDI
21.4/hr
23.8/hr
22.1/hr
18.9/hr
14.2/hr
52.7
snore
2-48
cisplatin/lipiodol
818
42.1
one-dose
four-dose
permeation
barbed
Suture
knots
tedious
tie
nidus
extrude
manipulations
knot-tying
glove
self-anchoring
slack
knot
tying
Pfannenstiel
nonemergent
cosmesis
3-0
polydioxanone
Cosmesis
Hollander
intelligibility-room
aircraft
helicopters
foam
plugs
headset
muffs
Much
spurred
earplugs
aircrew
intercom
so-called
hi-fi
custom
helicopter
BO-105
Fitting
plug
headset-only
headset-alone
exertional
false-negative
sextant
Screw
petrochanteric
fludarabine-mitoxantrone
CHVP
FM
mini-CHVP
full-mouth
supragingival
packing
aesthetics
self-perceived
SIT
Mite
IgG4
antibody-blocking
basophil
Foxp3
T-bet
GATA-3
CD63
up-dosing
Noninvasive
sloughed
legume-enriched
fermentable
cooked
beans
exhaustive
allowable
three-gene
distinguishing
chemoprotective
legume-rich
premise
interferon-α2a
HIV-HCV-coinfected
CORAL-2
4-coinfected
μg/week
epoetin-β
WBR
RBV-C
-sparing
NRTIs
P=0.039
NRTI-sparing
lactated
BSS
LR
Alcon
Ft.
Worth
NSS
MTL
unnumbered
lens-solution
postirrigation
flunisolide
salbutamol/ipratropium
1,875/375
shuttle
0.059
Anthonisens
purulence
-time
0.047
Unfortunately
troublesome
inefficacious
ninety-three
13C-Urea
Not-eradicated
quadruple
rabeprazole-based
Quadruple
100mg
07.00
13.00
19.00
01.00
bodyweight-corrected
AUC0-12
Cosinor
motilin
KC
11458
solid/liquid
'meal-related
t.d.s.
T100
T50
t.d.s
manufacturers
5,800/year
1,700/year
averted
THP
intravesically
non-recurrence
0.086
0.0137
0.079
Two-year
single-tooth
arch
non-occlusal
Straumann
fibronectin
brimonidine
tartrate
rosacea
Brimonidine
-adrenergic
vasoconstrictive
0·07
0·18
Self-Assessment
Chroma
Meter
30min
two-grade
0·001
tachyphylaxis
telangiectasia
medicare
navigators
Pacific
Islander
Moloka'i
island
Hawai'i
sponsored
488
Hawaiian
navigator
57.0
61.7
acetonemia
counted
insulin-withdrawal
insulin-deficient
Deslorelin
pre-pubertal
deslorelin
Sicilian
hound
bitches
ultrasonographically
endocrinologically
ovariohysterectomy
genitalia
ovariohysterectomized
oestrus
17-beta
cornification
50-80
oestrous
filiform
Nordic
Myeloma
NMSG
4/90
melphalan/prednisone
melphalan/
alpha-2b
quality-of
524
484
W.H.O
Durie
Salmon
cost-utility
MA-sensitive
chemotaxis
griseofulvin
Polymorphonuclear
PMN
microtubule
MAs
antimycotic
Griseofulvin
mild-moderate
griseofulvin-treated
reparative
first-dose
two-weekly
titrate
six-minute
lifescale
FLS
-at
post-first-dose
chemoreflex
metaboreflex
chemoreceptor
activity/sensitivity
metaboreceptors
chemoreceptors
177.0
PECO
breathed
SPo2
hyperoxia
Ve
hyperoxic
activates
sensitize
autosomal-dominant
octreotide-induced
1595
1524
453
-71
+14
Octreotide-induced
parenchyma
1506
1432
+162
-91
Octreotide
orthotic
ran
barefoot
12HL
18HL
Kinematics
.024
2382
717
2710
830
2538
sufficiency
4000
D₃
isotopes
1142
nonlinearity
Self-efficacy
precondition
standard-intervention
extra-intervention
748
26727615
ALL97
0.30-0.92
1.20-4.14
non-cirrhotic
periportal
self-directed
UCO
EX
SMEX
group-by-time
NCT00740038
recollective
M.E
Smith
componential
P300
jitter
waveform
memory-evoked
recollection
paediatrics
6.18
2.88
68.3
euphoria
0.396
nadifloxacin
-10.0
-17.6
p=0.010
-10.2
p=0.016
0.135
hypertriglyceridemic
MLCT
One-hundred-and-twelve
LCT
medium-and
transhiatal
Asians
reconstructed
retrosternal
Discharged
topics
vii
viii
sociality
ix
happiness
twelfth
eighty-seven
Transhiatal
conventional-dose
non-catheterized
etch
self-etch
composites
epoxy
replicas
stressing
adhesive-composite
Optibond
hydrotalcite
on-demand
NERD
non-erosive
0.065
person/day
Hydrotalcite
gilts
adrenocortical
sympathoadrenal
sympatho-adrenomedullary
axes
Landrace
sows
cross-fostered
PND
Glucocorticoid
stress-related
corticosteroid-binding
hippocampus
medulla
plasticity
fibrinolyis
0.8433
-0.1752
0.2465
47.052
Chlorhexidine-based
alcohol-based
povidone-iodine
chlorhexidine-based
disinfection
disinfected
benzalkonium
benzylic
30-second
soiled
481
catheter-days
1.24-3.24
1.87
1.18-2.96
contrary
50-mg/d
enterostatin
Enterostatin
Body-weight
MJ
hunger
satiety
hedonic
diet-induced
activity-induced
illness-related
Domperidone
teenagers
Routledge
2010a
right-hemisphere
gamma-band
left-hemisphere
Left-hemisphere
left-dominant
Modifier
Mundy
Res
Pract
Disabl
:124
isolation/withdrawal
electromotive
EMDA
iontophoresis
scapulohumeral
gonalgia
metatarsalgia
categoric
Scott
Huskisson
ketorolac-treated
relieves
longer-lasting
Saint-François
d'Assise
Québec
EPA+DHA
oily
servings/week
5161
969/2585
715/2576
441/2585
293/2576
VLDL1-
VLDL2-
IDL-
LDL-ApoB
AIMS/HYPOTHESIS
13C
allocate
VLDL1
VLDL2
IDL
catabolic
VLDL1-ApoB
6.70
4.52
pool/day
VLDL2-ApoB
8.72
IDL-ApoB
7.06
CONCLUSIONS/INTERPRETATION
catabolism
Miscarriage
attendances
CI95
0.3-1.6
Night
Hg/1.8
1.3/1.7
5-FU/FA
HAI
5-FU/FA-therapy
Poylmerized
glutaraldehyde-treated
polymerized
nonpolymerized
monomeric
AgE
ragweed-sensitive
serum-specific
PNU
monomer
2,813
1,574
postseasonal
Dobutamine
IDC
micro/kg/min
dyskinetic
16-
DeltaWMSI
0.0000
17.57
10.41
0.0013
8.23
8.08
0.0045
3.83
=0.44
69.4
0.00033
Beliefs
donation
intend
bolstering
donating
communicated
iron-deficiency
shengxuening
SXN
Tf
sTfR
qi-blood
Bi
materia
medica
footbath
fumigation
KOA
LKSS
meloxicam
Massage
indapamide
reflection
Hunter
DBT
DSH
Dialectical
TAU+WL
neurocognition
fragile-X
Fragile
Retardation
FMRP
motion/form
Repeatable
RBANS
reminiscent
neurodevelopment
GABA-ergic
neuraminidase
oseltamivir
zanamivir
GS4104/Ro64-0796
hotel
hemagglutination-inhibition
=1:8
A/Texas/36/91
H1N1
shedding
shed
23-151
79-306
culture-infective
doses50
83-131
35-59
Oseltamivir
score-hours
97-349
189-645
-11
PAX4
diabtes
209
repaglinide
rosiglitazone
rs6467136
GA+AA
2-h
Plog
rank=0.0093
homozygotes
P=0.0143
rank=0.0091
single-nucleotide
Iontophoretic
Dermal
iontophoretic
mA-minutes
23-mm
Iontophoresis
two-year
Describe
Survivors
registries
citywide
Medic
countywide
Neo-Gilurytmal
2589-47-1
metabolizer
0-Tlast
Ae
AUCs
α-linolenic
re-examination
longer-chain
isotope-labelled
synthesise
+2.0
+0.7
wastes
FSG
geographically-dispersed
64,554
55-74
39,385
7084
6496
55-59
2.40
2.27-2.54
0.62-0.72
6.24
5.78-6.75
bromperidol
Add-on
Odontogenic
Maxillary
Cyst
odontogenic
MLA
P=.074
P=.040
Parenting
Sanders
Psychology
2:71-90
Consulting
68:624-640
Roberts
:180-193
verbosity
sleeper
VPs
precisely
VP
branching
.The
Warwick
Keele
Birmingham
equating
fifteen
15-item
EViP
recorded.In
formative
Creative
Commons
Attribution-Share-Alike
license
dialyzer
high-flux
-associated
delineate
dialyzers
Stable
low-flux
polysulfone
polyamide
-microglobulin
tonabersat
spreading
CSD
Tonabersat
NCT00332007
1.0-5.0
0-3.0
non-aura
auras
Minster
Lundbeck
Harmonic
Scalpel
excisional
doughnut
forma
continence
20-month
doughnuts
incorporation
inflow
Ischemic
IPC
Cytoprotection
hepatocyte
steatosis
Kinetics
.137
.616
.980
.514
sinusoidal
Now
!
Operators
ATC
automatically
ATC-related
intramodal
interfaces
Conductive
Psycho-Educational
C-PEP
55.0
Chloroprocaine
2-chloroprocaine
Times
LX4211
SGLT1
SGLT2
Sodium-glucose
cotransporters
reabsorption
SGLT2-selective
clinical-trial
zalcitabine
herbs
combined-herbs
SH
ZDV
ddC
anti-retrovirals
Karnofski
HIV-RNA
anti-retroviral
somnologs
actigraphs
2-18
Recordings
somnolog
Sishen
Xue
Dingshen
Sanxue
tranquilization
Nao
Shou
Zhisanxue
Zozhi
Sonxue
Needles
25/30
pentavalent
b-tetanus
diphtheria-tetanus-pertussis-inactivated
SmithKline
Beecham
Biologicals
Pw
Pasteur
Merieux
Connaught
polyribosylribitol
phosphate-tetanus
polioviruses
5.06
23.12
6.66
13.59
presently
pertussis-H.
nonheparinized
flows
decannulation
cannulations
378
159.0
154.6
corrective
Actions
homologues
chemokinesis
C16:0
C18:0
PAFs
1:9
weal
alkyl
substituent
homologue
sestamibi
Nycomed
NC100100
versatile
harmonic
perfluorocarbon-filled
digitized
sestamibi-SPECT
segmental
segment-
Xylitol
MILIS
Limitation
Size
tenth
propranolol-
planimetry
technetium
scintigrams
R-wave
transmural
nondependent
encounter
directives
third-year
covariables
post-visit
uninformed
colleagues
Single-session
earthquake-related
Turkey
single-session
SSBT
fears
Follow-ups
1-2-year
Profiles
HT
Applied
tibolone
Kuntai
HT-managed
2.43
1.08-5.46
1.42-6.88
0.26-2.04
bit
Endometrium
coiling
Subarachnoid
ISAT
medium-term
equipoise
Sept
1644
10·0-18·5
Office
Statistics
ISRCTN49866681
809
1·35
1·06-1·73
1003
435
1·25
0·92-1·71
1·34
1·07-1·67
Rebleeding
disability-free
Mannitol
Citioline
Cefeazidime
etc.
Qu-chi
Waiguan
Binao
Jianyu
Fengshi
Xuehai
Yinlingquan
Sanyinjiao
Taichong
etc..
sweet
ostracism
Ostracism
activate
acetominophen
reliever
25g
sucralose
ostracized
Cyberball
lessen
ST-segment-elevation
HORIZONS-AMI
CI-AKI
Harmonizing
≥0.5
1.14-1.51
improvement=0.177
improvement=0.100
NCT00433966
tirasemtiv
amyotrophic
Tirasemtiv
sarcomere
Trends
ALSFRS-R
Minute
Inspiratory
Neuroleptics
Mefloquine
recrudescent
noninfected
Trunk
CLBP
SMT
Interdisciplinary
1-yr
20-60
SMT/TSE
Continuance
Atherogenic
Lipoprotein
Poorly
high-potency
1mg
EAT
RLP-C
sd-LDL-C
-24.6
-20.5
-3.7
-19.7
+5.5
51.0
-16.3
-20.7
-8.3
intensified-dose
RLP-C.
UMIN000002593
homovanillic
HVA
lethargy
Fenfluramine
pre-induction
pre-incisional
Pre-incisionally
pre-incision
communication-based
classroom-based
Howlin
R.
Gordon
Pasco
Wade
T.
Charman
Multilevel
=1.90
3.74
2.19
6.37
2.17
2.68
.237
Lord
beta2-agonists
P=0.10
EPX
Disabilities
Shoulder
Dexterity
nonsplinted
Prefabricated
etanercept-treated
TEMPO
n=682
RADIUS
n=4341
CDAI
CDAI≤2.8
≥6
≥35
GreenLight
photoselective
PVBT/PVP
outlet
PVBT
neck/prostatic
Clinicopathological
open-heart
i.
582
Red-cell
Thrombin-antithrombin
3-port
appendicitis
Proponents
multiport
halted
hydromorphone
attractiveness
Single-incision
Skillful
papillomavirus-associated
laser-CO2
deleulking
energetic
iron-depleted
rowers
IDNA
nonanemic
mg·d
FeSO4
6-wk
4-km
V˙O2peak
Rowers
group-by
tocolysis
26-month
Prolongation
105.2
38,593
40,887
43,158
37,116
0.445
artifactual
unequal
skewed
ASD+ADHD
upright/inverted
direct/averted
P1
N170
ASD/ASD+ADHD
midline-N170
ADHD/ASD+ADHD
specialisation
co-occurrence
Elucidating
aetiological
treprostinil
revolutionized
μg/breath
times/day
bronchospasm
455.7
71.5
antazoline
AnPAF
vernakalant
pro-arrhythmia
exceptionally
Antazoline
chinidin-like
cardio-pulmonary
valvular
Special
NCT01527279
Clomipramine
antiobsessional
tricyclic
obsessive-compulsive
compulsions
fail
treatment-resistant
age=14.5
=28.2
treatment-refractory
n=45
subtyped
TMA
Hans
associates
germinal
non-germinal
Choi
GCB
B-cells
subdivisions
BCL2
LMO2
predicate
R-CHOP
segregated
non-GCB
p=0.0015
p=0.039
profiling
GEP
entities
budgetary
committees
convincing
8-9
400-mg
2.12
unsupervised
instructor
Unsupervised
eprosartan
effectors
400-800
PF-4
beta-thromboglobulin
beta-TG
152.2
141.9
142.3
DPB
Eprosartan
mid-to-moderate
eprosartin
DBS
STN
GPi
Instability
best-treated
Switching
off/off
ViviScal
silica
baldness
minoxidil
non-vellus
hair
erythemal
deceased-donor
PSI
/mammalian
DGF
CALLISTO
Deceased-donor
protocol-specified
IE
DE
BPAR
66.2
0.860
37.8
DGF-risk
acid-rich
PUFAs
18-29yrs
1g
oxyhemoglobin
deoxyhemoglobin
near-infrared
Penetration
humor
blebs
investigator-masked
chromatographic
3.84
Ofloxacin
penetrates
10-fold
bleb-associated
lysate
Alfa-2b
Resected
Ad
lysates
MU/m2
1684
exceeds
excitatory/inhibitory
3.2-10.7
6.80
Tolerance
diethylcarbamazine
Wuchereria
bancrofti
helminth
Haitian
helminths
filariasis
30.7
53.4
69.9
ALB
DEC
DEC/ALB
microfilarial
Trichuris-infected
microfilaremia
everolimus-eluting
SPIRIT
EES
Periprocedural
MIs
n=669
n=333
2,048
N=1,345
N=703
346
NQMI
4.45
10.85
p=0.009
Alleviating
approach-avoidance
social-motivational
dominance-enhancing
social-anxiolytic
Approach-Avoidance
angry
tendencies
affiliation
REStenosis
Tranilast
PRESTO
portends
482
n=2694
n=8798
Cardiology/American
time-to-first
death/myocardial
infarction/TVR
cerebro-vascular
Hydergine
Erythrocyte
deformability
cyclosporin-treated
corn
cyclosporin-prednisolone
azathioprine-prednisolone
membrane-related
cyclosporin-induced
rigidified
Pedantic
clumsiness
pedantic
normal-intelligence
ICD-10/DSM-III-R
operational
5alpha-reductase
dutasteride
2,802
cc
-59.5
-37.2
0.737
0.804
0.578
0.548
polyvinylpyrrolidone-iodine
PVP-I
Terramycin
cum
sac
principally
Staph
albus
diphtheroids
Proteus
mirabilis
micrococci
Homeostatic
renin-aldosterone
low-renin
fertiliser
pasture-fed
pasture
farming
Spring-calved
grazed
paddocks
fertilised
40-50
/ha
High-N
allowances
Oestrous
inseminations
conception
luteum
p=0.10
Preventive
serotonin-migraine
1,3,4,14b-tetrahydro-2,7-dimethyl-2H-dibenzo
pyrazino-
1,4
-oxazepine
Org
1,3,4,14b-Tetrahydro-2,7-dimethyl-2H-dibenzo
1,2-d
antamine
anti-serotoninergic
anti-histaminic
tetracyclic
ring
C-beta
C-alpha
amine
profited
5-HIAA
anti-serotonin
hyperorexia
moxifloxacin
morbid
NCT01130922
3.38
0.75-4.00
0.75-2.50
∞
h/L
88.32
85.64
-91.08
enterohepatic
recirculation
Czech
Slovak
Ostrava
near-total
remnants
GBq
WBS
thyroglobulin
WBSs
Martin
Newly
Slovakia
economically
partnership
entrance
Union
propensity-matched
7788
Digitalis
3527
BSA
Propensity
2399
Matched
1636
4233/10,000
1587
3733/10,000
1.08-1.29
1.06-1.28
1.13-1.45
or=60
45-59
0.94-1.16
0.422
1.34-1.87
0.90-1.18
0.651
1.40-2.07
1.09-1.40
1.16-1.72
orchiectomy
4-year
13/50
Antinuclear
Venlafaxine
treatment-induced
14/59
5/53
hypersusceptibility
ACTG
368
IDV
EFV-HS
EFV+IDV
nucleoside-experienced
.509
nucleoside-sparing
nucleoside-resistance
L74V
uncommonly
EFV-resistance
K103N+L100I
Cephaloridine
PURPOSE/OBJECTIVES
10-contact
VARIABLES
social-functioning
value-added
NURSING
secondhand
SHS
Belief
HBM
Taiwan
two-group
government-mandated
focus-group
empowering
equipping
confront
smoke-free
pimecrolimus
cetuximab-associated
acnelike
eruption
cetuximab-related
rash-related
Pimecrolimus
Simplified
SWAT
sorting
pretask
II-receptor
dihydropiridine
J-RHYTHM
Rhythm
transtelephonic
male/female
219/99
days/month
umin
C000000427
primitive
neuroectodermal
PNET
adenosis
DES-exposed
DES
Fourty-four
re-isolation
duty-cycled
bipolar/unipolar
PVI
PV
PVs
reconnection
reconnected
Procedure
reconnections
0.722
Phased
redo-PVI
Phosphate
BRiC
Calcium-containing
binders
multislice
tomographies
U/l
eroded
ES/BS
BFR/BS
0.078
0.084
/microm
393
Cycles
rifampicin
brucellosis
3.85+/-1.98
2.78+/-1.03
P=0.044
Avatar
LFA
discriminating
avatar
College-age
Wingate
non-obstructive
Non-obstructive
PVT
streptokinase-mediated
5-13
3-18
6-72
3-32
7-35
12-60
beta-antagonists
Beta-antagonists
cardioselective
carteolol
betaxolol
3411/min
1.861
substituted
imbalanced
QCT
HR-pQCT
calciotropic
56-73
volumetric
vBMD
well-developed
nonmelanoma
selenized
1312
initiatives
one-to-one
preparedness
post-death
bereavement
inquiry
non-acute
sick-listing
Non-specific
2000-2004
primary-care
sick-listed
weeks-2
re-assessment
multiple-logistic
analyzes
time-points
1.9-12.3
1.6-8.7
1.5-17.5
1.3-9.1
self-prediction
non-predictors
widen
Pembrolizumab
PD-L1-positive
KEYNOTE-010
pembrolizumab
2/3
PD-L1
voice-response
0.00825
NCT01905657
Aug
Feb
1034
343
0.58-0.88
p=0.0008
0.49-0.75
0.74-1.05
p=0.07
0.66-0.94
0.38-0.77
17.3
0.36-0.70
0.44-0.78
0.45-0.78
339
Merck
Co
Trochanteric
r2
SEE
g/cm2
compute
imprecise
EDI
102.6
.0202
nonresuscitated
100.1
97.7
.1392
Psychomotor
.0430
.0164
Dopexamine
dopexamine
virtue
Edwards
Lifesciences
FloTrac/Vigileo
250-mL
Voluven
Hartmann
Morbidity
23-month
2242
95-120
SETTINGS
long-stay
domiciliary
listing
re-admitted
co-ordinated
percussion
Penicillin
1981-1983
Karelia
asses
semirural
polyunsaturated/saturated
0.4-1.2
Variability
isochronous
dependencies
intertap
Isochronous
ISIP
unpaced
influential
synchronization-continuation
ITI
partitioned
1st-order
ITIs
break
Moisture-vapour-permeable
moisture-vapour-permeable
MVPF
sulphadiazine
LIPID
IHD
angina-ischemic
9014
Running
life-years
placebo-in
best-guess
subsamples
substudies
Campaign
67.9
randomizations
peri-
hemorheologic
orthopaedics
Defibrotide
phleboclysis
15th
radiologically
favours
sure
handiness
really
Minority
Hispanics
PLCO
155,000
age-eligible
catchment
Detroit
age-eligibles
Blacks
racial/
Lichtenstein
Shahid
Sadoughi
N.=60
hematoma/seroma
8.13±2.19
13.15±1.5
safer
histatin-containing
mouthrinse
P-113
histatin-based
abstained
anti-plaque
anti-gingivitis
p=0.046
p=0.086
RRR-alpha-tocopherol
all-racemic
lipid-soluble
scant
RRR-AT
rac
-AT
oxidizability
all-rac-AT
Copper-catalyzed
peroxides
8-hour
lipid-standardized
conjugated-dienes
copper-catalyzed
trial-an
6-h
7/60
3/60
25/60
20/60
49.9
54.7
Mellitus
Higher-Complex
Carbohydrate/Low-Fat
Manifest
Adipose
Inflammation
Acids
GDM
low-carbohydrate/higher-fat
LC/CONV
hypothesizing
higher-complex
carbohydrate/lower-fat
CHOICE
carbohydrate/45
fat/15
/25
/15
biopsied
∼7
white-coat
22/11
14/8
Qingdao
crosssectional
6100
35-74
5355
3357
1562
1795
53.5
Expert
NCEPATPIII
NCEP
IDF
age-standardized
34.6
52.2
'catch-up
non-diet
GARS
VABS
Attention-Deficit
ADHD-IV
time*treatment
sub-domains
Surpassing
sanctioned
re-assignment
intra-group
disqualify
best-
ClincialTrials.gov
NCT00614198
clinico-ergometric
Eight-seven
clinical-ergometric
electrocardiographical
fexofenadine
H1-antihistamines
PC20
paradoxically
propionate-salmeterol
fluticasone-salmeterol
Fexofenadine
corticosteroid-treatedatopic
Epilepsy
Thames
anti-epileptic
wrote
Nurse
Hypertonic
expands
herniorrhapy
prehydrated
17/30
equipollent
Psychiatry
50:224-234
intrusiveness
Retrieval
Cause
proportional-hazards
2041
age-adjusted
3.7-fold
inception
ISRCTN20612367
thallium-201
advertisements
Bad
Pyrmont
latitude
Graz
Austria
mono
0.54-0.96
0.34-0.76
sway
N=28
N=31
advices
IL-1RA
apnea-hypopnea
well-justified
Preschool-based
preschool-based
video-taped
sociability
specialist-delivered
//clinicaltrials.gov/
NCT00378157
amoxycillin/clavulanate
bd
ESDM
18-
30-month-old
Nc
θ
penbutolol
glucose-controlled
Betapressin
Hoechst
watt
STH
M.G
Chez
Clarithromycin
semisynthetic
macrolide
p.r.n
males/six
males/12
t.id
males/15
0.1-1
0.6-2
0.1-0.9
2-2
clarithromycin-treated
Video-feedback
VIPP-AUTI
16-61
attachment-based
Disorder-related
Implementation
interveners
ADORA2A
neurobehavioural
vigilant
SWA
electroencephalogram
neuromodulator/receptor
2A
APPROACH
haplotype
HT4
non-HT4
waking-induced
sleep-deprived
Leeds
Help
40-49
13C-urea
Infected
929
8407
2329
1161
1163
710
58-64
967
71-76
81-87
2.1-2.9
dyspeptic
mites
build-up
steroid+D
Concomitantly
'adverse
DEX
CD45RA+
CD45RO+
Hemiarthroplasty
cannulated
Estimating
CUA
valued
0.15-0.20
€2,731
€2,474
€14,160
NCT00464230
Rioprostil
rioprostil
Diarrhoea
attention-control
FRIENDS
school-level
N=191
age=10.1
teacher-reports
N=253
age=9.8
story-reading
high-anxiety
anistreplase
1,615
Eminase
anisoylated
APSAC
infarct-related
reperfused
circumflex
Thermal
welding
TWT
BET
RATING
A-1b
dual-drug
Logistic-regression
colostomy
sarcomas
6000-6300
7-8
5500
no-chemotherapy
doxorubicin-induced
satraplatin
hormone-refractory
Satraplatin
HRPC
cisplatin-resistant
380
sponsoring
48/50
13.7-28.4
8.4-23.1
0.46-1.55
prostrate
9/27
2/23
2.8-13.7
2.1-
0.28-0.92
HPRC
facemask
compression-decompression
ITD
ETT
intratracheal
compression-to-bag-valve
15:2
transducer
Friedman
rank-sum
-7.3
.0009
Decompression
ITD-facemask
deployment
life-saving
fat-load-stimulated
chromogenic
FVII
Apical
Sparing
Useful
Than
Diagnosing
Amyloidosis
Borderline
Mildly
Wall
Thickness
RapSP-LS
amyloidosis
LVWT
≤14
RapLSI
LS/
LS+average
mid-ventricle
31/47
66.0
Best
Steroids
post-extubation
Overweight
K2
VK2
assigning
Glakay
=0.054
High-pressure
rapid-inflation
post-thrombotic
low-pressure
slow-inflation
ATL-Ultramark
Bothell
Wash
rapid-compression
molecular-weight
HAEST
Embolic
19/244
dalteparin-allocated
17/225
aspirin-allocated
ratio=1.13
0.57-2.24
6/224
4/225
26/224
32/225
24/224
21/224
16/225
avium
010
mycobacterial
rifabutin
forming
1.36-2.87
0.17-0.88
high-oil
distillers
grains
solubles
1,480
DDGS
1,198
PIC
1050
ADF
NDF
as-fed
jowl
327
17.6
quadratic
corn-based
3,871
3,515
4,347
4,648
4,723
4,904
3,417
3,690
3,838
3,734
ether
62.347
3,058.13
115.011
1,501.01
polyarteritis
nodosa
Churg-Strauss
PAN
CSS
virus-related
61.3
cure-defining
Uncontrolled
vasculitis
mCPP
Vilazodone
proarrhythmogenic
supratherapeutic
vilazodone
3-arm
time-matched
QTcI
Placebo-corrected
pharmacokinetic/pharmacodynamic
Couple-responsible
Therapist-couple
struggle
conceptualizes
couple-responsible
therapist-responsible
enactments
accommodation
inductive
Therapist-responsible
therapist-couple
Couples
responsibility
Mediation
trans-eQTLs
cis-mediation
1,800
transcribed
cis-eQTL
cis-eQTLs
SNPs
array-based
1,799
Bangladeshi
cis-
trans-eQTL
cis
trans-association
Sobel
434
false-discovery
cis-mediator
10-5
trans-associations
cis-trans
cis-transcript
unmeasured
eQTL
discovery
glucose-insulin-potassium
GIK
ml/kg/hour
streptokinase/30
0.0043
lactational
Honduran
Lactational
SF-M
breast-feed
64.5
80.0
min/d
introducing
glucose+1/2
Bicarb
350-500
Sal
'2000
oarsmen
23±2
mean±S.D.
7.41±0.01
7.02±0.02
7.36±0.02
21.4±0.8
32.7±2.3
arterial-jugular
from-0.03±0.01
3.2±0.9
3.4±1.4
5.8±0.6
1.7±0.1
1.8±0.2
blood-buffering
Narratives
ACEP
themes
conference
fictional
falsely
extraneous
theme
campaigns
noncommunicable
Canadians
wellness
origins
Winnipeg
aplastic
antilymphocyte
GITMO
SAA
anti-lymphocyte
ALG
CyA
g/kg/day
day1-5
1-180
n=39
+1
+90
+120
1.9x10
36x10
Metrics
stair-climb
timed-up-and-go
TUGT
6-inch
five-repetition
chair-rise
survey-36
LEFS
brace
20-times
nonoperative
antimetabolite
low-power
radiotherapy-
2009-2010
blockaders
triple-therapy
LPZ
RNT
metrinidazole
MTZ
LCM
RCM
79-97
84-99
autotransfusion
WSB
ABTs
ABT
unwashed
USB
n=75
160-406
Beta-Blocker
2830
in-
861
1151
=698
III-R
amantadine-placebo
toxicology
subtherapeutic
diethylpropion
n=32
Diethylpropion
well-selected
Low-Dose
Restricted
5HT1A
Positron
.400
time-by-treatment
2.5-mg
5.0-mg
.044
restrictive
NCT00873509
synemol
creams
vasoconstrictor
bioassay
Synemol
Diprosone
Aristocort-A
Valisone
Intensity
navigate
Settings
postdiagnosis
Problem-solving
91.0
aRR
Quick
Symptomatology
-1.67
-3.17
-0.18
NCT01021384
phosphosilicate
NovaMin
Alachua
Fla.
NovaMin-containing
onward
postconditioning
re-clamping
de-clamping
cTnI
postconditioned
µg/kg/minute
L/minute
0.0255
Bacteria
Infection
Startle
accomplishment
startling
high-magnitude
perturbed
movable
suddenly
translated
Perturbation
SAS-only
strengthened
backwards
SAS-triggered
startle
sarcopenic
Decreasing
72.7
56-93
16.6-46.0
appendicular
ASM
NL
SO
OO
27-month
1.5-3.9
≥80-
eGFRs
+1.0
treatment-group
mesiodistal
vestibulo-oral
fully-erupted
Orthodontics
Munich
palatally-displaced
dial
partially-erupted
widths
non-affected
unilaterally-
bilaterally-affected
tooth-size
space-analysis
dental-arch
5-month
QST
two-pronged
Trainers
MS01
n=137
ISRCTN54469112
0.72-1.10
p=0.29
0.63-1.02
p=0.08
0.78-1.27
p=0.95
aide
laundry
supplies
aides
Peer
mentor
reciprocity
5.94
90-days
strengthen
trialed
perampanel
partial-onset
noncompetitive
α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic
AMPA
antiepileptic
AEDs
drug-resistant
NCT00699972
19-week
Percent
387
-21.0
-26.3
-34.5
0.0261
0.0158
0.0760
0.0914
FloSeal
withstand
Hayward
otolaryngology-head
timeframe
managment
otolaryngologist
HSS
CU/kg
placebo/HSS
HSS/saline
ADI-R
CSBS
Ritvo
Real-life
GBRS
social-affective
post-infusion
erythematosus
NPSLE
dreadful
NP
neuritis
myelitis
Cy
18/19
TDS
flunarizine
AUCpredicted
C3h
121.4
C24h
reasonably
1230
mL-1
1203
ORG-2766
adrenocorticotropin4-9
oddball
nontask
A/Pcz/300
task-irrelevant
VaD
n=603
55.2
NINDS
Internationale
pour
la
Recherche
l'Enseignement
en
Neurosciences
AIREN
n=198
n=206
n=199
Scale-cognitive
-1.90
-2.33
Interview-Based
Change-Plus
P=0.014
Sum
Boxes
Donepezil-treated
-1.31
Donepezil
attention-controlled
performers
regress
re-uptake
antidepressant-induced
relapse-prevention
YMR
=8
hypomanic
hypomania
0.9-14
twenty-nine
embolic
deterrent
boots
venogram
coumadin
ultra-sonography
Colonization
ecology
colonize
Stools
8.79
colonizer
encounter-based
resident
DESIGN/METHODS
second-year
Postclinic
Acceptable
Resident
70-item
opportunities/vaccine
postponed
76.5
guidelines.immunization
ureteric
calculi
Siemens
Lithostar
shocks/minute
KV
6295
5300
Stone
47/54
50/52
96.2
48/52
4950
8544
Diuresis
ftorafur
Futraful
Ventilator-delivered
ventilator-delivered
VDMV
TV
MV
hand-delivered
self-inflating
Neopuff
inflations/min
PIP
end-expiratory
PEEP
inflations
dysmenorrhea
F17/M30
spina
bifida
Block
Waiting
List
time-processing
bogus
fist
nonaversive
17-34
slide
photoplethysmographic
sensors
ionisation
rheumatism
scapulo-humeral
displays
electricity
arginine/d
necessitated
arginine-supplemented
lytic
intercurrent
CYP2C19
bupropion-assisted
CYP2B6
hydroxybupropion
threohydrobupropion
erythrohydrobupropion
metabolize
CYP2C19*2
771
hours⋅ng/ml
hydroxybupropion/bupropion
540
reductive
metered-dose
342
breath-actuated
Diskhaler
albuterol
oncologist
2.9/10
4.4/10
4.2/10
5.5/10
2-dose
operatively
17/37
15/39
Two-dose
-96
Inotropic
CAHB
prednisolone/interferon-alpha2b
IFN-alpha2b
immunofluorescence
IF
chemiluminescent
molecular-hybridization
CD8+
1.1-2.7
pg
enumeration
prednisolone/IFN-alpha2b
arbutamine
Arbutamine
Beta
Rate-pressure
11,308
2,443
9,486
2,479
Arrhythmias
PRO
Organizations
20,136
Provided
MEDPAR
Annual
outcome-absence
unaddressed
examined-abnormal
discharge-were
Generic
substandard
MSM
DiSH
social-cognitive
risk-reduction
woven
exploring
condom
aromatherapy
hospice
postrandomization
Aromatherapy
Compeed
Hydrocolloid
hydrocolloid
wound-healing
728
SGAT
clinician-assessed
noticeability
embarrassment
7.57
7.03
antivirals
Tegaserod
prokinetic
tegaserod
promotile
2516
1679
837
12-lead
peer-led
-0.39
lb
Modeling
neocortical
complementary-learning-systems
neural-network
MTLC
recalling
tracks
matches
hippocampal-recall
MTLC-familiarity
target-lure
peri-PTCA
rarity
negated
on-time
Familial
strikes
0.54-1.10
nonaspirin
0.73-1.49
non-RS
crypt
normal-appearing
j-Cypher
12,812
2.21
3.76
5.60
7.70
1.99
Phosphorylated
p-70S6K
phosphatidylinositol-3-kinase
PI3K
mitogen-activated
MAPK
anti-estrogen
rapamycine
downstream-activated
recollected
constructing
micro-array
cores
563
immunostained
p-AKT
Thr308
Ser473
p-mTOR
p-p706SK
p-ERK1/2
Interactions
p-p70S6K
expresses
PI3K/Akt/mTOR
ziprasidone
Montgomery
Asberg
mates
Age-Equivalent
information-RUPP
NCT00080145
in-office
shade
photos
bleaching
Colorimeter
deltaE
lace
shoes
laces
eyelets
solve
properly
non-color-coded
shoe
transferring
lacing
non-criterion-related
step-by-step
accept
flavours
IG
puree
13-24
Plain
25-26
33-35
Vegetables
rotated
spinach
broccoli
pace
6m
18m
symphyseal-fundal
height-measurement
SCS
CMZ
SCS-free
reactivate
komatsuna
Brassica
rapa
var
perviridis
Japan.We
juices
T-Chol
LDL-Chol
amitriptyline
Levine
Pransky
-0.52
3.92
-0.33
-0.40
-0.21
-0.07
-0.05
malleable
rituals
heat/capsaicin
non-neuropathic
Sensitization
reheating
painfulness
Frey
mid-antiarrhythmic
nonneuropathic
experimental-induced
Hyperalgesia
ibutilide
procainamide
overdrive
terminate
pacing-induced
Ibutilide
electrophysiologic
cocktails
379
subjectively
cocktail
0.597
RD
/height
RD/BSA
outer
/RD
antispastic
morphometric
Masticatory
implant-retained
comminution
implant-supported
transmandibular
TMI
implant-tissue-supported
IMZ
comprehensibility
LISREL
PostureJac
cervicogenic
convergence
trigeminal
trigeminocervical
bi-directional
lordosis
SomatoCentric
jacket
Flexor
p=.001
p=.004
Flow
enumerate
bead
ICE
filgrastim
Fresh
Aliquots
tumour-specific
Ber
EP4
magnetically
bead-antibody
psychopharmacologic
uncommon
uninterpretable
pitfalls
methodologic
dilemmas
facing
industry-sponsored
interrater
alarm
extra-sternum
Real-time
PaCO2
HCO3
7.21±0.09
7.13±0.07
45.35±5.92
40.70±4.70
57.10±7.59
61.60±5.47
18.50±3.50
14.75±2.65
0.796±0.069
0.699±0.066
7.07±1.60
8.13±1.56
37.25±7.99
42.70±7.40
barotrauma
barotraumas
inputs
electrically
TRT
TENS+TRT
Spasticity
dorsiflexors
plantarflexors
plantarflexion
placebo+TRT
plantarflexor
dorsiflexor
UVB-induced
UVB
erythemogenic
backs
melanin
analytic
videomicroscope
interfaced
darker
melanogenesis
post-inflammatory
tyrosinase
melanocytes
stigma
Puerto
Rico
SPACES
accessing
manifests
denied
altogether
surpassed
Latino
disproportionately
finish
P1I
exudate
GEF
sheets
SCATA
toddlerhood
Mindlight
8-16
puzzle
Town
child/parent
institutes
NTR5069
ISRCTN66772971
Function-5
ED-specific
MED-QoL
Euroqol
2.09
-3.67
-5.46
encounters
willingness-to-pay
£20,000
synchronized
IMV
SIMV+PS
PICU
IMVG
SIMVG
tracheotomy
PRISM
0.120
1-6
0.262
2-22
3-20
0.113
ClinicalTrials.govID
NCT00549809
Philippine
polysaccharide-protein
PRP-OMP
PRP-T
HbOC
Expanded
Sera
Anti-Hib
Farr-type
0.3626
anti-Hib
6.62
microgram/ml
fuzheng
yiliu
factor-kappa
esophageal-gastric
Fuzheng
Yiliu
FZYLG
NF-kappa
flowcytometry
G0/G1
overload
antiadrenergic
Surge
doxazosin
-0.22
20-gauge
one-fourth
Chi2
pseudo-randomization
anesthesic
accompaniment
soap
bubbles
hetero-evaluations
child-doctor
boswellic
photo
age-damaged
biophysical
echographic
split-face
Boswellic
BAs
pentacyclic
triterpenes
Boswellia
serrata
grows
photoaging
Dover
ecographic
roughness
sebum
suppressant
DAISY
outweighed
restrict
Database
ISRCTN74848736
ticlopidine
heart-
kidney-transplant
heart-transplant
6-beta-hydroxycortisol
dud
dissimilar
fillers
lineup
dud-alternative
surrounded
implausible
Windschitl
Chambers
30:198-215
duds
non-dud
criminal
inflates
inflating
delineates
implicitly
kinesio
taping-compression
Kinesio
KT
ROAM
CVI
N=130
65.44±14.7y
KT-compression
tapes
bandages
8.76
4.96-12.55
pre-/posttreatment
1.02-2.49
3.45-1.47
stride
21.48-10.83
1.68-6.61
61-107
.56-.92
malleolus
1.15-1.63
fructose-1,6-diphosphate
Fructose-1,6-diphosphate
exenatide
Exenatide
three-part
premeal
Prandial
postmeal
excursion
arteriograms
dimethylarginine
ADMA
g/min
cGMP
insulin-induced
Paricalcitol
hyperparathyroidism
paricalcitol
SHPT
phase-3
m2
mL/s/1.73
iPTH
ng/L
calcium-phosphorus
balloon-expandable
endoprosthesis
Palmaz
2/62
5/69
artificially
flow-restricted
neointima
egocentric
metric
throwing
inches
oneself
intrusion
swapping
pretesting
threw
beanbag
donned
distorting
degraded
argument
stemmed
APPLICATION
creation
carbasalate
ergotamine
007
posthospital
portrayed
downs
adhering
Viewing
Aggression
phenomenology
Overt
OAS
Immunodepression
codified
thymostimulin
immunodepression
hypo-anergic
hypo-ergic
cefixime
Cefixime
gonococci
800-mg
94.6
gonococcal
'no
CLasP
'conservative
brovincamine
normal-tension
low-normal
30-2
CPSD
opacity
-0.778
0.178
-0.071
0.195
dB/year
Electrothermal
capsulorrhaphy
Radiofrequency
Reports
abandonment
ETAC
adopting
anteroinferior
labral
tears
.71
stiff
dose-effects
salvinorin
hallucinogen
Salvia
divinorum
Salvinorin
nonnitrogenous
constituent
mint
centuries
Mazatec
shamans
Mexico
divination
spiritual
hallucinogen-using
intermixed
Subject-rated
Orderly
time-
mystical-type
Mysticism
5-HT2
hallucinogens
Hallucinogen
Participant
disruptions
interoceptive
recurring
revisiting
cartoon-like
occasioned
similarities
ESS-1
scleroderma
nevertheless
MVA
polysiloxane
liners
bases
denture-supporting
Molloplast
Reline
Silagum
Mollosil
relines
odor
resilience
1=poor
2=fair
3=good
4=excellent
Unscheduled
Fungal
remaking
Endovascular
EVAR
instigated
n=172
aneurysm-related
adhered
6.0-13.5
0.87-1.69
p=0.25
pound
13,632
4983
8649
1248
reinterventions
tachyarrhythmias
Electrophysiologic
Electrocardiographic
pirmenol
propafenone
quinidine
Recurrences
electrophysiologic-study
Holter-monitoring
Sotalol
packet
return-addressed
alerted
resend
experience/familiarity
remembering
P2
N250
face-N400
Familiar
Novels
n=2453
9th
autoregressive
lagged
Marimastat
marimastat
sixty-nine
5-fluorouracil-based
protocol-defined
ratio=1.23
0.98-1.55
ratio=1.27
1.03-1.57
pre-defined
sub-group
P=0.045
ratio=1.53
1.00-2.34
ratio=1.68
1.16-2.44
ratio=1.32
1.07-1.63
FT
n=42
better-preserved
Torasemide
torasemide
tense
mmol/day
canrenoate
1450
Kaliuresis
natriuresis
root-surface
varnishes
Mutans
viscosus/naeslundii
decayed
peroxisome
proliferator-activated
receptor-gamma
Peroxisome
PPAR
thiazolidinediones
TZDs
EPCs
TZD
/kinase
1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine-labeled
acetylated
/lectin
EPC
SDF-1-induced
upregulated
NADPH-oxidase
GW9662
mimicked
normoglycemic
Somatic
DSM-
2005-2006
aesthetic
Hba1c
P-glucose
P-insulin
undersocialized
explosive
placebo-baseline
2.95
Porteus
Maze
1,166
Figures
20/23
87.0
0.664-0.972
13/25
0.313-0.722
0.028-0.512
Ultrasound
post-neoadjuvant
INTENS
post-NAC
n=155
n=123
P25=26
P75=100
P25=22
over-
underestimation
Gov
nr
NCT00314977
stinging
keratotomy
tap
Attention-deficit
IRENE
magnet
immunochemical
FIT
education/FIT
743
57.2
0.7-2.0
3.7-9.6
3.8-9.9
overdue
Transcervical
Foley
Cook
scarred
transcervical
El
Minia
Egypt
ripen
Caesarean
MAC-h
pre-eclampsia-eclampsia
pre-eclamptic
mumol
litre
Magnetic
EIS
EVL
MRA
hepatofugal
embolize
feeders
sclerosant
EIS-treated
reappear
embolization
hepatitides
NICE
Interest
Trust
ignorance
inheritance
agonist/HMG
luteal-phase
transfers
Childrens
CCSG
CCG-141
retreat
extramedullary
Isolated
22+
60+
80.8
Occult
minimal-residual
obviating
Conventional
Cigarette
Cytokines
macrophage-colony-stimulating
M-CSF
Prothrombin
11-dehydro-thromboxane
TXB2
1499
11-dehydro-TXB
ng/mg
cytokine-mediated
post-study
extant
add-back
A-daily
B-daily
norethindrone
C-daily
D-daily
intraaortic
pumping
IABP
EuroSCORE-stratified
Intra-
dialysis-dependent
aphthous
One-third
soybean
50/50
rapeseed
alpha-Linolenic
efficacy/tolerability
cibenzoline
Cibenzoline
anti-arrhythmic
PVC
succession
390
PVC/hour
328
477
646
anti-vascular
single-arm
pemetrexed
preliminarily
nonsquamous
bevacizumab-erlotinib
bevacizumab-chemotherapy
33.1
chemotherapy-containing
Supportive-expressive
CCOP
2x2x19
productively
hypofractionated
conformal
fractions/wk
seminal
383
incapacity
E-Mycin
Panmycin
Pustules
comedo
erythromycin-treated
tetracycline-treated
vaginitis
pseudotumor
cerebri
Graves
TSAb
post-antithyroid
microassay
1529
28/29
24/55
8/16
'short-treated
18/39
'long-treated
End-treatment
13/16
end-treatment
Relapses
8/10
Gabexate
mesilate
AT-III
heparinization
IU/kg/h
gabexate
Purified
Drug-drug
ACT-178882
CYP
metabolizes
drug-drug
pre-dose
AUC∞
20.1-35.8
454
351-587
ng·h/mL
36.8-51.4
781-1078
t½
1.62
1.36-1.94
1.75-2.34
Buccal
200-mug
Postpartum
1,604
848
756
antepartum
0.33-1.29
.52
uterotonic
Herpesvirus-like
saltwater
crocodile
Crocodylus
porosus
preserves
Evr
CsA-based
MDRD
Andersen-Gill
multiple-event
HCM
permutation
.027
364
.019
8-weeks
caregiver-completed
clinician-ratings
ACTRN12609000513213
cefotaxime
single-antibiotic
Infective
12/32
15/31
5/32
9/31
peri-operatively
topiramate+risperidone
1:1:1:1
caregiver-rated
presyncope
+1.3
+1.5
Gambian
trachoma
height-for-age
weight-for-age
weight-for-height
stunting
Gambia
20-35
GTD
DSG
18th
Cycle
levonorgestrel/ethinyl
micrograms/20
norethindrone/ethinyl
LNG
/20
Aless/Loette
NETA
Loestrin
1/20
LNG/EE
NETA/EE
63.8
62.3
LNG/20
NETA/20
DEFINE
EFficacy
INhibition
AnacEtrapib
Anacetrapib
anacetrapib
Determining
NCT00685776
Program-Adult
lipid-modifying
poststudy
2,757
1,623
T1-2
KROG-0201
CONV
Gy/33
Gy/35
HYPO
Gy/28
Gy/30
LPFS
2-122
p=0.213
T1a
76.7
93.0
3.65
p=0.056
52+/-2
ST+aerobic
carotid-femoral
vasoreactivity
heated
humidifier
humidification
bedroom
ThermoSmart
Auckland
desiring
WCGF
305-d
WCGF-L-cows
WCGF-DL
-0.11
WCGF-L
-0.04
prepartum
3.94
4.15
fat-corrected
Granulocyte-colony
mobilizing
subacute
mobilizes
iron-labeled
reinjected
ictus
minimization/prognostic
9.5-
4.2-fold
G-CSF-treated
migrated
subacutely
readminister
www.controlled-trials.com
ISRCTN63336619
Preemptive
degarelix
Markedly
Supraventricular
p=0.0459
p=0.0061
stellate
ganglionic
ganglion
SGB
one-lung
OLV
n=15
Swan-Ganz
CCO
1.5-2.0
Rocuronium
0.6-0.9
Endobronchial
occluder
indubation
Fio2=100
PETCO2
35-45
two-lung
TLV
mg/kg·h
μg/kg·h
o.1
45-55
S-G
ribs
braced
T7
T8
Qs/Qt
SVRI
T5·
fatigued
731
-0.82
adenovirus-p53
rAd-p53
intratumorally
rAd-p53-specific
Upregulation
p21/WAF1
Bax
2.73
Six-year
.34
.21
seven-day
Gram-stained
clue
sniff
prolapse
trocar-guided
polypropylene
colporrhaphy
Ba
Prolapse
Quantification
POP-Q
P-QOL
Anatomical
56.4
0.068-0.54
Trocar-guided
POP
chalazia
intralesional
chalazion
Chalazion
47/56
39/45
16/35
Inconvenience
Counselor
enhancements
stage-matched
fading
0,6,12
24,178
19,236
79.6
4,653
85.3
precontemplation
contemplation
transaminase
ALT
mL/min/kg
Scheuer
-.31
ankles
Kellgren
Lawrence
Orthopaedic
Foot
AOFAS
Ankle-Hindfoot
61.6+/-16.8
90.1+/-9.7
72.1+/-16.6
87.5+/-17.5
neuroleptics
7.8+/-2.1
7.9+/-2.5
1.4+/-0.7
F1,9
.0008
Colony
nigrescens
sphincterotomy
pure-cut
post-ERCP
non-conductive
guidewire
W/sec
blend-2
amylase
lipase
Post-ERCP
3-point
-4.8
non-ulcer
active-treatment
N.S.
P=0.048
antisepsis
chlorhexidine-alcohol
iodine-alcohol
scrubbing
intravascular-catheter-related
CLEAN
two-by-two
Intravascular-catheter-related
≥18
central-venous
random-number
chlorhexidine-70
isopropyl
iodine-69
microbiologists
NCT01629550
2546
1181
2547
594
1168
2612
580
Chlorhexidine-alcohol
0·28
1·77
0·05-0·41
p=0·0002
Scrubbing
colonisation
p=0·3877
p=0·0017
bundles
Poitiers
CareFusion
D5-D9
III-IV
planed
azimilide
Azimilide
314
.4596
1.104
0.849-1.436
Beihua
reflow
CKMB
CTFC
ECG-54
criteria/32
blush
MBG
arrhythmias-frequent
beat
1162
U/L
1732
22.23
26.97
3.42
10.60
vs.14.65
6.88
Ischemia
micrograms/kg/hour
photocoagulating
L-citrulline
HFpEF
aminoacids
outstanding
radioisotopic
rest/exercise
malate
56.67
7.96
47.67
8.59
'Exploring
Feelings
Attwood
episiotomy/laceration
Redness
Edema
Ecchymosis
Approximation
sitz
bath
laceration
Instituto
Nacional
Ciencias
Médicas
Nutrición
Salvador
Zubirán
MAT
MAT/TT
38.75
11.52
23.32
6.08
13.47
23.65
6.74
Post-ischemia
36.60
11.51
18.81
49.51
15.17
27.13
7.87
Teunisse
Gelder
285-294.
misalignment
aligned
misaligned
part-based
interpretations
metals
porphyrins
Zn
Cu
aluminium
Pb
565.0
0.595
atomic
Cu/Zn
Wald
uroporphyrin
heptacarboxyporphyrin
hexacarboxyporphyrin
pentacarboxyporphyrin
coproporphyrin
synthetase
Frusemide
midpoint
pre-frusemide
nimodipine
Engagement
ESM
animated
Gaze
Preferences
foundation
Fast-track
carbenoxolone
Biogastrone
hypernatraemia
potassium-retaining
ulcer-healing
resolving
medication-related
quarterly
137.8
168.9
135.9
164.6
145.3
175.8
76.0
77.0
KRAS-variant
miRNA
9708
9905
3'-UTR
microRNA
signatures
METHODS/MATERIALS
467
9905.
9708/9905
pyridinyl
evaluator-blind
0.133
steroid-dependent
nephrotic
nephrological
Relapse-free
N.S
relapses/patient/year
prednisone/patient
CsA-treated
cyclophosphamide-treated
relapsers
CsA-related
short-chain
SCFAs
low-fiber
triacylglycerols
millions
15,419
preschool-age
8333
base-line
symptom-specific
obtainable
under-nutrition
corifollitropin
150μg
200IU
1509
inhibin
⩾11mm
0.5-1.8
1.4-2.8
Corifollitropin
Gefitinib
gefitinib
during/after
0.59-1.18
therapy-naïve
0.52-1.15
endocrine-treated
0.63-3.45
CBRs
Biomarker
ER-negative
Andhra
Pradesh
unsupported
GBI
hitherto
cultural
Atlanta
Georgia
neighborhoods
gender-specific
NIDA
drug-using
drug-taking
nonaccidental
SAFE
PACE
cardioinhibitory
CSH
Cardioinhibitory
circumstantial
non-accidental
dual-chamber
seventy-five
669
Syncopal
syncopal
falls-28
Injurious
hemodiafiltration
sepsis-related
Hypercytokinemia
AKI
HDF
hypercytokinemic
desloratadine
ICAM
down-regulation
sICAM-1
montelukast/levocetirizine
desloratadine/montelukast
Aspartame
Neurobehavioral
anecdotally
aspartame
sodas
Order
Neuropsychologic
1115
deviants
11-20
roentgen
60Co
lasalocid
ring-necked
pheasants
Phasianus
colchicus
Coccidiosis
farm-reared
pheasant
coccidia
coccidiosis
poultry
Pheasant
chicks
day-old
parahippocampal
object-place
valence
enoximone
2-part
liters/min/m2
1,880
1,254
dynes
Broca
VC
-0.687
-0.843
nitric-oxide-generating
microcirculatory
nitric-oxidegenerating
mixing
KY
weight/volume
bud
pulps
fluxmetry
1024
5060
462
74,800
3940
1020
4420
84,500
fingers
3280
672
2380
441
6160
1160
33,400
108,000
13,600
52,000
8950
185,000
19,500
70-80
Serotonergic
mU/L
Multisite
t54
0.346
.73
watchful
P=0.14
Mastoiditis
diaper-area
nonsusceptible
Allergy
Infectious
Diseases
NCT00377260
PT3
PT5
3-methylhistidine
clouded
Paracetamol
chelate
iron-paracetamol
co-ignested
AUC8
42.88
3.8-34.25
18.75
originated
C1/F
/F
ErSn
1220
ErSr
4.9-11.7
81.4
mEq
/24
Cancer-related-fatigue
CRF
FACIT-F
Edmonton
ESAS
MP+NTI
PL+NTI
CTI
PL+CTI
MP+CTI
RCT/preference
Self-Directed
PRIDE
disease-management
Cisplatin
Hoosier
extensive-stage
VIP
Myelosuppression
.039
misattribution
delusional
Delusions
non-delusional
meanings
Unpleasant
delusions
VTACH
cardioverter
18-80
left-ventricular
or=50
NCT00919373
n=55
violaton
determinable
0.8-26.7
0.37-0.99
p=0.045
device-related
Jude
Cyproheptadine
neurotransmitters
hyperserotonaemia
cyproheptadine
Roozbeh
groups-by-time
Greenhouse-Geisser
7.30
d.f
8.21
4.17
pre-screen
ARU
VerifyNow
pre-screening
esomeprazole/ASA
99.5
gov
NCT01199328
SaO
non-invasively
/=2
ApoA-I
cardioprotective
SUSTAIN
ASSURE
apoA-I
Lipids
NCT01423188
RVX-208
Atheroma
NCT01067820
IVUS
generating
nascent
CHAT
non-matching
checking
Methodological
fiber-rich
5.52
beta-glucan
MEASURED
lt.01
lt.02
Bergman
Soluble
lymphoscintigraphy
99m
Tc-sulfur
Tc-SC
anesthetizing
bicarbonatehether-buffered
patient-masked
preprocedural
injecting
-90
propofol-induced
One-hundred-twenty-four
Thiopental
37°C
cooler
36°C
blastulation
Mature
ICSI
vitrification
euploid
fingerprinting
blastocysts
399
zygote
41.2
NCT01506089
Towards
Abuse
post-program
TND
1994-1999
9-session
semester-long
school-as-community
middle-term
1578
limited-session
064
519
textile
factories
Shanghai
085
864
896
fibroadenomas
lumps
labels
UMS
standardizes
noon
'carriage
returns
depict
vans
federally
FQHCs
Virginia
intravitreous
fomivirsen
retinitis
COSTART
dictionary
165-microg/injection
330-microg/injection
events/patient-year
events/person-year
epitheliopathy
microg/injection
4.06
6.58
Intravitreous
triggers
ischaemic/reperfused
morphotic
lysozyme
beta-glucuronidase
unclamping
cardioplegic
G/L
1.73
3.64
6.59
10.19
12.83
Beta-glucuronidase
pre-clamping
degranulation
nulliparas
39-41
Paromomycin
oocyst
Oocyst
fewer/24
pediatricians
formatted
underperforming
Pediatrics-recommended
ESI
individual-ESI
group-ESI
embed
examiner-administered
Individual-ESI
pains
ST-T
Pre-transplant
whole-blood
pre-transplant
≤20
21-59
82.9
P=0.19
Performing
adherance
Baron
Kenny
13,277
Modification
fruit/vegetable
submitting
APPLICATIONS/CONCLUSIONS
Understanding
healthful
MADIT-II
otospongiosis
otospongiotic
cosmopolitan
audiometric
otosclerosis
gadolinium
neuroradiologist
eFilm
Workstation
Otospongiosis
oval
Cognitive-Behavioral
Recreational
9-16
SCAS-C
SCAS-C.
autism-friendly
lignan
proanthocyanidin
Lignans
proanthocyanidins
polyphenols
1,859
lignans
1.22-3.52
post-ICU
Autonomy
81.5+/-30.4
70.5+/-33.4
specifies
inequivalence
H0
r0
Ho
restricting-
restricting-purging-type
Anorexia
restricting-type
Anorexics
electromagnetic
nootropic
age-associated
Actovegin
LORETA
AAMI
protein-free
hemoderivative
hilliness
toenail
pulse-dose
continuous-dose
Minneapolis
dermatophyte
subungual
mycological
toenails
70.9
105/148
84/143
1.02-1.43
66/148
42/143
=1.52
1.11-2.07
60/148
28.0
40/143
RR=1.45
1.04-2.01
36/143
21/143
=1.71
1.05-2.79
=1.63
=.65
continuous-
Tacrolimus/sirolimus
tacrolimus/methotrexate
MRD
Tac/Sir
Tac/Mtx
114-day
GVHD-free
.48
Oropharyngeal
.36
NCT00406393
11,237
Employees
preaction
Net
post-heparin
butyrylcholinesterase
PH-LPL
BChE
3g
HOMA-IR
29.5±11.0
ATs
epinastine
EH
volume-matched
nonpharmaceutical
Artificial
Cold
antigen-raised
pre-exposure
antigenic
Object
Responsive
Prelinguistic
Milieu
RPMT
unstructured
enzalutamide
PREVAIL
Enzalutamide
n=872
n=845
Therapy-Prostate
FACT-P
BPI-SF
NCT01212991
16·6
10·1-21·1
4·6
2·8-9·7
11·3
11·1-13·9
5·6
5·5-5·6
0·62
0·54-0·72
790
224
623
5·6-5·7
5·4-5·6
0·53-0·74
705
p=0·068
845
31·1
29·5-not
31·3
23·9-not
0·72
0·61-0·84
Medivation
aflibercept
antitumour
LV5FU2
cycle-1
irinotecan-LV5FU2
Anti-vascular
DCE-MRI
upfront
1-44
≥20
anti-aflibercept
factor-bound
cycle-3
Aflibercept
arthrography
Meglumine
Conray
Meglumin
sodium-calcium-meglumine
metrizoate
Isopaque
dimeglumine
iocarmate
Dimerex
I/ml
5-HT4
tonus
11C
SB207145
5-HT4R
P=0.52
wherein
adjusts
Microbial
millet
straw
Eleucine
coracana
rumen-degradable
synthesised
rumen
RDN
straw-based
MPS
NCE
Nellore
rams
RDN0
RDN1
RDN2
RDN3
groundnut
cake
digestible
DOMI
digested
DOMR
FMS-based
1:500
Postanesthesia
homogenous
decaffeinated
coffee
chlorogenic
trigonelline
Coffee
Chlorogenic
-73
-117
addicts
Focus
casual
married
romantic
Pemetrexed
SCCHN
Platinum-based
pemetrexed-cisplatin
placebo-cisplatin
0.75-1.02
.082
0.76-1.03
.166
.047
Pemetrexed-cisplatin
DELTA
Lipoproteins
Thrombogenic
DELTA-1
SFAs
SFA
procurement
fat-containing
menus
8-day
Means
specifications
APPLICATIONS
Prestudy
Causes
REVAC
places
nearest
equator
Manaus
sixty
socio
239,934
7-53
39-40
p=0.686
3-33
p=0.022
27-23
p=0.932
22-54
11-53
Insertion
Deletion
Monthly
pre-enalapril
post-enalapril
neurohormone
sACE
A-II
ALDO
predose/postdose
predose
Predose
BACKGROUND/OBJECTIVES
explores
Fall
SPF
hat
Hillsborough
brim
59.1
wide-brimmed
-16/-13
-14/-11
-15/-12
AER
microalbuminuric
x:1.3
micrograms/min
aphakia
IOL
post-VA
Preparation
H5N1
avian
protein-based
Avian
farmed
free-living
chicken
Hemagglutinin
immunogen
pBCX
pET32a
AIV
BL21
DE3
Fused
msyB
97-kDa
msyB-HA
dodecyl
sulfate-PAGE
nondenaturing
Ni-NTA
rHA
posttranslation
folding
antibodys
epitopes
biofunctions
810-nm
overheating
Hair
5-HTTLPR
dietician
loose
CIT
counterregulatory
reactivates
anabolism
369
IGFBP
IGFBP-3
IGFBP-1
urea/creatinine
11-week
self-direction
EFL
5th-8th
waitlisted
once-weekly
team-focused
.55
.500
-.062
mycologically
Mycological
interdigital
imidazole
leech
Histologically
SECSG
1,087
Adenocarcinoma
biologists
laquinimod
MRI-monitored
relapsing-remitting
36-week
GdE
18-50
n=102
n=98
n=106
NCT00349193
p=0.6740
Budd-Chiari
syndrome-ie
liver-occurred
hypercoagulability
Anticoagulant
MRI-measured
symptom-related
mortality/morbidity
out-of-office
'white-coat
Tecumseh
non-pharmacologic
Bilateral
transversus
Transversus
TAP
exclusions
researched
OKT3+
OKT4+
OKT8+
non-medical
€4,724
UI
€2,770-€6,678
bootstrapped
-0.024
€73,359
€80,000
Concluding
B-domain
deleted
BDDrFVIII
ReFacto
crossover-design
reconstituted
USP
full-length
FVIII
Hemofil
haemophilia
RESULTS/CONCLUSION
diphtheria/pertussis/tetanus
ADPT
freeze-dried
Ashaiman
diphtheria-pertussis-tetanus
8/399
9/385
122/394
7.27
29/399
38/385
145/394
WCDPT
antitoxins
fallen
56.23
62.63
44.97
11.30
49.94
41.73
20.74
7.26
7.72
5.91
anti-PT
anti-FHA
cotyledon
Abalon
LDL/UHDL
B100
B100/apo
hypercholesterolaemic
beta-hydroxy-methylglutaryl-coenzyme
Lifestyle
60-67
4292
non-vertebral
Odds
2.10-3.40
1.63-2.59
1.01-1.05
2.31
1.31-4.08
2.20
1.28-3.77
0.85-3.31
1.70-5.01
1.04-1.13
1.56-3.34
1.10-2.31
smoker
153Gd
non-rigid
nine-parameter
TCT
99mTc-ethyl
cysteinate
dimer
ECD
mutual
NMI
Emission
ECD-based
TCT-based
Scheffe
ECD/CD
ECD/NMI
TCT/CD
z-scaling
yz-rotation
TCT/NMI
blends
college-aged
20.65
4.38
script
iPod
Stress-O-Meter
F2,97
Females
1.796
18.31
5.833
1.741
15.272
5.390
uncorrelated
bioactivity
Turbohaler
B800
1600
B1600
F750
F1500
mouth-rinsing
obviate
hypothalmic-pituitary
B0/F0
B0
tetracosactrin
Medrol
Solu-Medrol
14-hour
AUCi.v
AUCtablet
4,049
3,334
ng.h/ml
Volunteers
Parent-defined
customer
consumer-oriented
consumer
patient/caregiver
multisymptom
9-point
disastrous
Interrater
collinear
dimensional
participant-chosen
consumer-friendly
overselectivity
matching-to-sample
identity-matching
verifies
Nicardipine
postcraniotomy
Emergence
renin-angiotensin-aldosterone
monotherapeutic
titratable
nicardipine
O'Brien-Fleming
Spending
-76.9
-75.7
endonasal
transsphenoidal
-39.2
-30.2
-41.7
-72.3
-27.4
-63.8
-9.2
0.143
-35.4
-66.9
0.0254
TSB
non-fasted
Iressa
third-line
1692
1839IL/709
1129
0.77-1.02
p=0.087
0.68-1.03
p=0.089
Preplanned
never-smokers
n=375
0.49-0.92
p=0.012
0.48-0.91
coprimary
hyperimmune
anti-human
newborns
HIVIG
maternal-infant
IVIG
-controlled
Vd
mL/kg/day
Transplacental
complex-dissociated
clears
antigenemia
conatumumab
oxaliplatin-based
Q2W
Arms
0.998
0.650
0.357
A/B/C
/18
/2
/10
Conatumumab
intra-arterially
CMFV-combination
badly
GERD-related
GERD-associated
Productivity
Impairment
Nighttime
111/209
111/220
28/221
29.9
shirts
Transurethral
electrovaporization
TUVP
Qmax
43.1
Sphincteric
contractures
Chumnguh
thleum
Cambodian
Carriers
non-carriers
Culturally
unanticipated
sociocultural
Khmer
biomedicine
biomedical
adsorption
purifying
hollow-fiber
eicosanoides
coagulative
hemofiltration
hypoactivity
accelerometry-based
13-15
r=0.58
r=0.48
training-related
haemato-immunological
Labeo
rohita
fingerlings
sixty-day
hemato-immunological
6.71
triplicates
fish/tank
iso-nitrogenous
356.3
g/kg
P10T26
P0T33
P10T33
P50T33
P100T33
P200T33
leucocyte
PN/kg
diet-fed
non-PN-fed
counterpart
PN-fed
Intraluminal
exfoliated
ligatures
sigmoidectomy
PURPOSES
distally
suction-device
LTS-D
rescuer
compressions
bag-mask-valve
BMV
no-flow
NFT
ABVD/MOPP
ABVD/OPP
Kaplan
Meier
schemes
NGM
investigator-blinded
18-45
EE/NGM
EE/DSG
74.4
65.1
p=.070
p=.005
Multiphasic
prickle
pilaris
Keratosis
KP
FCR™
mexameter
cross-section
midsagittal
planes
Ellis
quoted
extradural
Noradrenaline
ulinastatin
oesophagectomy
-70
bronchoalveoar
BAFL
-T
inplasma
cyclophosphamide-methotrexate-5-fluorouracil
prejudice
beta-alanine
2000-m
rowing
2,000-m
maltodextrin
pre-TT
post-TT
TT+5
Beta-alanine
PMBCL
mantle
CEOP-Bleo
mega
77-86
p=0.2
44-59
65-76
48-57
therapy-related
myeloablative
Nakhon
Pathom
SCT
genome
privacy
collecting
tiered
Baylor
Houston
Debriefing
debriefing
83.9
opted
publicly
prefers
desires
Pyridoxine
antilactogenic
hyperprolactinaemic
postdelivery
chlorpromazine-induced
hyperprolactinaemia
galactorrhoea
power-driven
scalers
non-periodontally
scaler
Periopolisher
diamond-coated
inserts
US-POL
MANUAL
Perioplaner-Periopolisher
PPL-POL
Periokit
ultrasonic-designed
PERIOKIT
or=0.05
vancomycin-susceptible
heparin-vancomycin
9158
0.6/1000
1.4/1000
viridans
postprocedure
colonoscopies
MMSE
TICS
34.53
34.96
34.76
36.26
propofol-alone
35.09
35.98
.924
Extreme
Massachusetts
averages
myocyte
tai
Endothelin-1
5°C
CRP-predictors
consultancy
TREATMENT
half-day
ADOS-G
Ratio
1.22-6.09
1.75-8.68
training/consultancy
ceased
Racial
multihospital
above-
below-knee
limb-preserving
through-foot
other-race
risk-adjusted
amputees
Race
lower-income
Beclomethasone
vacuum-compression
VCT
nonprobability
stereologically
Cavalieri
offloading
46.88
4.09
46.62
10.03
42.89
re-therapy
Roughly
MIU
Virological
of-
12/19
14/18
10/19
13/18
Prolonging
praziquantel
schistosomiasis
schoolchildren
Schistosoma
mansoni
187
praziquantel/kg
re-treated
six-
once-yearly
Optimum
high-impact
superolateral
thinning
hops
RM-MANOVA
33.6+/-11.1
86.7+/-10.6
p=0.015
p=0.048
p=0.439
hopping
Repeatability
presyncopal
PSL-LBNP
9-min
hemotocrit
Δ-hemoglobin
Δ-hematocrit
=0.001
Norfloxacin
norfloxacin
0.5-4
22-24
ascitic
trimethoprim/sulfamethoxazole
NF
-kappaB
NF-kappaB
IkB-alpha
norfloxacins
-0.66
concurred
Intracellular
microg/mL/10
anion
phorbol
myristate
Trimethoprim/sulfamethoxazole
Chagasic
Cardiopathy
STCC
Trypanosoma
cruzi
Chagas
chagasic
cardiopathy
nonchagasic
residues
selenite
NCT00875173
phospho-HER2
HER2-targeted
HER2+
stratify
immunofluorescent
mathematically
trastuzumab-
nab-paclitaxel
BrUOG
BR-211B
NCT00617942
AQUA
2111
3+
pathCR
10251
4766
0.0021
non-pathCR
Phospho-HER2
pre-surgical
3837
Policy
Board
2.82
declaring
impressive
Beyond
Late-life
sub-threshold
brain-imaging
imperative
long-neglected
2017
ACTRN12610000032055
self-shoulder
Life-BREF
WHOQOL-BREF
BFI
WHOQOL
Bizzy
Break
Irish
Teachers
5351
5054
5469
4246
radiochemotherapy
invading
mesenteric
5040
UKEP
4400
GeparTrio
NCT00544765
immunohistochemistry/in
situ-hybridization
anthracycline/taxane-based
formalin-fixed
FFPE
overexpression/amplification
91/244
41/229
55/278
0.856
95.6
0.77-0.94
3.29
3.04
EuroPharm-Forum
self-developed
inhaler-use
refresh
NPT
GOA
NTR2137
2-long
circles
raltegravir
2-LTR
ART-suppressed
≥350
droplet
8.8-fold
.0025
5.7-fold
Intensification
Raltegravir
cervicitis
Mucopurulent
MPC
mucopurulent
seventy-seven
131/577
53/87
10/33
8/33
concluding
rhesus-human
reassortant
rotavirus
gastroenteritis
Rotavirus
heterologous
tetravalent
RRV-TV
4x10
plaque-forming
seasons
=11
20-point
2398
n=1191
n=1207
n=1128
n=1145
1191
1207
1128
1145
57-76
82-96
apnea/hypopnea
sleep-recording
in-laboratory
SAHS
sleep-disorders
Diagnoses
technician
faulty
artifacts
study-derived
143.86
euros
93.08
129.97
methadone-maintained
topiramate/placebo
n-back
risk-taking
metamemory
PsycINFO
Record
paranoid
nonparanoid
High-sensitivity
3225
adjHR
angina/non-ST-elevation
diagnosis-specific
cutpoints
Persistence
entitle
dispatcher
Conduct
Dispatcher-Assisted
DART
bystander
8626
non-traumatic
King
Bystander
dispatch
B-CPR
DA-CPR
1817/3468
2093/3527
885/1631
OR=1.35
CI=1.23-1.49
OR=1.10
0.98-1.24
OR=1.79
1.59-2.02
OR=0.94
0.80-1.10
community-wide
Stories
ASSSIST
tackling
meaning
Case
toolkit
11/YH/0340
permission
Partnership
ISRCTN96286707
bar/restaurant
-alpha
/FVC
smoke-induced
recede
propionyl-L-carnitine
17298-37-2
bidimensional
undoubted
efficaciously
Kang
Gang
Qian
KGQG
PCIII
CIV
therapeusis
hard-to-cure
fillings
levofloxacin-based
Mercury
rabeprazole-amoxicillin-clarithromycin-metronidazole
n=122
rabeprazole-tetracycline-metronidazole-colloidal
n=97
rabeprazole-amoxicillin-levofloxacin
n=87
nonfilling
53.7
78.8
67.0
58.6
69.6
vesical
blockades
120.92
36.21
145.83
35.81
106.29
38.16
133.16
42.21
cephalea
corticotrophin
luteinising
thyrotrophin
hypo-function
Usage
titanoreine
PPH
Titanoreine
200-mg
cholestasis
unwell
REGENERATE-AMI
BMCs
enrol
Declaration
NRES
07/Q0603/76
//clincialtrials.gov
NCT00765453
CONSORT
journals
Around-the-clock
Placebo-
Tono-Pen
Bio-Rad
Glendale
Calif
clock
+/-SEM
17.9+/-0.6
20.2+/-0.6
16.8+/-0.3
20.6+/-0.5
.31
around-the-clock
pMDI
Short-acting
-agonists
short-acting
P=0.704
P=0.270
P=0.340
P=0.559
P=0.526
P=0.818
11.93
tipping
bone-borne
tooth-borne
SARME
skeletally
non-syndromal
hypoplasia
corticotomy
Expansion
postero-anterior
cephalograms
Widening
maxilla
moves
Segmental
widening
Over-correction
Tipping
Ferrokinetic
iron-replete
nandrolone
decanoate
androgen-treated
Erythron
restudied
erythron
turnovers
dialysis-associated
phytonadione
nonbleeding
6.0-10.0
Overcorrection
reinitiating
overcorrection
Liposome-encapsulated
liposome-encapsulated
D-99
Myocet
Elan
Princeton
Responses
cardiotoxicity
multiple-gated
cardioangiography
doxorubicin-treated
Protocol-defined
785
3.56
palmar-plantar
erythrodysesthesia
Single-agent
meropenem
imipenem-cilastatin
SBAs
imipenem
cilastatin
mg/liter
recoveries
96.1
mg.h/liter
Imipenem
liters/70
clearances
144.6
microdilution
Reller
Stratton
Infect
Dis
136:196-204
97.9
cloacae
90.7
carbapenems
SBA
5-HT1d
diagnosisxdrugxtime
Hib-specific
PRP
PRP-P.
Anti-PRP
PRP-P
Immunoresponsiveness
haematocrit
Fontaine
PFWT
MWT
20,5
Haematocrit
haze
1501
proparacaine
wetting
cry
2-CP
Pinprick
L2
T11
off-the-shelf
11-17
Entonox
haloperidol-placebo-haloperidol
placebo-haloperidol-placebo
Discrimination
METH
PLAC
food-selection
mg/30
4,554
1,857
2,867
846
kcal/day
levetiracetam
head-up
pre-syncope
Glyceryl
Commonest
amitritpyline
s-NAC
classed
cis-diamminedichloroplatinum
5-FU+CDDP
anti-MIB-1
MIB-1
slush
vitrified
meiotic
spindle
Metaphase
incubation
denuded
denudation
cryoprotectant
Re-Infarction
pathoanatomic
WARIS
1918
1214
Analyzed
warfarin-treated
Relapsing
GET
organisations
secondary-care
SMC
APT
Chalder
form-36
statistician
//isrctn.org
ISRCTN54285094
641
SMC-alone
3·4
1·8
5·0
4·8
0·0003
0·7
-0·9
2·3
0·38
7·1
2·0
12·1
0·0068
9·4
4·4
14·4
0·0005
-1·6
8·4
p=0·18
0·0027
0·0059
Scottish
Chief
Scientist
Pensions
Minocycline
transgenic
rizatriptan
Rizatriptan
030
5-HT1B/1D
triple-dummy
1268
Zn/kg
2425
ZnO
Piglets
killed
villus
goblet
sulfated
sialylated
mucins
mucin
MUC2
MUC20
β-defensin
trefoil
TFF3
Villus
sulfomucins
sialomucins
crypts
T-cells
γδ
apportionment
CD8β
postweaning
Twelve-week
generalizes
family-oriented
8770
719
Received
End-of-study
Up-to-date
up-to-date
.0139
.0054
form-letter
customizing
Polycystic
drospirenone-ethinylestradiol
Bologna
drospirenone+ethinylestradiol
Utero-ovarian
nitrites/nitrates
hyperandrogenemia
insulinogenic
verbalisations
CRM
TMV
leader
verbalisation
obligatory
final-year
25.35±1.03
alphabetically
four-person
CRM-training
ALS-training
follower
FV
31.4±6.1
36.3±6.6
unsolicited
glycinergic
cation-chloride
K-Cl
KCC2
Na-K-Cl
NKCC1
co-transporter
depolarising
Furosemide
reversibly
postsynaptic
co-transporters
Non-invasive
presynaptic
terminals
motoneurons
interneuronal
introducer
gastropexy
Peristomal
PEG-placement
sojourn
PEG-gastropexy
peristomal
633
Introducer
Freka
Pexact-15
CH/FR
nonsurgically
sutured
post-PEG
pull
NCT00375414
Chronopharmacology
BK
enalapril-induced
10:00
22:00
enalaprilat
Remarkable
hyperinsulinaemic
DM2
BMI-matched
Ctr
dysmetabolic
predisposition
Guillian-Barre
IVIg
GBS
week/2
Fib
MON
TUPAC
ask
advise
arrange
Theories
theoretical-domains
theoretical-domain
ISRCTN15427433
solids
13C-octanoic
C-octanoic
m*k*beta*e
-k*t
*
beta-1
1/2b
ln
-1/beta
/k
lnbeta
speeds
vasoconstrictors
1066
O2-enriched
Dihydroergotamine
preferentially
Generalizability
coronary-prone
faring
logical
optimism
coronary-type
Links
simultaneity
continuum
pre-hospital
deciders
Community-supported
2750
2719
well-equipped
well-staffed
drank
familiarization
ml/day
2.6-4.8
2.2-3.0
Hills
Armitage
Low-frequency
Sokhadze
Appl
Psychophysiol
Biofeedback
34:37-51
2009a
attention-orienting
sustained-attention
centro-parietal
over-process
DLFPC
bouquet
interneurons
post-TMS
parieto-occipital
P50
distracters
later-stage
P3a
middle-latency
analyte
liquid-liquid
diethyl-ether/dichloromethane
70/30
solvent
acetonitrile/water
+0.1
LC-MS/MS
Chromatography
isocratically
Alltech
Prevail
C18
µm
I.D.
HPLC/MS/MS
cobamamide
Cobactin®
Zambon
Laboratórios
Farmacêuticos
Ltda
Cobavital®
Solvay
Farma
physostigmine
anti-dementia
according-to-protocol
interindividual
ice-slush
menthol
Tco
humid
cyclists/triathletes
20-km
30.7°C±0.8°C
±0.03
aromatized
gr/L
non-aromatized
23°C±0.1°C
3°C±0.1°C
-1°C±0.7°C
aroma
non-menthol
ice-slush/menthol
cold/menthol
neutral/menthol
piracetam
Nootropil
UCB6215
rCBF
presenile
133-Xe
weekks
Piracetam
'eating
exchange-based
'eat
VBC
EXB
sweets
E-PEG
decompressant
gastrointestine
extra-corporeal
ordinary
pull-method
14-37
26.9
8.39
speedy
Sulforaphane
medico-economic
enormous
13-27
phytochemical
sulforaphane
sprout
50-150
µmol
0.015-0.007
neuroinflammmation
thermodilution
-44
abundances
normolipidemic
non-public
unengaged
Modulation
Amantadine-sulfate
vivo/in
N-methyl-D-aspartate
NMDA
blockage
TMS
stimulation-induced
ICI
facilitation
ICF
L-ICI
M-amplitudes
minimi
MEP
polysynaptic
NMDA-receptor
use-dependent
ethynylestradiol
FSFI
EE30/LNG150
EE20/LNG100
Durability
25-846
9-228
accidentally
1189
material-enhanced
Institutional
19-88
0.821
unenhanced
MHE
-0.79
-0.80
-0.86
patient-to-patient
Wilms
1439
I-IV
UH
postnephrectomy
I/FH
Actinomycin
Sharp
Dohme
VCR
92.2
II/FH
86.9
275
III/FH
Adria
73.0
Epirubicin-based
anthracycline-naive
restart
Nausea/vomiting
49.2
=.07
56.9
=.012
=.49
epirubicin-based
Mammography
Axillary
1983.
Sunbathing
sunbed
self-image
4,020
sun-related
2,615
sunbathed
sunbeds
Boys
sunbathing
'important
'feeling
'clinician-blind
'bad
news
audiotape
30-item
poor-prognosis
non-tape
factual
unhelpful
Hypoglycaemia
22.00-12.00
PHD
PHDC+
PHDC-
ketones
04.00
12.00
BG
Unrecognized
carbapenem
seventy-six
q.i.d
extrapancreatic
Meropenem
cold-adapted
influenza-related
inadvertent
Reactogenicity
runny
63.3
mobilize
PBSC-mobilizing
post-chemotherapy
22-59
Dexa-BEAM
5/microg/kg/day
leukaphereses
autografting
autografted
31.3
0.837
0.696
Anecortave
angiomatous
anecortave
RAP
juxtascleral
Best-corrected
Retinopathy
funduscopy
indocyanine
exudation
Like
Vulvovaginal
mycoses
clotrimazole
ITA
24-
Dimensions
millimetric
stop-watch
ranks
10-second
TO
hypertrophied
Hypertrophied
ano
Usually
Childcare
Region
gaps
ACTRN12610000087055
eltanolone
Eltanolone
Asa
doss
toleration
Seattle-King
Indoor
Seattle/King
closed-end
caretakers
poverty
Homes
empower
Mold
damp
Dust-trapping
reservoirs
76.8
bedrooms
carpeting
Cockroach
infestation
roaches
allergy-control
mattress
Substandard
Initiatives
insurers
agencies
officials
milligan-morgan
single-masked
balancing
1.89-3.07
pain/discomfort
0.089
fecaloma
tenesmus
0.194
well-described
anorectal
Hemorroidopexy
reducible
Sibutramine
OUTcomes
SCOUT
SUBJECTS/METHODS
9804
27-45
POE
Time-to-event
-8.1±10.5
-10.8±11.0
⩾5
POEs
diseased
Classes
Mallinckrodt
Hi-Lo-Evac
subglottic
roflumilast
PDE4
CYP3A
N-oxide
acebutolol
Acebutolol
single-pass
indium
platelet-activating
Athens
Aretaieion
Greece
infertility-all
12.24
11.11
Plerixafor
Preapheresis
PB
HSC
institute-specific
plerixafor
preapheresis
cells/μL
apheresis
plerixafor-treated
proceeding
mobilizers
validates
adjudicators
expended
adjudicate
adjudication
adjudicator
person-time
4'-epi-doxorubicin
27/44
35/52
2.
oxybate
narcolepsy
SXB
narcolepsy/cataplexy
sedative/hypnotics
g/night
mock
architecture
Coping
START
RelaTives
emotion-focused
intervention׳s
manualised
HADS-T
COPE
16+
effect=-0.63
-1.11
effect=33
Anti-VEGF
Predominantly
Classic
Choroidal
Neovascularization
CNV
Degeneration
photography
Months
535
Antacid
0.0009
Rabeprazole
Pacifier
discounting
confession
Drawing
suspects
short-sightedness
interrogation
unethical
incurring
ruling
confessions
tetracycline-
clarithromycin-containing
omeprazole-clarithromycin-amoxicillin
ulcer/non-ulcer
70.4-92.7
43.3-73.0
P=0.036
Tetracycline-containing
omeprazole-amoxicillin-clarithromycin
blunts
endotoxin-induced
3-hydroxy-3-methylglutaryl
high-sensitive
MCP-1
sCD40L
sCD40
F1.2
Monocyte
monocyte-platelet
aggregates
spurt
acid/day
bread
+/-0.5
FO
+/-0.3
+/-0.9
3.8+/-1.4
2.6+/-1.1
.01-.02
Fish
Keihanshin
Hematological
Malignancies
random-allocation
61.1
55/93
47.3
44/93
hemopathy
SOFT
dihydropyrimidine
SOX
FOLFOX
modulators
mFOLFOX6
JapicCTI-090699
sympathectomy
sympathectomy-induced
clearer
26/29
29/29
4/29
6/29
18/29
3/29
8/29
14/29
epidural-induced
rib
ventilator-free
unit-free
Modelling
exEn
laborious
network-genetic
ANN-GA
ANN
starter
0-21
grower
22-42
ANN-GA.
multilayer
feed-forward
matlab
Crude
RMSE
0.1286
0.876
sponsorship
tax
funding
Healthway
sponsorships
arts
racing
sporting
companies
Normally
attends
organizers
promotional
featured
kits
health-state
multicountry
five-dimensional
HIT-6
Quality-of-Life
Preferred
utilities
preference-based
Uvulopalatopharyngoplasty
uvulopalatopharyngoplasty
UPPP
Snore
Box
microphone
78.2
snores/h
Mastication
denate
mastication
M3s
dentate
nonroutine
.735
.552
.427
.424
angulations
.925
impaction
.445
jawbone
precautions
reiable
technic
brochures
erythropoietic
probrain
CPB-induced
Atrioventricular
single-chamber
PQ
pacemakers
stimulus-Q
5.5+/-2.4
Wenckebach
upgrading
bundle-branch
maturity-onset
M-value
19-23
graduation
Employment
SEARCH
Supports
18-21
non-traditional
jobs
290.21
GDS
sedating
TCMs
5-period
Tong
Xin
Luo
Guan
Mai
Ning
Xing
Ye
97.5
AUC0-48
bronchoprovocation
bronchodilatation
concentration-response
calibre
fixed-duration
2x100
deltaFEV1
init
9.0-31.9
11.6-31.2
histamine/methacholine
gynaecologic
haematoma
intra-abdominal
antiFXa
enoxaparin/day
asperger
neurotypical
Side-Effects
actometer
Impulsivity-Hyperactivity
Actometer
arthrodesis
monoiodoacetate
MIA
PIJ
Peri-operatively
abaxial
sesamoidean
lameness
Radiographs
Horses
non-exercised
trotting
euthanized
Slab
grossly
cartilage
tendinitis
chondrocytes
Subjectively
Gamma-hydroxybutyric
clomethiazole
Clomethiazole
AWS
Gamma-Hydroxybutyric
GHB
randomally
n.
=.021
Isoniazid
isoniazid
tuberculin
test-positive
Meta-analysis
Haiti
Kenya
2367
2162
Pooling
0.43-0.80
0.83-1.07
0.24-0.65
0.54-1.30
Consistency
2-12-week
827
=3.36
=6.47
=3.95
LDL-C.
µg/kg
0.00-3.00
dyscirculatory
ozonotherapy
klimadynon
estrogen-like
lipolytic
22-46
IBW
protein/kg
IBW/week
-2.62
-4.52
1.81
L-dopa
Logiparin
XaI
IIaI
enzymatically
depolymerized
LMW-heparin
mu/kg
b.w
THR
mu/ml
phlebographically
over-all
Peroperative
mainstay
2-monthly
Suggestive
Sub-domain
non-intensive
dyadic
lymphedema
Pneumatic
two-hour
five-week
Lymphedema
'delta
-41
REFLO-STEMI
Microvascular
ischaemic-reperfusion
underappreciated
REperfusion
Facilitated
LOcal
P-PCI
IRA
Bivalirudin
CMRI
hypoenhancement
collectively
NCT01747174
verbascoside
biotechnologically
aspirin-naïve
preincubated
μM
aggregometry
multiplate
preincubation
Verbascoside
aspirin-treated
Paraesthesia
needle-through-needle
27G
pencil
18G
20G
31.6
2327
BMI:35.8
ILI
Look
AHEAD
CI:4.5
CI:8.6
opportune
NCT00017953
federally-funded
±3.12
PDD-not
intellectually
Marked
pedicle
VPW
FACTT
NHLBI
PAOP
VPW/PAOP
VPW/CVP
discriminated
≤67
hydrostatic
unavailable
client-centered
supportive-experiential
SET
9,045.03
6,359.07
12,091.87
6,682.78
4,998.09
8,440.95
78,741.66
-154,987.20
110,486.32
payers
high-single-dose
provocations
INF-γ
eNO
Th-2
Th-2-mediated
proof-of-concept
ClinicalTrials.govNCT00677209
AFF
RVR
diltiazem-induced
totaling
CaCl
apneic
African-Americans
P-interaction
basline
JAK
CP-690,550
58.1
ACR50
ACR70
3-variable
DAS28-CRP
Sporadic
Erythropoietin
Dose-finding
Avoidance
homologous
Augmentation
Erypo
Cilag
Sulzbach
distributor
Fresenius
Oberursel
cancelled
phlebotomy
guarantee
jeopardizes
predonation
high-dosage
Biomarkers
Fibroadenomas
fibrocystic
258
1035
Conditional
0.16-0.79
P-trend
0.19-0.84
genistein
0.19-0.77
docosapentaenoic
0.15-0.70
fibroadenoma
art
creative
ACES
CEIs
artists
in-patient
visual-arts
Artists
artistic
artist
only.Data
Stroke-related
purposively
refusing
Summary
Thematic
Framework
Trials.Gov
NCT02085226
GES
stimulator
on-
p=0.63
p=0.19
p=0.76
butylscopolamine
p=0.67
p=0.17
p=0.57
p=0.52
p=0.75
p=0.51
GES-induced
unambiguously
adrenocorticotrophic
4-9
ORG
2766
ethologically
pmol
UNaV
+56
+23
Ccr
-58
+64
-52
antidiuresis
Dong
Nai
Typhoid
fluoroquinolone
multidrug-resistant
quinolone-resistant
typhi
cefixime-treated
Endometriosis
childbearing
CHM
Hove
WLC
Profile-30
EHP-30
endometriosis-specific
Yourself
MYMOP
Provisional
more-definitive
Multisensory
DSM-5
percept
perceiving
higher-level
mapped
perceptually
audiovisual
speech-specific
psychedelics
Psychedelics
sensorium
psychedelic-induced
psychedelic
entropy
ayahuasca
5-HT2A
N-dimethyltryptamine
anterior-to-posterior
posterior-to-anterior
incapacitation
hierarchies
bottom-up
biochemically-confirmed
1.03-1.10
non-tobacco
1.24-5.20
1.01-1.08
0.22-0.97
tobacco-related
cancer-type
Mylanta
oz
V-wave
MVC
time-to-task-failure
wave-to-maximal
V/M
55.1
/M
Strength
Ia
manuvacuometry
Shwachman-Kulczycki
7-19
manuvacuometric
36.38
4.48
-1.30
Metoprolol
CR/XL
release/extended
MERIT-HF
deceleration
E-wave
mucosectomy
thrombosed
circumferentially
prolapsed
piles
haemorrhoidectomy
endoanal
passing
continent
encapsulated
Phytonutrients
JPC
Forces
28-wk
0.068
thyrotropin
attendant
Tg
Radioiodine
TSH-stimulated
0.108
Antibacterial
chlorhexidine-thymol
3-17
Fluor
Protector
Cervitec
chlorhexidine-
chlorhexidine-0.2
LB
VPI
U-tests
Nutrient
anti-social
13-16
disciplinary
n-6
P=0·0005
F=5·555
d=0·35
P=0·02
infringements
Bayes
factor=115
offences
high-misbehaviour
discipline
misbehaviour
silastic
fallopian
arthropathy
Optisource
1109,3
166,4g
63g
21,3g
cal/day
7,7
4,7
3,92
3,32
-2,9
1,8
-1,4
0,9
-3,8
3,4
-2,3
1,7
P=.0,05
-2,0
2,2
-0,4
1,82
Obese
valacyclovir
RTx
GAN
q.i.d.
VAL
CMV-nested
94.7
CMV-seropositive
post-RTx
viremia
P=NS
CMV-associated
2,449+/-1,178
2,485+/-581
4,259+/-4,616
teacher-student
Classroom®
n=132
n=107
business
Teacher-student
β=0.85
p=.002
β=1.62
R2=.69
β=0.52
R2=.32
Discussion
administrators
Tropisetron
emetogenic
mg/kg/24
micrograms/kg/24
emetogenicity
ganisetron
osmolality
meq/L
exponential
interdialysis
postdialysis
Hypotensive
cephalosporins
PROSIT
organ-confined
PCa
understaging
NHT
mount
sectioning
haematoxylin
eosin
reviewing
CGAS
-4-thiazolyl
-4-bromo-benzenesulfonamide
perfectly
perfect
long-bone
corticosteroid-
petechial
oxidant
radical-induced
8-epi-prostaglandin
PG
8-epi-PGF2
pmol/mmol
176.5+/-30.6
92.7+/-4.8
54.1+/-2.7
145.5+/-24.9
114.6+/-27.1
112.6+/-24.9
11-dehydro-TxB2
TxB2
194.6+/-40.9
137.2+/-34.1
171.0+/-39.8
133.5+/-29.6
hepatobiliary
letrozole
gonadotropins
gonadotropin-treated
13/30
6/31
817.5
907.5
9/42
0/18
radiocontrast
postprocedural
1.7-8.7
telephone-delivered
broad-reach
Counselling
cluster-randomised
state-transition
Markov
78,489
29,375
12,153
Choosing
'Usual
makers
convinced
allocating
Anzcrt.org.au
ACTRN012607000195459
antiserotonergic
antidopaminergic
zuclopenthixol
military
Distance
55.8
1002
BDP
1-mg
immediate-release
Inconsistent
obscured
proctocols
hormone-agonist
profoundly
explainable
11/95
RPF
NG-monomethyl-L-arginine
2/1
1/0
clear-cut
+59
+113
Intraumbilical
intraumbilical
Hembate
Upjohn
placental
expulsions
lysis
Transplantation
FAVORIT
constellation
aortic/lower
2234
tHcy-lowering
community-intervention
Manuka
honey-impregnated
manuka
MHID
NDFU
78·13
35·5
15·62
38·7
6·25
12·9
glucose-clamp
glibenclamide
-randomly
Biostator-based
enalapril-compared
placebo-resulted
0-600
1267
1286
sulfonylureas
merges
relationship-oriented
neuro-developmental
Nimodipine
voltage-sensitive
VSCCBs
VSCCB
milieu-oriented
cue-induced
cocaine-induced
anticraving
mood-stabilizing
cardio-
intoxication
avenue
survivin
antiangiogenesis
anti-neoplastic
aCECs
anti-angiogenesis
Endostar
CECs
0.293
Endotatar
pre-therapy
0.322
-0.291
Activated
forecasting
sensitively
alfuzosin
DAN-PSSsex
n=186
ejaculatory
EjD
Dizziness
symptoms/
XS0601
Chuangxiongol
paeoniflorin
47.2
MLD
Structural
epidemiological-operational
analogues
carbonic
anhydrase
preservative
Sciences-
Babes
-Bucharest
subepithelial
fibrocytes
antiglaucoma
dilational
Ciaglia
Griggs
dilating
Tracheostomy
GLN
glycine-control
GLY
ALLO
AUTO
500/mm3
Posttransplant
nonpharmacological
reevaluated
190+/-75
106+/-48
mEq/d
146+/-21
116+/-11
89+/-8
72+/-10
complies
Lamotrigine
excitotoxic
lamotrigine
stereotypies
pleasures
PL-ADOS
conformally
Scored
dose-based
Lyman-Kutcher-Burman
LKB
Seriality
0.011-0.013
0.012-0.016
0.039-0.048
benefitted
0.003-0.006
steepness
Anal
DVHs
NTCP
Nontarget
mm³
41.6
spastic
10y
1mo
1y
8mo
7-13y
GMFCS
StepWatch
5169
1641
4158
2048
43-53
21-42
Correcting
Pharmacogenetic
polygenic
CAPOX-B
Multifactor
9.4-12.4
TYMS
enhancer
+405G
11.4-15.3
7.6-11.8
1.14-2.19
anti-helicobacter
province
Nariño
Colombia
Andes
Mountains
multifocal
nonmetaplastic
polytomous
1.6-14.2
1.7-15.0
1.7-14.4
1.0-9.3
1.1-9.8
1.1-9.5
Curing
2.7-28.2
1.7-17.6
bare-metal
Cypher
SESs
Cordis
Joshson
Company
Miami
Lakes
BxVelocity
BMSs
Consortium
D-cycloserine
n=23
SANS
Bulimia
Nervosa
BN
/Eating
EDNOS
Hundred
BN/EDNOS
Caregiving
Expressed
Self-report
Interpersonal
130/90
mmoles/24
-38.8
-36.8
p=0.580
p=0.784
Middle
resistivity
basketball
off-season
14.7+/-0.5
Tanner
3.5+/-0.5
MX
100-120
4.9+/-1.8
4.9+/-1.4
21+/-5
15+/-6
23+/-4
25+/-5
50+/-11
11+/-14
17-27
shooting
on-court
irradiating
55-75
in-breast
IBR
surgery-only
distant-disease
gluconeogenesis
proteolysis
¿6
ğlucose
¿3-
Călanine
microg.min
.kg
0.62+/-0.07
mmol.h
44+/-0.13
¿baseline
0.30+/-0.16
0.37+/-0.13
37-50
radiology
Radiology
lectured
Simulator
P=.045
oblique
P=.035
Glibenclamide
gliclazide
noninsulin
noncrossover
Superoxide
SOD
malonyl-dialdehyde
FBS
Normalization
combating
That
eye-tracking
fixations
typicality
Eye-tracking
fixate
Self
Faces
Correlational
socio-communicative
iQuit
aiding
individual-level
remotely
1758
QUIT
hand-rolled
0.73-1.42
bradykinin-stimulated
6-oxo-PGF1
13,14-dihydro-15-oxo-PGF2
salicylate
identically
Prostanoid
Biosynthesis
TXA2
2,3-dinor-6-oxo-PGF1
2,3-dinor-TXB2
cyclo-oxygenase
bradykinin-responsive
PGI2
periinfarct
Recatheterization
Periinfarct
thallium
IAN
NST
LN-injured
TISSEEL
VH
S/D
ready-to-use
solvent/detergent
3.70
care-seeking
Alaskan
Gastroscopy
miles
7/16
7/21
stress-associated
AP+AB
Pathogens
16S
rRNA
oligodeoxynucleotide
dot-blot
69.9-
10.2-
5.7-
3.3-fold
=or
Nonsurgical
taxa
TAMI-5
V4
aVL
V5
narrowings
28.57
P=0.035
tachycardia/fibrillation
21.43
46.43
92.86
cardio
P=0.078
high-adhesion
parallel-design
L*a*b*
b*
L*
Ab*
AL*
PlasmaKinetic
69.1
hyperosmolar
catheterized
Reoperation
milligrams
precocious
CPP
11.25-
peak-stimulated
Peak-stimulated
78.4
95.2
11.25-mg
Disparities
accessibility
OSHCN
Needs
transitioning
neonate
Mantel-Haentszel
EMIAT
Amiodarone
small-scale
1486
0-58
proarrhythmia
crust
satisfactorily
MILOR
H1-antagonist
CIU
-36.7
-29.8
0.0071
0.0090
0.0061
0.0221
Angioedema
repolarisation
urticarial
NCT00065910
DMS-IV-TR
13-26
Checklist-irritability
.097
NCT01227668
Transesophageal
emboli
AO/ASIF*
CoSeal
Gelfoam/thrombin
nonruptured
reestablishment
control-treated
Ilioinguinal-iliohypogastric
travenous
dexketoprofen
trometamol
ilioinguinal
iliohypogastric
post-anesthesia
dexketoprofen-block
fi
rst
cytostatic
419
0.0059
Pairwise
0.506
Microtensile
leucite-reinforced
feldspathic
Omega
VITA
conditionings
hydrofluoric
silane
tribochemical
6x6x6
G1-
rinsing
G2-
airborne
CoJet-Sand
chairside
CoJet
Z-250
incrementally
build
Bar
composite-ceramic
G2
10.17
p=0.982
á
ROCA
CA-125
TVU
UKCTOCS
considers
best-case
stage-shift
Best-case
0.69-1.17
0.74-1.23
bushen
quhan
zhiwang
BQZD
lessening
LDCO
premedicated
leveling
TPLO
client-owned
pedal
DAP
SVV
inhalant
Epinephrine-induced
hyperventilation
tcPCO2
panicking
epinephrine-induced
anxiety-related
gaviscon
alginate
Geviskon
aluminum-magnesium
ERD
KGVV
sachet
EBS
Suspension
generations
Supraphysiologic
Step
mU/m²/min
4.95
M/I
Si
mediolateral
5.5-11.7
reliabilities
Schizophrenic
Pre-exposure
chick
rabies
diploid
PCECV
HDCSV
Neutralizing
i.d
atopy
Bradykinin-induced
-log
coughed
-9
BK1-7
Beta-cytotrophic
tolbutamide
astaxanthin-rich
Haematococcus
pluvialis
algal
astaxanthin
35-69
gelcaps
safflower
candida
in-patients
neurosteroid
neuroactive
pregnanolone
cyclicity
3alpha-hydroxy-5beta-pregnan-20-one
SEV
+progesterone
anti-Pseudomonas
cloxacillin
blind-controlled
Photoplethysmographic
II-III-IV
folinic
fare
Chemotherapy-related
HTs
PR-STENT
N=9
NO-STENT
99mTc-DTPA
Echo-Doppler
140.1
170.0
hairy
pentostatin
2-chlorodeoxyadenosine
2-CdA
Flexibility
ASTAMI
mBMCs
Stem
re-assessed
mBMC-treated
mBMC
RETURN
Millions
telerehabilitation
technicians
sporadic
worker
televisits
physical/functional
well-normed
Tower
11.5-14.0
4.0-8.5
-3.0
6.0-11.8
pancreatoduodenectomy
Interventional
combat
conceptualized
Rosenstock
Becker
anaemic
2,190
=11.910
=20.92
non-anaemic
inspite
socio-cultural
osteitis
extractions
Apparently
gargle
15.00
4.33
Warm
neutron
MSAT
widely-used
NCT01315561
DRE
PCs
7,280
PSA-determination
2,102
TRUS
DRE-outcome
PSA-range
PSA-level
TRUS-outcome
443
2.80
2.21-5.96
observer-dependent
electroacununcture
Sjögren
luteotropic
Shenshu
Taixi
KI
hydroxyl-chloroquine
Vit
fish-liver
tablet/time
abovementioned
electro-chemiluminescent
CLIA
self-comparison
dinucleotide
intron
oncogenic
cascades
First-intron
repeats
downregulate
extracapsular
ICCE
ECCE
PCL
statisticians
dismission
Cystoid
prolaps
YAG-laser
capsulotomy
harmless
burdened
ACL-implantation
iris
clay
Elaborated
Intrusion
Kavanagh
Andrade
posits
craved
elaborative
visuospatial
shapes
plasticine
'letting
wander
threes
Clay
sketchpad
trimetazidine
/workload
+11
brings
hyoscine-N-butylbromide
Hyoscine-N-butylbromide
time-averaged
blood-flow
8.3+/-3.3
standard-care
Boosting
appointing
Immunisation
serologically
bygeneral
receptionists
irfluenza
east
Essex
ELENoR
1,820
receptionist
nurse-run
telephone-appointing
recieved
immunised
controlgroup
'number
Uptake
Retaining
item-of-service
payments
alpha-hydroxyprogesterone
caproate
Imminent
37.82
malformations
3111.9
2680
813.4
MEDI-545
anti-interferon-alfa
Interferon-alfa
anti-IFN-alpha
0.3-30.0
dismissal
nonimmunogenic
61.6
56.8
72.8
8.8+/-2.7
2.7+/-2.9
0.8+/-2.2
tardive
TFPTD
0.35-0.86
0.35-0.81
0.41-0.98
0.60-1.31
non-eosinophilic
Non-eosinophilic
responds
immunopathology
bronchoalveolar
givers
escalates
attract
nurse-initiated
giver
patient-specific
replacements
THRs
anterolateral
riding
12-question
Harris
drove
ambulated
cane
incidents
ambulate
Pace
case-managed
health-promoting
homeless
sober-living
shelters
shelter
peer-mentored
noninjection
vulnerabilities
Dissociation
etilefrine
foreperiod
Cz
Etilefrine
Inhibitory
3-minute
doctor-controlled
1-minute
37.8C
Bacteriuria
post-biopsy
ICERs
124.05
54.63-
314.57
213.90
133.51-
394.94
309.31
151.27-
548.28
ecstasy
3,4-Methylenedioxymethamphetamine
MDMA
subculture
Reaction
neuro-endocrine
dexfenfluramine
Ecstasy
Heavy
Pentaglobin
Basing
pointers
reintervention
Fusion
Shouldice
Hernia
non-mesh
prostamol
uno
Prostamol
Uno
PU
open-population
say
dihidroergocriptine
mastopathy
mastalgia
nipple
Mastodinia
61.11
Mastalgia
64.86
Galactorrea
93.33
fribrocystic
limited-stage
multimodality
LSCLC
post-
GTV-T
CTV-N
Fx/19
INF
Medastinal
N3
1.47-136.13
0-I
75.8
irradiant
polymyositis
dermatomyositis
blow
BFR
one-repetition-maximum
sectional
leg-press
knee-extension
timed-stands
Quadriceps
4.57
=0.01
aldolase
NCT01501019
Mycoplasma
Halothane
ERPF
131I-hippuran
99Tc-DTPA
118.4
253.4
isoflurane-anesthetized
232.9
halothane-anesthetized
132.4
467.8
362.5
80-kV
80-kilovoltage
kV
CCTA
-gated
dual-source
standard-tube
120-kV
low-tube
4.5-5.5
dose:2.7
agent:57.1
Image
2.1HU
33.2
Signal-to-noise
RCA
vs.19.6
vs.22.9
93.4
139.1
p=0.068
Quantifications
7alpha-hydroxy-5,11-diketotetranoprostane-1,16-dioic
PGE-M
stable-isotope
techniqe
SIM
gas-liquid
chromatography-mass
bis
D3-methyloxime
bis-methyl
tritium
11-hydroxy-9,15-diketoprostanoic
intra-assay
authentic
underivatized
mug/24
age-grou
age-group
45-80
salicylic
Addictive
'Internet
population-level
57,857
13-18
surveyed
two-level
addictively
coeducational
hyperparasitaemia
nM/litre
200.8
119.6
dentin/restoration
deionized
mesio-distal
600-grit
SiC
ionomer-based
reimmersed
addition-cure
vinyl
sputter-coated
Replicas
tooth/restoration
self-contained
edge-effect
restenotic
In-Stent
WRIST
Intracoronary
iridium-192
Ir
ribbon
ribbon+margin
radiation-ribbon
60.7
4.34
17.54
10.48
edge
restenoses
0.806
fall-off
Goldie
Coldman
CAV-
CMC-protocol
CMC-derived
cisplatinum
3-arms
shifting
non-responding
Promptol™
-application
Sublingual
Cp-prop
Inderal
compartmental
ACAT
imported
AMET
Gastroplus
buccal/sublingual
goodness
Cp-prop-time
every-other-day
Kegel
KE
PAD
perineometer
PRAFAB
score/quantity
Split-face
micropeel
photorejuvenative
nonablative
light-based
yttrium-aluminum-garnet
IPL
35-63
dyschromia
rhytides
interpulse
560-nm
2.4/4.0-ms
10-ms
rhytid
downtime
1/10
exfoliation
blistering
5/10
low-fluence
supporters
finite
Finite
geometrical
a-p
reconstructing
meshed
±1.17
=64
=24
Nicoderm
Marion
Merrell
Dow
ALZA
Palo
Alto
42-day
Nonallergic
polynomial
untransformed
curve.A
dirithromycin
Macrolide
q.d.s.
q.d.s
omepirazole
omeprazole-amoxycillin
Dirithromycin
southwest
OP
Coexistence
PMO
PEMFs
anti-osteoporosis
anti-osteoarthritis
hyperlipidemia
etcetera
ChiCTR-TRC-14005156
sheltered
earned
129.36
191.42
6,065.08
2,440.60
non-sheltered
Synchrony
Non-Interpersonal
student-to-teacher
ingredient
//www.clinicaltrials.gov/ct2/show/NCT00106210
landa
desonide
Desonide
dermatoses
ointments
ACTH-stimulated
Bispectral
delirium
Charlson
0.19-0.97
0.12-0.94
Neurologic
Music
NMT
Instrumental
TIMP
TOT
foran
HAND
Directions
8-year-old
85-99
tile
Session
behaviour-specific
girl
000/year
4/6
4.35
carbohydrate-protein
7.75
carbohydrate/1.94
student-directed
Dundee
post-course
pre-course
'traditional
'novel
plyometric
Ga-As
CW
mW
epicondyle
resisted
weight-test
valaciclovir
viruria
204/Glaxo
Wellcome
123-014
PCR-positive
PCR-negative
threatening
triple-blind
.440
.844
25th-75th
1-7.6
1-6.6
.932
.539
.628
-0.285
.776
PEs
dealt
paravalvular
intra-core
PAR
Transcatheter
Valves
PARTNER
consortium
directors
regurgitant
multiwindow
multiparametric
four-class
seven-class
0.481
0.367
0.517
0.431
0.607
multi-parametric
granular
libido
Glombock
Rast
GRISS
Videofluoroscopic
videofluoroscopic
case-matched
dysphagic
barium
ml-thin
pudding
1/4
cookie
aspirated
thickened
consistencies
Dehydration
aspirating
rh-TGF-beta
Standardbred
geldings
metacarpus
metatarsus
Methyl
Cellulose
ng/wound
rhTGF-beta
exuberant
granulation
BTM
4,724
EOT
0.63-2.43
-2.91
bortezomib
GMMG-MM5
MM5
German-Speaking
intravenous=65
subcutaneous=56
intravenous=8
subcutaneous=2
Staging
eudract.ema.europa.eu
2010-019173-16
chlorofluorocarbon
CFC
hydrofluoroalkane-134a
Chlorofluorocarbon
propellants
deplete
stratospheric
Production
CFCs
exemptions
Hydrofluoroalkane-134a
non-ozone-depleting
propellant
reformulate
yearlong
prestudy
intraseptal
computer-controlled
articaine
ISA
Ar
Ep
CCLADS
pulpal
Guideline
education/audit/feedback
leaders
guideline-consistent
feedback-supported
IDvIP
two-centre
diamorphine
accelerations
Diamorphine
Consent
meconium
ISRCTN14898678Eudra
2006-003250-18
REC
06/Q1702/95
MHRA
Authorisation
1443/0001/001-0001
NIHR
UKCRN
6895
RfPB
grant
PB-PG-0407-13170_IR5
autotransfused
HTLV
reinfusion
predonated
anterior/posterior
A/P
thoracolumbar
scoliosis
PSF
Dipyridamole
1960
p.o.
n=202
nitrates
P=0.040
mVolt
+21
Antianginal
antiischaemic
Supervisor
tolerance-responsiveness
troubled
supervisor
employee
interfacing
Employee
EAP
workplaces
supervisors
dialogue
team-oriented
Supervisors
help-seeking
maps
work-site
empathise
judgements
non-conscious
Execution
attribution
Riding
rapids
Rapids
multi-ethnic
locality
non-randomised
Eyberg
parent-set
Receipt
spillover
MSA
radioisotope
Resting
10/95
5/94
nonuniform
Visit-to-visit
Lacidipine
visit-to-visit
Partly
intraindividual
ELSA
lacidipine
20-25
loosely
Interindividual
intra-individiual
stapling
brands
Ethicon™
PROXIMATE™
ILS™
Autosuture™
Premium
CEEA™
Anastomotic
leaked
25/265
19/260
.419
staplers
stipulated
NCT00399009
Hierarchical
acculturation
immigration
acculturated
Ethnic
ethnic-specific
Epicutaneous
pollen-induced
epicutaneous
monocentric
Hay
mydriasis
cyclopentolate
0.112
0.123
Intrapleural
MFC
ara-C
syndrome-X
etiopathogenesis
Nebivolol
nitrite+nitrate
GM
sibling
regional-field
lidocaine/prilocaine
carbocaine
vasectomy
vasectomies
primaquine-resistant
vivax
Fansidar
Hoffmann-La
Roche
sulfadoxine
15-65
Thailand-Myanmar
parasitemia
parasitemias
ineffectiveness
illusions
interstimulus
47°
48°
49°C
JUMPs
-long-term
viewpoint
104-week
blonanserin
intolerability
000007942
explorative
UGIA
5-FU/leucovorin
TPS
CA72-4
CA242
SD4
PR+SD4
Beta-adrenoceptor
immersed
pre-immersion
rhG-CSF
countering
lenograstim
primiparas
Lebanon
breastfeed
high-income
Beirut
hotline
OR=3.92
OR=2.42
p-value=0.010
OR=3.28
p-value=0.043
OR=1.87
p-value=0.039
OR=2.55
p-value=0.044
OR=3.87
p-value=0.004
OR=4.13
p-value=0.003
maternal-child
ecosystem
NCT00857051
FK506
overgrowth
Gingival
15-196
immunosuppressant
CAELYX/Doxil
CAELYX
n=509
=1.00
0.82-1.22
HR=3.16
1.58-6.31
HR=0.94
0.74-1.19
Alopecia
Palmar-plantar
eight-repetition
8RM
gender-
weighted-box-stacking
P=0.0120
d=0.94
P=0.0088
d=1.57
hypnotherapy
Ss
50-minute
glycoPEGylated
Extensive
glycoPEGylation
rFVIIa
N7-GP
hemophilia
12.5-100
FVIIa
dose-proportional
DaVINCI
Second-line
400mg/m
46-hour
20mg/m
2-weekly
6-weekly
amended
P=0.24
overall-survival
irinotecan-based
pinacidil
Atorvastatin
quinapril+atorvastatin
FVa
Fbg
B-chain
thrombin-antithrombin
Sinemet
carbidopa/levodopa
sBCC
R1
-14
R-salbutamol
discoid
therapy-resistant
DLE
scaling/hypertrophy
0.0262
0.0238
0.0135
lesional
R-salbutamol-treated
0.0197
Step-down
step-down
nonerosive
84.0
46.0
0.273
0.852
completers
Radiography
step-up
chemo-radiotherapy
Gy/25
fx/5
teletherapy
fx
high-dose-rate
intra-lumenal
fx/6.5
47/60
58/65
41/65
0.08-1.11
0.16-1.01
95/125
0.44-0.98
P=0.038
PRE
-delta
voltage-gated
Craving
150-450
CIWA-Ar
SCL-90-R
hostility
psychoticism
immunostimulants
Alveolar
AMs
synthesizing
D53
Ribomunyl
immunostimulant
thymocyte
D53-treated
1,238
287
U/10
577
primes
NLFC
LOCHI
Phonak
Naida
UP
DSL
consonant
articulation
affricates
fricatives
multi-detector
yes
intention-to-diagnose-and-treat
plotted
thermocoagulation
Trigeminal
stabbing
RFT
PRF
tomography-guided
Gasserian
70°C
75°C
42°C
70°
Chemical
generalised
tonic-clonic
LTG
CBZ
51.3
Atrophy
evolves
develops
Yantai
OAC
co-trimoxazole
glomerulopathy
normoalbuminuric
inulin
para-aminohippuric
mesangial
Deterioration
Manchester
pretrial
oxpentifylline
ulcer-free
Non-contrast-enhanced
STAR
Dural
Arteriovenous
non-contrast-enhanced
VFA
DAVF
CEMRA
tagging
readout
DAVFs
CVR
Polydioxanone
sutures
Sternal
sternotomy
approximation
sixty-six
P600
P900
7.7-30.8
6.5-29.5
pemetrexed-related
Folylpolyglutamate
thymidine
phosphorylase
folylpolyglutamate
0.115
gamma-Glutamyl
hydrolase
gamma-glutamyl
endocrine-responsive
12-93
chemoendocrine
893
STEPP
adoptive
tumor-infiltrating
TIL
invaded
=0.0285
=0.039
TIL+IL-2
AJCC
weighted-blanket
actigraphically
Surrogate
Prentice
'true
Auxiliary
ideas
MEDAL
/liver
3.4-3.6
1.0-1.5
0.9-1.9
0.0-0.5
renovascular
GI/liver
626
Gastro-intestinal
psychometrically
ReQuest™
GERDyzer™
Therapy-associated
NCT00325676
splanchnic
inodilator
intramucosal
microgram/kg/m
micrograms/kg/m
interrupt
Bubbles
IQ-
away
52-mg
levonorgestrel-releasing
LNG20
Nulliparous
parous
16-45
16-35
Pearl
36-45
1011
nulliparous
438
1714
0.02-0.55
0.10-0.57
0.08-0.49
life-table
0.24-1.23
Expulsion
universally
bear
V-HeFT
hydralazine/isosorbide
esomeprazole-based
pylori-related
GU
401
GUs
EAC
E20
unhealed
Healed
Esomeprazole-based
translating
guideline-based
937
hospital-
caretaker
reevaluate
Patient-specific
Esophageal
EVH
sequela
EL
=.027
ES-treated
9,696
13,197
=.46
cost/variceal
28,678
29,093
cost/survival
27,313
23,804
bleeders
28,523
51,696
EBUS
TBNA
PPLs
CDPs
TBB
EBUS-guided
NCT00626587
Esmolol
speculative
CBFV
5-60
COe
vicarious
school-term
non-riding
Pedagogical
PAC
time-series
sagital
subatmospheric
LBSP
FABF
444
cocaine-negative
engendering
Whites
muted
acarbose
sulphonylurea
late-term
acarbose-treated
20/24
sulphonylurea/insulin
Acarbose
split-dose
GP1
GP2
gemcitabine-taxane
Split-dose
Rebound
32-77
9-day
encompassed
eugenol
pegvisomant
abdominally
Pegvisomant
anti-emetics
echolucent
Hypothetically
instable
rupture-prone
echogenicity
dominantly
echogenic
4/13
4/17
Aldred
45:1-11
synchrony
microvasculature
germane
Pentosan
Polysulfate
PPS
sVCAM-1
abdominoperineal
presacral
APR
Perineal
reopened
got
vs.21.6
arrive
competitions
hypohydrated
euhydrated
HYD
USG
1.020
salt-water
SW
carbohydrate-electrolyte
CES-L
CES
Pretrial
1.022
1.013
1.011
1.017
euhydration
Cool
intra-dialytic
inter-compartmental
quantum
Collected
β2-microglobulin
self-controlled
35.5°C
post-dialysis
large-sized
NCT02064153
mebendazole
de-worming
Phardazone
271
30-81
47-88
58-97
anti-helminth
Enclosed
juxta-subfoveal
Fluorescein
-K
-ATPase
hyperkaliema
mechano-
cross-over-design
MBP
SpO
Digoxin
post-handgrip
digoxin-induced
mechanoreceptors
Silent
micronutrient-fortified
middle-income
catered
semi-urban
Hyderabad
869
micronutrient-enriched
pairing
Designing
Nonfasting
grandfather
uncle
5.92
5.47-6.36
5.25
5.16-5.34
5-30
nutriture
sucrose-formulated
SPINART
rFVIII-FS
PATIENTS/METHODS
Males
12-50
6-24
binomial
annualized
Which
screen-positives
96,517
87,655
8688
non-screened
OR=4.51
4.28-4.75
1.25-1.41
television/radio
OR=1.50
1.43-1.58
OR=2.75
2.57-2.95
OR=0.39
0.37-0.42
high-size
OR=0.73
0.68-0.78
5143
OR=0.79
0.65-0.95
assuring
SQ29,852
monotherapies
CASTLE
self-injector
1566
injector
self-injected
Advantages
ICT
VATS
radically
1730
treats
cephacetrile
cephaloridine
Codeine/acetaminophen
hydrocodone/acetaminophen
23-day
Analgesics
Pharmacologic
Colombian
Libre
Security
Medellín
Cali
pain-intensity
codeine/acetaminophen
C/A
30/500
H/A
5/500
q4h
150/2500
25/2500
medium/large
B/C
seventy-three
2.5-5.9
2.6-7.5
Pakistani
Aker
Ullevål
Pakistanis
Norwegians
micrograms/day
margarine
793
1134
pT2/T3
0.00018
intestinal-type
diffuse-type
Immunochemotherapy
tipless
baskets
caliceal
Tipless
Microvasive
Zerotip
2.4Fr
3.0Fr
N-Circle
2.2Fr
3.2Fr
Bard
Dimension
Sacred
Halo
1.9Fr
Vantage
Circon-ACMI
Sur-Catch-NT
basket
convex
retrievals
0.174
Sur-Catch
=.0005
expeditious
Caliceal
basketing
urology
Hannallah
postextubation
garment
garments
Chromameter
CR-300
Dermascan
4.82
Scars
ozone-induced
L/min/m
tocopherols
Rilmenidine
sympatholytic
Heightened
imidazoline
rilmenidine
HERA
Hyperium
Reflex
Adrenaline
ng/min
untouched
reflexive
contrasts
emphasises
suprabulbar
Sympathetic
affirming
medullary
7-18
State/Trait
youth-to-parent
drains
faced
clamped
Responsivity
Parent-child
canonical
PMT
nonspeaking
AT-1
OPTIMAAL
Cozaar
trade
captonpril
Capoten
499
447
363
asocial-communication-based
social-communication-based
social-interaction
subsolid
semiautomatic
segmentation
part-solid
nonsolid
disagreements
radiologist
Semiautomatic
Hounsfield
-300
-130
POINTS
•
Fleischner
selections
no-
TBI-related
Gum
elastic
bougie-guided
elastic-bougie-guided
anaesthetized
palato-pharyngeal
attaching
single-handed
palatopharyngeal
Failed
malposition
15/50
35+/-17
54+/-45
33/35
9/50
2/50
Psychoeducational
wives
spouse
denial
spouses
Rush
Shaw
Emery
BA
schema
competent
attributional
dual-isotope
domperidone
galactorrhea
HUNT
n=1,505
case-cohort
n=66,140
Nord-Trøndelag
sex-adjusted
1.2-2.2
three-fold
1.1-1.6
Bites
saw-scaled
carpet
viper
Echis
carinatus
antivenoms
snake
echis
antivenom
S.A.I.M.R
Behringwerke
polyvalent
coagulability
non-melanoma
BACKGROUND/PURPOSE
aminolaevulinic
protoporphyrin
PPIX
Bowen
gentle
405+/-5
photodiode
Spectra
6.1+/-1.2
non-prepared
+/-1.8
agrees
unprepared
disparate
tonicity
office-measured
55.4
significative
damaged
lithiasis
3/75
1/75
5/75
pneumoperitoneum
4.5+/-0.4
3.2+/-0.2
symptomology
Informal
Colonoscopic
back-to-back
6-9
1.69-6.46
meticulous
Miss
kill
imidacloprid
fipronil-
-methoprene
spot-on
Ctenocephalides
cat
infested
99.4
epigallocatechin-3-gallate
Epigallocatechin-3-gallate
EGCG
polyphenol
photoprotective
anti-angiogenic
w/w
HIF-1
α.
telangiectasias
OHTS
substituting
1433
cup-to-disc
VCDR
Predictive
c-statistic
C-statistics
Calibration
Sublingually
emergencies
SLC
13/8
52/36
15/11
57/38
Pulsatile
mU
on/off
arginine-induced
arginine-stimulated
A-
reproduce
Glycerol
abacterial
Inflammations
ear-nose-throat
56-81-5
lidocaine-HCl
73-78-9
earache
otorrhea
clogged
10.95
15.71
0.5-3.5
rerandomized
urinalyses
Simpson
Angus
SARS
Involuntary
Somnolence
Difficulty
CDC
decelerated
omnivorous
ethnicities
Serum-free
53.85
Estrone
55.56
42.86
3.52
low-response
Low-response
LTA
collagen-epinephrine
youdujing
papilloma
Youdujing
YDJ
HR-HPV
vaginoscope
telomerase
hTERT
down-regulating
trough-to-peak
SYST-EUR
smoothing
handled
europe
176/86
149/80
corrections
16.6/7.3
9.8/4.7
disregarding
0.46/0.40
0.77/0.99
nonnormally
smoothed
0.20/0.13
0.20/0.14
0.16/0.21
0.32/0.38
0.28/0.40
0.48/0.49
Accounting
Smoothing
interrelationships
age-drug
volume-to-heart
respiration-heart
interrelations
salbutamol-treated
RDAI
solar
Outdoor
work-sites
per-person
worksites
Science
EBTs
Appalachian
hyperactivity/impulsivity
delinquent
Malnourished
tube-feeding
COOP-WONCA
P=0.050,0.031,0.045
P=0.049
pre-fed
3-yr
DDP
Cb
non-nasopharyngeal
HNC
53.2+/-14.2
1.76+/-0.14
mIU/l
3.8-12.0
FT4
FT3
L-thyroxine
N-Ns
SDNN
r=-0.42
/high
r=0.42
r=0.64
r=0.63
L-tiroxine
1-63
randomisations
Mastectomy
exhausted
POINT
uncuffed
Uncuffed
Full-term
age/4
Cole
21.min-1
Cuffed
1.min-1
coformulated
elvitegravir/cobicistat/emtricitabine/tenofovir
disoproxil
efavirenz/emtricitabine/tenofovir
EVG/COBI/FTC/TDF
EFV/FTC/TDF
+3.6
Virologic
+2.7
malignantly-converted
cytostatics
HPV6
VLPs
VLP
µg
Brisbane
Wart
s.e.m
immunotherapy/dose
Wenzhou
liniment
open-ended
fill-in
myelomatosis
seventy-two
renal-function
plafibride
hyperlipoproteinemia
N-2-
p-chlorophenoxy
-isobutyryl-N'-morpholinomethylurea
lipoproteinogram
pre-beta-lipoprotein
beta-lipoprotein
inductors
adhesiveness
palpebral
xanthelasmas
alkalines
malfunctions
GOT
GPT
LDH
Extinguish
DUET
multi-level
audits
semi-structured
comparative-effectiveness
guidelines-staff
pay-for-performance
P4P
NCT01615237
Atopic
817
cookers
21-65
5.37
pericardium
Ei
Ai
Ei/Ai
valvar
hearts
Aminocaproic
hyphema
aminocaproic
Amicar
rebleed
220-microgram
adenosinergic
ADA
HF-rTMS
DLPCF
Comorbid
seminars
aliskiren
proteinuria-lowering
perindopril
1.36–2.66
93±6.8
Aliskiren
2–44
17–55
11–26
11–39
antiproteinuric
proteinuric
hippotherapy
Stratification
OFF
0.01-0.71
0.13-1.47
Hippotherapy
supratentorial
astrocytomas
giant-cell
2-chloroethyl
-3-cyclohexyl-1-nitrosourea
mg/sq
Hitting
absolutely
absolute-direction
relative-direction
eye-position
viewing-eye
ecologically
darts
fixated
monocularly
binocularly
gun
fixating
rear
gunsight
absolute-
phoria
inaccurate
single-tapered
load-free
submerged
Southern
43.25
23-71
=14
Tapered
roughened-surface
screw-retained
second-stage
metal-ceramic
Peri-implant
Prosthodontic
prosthodontically
Restoring
Micronized
MFF
POD
PODs
Multifaceted
facilitator
anti-diabetic
1410
1.19-2.39
1.07-2.16
0.99-2.32
facilitators
family-based
z-BMI
-1.21
-0.76
-1.05
-0.51
radiolabelled
anti-carcinoembryonic
KAb201
drawback
16857581
histological/cytological
KAb
2/6
1/6
0/3
1/18
IVtr
APA
Federal
Paulo
Krug
Portuguese
Marteleto
non-adaptable
Psycho-social
psycho-social
Perispinal
spinal-epidural
Faulty
sentences
punctuation
Chomsky
grammaticality
bitransitive
legitimate
violated
prohibits
sentence
commas
enclosed
7-point
=least
7=most
N=100
shortand
multi-clinic
discolouration
Complementary
18-month-old
Malawians
FS
maize-soy
likuni
phala
Rural
Malawi
six-month-old
FS50
FS25
2.37
.23
LP-supplemented
below-median
One-year-long
Trimetazidine
anti-ischaemic
Reproducibility
ST-depression
P-TMZ
-4.4
-33
-24
high-energy
phosphates
stroke-work
5/15
9/14
counterregulation
retains
clamps
=.039
=.018
Hypoglycemia-induced
menorrhagia
Naples
Reintervention
low-salt
intralymphocytic
re-checked
p=0.85
competitor
preintervention
desensitization
papular
Papular
ailments
insect
RAAS
Autonomic
RR-variation
MCR
expiration/inspiration
E/I
µg/l/h
Parasympathetic
inotropes
DP
Paediatric
Padua
0-36
spreadsheet
-3.1
+3.7
same-day
practitioner-led
ESTEEM
GP-led
computer-supported
Pragmatic
Devon
Bristol/Somerset
Warwickshire/Coventry
Norfolk/Suffolk
out-of-hours
walk-in
20,990
7283
6695
7012
16,211
5572
5171
5468
patient-clinician
£75
ISRCTN20687662
Vol
Journals
Library
GGT
157.0
IU/l
141.3
86.2
corneum
ELA-Max
painlessly
ablated
Full-face
passes
Laser-assisted
Resurfacing
full-face
1:4
UFT/LV
5-FU/LV
=.591
=.010
bioelastic
dazmegrel
greyhound
sparring
matrices
conformation
TSI
harm
distress-coping
gatekeepers
self-destructive
homeroom
vantage
lend
234.1
137.3
4.4+/-1
7.9+/-1.2
whole-pelvic
prostate-only
9413
WP
NCHT
AHT
1,323
=.022
=.56
ritualistic/repetitive
edn
Arlington
discourse
storytelling
Tager-Flusberg
Handbook
Wiley
pp
335-364
Latent
Semantic
LSA
narrator
narrating
hand-coded
proves
glyceryltrinitrate
Valproate
Fulfillment
IHS
photophobia
phonophobia
0.781
revise
Re-entry
Program-Japanese
DPP
'Issues
'Autistic
3.818
4.155
rural-dwelling
Reach
Wellness
RENEW
n=729
45-
dwellers
starches
Stain
Added
Booster
qualifying
Hammer
Truly
Radiant
Spinbrush
Colgate
Extrinsic
Lobene
MLSI
directionally
0.0673
ShvO2
SvO2
saturations
Enflurane
hyoscine
N-butyl
resolve
peristaltic
Glucagon
hyperamylasemia
premedications
mastery
loud
spider
crawling
bouncing
verbalizations
acknowledge
intervener
antipsychotic-associated
arresting
-3.40
+1.37
Mainly
reward-based
overeating
Rational-emotive
rational-emotive
RET
REI
sociometric
postassessment
interpersonally
antimetabolites
calcanean
calcaneus
0.2-0.4
apoproteins
MK
733
sequestrant
cholestyramine
simvastatin-cholestyramine
Critics
assertion
placebo-informed
placebo-uninformed
steadiness
Instructions
NSTE
26,466
GUSTO-IIb
Glycoprotein
PURSUIT
PARAGON
Chromium
Ovary
picolinate
µIU/ml
assessment-insulin
assessment-beta
HOMA-B
-15.5
+13.6
-0.008
+15.2
+3.0
21.9
new-onset
nondepressed
Cox-regression
1.14-1.53
13.57
1.08-1.44
8.86
Incident
hip-fracture
Buprenorphine
non-dependent
agonist-antagonist
non-physically-dependent
abuser
mg/70
liability
vortices
Swirling
flow-mapping
VFM
Aloka
Alpha-10
vortex
V2
hypocalcemic
CND
Hypocalcemic
Hypercalcemia
gs
4-14
juice-making
sighted
tactually
post-instruction
‘
Interleukin-6
tocilizumab
reactant
∼20
tocilizumab-treated
∼21
Tocilizumab-treated
ESRs
ASP
P+EN
anti-infection
anti-acid
21.00
7.07
μg/L
48.00
10.32
32.00
9.30
103.2
78.1
37.4
10⁹/L
×10⁹/L
Expectancies
reputed
post-stress
mixed-factorial
manipulate
relax
expecting
manipulable
very-low-birth-weight
Nosocomial
hypogammaglobulinemic
hospital-acquired
two-phase
2416
501
1001
1204
1800
meninges
439
Septicemia
cocci
ill-defined
Technical
one-stage
through-the-scope
TTS
Experienced
sicker
extracolonic
magnetophoresis
Amus-01-Intramag
Intrastim
electroneurostimulation
oxibutinin
flowmetry
corrects
transaxillary
21-60
gasless
permeable
RGP
Quantum
Dk
microcystic
SEA
WeeFIM
PEDI
Leiter
RFRLS
RDLS
p=0.034
Mechanisms
DINAMIT
ICDs
n=311
competing-risks
nonarrhythmic
nonsudden
negating
colonography
post-processing
tag
self-completed
16/17
12/13
palifermin
keratinocyte
0·21
0·0007
0·003
0·01
Palifermin
protectant
ACTRN012605000095662
Mending
RACE
rate-control
2.3+/-0.6
thrombo-embolic
TECs
rhythm-control
nicorandil
vasospastic
ergometrine-induced
ergometrine
Methergin
0.0034
0.0039
Nicorandil
hypertonia
8/27
10/34
7/22
p=ns
Stoppage
formaldehyde
Formaldehyde
FA-specific
nonallergic
CAP
UA/ml
ILP
TNF/IFN/M
CIM
iodine-131
12,395
10,374
TNF-R
I131
tourniquets
semi-permanent
fibroids
polyglactin
tied
occlude
polythene
infundibulopelvic
obstruct
1870
1159-2580
0.165
DIG
/=0.45
Planning
closeout
5602
5070
contract
hired
locate
non-comorbid
overactivation
IFC
downregulated
normalises
upregulating
tositumomab
I-131
BNP-guided
symptom-guided
Intensified
Congestive
TIME-CHF
Uptitration
0.72-1.14
0.50-0.92
isrctn.org
ISRCTN43596477
β-blockers
12,855
7,967
4,474
unmatched
β-blocker-treated
Calculating
β-blockade
D-glucose
99-126
trans-telephonic
PAF/PAFL
mg/BID
39.4
inter-ethnic
life-skills
shall
therapy.Consistent
fallers
quantifying
ANZCTR
ACTRN12606000344594
dujieqing
MGMT
middle-and-late
Dujieqing
DJQ
O6-methylguanine-DNA
methyltransferase
methylation-specific
MSP
hemogram
toxic/adverse
20.00
46.67
IMPALA
underestimations
1.0-1.1
1.2-7.3
1.7-8.9
miscalculated
misclassified
risk-reducing
undertreatment
Vicodin
Tylenol
30/300
DEA
mg/500
mg/300
reclassifies
advisory
795
preneoplastic
anti-H
Non-linear
1703
Preneoplastic
medroxyprogesteron
vincristin
belong
ER-positive
appendix
1991-1992
Laparoscopy
normal-looking
SAKK
40/81
1:0.75
0.57-0.99
small-group
acquiring
six-session
high-need
thoracoabdominal
inductance
Respisomnography
Chest
time/duration
Contribution
cage
tachypnea
partitioning
conceivably
ramosetron
strabismus
suite
Seoul
Reaching
inviting
IVR
recycle
Quitline
recycling
manuscript
QL
2985
callers
re-cycling
reinitiate
Re-enrollment
194/715
re-enrollment
recycled
re-engaged
Integration
NCT01260597
Gynecologic
serous=S
cell=CC
endometrioid=E
doxorubicin/cisplatin
doxorubicin/paclitaxel
paclitaxel/doxorubicin/cisplatin
Breakdown
S/CC
E=44
S=44
CC=32
Histology
1.02-1.4
1.1-2.07
advanced/recurrent
Poorer
lower-intensity-generalized
LG
higher-intensity-individualized
p=0.030
Biodistribution
photosensitizers
Photosensitizers
porfimer
tin
etiopurpurin
chlorophthalocyanine
fibrosarcoma
solubilization
fluorimetry
Porfimer
175.3
0.0028
L/kg/hr
microg/g/hr
Mediastinal
micrometastatic
n=94
n=53
Ber-Ep4
pN0
pN1
pN2
T-stage
N-stage
P=0.39
Awareness
Sloutsky
sizeable
6-year-olds
Crucially
Diamox
Sustets
intracameral
Miochol
perindopril/indapamide
mg/indapamide
Per/Ind
Ate
sSBP
sDBP
-20.1
intertreatment
-16.2
Individualized
1,53
Cdn
23,437
15,151
SICOG
Alimta
10-33
20-46
3.7-6.5
5.9-10.7
7.1-13.9
11.7-14.9
chinese
Self-control
repetitive/rigid/impulsive
Chan-based
Nei
Yang
Gong
PMR
inhibitory-control
concurs
mediates
ChiCTR-TRC-12002561
www.chictr.org
Opposing
epicardial
haven
Upright
counteracts
whiplash
toxin-A
contributory
WAD-II
injectant
gauge
Vernon-Mior
preinjection
Hexetidine
'Oraldene
hexetidine
pre-dosing
mouths
3-times
post-dosing
neighborhood-based
organizing
organizer
COLLECTION/EXTRACTION
interviewers
1-phase
malocclusion
bionator
headgear/biteplane
Arch
Alginate
poured
trimmed
photocopied
arches
SPACE
stent-supported
6.92
6.45
-1.94
+2.87
'ipsilateral
0.74-1.82
Instent
2.14
1.10-4.18
Stent-supported
interventionalist
oxolamine
achaete-scute
hASH1
esthesioneuroblastoma
sinonasal
esthesioneuroblastomas
olfactory
triplicate
menopause-related
40-62
at-home
facility-based
0.615
MENQOL
7.6/day
1-8
irides
eyedrop
PML-RAR
APL
break/fusion
PML
RAR
-form
variably
0129
molecularly
alpha-positive
S-form
L-form
V-form
2,500/microL
1,600/microL
promyelocytes
884/microL
126/microL
.40
previously-identified
lanreotide
acromegalic
macroadenomas
mg/2
microg/l
IGF1
35.0-63.0
7.6-29.2
P=0.538
4.5+/-1.6
4.8+/-1.9
P=0.328
GH-secreting
NCT00993356
10-year-old
BASC
Playing
typewriter
piano
sensory/motor-based
man-made
prime-target
auditorily
'typewriter
'piano
'blanket
bucket
couch
lexical-semantic
30-64
vibration
isocapnic
tight-fitting
rebreathing
blended
two-minute
continuous-wave
6.84
L/min
FIo2
8.44
ATP-sensitive
opener
P=0.0058
Postprocedural
Corrected
21.0+/-9.1
25.1+/-14.1
P=0.0009
washouts
Blockage
deposit
Contisol
Maelor
Ltd
Wrexham
Endpoints
'UTI
latex
deceased/severe
eprinomectin
chorioptic
mange
alpacas
treatment-controlled
un-controlled
Chorioptes
sp
500mug/kg
400mug/kg
localised
Beth
One-month
urinalysis
actigraphic
oversensitivity
p.m
atomoxetine/fluoxetine
placebo-only
spring-calving
POST
dry-rolled
DM/d
germ-supplemented
dam
bulls
Primiparous
3-yr-old
+7
Calving
Supplementing
Intense
androgen-deprivation
abiraterone
Luteinizing
LHRHa
CYP17
ng/dL
intraprostatic
dihydrotestosterone/testosterone
Δ
-androstene-3,17-dione
Prostatectomy
T3-
D4
differentials
LTE4
LTD4
bronchoconstrictor
saline-induced
PC20FEV1
95.7
diluents
PBS/ethanol
PBS
postchallenge
cytospins
55.9
recruits
vigourous
Rehydration
rehydration
ORS
hypovolemia
20-50
nothing
FloTra/Vigileo
OT
re-detection
Contact
spoliation
hydrogel
PureVision
balafilcon
Acuvue
etafilcon
EW
subject-masked
Worn
OTG
Consultancy
triglycerides/phospholipids
0.0025
acids/di-
monoglycerides
1,116
ex-smokers
rashes
cuts
canister
moderate-to-high
ICSs
neurobehavioral
Saccade
brain-stem
FASD
tracker
cerebellar
Bevacizumab-augmented
fellow-eye
Avastin-assigned
Genentech
Francisco
39-68
Avastin-injected
PDR
sizable
Avastin-treated
p=1.000
scatter
Avastin
Azelnidipine
anti-coronary
Juntendo
ALPS-J
azelnidipine
naftopidil
BPH/OAB
Naftopidil
19.2±7.9
11.7±5.8
19.4±6.4
12.3±6.8
4.9±0.8
3.2±1.4
5.0±0.8
3.6±1.3
7.8±2.6
5.0±2.5
8.6±2.9
5.8±
A4250
interrupting
Reabsorption
homoeostasis
single-ascending
SAD
multiple-ascending-dose
HPLC-MS
FGF19
7α-hydroxy-4-cholesten-3-one
555
664
0.01-0.05
cholic
chenodeoxycholic
A4250-treated
EudraCT
2013-001175-21
methotrimeprazine
mice
non-sedative
Methotrimeprazine
Anaesthetics
INCLUSION
CRITERIA
normokinetic
Transoesophageal
basally
interventricular
self-paced
low-active
min/week
25.0-39.9
print-based
30-60
64-76
minutes/week
exercise-related
expenditure/week
0.243
kilocalories/week
Explicit
dual-coil
transvenous
coils
Lead
Shocks
cathode
Delivered
10.1+/-5.0
single-coil
8.7+/-4.0
Leading
unipolar
147/98
126/82
122/81
Dosage
MDA-basal
ethylmaleimide
MDA-activated
mg/daily
Malondialdehyde
45.33
36.79
2.89
3.58
10.34
Cobicistat
Ritonavir
Pharmacoenhancer
Atazanavir
Emtricitabine/Tenofovir
Disoproxil
Fumarate
COBI
pharmacoenhancer
atazanavir
emtricitabine/tenofovir
+0.13
+0.07
6R-l-erythro-5,6,7,8-tetrahydrobiopterin
Treatment-induced
nephrolithotomy
supracostal
tubeless
18F
6F
Double-J
accesses
stone-free
urinoma
platelet-transfusion
charges
39,800
62,500
exacerbation-free
-9.8
.832
.90
.549
NCT00791505
adsorbent
recirculating
MARS
heparin-free
dynamically
min.The
ravine
adsorbed
touches
FDP
coaguation
heparin-like
incipient
51Cr-EDTA
125/79
104/68
31-369
6-200
pressure-dependent
autoregulation
Fake
faking
FB
TOVA
subtly
fake
affirms
test-taking
sclerectomy
pseudoexfoliative
DSMMC
7.13
27.59
11.68
42.25
72.5
Descemet
attentiveness
Cross-over
prolactinemia
in-between
radioenzymology
remanent
colds
MU/day
10-MU
20-MU
rhinovirus
rhinoviruses
Antibiotics
PVB
VAB-6
BVP
PEB
IIIO
IIIB2
IIIC
Seminomas
non-seminomatous
Salvage
nonchronic
Sickness
gainfully
cocoa
constipated
toilet
verifying
50th
45.4
-38.1
scybalous
pebble-like
transgluteal
Watson-Jones
Hardinge
electromyograms
Temporospatial
joint-kinematic
temporospatial
ten-day
twelve-week
myringotomy
CHEOPS
CHEOP
contingencies
temporally
PC-supported
self-evaluation
verbal-semantic
self-appraisal
designation
'neuropsychologically
ErbB2
overexpressing
Vinorelbine
HER2-overexpressing
Antimigraine
telcagepant
triptan
triptans
Telcagepant
Responder
HTR
75-100
25-74
HTR/no
407
triptan-naïve
116/162
29/62
poor/no
44/111
48-58
52-58
26-31
56/98
1.20,3.71
57/119
.211
NCT00442936
Morphological
NMR
spadelike
ventriculogram
LVG
segmented
nonspade
short-axis
=1.3
54+/-10
anterior-lateral
septal-anterior
vitD3
perinatally
PHIV
BHIV
5.0-24.9
D-related
Percentage
T-helper
Th
Adjunct
Moclobemide
moclobemide
Imipramine
Self-rating
r-metHuG-CSF
methionyl
-adrenoceptor
5.5-11.1
counter-regulatory
Glycaemia
1990-1991
999
VB
Multiparous
64.2
dyspareunia
perineums
Places
SUBJECT
2794
Pregnant
fetuses
antenatally
3.11
audiograms
ototoxic
47/51
49/52
4/37
3/39
1/31
Phlebitis
7/51
12/52
Red
5/52
customary
zengjing
oligospermia
Zengjing
Capsule
ZJC1
OSM
Wuzi
Yanzong
Pill
WYP
WLJY-9000
semen
HIF-1α
CD18
haemoxygenase
HO-1
PCR/electrophoresis
post-CPB
GT
isofluorane
72-hour
0-19
0-13
0-60
0-411
E-mail
invitations
parent-
teacher-rated
ABC-H
1.9-point
definitively
information-Omega-3
NCT01694667
+/-13
Uric
Intercellular
last-resort
introduces
posterolateral
Discrepancies
13.37
ChiCTR-OOC-15005904
2015-01-30
eradicate
blood-borne
Assessing
slice
unidimensional
VOL
semi-automatically
±3.5
±6
prudent
Ang
rennin-angiotensin
Na/day
RBF
para-aminohippurate
DeltaE
DeltaRBF
-135.2
-62.5
Diet-Related
Population
diet-related
healthier
Sandra
Tunis
PhD
formulary
oryzae
cervisiae
lambs
markets
Dorset
Amaferm
AMF
Lambs
pen
wethers
arrangement
Saccaromyces
CNCM
1079-Levucell
SB
LEV
whole-shelled
non-feed-supplemented
0.208
learnt
Conducting
Etomidate
flumazenil
etomidate
2-12
RSS
Myoclonus
Rifampicin
6H
3RH
Immigrants
1.26-2.82
illegal
1.01-2.15
1.28-2.85
illiteracy
1.04-2.88
2.54-5.4
1.68-3.57
lethal
CMV-hyperimmune
anticytomegalovirus
anti-CMV
Plasmapheresis
plasmapheresis
oliguric
polyuric
irreversibility
'The
Therapy-Anaemia
FACT-An-
FACT-G
FACT-An
Supervised
relaxation-
0.17-0.72
5.40
Toi
Anaemia-ANS
.87
.83
MC-1
Eliminate
Damage
Graft
MEND-CABG
5'-phosphate
High-risk
3023
90-day
Vivo
Rehearsal
High-Functioning
decoding
7-12
HFASD
Scholars
settled
precedence
drives
untangling
chicken-and-egg
hypoxia-inducible
factor-1alpha
HIF
-1alpha
HIF-1alpha
C1772T
C/C
C/T
T/T
house-dust-mite
cetirizine/PSE
7-h
Vienna
Chamber
VCC
Flow-cytometric
eleutherococcus
senticosus
Eleutherococcus
Eleukokk
multi-parameter
ethanolic
vincamine
wine
drastic
helper/inducer
Neuroleptic-related
anti-smoking
non-drug
1232
middleaged
exercise-ECG
5FU
reserved
Eight-eight
cost-benefit
pumps
programmable
cost-benefits
events/month
2.6-fold
larger-scale
Bright
BLT
Illuminance
7.500
lux
doubly
Fieldwork
2007-May
WOMEN
MPI
Duke
NCT00282711
4-site
fifty-four
vero
2-site
8-site
ampoule
5-dose
Neutralising
neutralisation
meets
30087513
anti-stigma
seventh-
eighth-
ninth-grade
Two-eighth-grade
non-peer
attitudinal
spill-over
non-targeted
multi-session
Copenhagen
Instant
Recess®
overweight/obesity
Forsyth
fifth-grade
semesters
PA.
nutrient-sensitive
gene-diet
DiOGenes
SNP-diet
low-energy
SNP-dietary
lipin
LPIN1
rs4315495
20.26
A-allele/protein
20.38
20.14
P=0.000043
precipitating
GER
eaten
preeclampsia
9801
radioprotector
chemoradiation-induced
IIIA/B
no-AM
≥70
≤70
0.79-1.34
0.66-2.32
813
IFL
411
fluorouracil-based
microdialysis
mas
HFD
high-carbohydrate
HCD
EGC
0.0375
microg/min/kg
V*O2max
1,534
micromol/90
1,108
micromol/30
1,641
micromol/60
963
=.056
microleakage
flowable
pit
diamond-bur
high-speed
handpiece
mJ/cm
Teeth
darkness
bucco-lingual
slices
photographed
Preparing
TP53
cyclophosphamide/cisplatin
suboptimally
debulked
platinum-resistant
platinum-free
equitoxic
hyperactive-inattentive
oppositional
defiant
ODD
.125
.25
.5
half-dose
Swanson
Nolan
Pelham
.25-
.5-mg/kg
Convergent
5F
Band
plethysmographic
0.231
-1.095
self-collection
EMA
Jujuy
Argentina
self-collect
NCT02095561
7650
3632
3049
4018
2964
2618
4·02
3·44-4·71
del
Cáncer
Line-item
ABC-Irritability
cries/screams
stamps
feet/bangs
tantrum-like
hyperkinesis
tantrum
M-Mode
2D-echo-cardiography
Constraint-induced
Loewenstein
paresis
restrained
mitten
pegs
saucer
pegboard
grasp
spoon
plegic
two-sentence
vignette
privatisation
Insurance
2008-2010
privatising
facet
facet-joint
86.5
shunt-dependent
BRAT
Ultimately
ventriculoperitoneal
vertebrobasilar
intraparenchymal
ventriculostomy
hemicraniectomy
Clipping
beta-adrenergic-blocking
partial-crossover
Tomato
lycopene
UVR
tomato
UVR-induced
21-47
phototype
postsupplementation
unexposed
UVR-exposed
buttock
immunohistochemically
pC
fibrillin-1
MMP
3895-bp
26·5
7·5
6·6
36·6
14·7
0·03
35·1
9·9
32·6
9·6
42·2
Presupplementation
MMP-1
Postsupplementation
0·04
abrogated
pCI
Obhi
Haggard
wo
Scientific
358-365.
anticipatory
circle
spacebar
revolution
Ciprofloxacin/dexamethasone
/dexamethasone
CIPRODEX
evaluator-blinded
wet/dry
wet/wet
dry/dry
Ciprodex
Physician-observed
39.39
=0.0006
myopathy
vincristine/corticosteroid
Cronassial
gangliosides
vincristine-induced
Weakness
fine-motor
electrodiagnostic
vincristine/corticosteroid-based
etretinate
palmoplantar
pustulosis
Re
Re-PUVA
UVA-control
Tonsillar
DFI
6/20
17/20
FI
prehypertension
II-induced
6/3
/diastolic
homogeneously
6/4
sleep-time
prehypertensive
netilmicin-cefoxitin
gentamicin-cefoxitin
G-C
20/21
33/34
13/13
19/20
2/27
3/19
N-C.
5/27
Fertilization
849
microinjected
IVF-
92/182
IVF+
ICSI-treated
271/528
334/658
0/6
0/9
motile
hook
10-hook
Roll-off
6-15
1,045
W.m
RFA-induced
23-37
0-42
linezolid
oxazolidinone
Non-compartmental
Linezolid
valsartan/hydrochlorothiazide
stage-1
stage-2
age=52.6+/-10
=161/98
V-low
V-high
valsartan/HCTZ
160/12.5
V/HCTZ
160/25
-27.7+/-13/-15.1+/-8
-21.2+/-13/-11.4+/-8
-24.0+/-13/-12.0+/-10
Reinfarction
MB-creatine
0.0103
2-tail
salpingostomy
sphygmomanometry
25-100
10-40
Scale-Parent
SRS-P
in-session
anxiety-disordered
FCBT
ICBT
Coded
At-home
IIB/IIIA
fluocinolone
0.59-mg
2.1-mg
noninfectious
Uveitis
preimplantation
postimplantation
nonimplanted
Implanted
Cataracts
pressure-lowering
NCT00407082
ADHD-Improvement
CTRS-R
29.2-33.9
36.0-40.6
subscore
information-A
d-tubocurarine
24891
larynx-preservation
epilarynx
pharyngectomy
preservation/surgery
1.428
SFL
posttonsillectomy
Post-tonsillectomy
C-fiber
peritonsillary
impulses
preincisional
tonsil
FLACC
02322346
sometime
kilohertz
sharp/surgical
socks
KHz
epithelialization
0.0366
debrided
bioburden
Glucocorticoids
20-fold
barbiturates
Exogenous
epidural-general
low-flow
insulation
forced-air
Inpatient
alkalinized
invasiveness
Medications
Balaam
PROC
MIXED
Diazoxide
diazoxide
alpha-beta
adrenoceptor
diazoxide-treated
3/115
8/85
labetalol-treated
5/104
7/89
blood-sugar
Lancet
lancet
Hepatobiliary
medium-chain
triglycerides/short-chain
MCT/LCT
four-component
Olive-oil
Fish-oil
gastrointestial
5-days
2,4
SMOF
21,9
52,9
Lipofundin
32,5
79,6
4-days
Heat-exercise
pyridostigmine-treated
clothing
Pyridostigmine
warfare
exercise-heat
Tdb
rh
m.s-1
Non-evaporative
W.m-2
Tre
832
g.h-1
AVCMF
SWI
≤1
labouring
ACTRN12609000964213
63.5
subjects-either
active-performed
two-days
telemetric
autism-like
Woo
Leon
one-handed
two-handed
500-bed
1-liter
Wright
694
Tidal
Ages
Thermodilution
flipping
coin
45-degree
-0.539
-0.083
0.0083
comet
microelectrode
head-and-neck
Eppendorf
histograph
histographs
fine-needle
single-strand
MTM
Nonirradiated
oxygenated
MTMs
Comet
Intertumor
radiosensitivity
entacapone
peripherally
catechol-O-methyltransferase
Catechol-O-methyltransferase
COMT
Entacapone
OR-611
levodopa/50
carbidopa
levodopa/carbidopa
FAMTX
DGCG
resectability
D1
para-aortic
15/27
-32
Downstaging
MEG
observation/execution
Mu-rhythm
10-12Hz
magnetoencephalographic
Mu-modulations
grasping
Mu-power
Source
intraparietal
lobule
mid-occipito-temporal
MOTG
Mu-sources
localize
Mu-activity
motor-system
social-function
opioid-dependent
CURE
PCI-CURE
Funding
Costing
Alberta
Mix
Saskatchewan
20,000
0.975
0.904
reimbursed
Tranexamic
Transfusions
pre-discharge
Post-Discharge
ipw
demonstrably
participates
Psychiatrie-Zentrum
Hard
Embrach
Klinik
Schlosstal
Winterthur
intervenes
coordinating
ISRCTN58280620
Thoracoscopic
video-assisted
trapped
Video-assisted
dirty
ORC
SSI
soaked
suturing
swab
racial/ethnic
miscommunication
redress
rehearse
dialog
bronchoprotective
salmeterol/fluticasone
allergene
50/250
Diskus
age+/-SD
31.3+/-11.0
EAR
MaxDeltaFEV1
computing
felodipine
Rapeseed
turkeys
digestibilities
killing
Ileal
Killing
leaflet
OPTIMA
Morisky
EuroQoL
745
n=366
n=379
62.7
P=0.22
EQ
Physiotherapy
physiotherapists
non-therapeutic
51/73
43/73
48/67
33/67
spouses-caregivers
Random-effects
20-37
AnKang
36-item
Duraflo
uncoated
0.058
Material-independent
blood-air
cardiotomy
32/98
Cladribine
CDA
64-88
54-80
leukocytopenia
Rosiglitazone
clozapine-treated
receptor-γ
PPAR-γ
4mg/day
Scale-III
Hopkins
HVLT
Sorting
WCST
offenders
OST
program-based
community-supervised
jail
diversion
Participation
post-participation
Specialty
-.24
offender
SCIENTIFIC
co-morbidity
caregiver-based
alpha-interferon
title
Contents
tracing
sprouting
neurorrhaphy
double-labelling
axons
end-to-end
coaptation
tracers
diamidino
yellow
ends
single-labelled
dual-labelled
Empathy
empathy
9-item
TES
attunement
315
Martino
.91
.94
single-factor
Discriminant
MI-inconsistent
-.33
End-expiratory
recovers
suctioning
derecruitment
postsuctioning
Conflicting
EELV
postsuction
postcardiac
Oximetry
alveoli/fraction
-905
-1234
-587
counterintuitively
industrialized
probiotic-supplemented
lactis
Bb-12
hydrolysed
cytokines/chemokines
methyl-histamine
SCORAD
7-25
unsupplemented
12.27
0-3.8
0.1-8.7
4.5-18.2
pharmacotherapies
MA-dependent
Seeking
residential-based
20-day
clomiphene-citrate-resistant
Dhaka
CC-resistant
P-value
89.09
54.55
74.55
29.09
27.27
ovulation-inducing
naphcon
Lasik
Naphcon
postgraduate
bedside-precepted
specialization
workshop-only
enriched-model
daylong
zonegran
ZNS
Fahn-Tolosa-Marin
FTM
CGI-C
subsections
Tremor
-0.50
paresthesias
16.0-16.9
18.0-18.9
HP-hMG
n=227
n=207
periapical
Weibull
re-open
NCT00887952
low-affinity
AR-R15896AR
N-Methyl-D-Aspartate
NIHSS
GCT
GTT
non-blind
736
Carpenter-Coustan
24-28
negatives
25/486
15/248
27/238
0.623
0.792
Sensitivities
47.17
68.18
87.1
Specificities
77.37
20.33
92.29
SIDS
Swallowing
Polygraphic
quiet
/=10
swallows/min
-9.6
Multidose
cold-recombinant
TCID50/dose
A/Kawasaki/9/86
A/Los
Angeles/2/87
H3N2
B/Yamagata/16/88
H3
amnestic
calendar/notebook
MSS
notebook/calendar
calendars
Ginko
T.D.
Tolidaru
T.D
Incidents
Cys
LT1
MK-571
8-24
allergen-induced
Dicang
Jiache
Yangbai
shallow
Heel
heels
waves/session
mJ/mm2
Mometasone
LAVH
Paolo
Milan
Conversions
0/20
sizofiran
SPG
Schizophyllum
commune
Fries
sizofiran-administered
21.426
9.262
6.507
9.345
laparoendoscopic
LESS-DN
LDN
postdonation
recovery/satisfaction
living-unrelated
hand-assist
Recipient
LESS
Contingency
antipsychotic-induced
SMI
rewards
payment
Abbreviated
Parent-Teacher
Anger
Deviance
downtimes
stood
frequency=28
enjoyed
hernioplasty
hernioplasties
prolene
Cooper
0.0081
herniotomies
conventionel
face-matching
house-matching
fusiform
prerequisites
Alvimopan
ileus
alvimopan
mu-opioid
PAM-OR
opioid-based
GI-2
DCO
NNTs
enteral-tube
2115
enterally
five-day
pedicled
multi-dose
lymphadenopathy
GMTG
MM01
TRS
2M
Bence
Durie/Salmon
150,000
extravasation
Self-adhesive
Headaches
Yes-associated
YAP1
oncogene
1107
WST-1
luciferase
ERE
siRNAs
ER+
ER-
proliferating
physiotherapist-directed
mobilisation-only
mobilisation-plus-deep
non-deep
-22
NIPPV
mini-ventilator
Unpacking
clarity
correctness
Attitude
persuasion
distinctness
knows
antecedents
counterattitudinal
Metronidazole
underestimate
spirochetes
BANA
Leukocyte-depleted
Leukocyte-mediated
leukocyte-depleted
phosphokinase-MB
EU/min
units/min
Thromboxane
pg/min
Safe
expand
crossmatching
MEDLARS
MeSH
heading
1966
Spanish
languages
bibliographies
1880
citations
Articles
5198
5402
Unadjusted
0.22-1.09
0.31-1.17
sustained-
0.49-4.03
0.59-3.32
0.03-0.65
beta-pregnanolone
theaters
oscillometric
bioimpedance
calciferol
halisteretic
crush
four-stage
infirmity
field-based
CODS
team-sport
4-min
straight-line
FST
BST
RSA-SS
CODS-SS
CODS-CON
humeral
PEMF
thermographic
Imitation
dexibuprofen
-ibuprofen
cefdinir
test-of-cure
114/142
100/139
parainfluenzae
AMPA-sensitive
5.85
-11.90
3.79
-5.15
6.017
bromazepam
executing
Br6
Fp1
Fp2
F7
F8
CZ
FP1
electrocortical
Stereotactic
SBRT
40Gy
V20
V30
V40
dosimetric
protons
photon-based
2.5cm
364.0cm
160.0cm
144.6cm
77.0cm
V35
93.9cm
57.9cm
66.5cm
45.4cm
0.0112
5.9Gy
3.8Gy
photons
standpoint
postacute
qualify
billing
Nationwide
Split-sample
survey-logistic
hyperpathia
pre-infusion
Rank
enjoyment
L1210
lipoceutical
3-13
taurine
transsulfuration
r-hGH
discontinuous
growth-retarded
TOTO
TTOO
Height
HV-SDSCA
Interruption
H-SDSCA
01
10-J
reconfirmation
DFT++
702
PDE
DAPT
vasodilator-stimulated
phosphoprotein
transmittance
Accumetric
P2Y
Intra-group
Simulating
amnesics
simulating
memory-impaired
feign
honestly
brain-injured
coin-in-the-hand
autobiographical
misclassifying
malingerers
gravid
7.31
7.21
glucose-infused
non-glucose
Confounding
threonine
Thr
Eimeria
Thr-deficient
Thr/kg
sand
high-methoxy
pectin
hatch
posthatch
sporulated
schizonts
pectin-fed
ceca
heaviest
tonsils
pectin-containing
Ninety-one
bulimic
psychopathologies
pamphlets
BENEFIT-EXT
LTE
PTLD
Abrasive
acid-eroded
A-F
intraoral
erosive/abrasive
extraorally
immersing
Dunnett
A-D
Adult-Driven
adult-directed
K+
SO4=
parturition
milliequivalents
meq
monozygotic
+572.5
rations
KCl
K2SO4
NH4
2SO4
K2CO3
hypocalcaemia
areata
dinitrochlorobenzene
croton
regrowth
regrew
mutagenicity
prisoners
Extended-release
XR-NTX
unexamined
justice
CJS
prison
Medication-assisted
electro
robotics
weight-supported
dose-matched
Limb
Capacity
SULCS
Intrinsic
Motivation
interest/enjoyment
Intravenously
velocimetry
Subfoveal
subfoveolar
Calculated
Sustaining
Côte
d'Ivoire
SCORE
Schistosomiasis
parasitic
tropics
subtropics
evidence-base
multi-country
Operational
provinces
12,110
13-14
Kato-Katz
village
social-ecological
ISRCTN99401114
Laugeson
:596-606
years-old
get-togethers
pre-to
post-PEERS
empirically-supported
mayo
Telemedicine
rural-metropolitan
Digital
Camera
STRokE
DOC
telephone-only
California-based
TIME
single-hub
multirural
telestroke
2-spoke
site-independent
hemorrhages
aborted
multispoke
consultative
Kata
Stereotypy
42.54
martial
Androgen
musculoskeletal-related
Multi-site
Perth
resistance/impact
resistance/cardiovascular
care/delayed
ACTRN12609000200280
INVESTIGATION
ultrashort-acting
esmolol-treated
Disclosure
HSV-2
ELISA-positive
WB
orphans
orphan
Kalon
indeterminates
virginity
WB-confirmed
positives
deciding
NCT01501864
Position
capsulorhexis
opacification
61-86
SI40NB
AcrySof
MA60BM
EPCO
retroillumination
optics
0.0014
IOLs
rhexis
round-edged
sharp-edged
hydrophobic
micrograms.kg-1.min-1
mg/min
Shenmen
IRB
Hiser
preoperation
postoperation
contration
exhaust
neuroendocrinological
characterizes
participants/study
19-54
800-1,000
medium-fat
medium-calorie
70-78
62-69
Macrovascular
'Sweet
Talk
text-messaging
twenty-six
Sweet
Glycaemic
p=0.053
Investigating
Vocabularies
vocabularies
augmentative
repertoires
phonotactic
multiple-probe
spoken-word
vocal/verbal
untaught
bulbospinal
single-joint
multi-joint
head/neck/trunk/extremity
constituents
Judy
Wagner
metatarsal
amputate
NCT00621608
salt-sensitive
5.81
909
Dronabinol
dronabinol
palliating
calories/kg
acetate-treated
dronabinol-treated
Anorexia/Cachexia
anorexia-related
combination-treated
Uniscale
58-55-9
Bronchoretard
Capsules/R
tablespoonful
apple
sauce
100-300
Cav
peak-trough
AUCss
concentration/time
Translating
underresourced
antihypertension
130/78
ISI
ms.
Electromyographic
brachii
=modification
step-tracking
AG1
ANT
Benign
Prostatic
Hyperplasia
ng./ml
cytotoxicity-effects
cisplatin-5-fluorouracil
N2C
irradiation+/-surgery
RESPONSE
48/74
54-75
47-67
36/80
35-56
32-52
neutropenias
P=0.00015
2+3
Mobitz
climb
flights
stairs
89803
Alterations
RAS-RAF-MAP2K
MEK
-MAPK
MSI
c.1799T
p.V600E
FU/LV
CPT11
BRAF-mutated
1.05-2.63
MSI-high
0.25-1.10
0.72-1.46
Physostigmine
unconsciousness
Steady
ASSR
electrooculogram
Unconsciousness
microV
55.7
physostigmine-induced
post-dural
arborescens
pro-oxidant-antioxidant
Biostimine
Rowing
2,000-meter-maximum
camp
antecubital
TBARS
TAC
Magnocellular
Everyone
high-scoring
low-scoring
magnocellular
scorers
parvocellular
High-scoring
Navon
cross-validated
psychophysically
visual/prestriate
diminishes
epinephrine-free
epinephrine-containing
felypressin
Kesho
Bora
low-resource
Burkina
Faso
28-36
lopinavir
6·5
partum
0·6
breastfed
AIDS-free
ISRCTN71468401
882
liveborn
3·3
1·9-5·6
3·3-7·7
5·4
3·6-8·1
9·5
7·0-12·9
p=0·029
10·2
7·6-13·6
16·0
12·7-20·0
p=0·017
declared
3·4-8·9
10·7
7·6-14·8
Agence
nationale
recherches
sur
le
sida
les
hépatites
virales
Developing
Countries
Thrasher
Fund
Directorate
Cooperation
Eunice
Kennedy
Shriver
UNDP/UNFPA/World
Bank/WHO
21st
sequesters
Hypericum
hypericum
B-L
Typical
Hepatorenal
wedged
paracentesis
azelastine
azelastine-fluticasone
single-delivery
cedar
nostril
TNSS
itchy
NCT00660517
Oxidized
Regenerated
Reduces
Amount
Drainage
resection-related
debit
406.9
308.1
627.0
301.6
AZ
anti-tachycardia
shock-terminated
cardioversion/defibrillation
inducible
monomorphic
VT.
AZ-treated
patient-year
TOMBOLA
2166
20-59
Programmes
6-monthly
'on-time
≤6
'late
'non-attendees
non-attendance
post-secondary
9.65
6.60-16.62
Non-attendance
Tackling
underpinning
Sialyl
Lewisa
sialyl
Lewis
metastasizing
preponderance
'theory
Hypotheses
NTR2327
Cone
endocervical
Colposcopy
Infirmary
Kevorkian
Medscand
Endocervical
Transitions
cocaine-abusing
reestablishing
abstinent-contingent
DT+
toxicologies
self-stimulatory
clinic-directed
parent-directed
Lovaas
McEachin
abrasions
forearms
glistening
punctuate
plasters
Visible
Superficial
DECLARATION
INTEREST
Beiersdorf
CHART
Locoregional
Tumours
affectivity
ionomer-lined
liner
wall-lesion
ionomer
copal
thermocycled
acid-gel
cavosurface
Pharmacokinetic-
metabolizers
PMs
EM
pharmacokinetic-pharmacodynamic
eo
gastrin-time
Rabeprazole-based
SATOS
PGY
23-step
PGY-3
PGY-4
PGY-5
differentiable
expose
residency
Carbenicillin-trimethoprim/sulfamethoxazole
carbenicillin-gentamicin
C-T/S
C-G
favorable-prognosis
unfavorable-prognosis
Over-all
mwithin
Manetl-Naenszel
Problem-based
casualty
True/False
penalty
Papers
chemo-
glutathion
antigen-negative
CHB
HBeAg-negative
deoxyribonucleic
or=2
9/13
Pharmacological
endotoxicosis
cytoflavin
1-13
F-test
Rye
elevates
ferulic
Ferulic
Firstly
wheat
breads
hydroxycinnamic
JATOS
65-85
n=2,212
n=2,206
efonidipine
strict-treatment
mild-treatment
135.9/74.8
145.6/78.1
p=0.99
p=0.22
Amisulpride
benzamides
hints
TQ
RMT
intra-cortical
near-significantly
colposcopic
551
436
3'-dehydro-lutein
all-E-Zeaxanthin
mol/L
dose-normalized
all-E-zeaxanthin
the10-mg
all-E-3-'dehydro-lutein
beadlets
all-E-3-dehydro-lutein
Ca/Mg
ACC
CAIRO2
oxaliplatin-related
carcinomatosis
0.707
0.520
extraperitoneal
IB-IIB
TPL
EPL
LPL
30th
60th
63+/-7.6
54+/-6.7
75+/-8.4
P=ns
5.6+/-0.9
3.2+/-0.4
3.1+/-0.3
Jamaican
seminaturalistic
0-124
echolalia
rho
Volumatic
44.5
Dysthymia
dysthymic
intimacy
husband
Tirofiban
ReoPro
Give
TARGET
abciximab
small-molecule
4809
tirofiban
n=1117
P=0.056
n=560
n=557
P=0.540
P=0.610
0.366
0.436
non-glycoprotein
transvaginally
FSH-primed
TCM-199
Suitable
92/156
non-primed
36/81
0/12
implantations
abortions
harvesting
cleaved
rheopheresis
MIRA-1
Rheopheresis
placebo-control
nonexudative
0.213
.977
Excluding
GOAL
54/109
imiquimod-treated
11/100
Bovine
heterografts
polytetrafluoroethylene
BCAH
PTFE
salvageability
BCAHs
Albuterol
24-hours
T-Test
exacerbations/year
lts
shear-induced
annoying
cyclooxygenase
Thrombostat
arteriole
Prostaglandins
PGs
E-type
vasodilators
PGEs
antiulcer
vasodilative
Cemented
CeraOne
porcelain
fused
TiAdapt
abutment
noncemented
baked
custom-made
abutments
Nobel
Biocare
Göteborg
Brånemark
cement/enamel
2.5-10.0
Implants
apically
coronally
Occasionally
one-piece
household/occupational
proliferator
vasculoprotective
forty-three
duration/arm
NMD
RHI
28-Joint
Count
DAS-28
NCT00554853
terbutaline
beta2-adrenergic
TP
0.15-0.40
0.04-0.15
LF/HF
Perspectives
Indicator
Tunnel
MTT
pinch-holding-up
PHUA
2PD
Semmes-Weinstein
monofilament
SWM
CTS
pinch
sensibility
post-operation
depression-related
converse
spanned
Study-Short
Bodily
helper/suppressor
Controlled-release
singly
moderate-to-large
63.38
84.62
hEGF
cetraxate
CH
prospected
EGF
67/86
45/87
anticuler
mEGF
hydroxypropyl
HPC
uninsured
safety-net
Navigation
993
no-navigation
628
BIRADS
navigated
4/5
0.0017
Expected
scrotal
subinguinal
antegrade
varicocele
varicocelectomy
Ivanissevich
Tauber
Selection
sonographic
regurge
13.73
Hydrocele
Large-dose
carboxymaltose
large-dose
or=1000
12.2-28.3
replenishing
25.4-32.5
26.6-33.4
26.7-31.1
29-30
O2-
propulsion
wheelchair
rim
able-bodied
post-tests
stationary
Push
double-looping
single-looping
Reporting
WCRS
3,585
rosters
control/chemoprevention
Ao
Sat
28.61
39.40
10.80
PA/Ao
26.30
28.49
10.93
nonweight-bearing
NWB
Kinesiology
N=106
extension-flexion
reposition
Equally
non-randomising
oxide-fentanyl
oxide-sevoflurane
PK-PD
N2O/O2-fentanyl
N2O/O2-sevoflurane
electrochemical
HPLC-EC
sigmoidal
EC50
constants
e0
Disposition
N2O-fentanyl
N2O-sevoflurane
tubercle-trochlear
groove
patellar
TT-TG
malalignment
interchangeable
fellowship-trained
Interobserver
intermethod
8.3-25.8
1.5-25.1
0.777
0.843
0.532
0.539
realignment
tubercle
19.8-25.8
14.4-22.8
3.80
Confidential
rights
legislation
safeguards
dignity
speak
overhead
hear
overheard
brand-name
n-of-1
Coumadin
Apo-warfarin
Inter-
intrapatient
birthweights
selumetinib
uveal
Uveal
GNAQ
GNA11
non-adenosine
MEK1
MEK2
temozolomide
120-patient
safety/toxicity
4.3-8.4
4.3-16
8.4-21.1
8.1-25.3
0.30-0.71
6.1-11.1
9.8-15.7
0.41-1.06
Treatment-related
hypothesis-generating
NCT01143402
ICP
CBF
dura
subdurally
22-gauge
canula
AVDO2
indomethacin/placebo
lactate/oxygen
tightness
hypocapnia
normocapnic
Enjoyment
physical-activity
N=12
4044
2087
1038
1049
thermoablation
multifibre
yttrium-aluminium-garnet
expandable
postablation
3.08
7.99
unpublished
fidgety
Elastic
midshaft
clavicular
fractures-a
ESIN
sling
MEASUREMENT
protrusion
Clavicular
Scandinavian-Polish
Chlorthalidone
897
county
815
advisor
letter/brochure
STD
0.221
post-anesthetic
multi-factorial
antidopaminergics
phenothiazines
8-to-24-hour
pigmentosa
nonuse
30-Hz
electroretinogram
=.05
=0.20
medialis
ACLR
Diminished
motorneuron
VM
SOL
H-reflexes
hamsting
bone-patellar
tendon-bone
BTB
girth
mid-patella
718,409
NHIRD
519,831
IRs
case-number
‰/y
0.06‰/y
10.04
7.58-13.30
5.03-10.01
5.46
2.26-13.18
1.02-3.52
0.44-0.65
0.44-0.66
three-time
age=38.0
SD=9.9
paper-and-pencil
Perception
17-valerate
seborrhoeic
Seborrhoeic
propionate/salmeterol
fluticasone/salmeterol
FSC
250/50
TIO
≤0.70
DISKUS
NCT00784550
TTM
SETTINGS/LOCATION
Diary
inattention-passivity
Lead-time
lead-time
56,294
92,142
7.9-8.4
50-64
4.6-6.0
5.4-6.4
Overdiagnosis
non-progressive
DESCRIPTION
lifestyles
AML10
1-hour/wk
fosters
child-centered
embeds
alliances
intensive-treatment
HLACs
high-accruing
HHACs
lobectomy
tented
12.46
leva
3840
5160
3890
neuroendocrineimmune
attributions
coined
trivializes
Name
appointed
Coordinating
umbrella
CNDS
sub-types
PAs
sounding
chemohormonal
bulk
E3186
ER-unknown
¿CAF
CAF
Halotestin
¿fluoxymesterone
Pharmacia-Upjohn
Kalamazoo
¿CAFTH
CAFTH
=.99
=.087
=.048
casein-controlled
45-65
equinitrogenous
portal-systemic
61-92
Casein-treated
acid-treated
Dairy
1-y
2200
1000-1100
1300-1400
thirty-five
742.4
321.5
1026.4
311.3
1131.29
337.2
medium-dairy
high-dairy
DESIGN/SETTING
trial/tertiary-care
tachyarrhythmia
6,869
4,019
13,164
6,740
9,204
9,217
3,784
4,944
16,073
9,423
16,949
7,174
Austrain
PRISMA
500mg
3046
253.38
fulfil
Yizhi
Jiannao
Granules
Dazhui
Guanyuan
Aricept
dating
rump
uncompleted
crown-rump
EDD
LMP
no-scan
abandoned
0.59-2.07
Acknowledging
somatostatin/somatomedine
enfeebled
rhGH
IU/m2
LVM
MWC
rhGH-treated
B-Hb
Irregular
Obeticholic
Biliary
Cholangitis
cholangitis
ursodiol
Alkaline
farnesoid
obeticholic
5-10-mg
-113
μmol
Intercept
POISE
NCT01473524
ISRCTN89514817
colestimide
5.07
Ablative
External
Amsterdam
recursive
RPA
ES-NSCLC
SABR
703
RPA-selected
datasets
0.52-0.60
RPA-identified
individualize
Thrombocytopenia
bypass-induced
oxygenator
platelet-leukocyte
Platelets
Ib
platelet-derived
CD11b/CD18
Mac-1
receptor-activating
peptide-induced
microparticle
aggregative
trios
Two-factor
postinfusion
teacher-report
C21
progestogen
mid-range
CEE
7-hexanoyltaxol-eluting
COmpare
REstenosis
QueST
QuaDS-QP2
stent-based
7-hexanoyltaxol
QP2
-eluting
qDES
bare
tightest
stent-vessel
malapposition
thickenings
IFT
Single-blind
self-referral
Book
3.85
RMDQ
.030
LBP-specific
L3-4
t-
Identify
warn
CGM-derived
horizon
CGM-measured
Fibroblast
FGF23
shares
subfamily
654
4,212
1,411-13,816
RU/ml
-6.46
-4.73
-2.14
1.06-2.20
pegged
screw-fixed
Lasting
radiostereometric
high-porosity
low-porosity
fiber-metal
Ti
backings
pre-study
hexagonal
Stereo
single-direction
regained
Troponin
TnT
1.02-1.10
1.12-9.73
1.04-5.61
Majority
consulted
ciclesonide
Ciclesonide
502
grains/m
+/-500
0.175
27-29
high-dose-
high-versus
Acetylsalicylic
14C-serotonin
ecASA
cASA
salicyclic
incubating
MDMA-assisted
3,4-methylenedioxymethamphetamine
-assisted
SAEs
non-life
1133
expedited
catalyzes
openness
introspection
mitigates
risk/benefit
Reflexive
non-social
disregard
uncued
Typically
import
countermeasures
Root
devising
rotating
non-BL
00
day-shift
misses
night-shift
MCIC
PI-NRS
QBPDS
policymakers
442
operant
GPE
interpretability
irresectable
dearterialization
SUMS
Lund
HPB
Affiliated
Feb.
RTD
oxygen-derived
polliative
allostatic
Allostatic
SRH
poliomyelitis
Poliomyelitis
Diploid
month-old
Jiangsu
OPV
HDC
neutralization
98.28
99.45
95.71
1:1243.72
1:234.38
1:273.10
Green
banana-supplemented
banana
2968
Wards
diarrhoeal
village-based
0.56-0.67
0.26-0.59
79.9
0.41-0.55
0.22-0.46
79.8
0.23-0.73
67.2
0.08-0.54
Comorbidity
cetuximab-treated
ACRC
CO.17
non-neutropenic
restricting
fee-based
Arsenic
HELM
fee
wells
purchased
judo
national-ranked
6.95
12.61
11.53
17.02
10.53
16.81
moderation
AX
AX-CPT
BX
propranolol/placebo
AY
bereaved
non-bereaved
Study-trained
guideline-concordant
Bereavement
Louisville
HDRS
≤7
vitro/in
Perindopril
erbumine
Biopharmaceutics
converts
heptapeptide
F3-coded
98.03
45th
cross-designed
peroral
Perindoprilat
perindoprilat
105.946
100.218-112.002
110.437
102.534-118.948
109.542
98.364-121.992
115.729
101.031-132.565
Pulmicort®
nebulised
collapsed
re-expansion
ml.cmH
interleukin-1β
alanyl-glutamine
CD14
PlayWisely
CARS2
M-CHAT
Yellow
Sets
Purple
Blue
phonemic
Everolimus
subependymal
tuberous
EXIST-1
SEGA
Article
4·5
SEGAs
NCT00789828
29·3
19·4-33·8
28·3
19·3-33·0
39·0-58·3
2·1
Stomatitis
stabilisation
4-year-old
Health-education
Soil-transmitted
Linxiang
Hunan
worms
soil-transmitted
1718
health-education
cartoon
poster
hand-washing
UBS
Optimus
Zurich
ACTRN12610000048088
bedded
nonpathological
DA-supported
1,105
kcal/24
259-440
mid-arm
Dietetic
linagliptin
Linagliptin
saturable
PK/DPP-4
FOCE
INTERACTION
concentration-
inhibition-
Nonlinear
2-compartment
concentration-dependent
model-predicted
occupancy
84.2
≥80
target-mediated
Simulations
arthrotomy
inferolateral
stab
number-11
superomedial
inferomedial
mL/sec
extravasated
arthrotomies
64.0
1-cm
effect-site
target-controlled
Nothing
Measured
additively
awaits
subfascial
perforating
SEPS
fasciotomy
CEAP
413
C6
31/2
Uniformity
senior
preceptorship
theater
incompetent
months-2
Repeat
paradysthesia
embolus
Wheelchair
community-living
70y
WSTP
Scale-Manual
WheelCon-M
1-way
F1,17=10.9
P=.004
η
=.39
maneuvering
behaving
Ashworth
TTT
0.365
denopamine
beta-stimulant
Symptom-limited
ml/min/kg
Denopamine
videophone
back-channel
jokes
Compliments
closed-ended
trade-offs
complexities
EDICT
Salm/FP
Bud
Form+Bud
1000-1600
50-85
inhaleror
12+800
Turbuhalers
asthma-related
PEFam
PEFpm
0.472
0.735
'live-in
Carpenter
Coustan
cephalopelvic
disproportion
macrosomia
OR=3.90
CI:1.95-
7.84
OR=2.92
CI:1.56-5.46
Atrioesophageal
ulcerations
ESUL
esophagoscopy
2:1:1-randomization
CONTROL
Watt
5/175
open-irrigated
I.V
1,085
cyclophosphamide-
nausea-
ondonsetron
Ipilimumab
HLA
antigen-4
ipilimumab
class-I
HLA-A*0201-positive
HLA-A*0201-restricted
gp100
HLA-A*0201
7.4-11.5
HLA-A*0201-negative
9.3-15.1
8.0-13.8
Ipilimumab-induced
immune-related
ipilimumab-treated
LV5FU2-irinotecan
LV5FU2-cisplatin
imputation
GHS
irinotecan-based-therapy
PROMISE
postulate
1,068
hypomagnesemia
Hypomagnesemia
hypermagnesemia
counterirritation
DNICs
Aδ
μg·kg
·min
RIII
sural
hyperpnea
adenosine-induced
fueling
leishmanial
promastigotes
leprae
MLSA
Leishmania
mexicana
LV4
leishmanin
skin-test
Vaccinees
bled
Anti-BCG
anti-PPD
anti-MLSA
tuberculosis/Mycobacterium
bovis-related
leprae-related
non-BCG-vaccinated
Venezuelan
non-endemic
anti-mycobacterial
anti-leishmanial
'low-responder
exacerbatory
TH2-associated
Erythropoiesis
r-HuEPO
sideropenic
/=110
r-Hu
176.3+/-90.8
268.4+/-79.4
22.3+/-2.0
14.1+/-2.7
phosphodiesterase-4
cilomilast
Ariflo
Cilomilast
Interleukin-8
CD68+
Phosphodiesterase-4
vector-parasite
microfilaraemia
Papua
Guinea
hydroceles
Mosquitoes
landing
infectiveness
2219
2534
Microfilarial
community-specific
0.0047
26,641
punctulatus
person-nights
catches
third-stage
larvae
75.7
combined-therapy
Transmission
Hoe
069
recommendable
NSC-63878
synchronization
NSC-67574
NSC-10023
NSC-109229
Cytosine
synchronize
Disturbances
truncal
adipocyte
hyperinsulinaemia/insulin
SHBG
MRC-ALL97/99
2.6-13
nonanterior
PTCA-treated
+Be
neutrons
RBE
donor-site
vascularized
reconstruct
Fibula
scapula
osseocutaneous
Troublesome
spiral
bone-graft
tibiae
radii
beveled
rounded
incisura
one-diameter
two-diameter
3c
three-diameter
four-diameter
CD38
rs3796863
Homozygotic
homozygotic
makeup
SANICS
dampens
selfmigrating
nasojejunal
tubing
Clavien-Dindo
dampen
NCT02175979
NTR4670
ALVAC-CEA/B7.1
ALVAC-CEA/B7.1-induced
ALVAC
anti-CEA
CEA-specific
osteopontin
malignancy-associated
667
MA.14
Mammary.14
2,540
1,852
non-bone
NCT00002864
//clinicaltrials.gov/show/NCT00002864
Coenzyme
CoQ
cardiocirculatory
59+/-9
37+/-7
EDDBA
SWTI
amplifies
test-dose
Speilberger
Trait
essence
exemplary
factor-kappaB
interleukin-1beta
calcium/vitamin
D-treated
1.
neuroleptanalgesia
3.
carbohydrate-containing
adult-type
TIG
Antitoxin
Titers
9.91
veterans
lower-level
sarcasm
deception
d=1.0
iodixanol
iohexol
urograms
dimeric
gI
Iodixanol
Iohexol
Malmö
6,956
47-49-year-old
life-style
check-ups
2.3-3.7
0.5-1.7
non-intervened
ml.min-1.kg-1
10-14
thrombogenesis
dipyridamole+ASA
collagen-coated
parallel-plate
2600
immunoenzymatic
63.9+/-5.9
18.4+/-5.6
49-79
64.9+/-4.8
18.3+/-9.7
45-67
serums
entecavir
rituximab-associated
rituximab-based
ETV
Undetectable
reactivation-free
Xuanju
prostatitis
Compound
Tamsulosin
Hydrochloride
Quinolinone
NIH-CPSI
77.69
94/121
71.56
78/109
47.10
57/121
31.78
34/107
Removing
bee
stings
honey-bee
sting
scraped
pinched
venom
envenomisation
Weal
emphasise
pre-release
Imprisonment
re-entry
releasees
BCM
prison-administered
SOC
inmates
post-release
24-90.7
4.07
3.20
re-incarceration
books
noneducational
no-book
-.30
putting
hassle
installing
latches
cabinets
Dopamine
moderates
deficit/hyperactivity
SCL6A3/DAT1
DAT1
10-repeat
moderator
.57
gastroprotection
pylori-negative
ibuprofen-arginate
mg/6
Endoscopies
COX-1
Ibuprofen-arginate
18-23
caregiver-report
menstruated
oestradiol-17
atrophied
oestradiol-progestogen
BPPV
/=70
Quitting
LITE
Oulu
SCID-I
Anhedonia
0.8-11.6
p=0.091
1.1-38.2
p=0.038
MF101
split-course
adrenocarcinoma
Split-course
spares
futile
biomodulation
IFO
2-hr
Mesna
1-38
1-49
1-43
galantamine
9-hydroxyrisperidone
Galantamine
orgalantamine
third-party
Antigen
pre-transplantation
transfusion-induced
anti-idiotypic
Anti-HLA
Anti-idiotypic
anti-HLA
2-Chloroprocaine
LEA
post-cesarean
Epi
micrograms.ml-1
Lido
Chi-squared
2-CP+Epi
Lido+Epi
33.1.5
Focal
styrene
maleic
neocarzinostatin
carcinostatic
TAI
Lipiodol
chills
aminotransferases
3/18
8/17
1/13
beachchair
hypoperfusion
room-air
Phenylephrine
ureter
Reich
paracervical
confidently
desiccated
uterosacral
PRN
mg/2.5
N=39
-every
N=34
N=40
opioid-related
Scheduled
Tetracaine/adrenaline/cocaine
0.3219
0.0203
E9486
CD19+
clonotypic
rearrangements
E9487
CD19
allele-specific
oligonucleotide-polymerase
.033
125/microL
beta2-microglobulin
plasmablastic
Mineralocorticoid-receptor
3445
1723
hyperkalemia
gammaglobulin
gammaglobulins
dose-assessing
Out-patient
305
infection/infusion
N/S
infection-free
TSF
re-interviewed
ANCOVAs
Clients
manually-guided
37-39
donor-recipient
pro-tolerogenic
sirolimus/tacrolimus
methotrexate/tacrolimus
27-60
29-63
Sirolimus/tacrolimus
821
P=0.78
H1-receptor
prechallenge
no-show
Swenson
Pekarik
acceptance-enhanced
∼48
∼52
∼67
Phase-dependent
rhythmical
swung
reciprocally
conditioning-testing
overlapped
Activator
AP-1
implicate
phospho-c-Jun
biobank
hs-CRP
non-diseased
borderline-significant
μg/ml
HBe
antigen-positive
icteric
writer
cramp
representational
corporeal
inanimate
handwriting
Videos
'pre-dark
'dark
clicking
bar
keyboard
purely
non-motor
Microban
Toothbrushes
air-dried
Toothbrush
heads
vortexed
Pg
Aa
plates
incubated
matched-pairs
39/50
parenterally-fed
insulin/kg
weight/24
Pre-operatively
9-h
15N-glycine
end-product
diethylamine
DDEA
4x/day
pain-on-movement
POM
pain-at-rest
NDI
over-the-counter
NCT01335724
amnioinfusion
oligohydramnios
post-dates
amniotic
room-temperature
decelerations
gestations
Adoption
6:468-478
Adamson
39:84-96
mastered
isoflurane-nitrous
-nitrous
controller
1077
Optic
Neuritis
-56
pool-derived
IVRT
PAP
derivation
imaging-derived
IVRTs
regurgitation-derived
nonrecordable
surfactant
Biofilms
self-produced
surfactant-containing
septoplasty
48th
72th
96th
Surfactant-containing
alpha-metabolism
finasteride-treated
pseudohermaphrodites
inherited
alpha-reductase
MPHs
C19
alpha-reduction
ambiguous
alpha-steroid
strikingly
Catheterization
ESCAPE
index/cardiac
index/output
Prazosin
polythiazide
prazosin-treated
captopril-treated
L-5-HTP
10.38
rhNGF
neurotrophic
1019
515
Limbs
CASE
PBQ
418
461
pain/hyperalgesia
=.25
Exceptions
JAMA
284:2215-2221
Metal
Metal-on-metal
MOM
reintroduced
metal-on-polyethylene
MOP
nano-size
51-64
ReCap
arthoplasty
Mallory
Head/Exeter
Spot
inductively
plasma-sector
55-60
cartoon-based
hostile
illustrations
collaborations
stakeholders
bullying
3920
Indobufen
lengthen
Translucency
zirconia
copings
PROBLEM
Zirconia
translucent
disilicate
alumina
zirconia-based
translucency
complete-crown
ZrO
ZirCAD
YZ
Procera
AllZircon
Digizon
Zircon
Cercon
Base
glass-ceramic
Press
milling
40-mum
photoradiometer
150-W
halogen
lamp
alpha=.05
3.572
018
lx
3.181
63.9
4.98
uninterrupted
72.6/27.4
77.9/22.1
2.13
Nm/kg
watt.min.kg-1
Partial-area
Regulatory
authorities
noncomplicated
erroneous
lieu
logic
robustness
partial-area
5h
single-point
brain-damaged
individual-subject
scrambling
reconciling
jaws
maxillas
and/
mandibles
MPQ-DLV
killers
HRQOLI-instrument
Materialise
Mucosa
flapped
shivering-like
thermoregulatory
nonthermoregulatory
clonus
hemi-body
cytopoenias
35-294
61-241
26-160
2-33.5
worksite
621
Functioning
child-
NVIQ
play-based
separable
09/10
delineation
DR-based
delineated
dose-volume
histogram
DVH
3-dimensional
3D-CRT
VMAT
79.3
DR.
acquaintance
Limiting
regaining
Low-fluence
chorioretinopathy
CSC
68.8
hyperpermeability
supraglotttic
paramedics
Ensuring
ILMA
Intavent
Buckinghamshire
Cobra
Engineered
Indianapolis
Supraglottic
Laryngopharyngeal
SALT
ECOLAB
Paul
Air-Q
Clearwater
40.46
4.64
33.96
6.23
49.23
13.19
autism-spectrum
one-back
semi-automatic
volumetry
Accurate
Nodule
semi-automated
packages
VDT
NELSON
12.0-436.6
Software
gamma-secretase
Amyloid
Abeta
LY450139
1-X
20-mg
myometrial
salpingo-oophorectomy
radium
stump
gestonorone
alpha-hydroxy-19-norpregn-4-en
dione
adjuvant-treated
82.8
undifferentiated
Naftidrofuryl
ethanol-induced
ICG
glutamyl
transpeptidase
lentigines
Post-inflammatory
hydroquinone
dorsum
Melanin
lentigo
narrowband
spectrophotometer
Lentigines
Cognitive-behavioral
psychogenic
nonepileptic
PNES
video-EEG
PNES/month
3.125
Yufeining
TCC
DCCs
5.216
2.914
4.222
2.140
terazosin
Terazosin
1-adrenergic
1180
methyclothiazide
Fulvestrant
third-generation
0-66.9
74.5
76.1
0.84-1.15
0.809
0.0234
hypogonadal
ng/dl
1:1:3
mg/twice
equalling
no.=10
mg/12
no.=32
free-
Aging
HOMA-index
medium-high
homeopathic
Galphimia
D6
pollinosis
1:10
decimal
homeopathically
Inhibin
Inhibins
glycoproteins
alpha-subunit
INH-α
beta-subunits
βA
βB
α-βA
p=0.744
amenorrhoea
25-mg
mg/hr
151.8
l/hr
Percentages
desacetyldiltiazem
N-desmethyldiltiazem
Emax
0.24/0.36
coriander
Half-side
0.0654
Coriander
contraceptive/clomiphene
beta-estradiol
ELCWP
multi-variate
POG
8625
IIIA1
=21
oncovin
procarbazine/doxorubicin
+2550
involved-field
low-stage
response-based
risk-adapted
Sulfadoxine/pyrimethamine
antimalarial
Kampala
preassigned
Recrudescent
merozoite
MSP2
sulfadoxine/pyrimethamine
36-66
sulfadoxine/
12-54
JCCLSG-S811
PRD
VDS
6MP
mg/m2/week
LIT
49.7
72.1
pyeloplasty
retroperitoneoscopic
intracorporeal
30.75±4.85
30.99±5.59
Transperitoneal
cytodiagnosis
softcyte
endocyte
cytologic
manipulability
freshness
clumping
Small-dose
SSA
O.
stretcher
Strategy
metacognitive
HF-ASD
phenothiazine
tetrabenazine
Tetrabenazine
Braced
paratroopers
sprains
outside-the-boot
braces
parachuting
Army
paratrooper
777
Airborne
Benning
Ga.
brace-wearers
non-brace-wearers
parachute
jumps
3,674
non-brace
1.2:1
Inversion
single-rooted
tips
curets
grit
FINDIAM
MEDDIAM
atraumatically
10X
histometric
rough
7/20
DIAM
Diamond-coated
moderate-deep
HFLCS
Fuji
Ortho
Leuven
Pro
Seal
Reliance
Orthodontic
Itasca
Ill
stereomicroscope
SMZ-1B
Nikon
Osaka
magnification
HeCOG
Purpose
non-operable
three-hour
0.733
spondylosis
co-relation
deworming
cohesive
filler
preincorporated
24-mg/mL
non-lidocaine
HA-alone
HA+lidocaine
35/20
38/20
incapacitating
precluded
Scintigraphic
capsule-type
Colonic
Colon-Targeted
disintegration
visualizing
glycation
AGE-RAGE
renoprotective
sRAGE
BP-lowering-independent
Bet
rBet
1-FV
EEC
re-exposed
-18.8
-71.9
0.0022
-75.6
-81.8
-78.3
EAACI
160-
320-μg
Dose-reduced
nonmedicamentous
non-medicamentous
CNT
medicamentously
CNT-group
hypertension-associated
far-reaching
economization
scarcely
non-medicamentously
exacter
index-patients
Notwithstanding
dose-reduced
mild-to-moderately-active
balsalazide
MMDAI
2-weeks
=8.0
Balsalazide
Cisapride
BR19
1,242
.15
7.73
.395
3.16
16.45
mutation-positive
Truncal
Theta
semirandomized
semi-randomized
TBS
contralesional
9-hole
Peg
9HPT
Jebsen
Taylor
JTT
pinch-grip
sustainable
Canadian-European
1.73-m-2
536
psycho-educational
2011-February
Spoken
nonimitative
non-consecutive
Spirometric
Dose-dependent
chromatography/mass
90th
-0.42
+0.03
haploidentical
T-cell-depletion
//www.chictr.org
ChiCTR-TRC-11001761
ATG-6
9.1-23.1
ATG-10
0.7-8.3
17.1-33.5
4.0-15.2
77.3-91.3
86.0
79.2-92.8
P=0.88
exposes
Doxymycine-cyanoacrylate
singularly
doxymycine
calcii
gluconase
isobutyl
Iso-Dent
singular
doxymycine-cyanoacrylate
premenarcheal
co-twin
dizygotic
1200-mg
Caltrate
Areal
aBMD
within-pair
You
ENERGY
Co-morbid
≥21years
≥1cm
strategically
fully-powered
45kg/m
newsletters
initiates
century
issued
2,321
980
dmft
4.85
n=352
n=312
inequalities
hydrophilic
Theo-dur
syrup
drum-dried
DDCS-70
mg/sec
papaveretum
Efficient
undefined
ultraviolet-deprived
TT-specific
TT-IgG
secreting
polyclonally
e-learning
conceptually
overwhelmingly
interactivity
dialogic
cryoglobulinemia
Mu/day
Mu
anti-HCV
exchangers
BRAINE
program-Providence
Rhode
2/98
10/99
AUDIT-positive
time-line
follow-back
CDDP-induced
Angio-Seal
StarClose
Devices
138/150
124/150
Oozing
bandage
Hematoma
oozing
Resonance
Spectroscopy
Predicts
Hepatocellular
Carcinoma
H-MRS
B.This
LCModel
Cho
Choline
Lip
Cho/Lip
groups.Choline
.H-MRS
Methodologic
polyfrequency
oscillation
metacholin
bodyplethysmograph
polyfrequent
tc-PO2
PD60
sGaw
bodyplethysmography
Socio-demographic
PREFER
SELF
SMART
Inventory-II
BDI
Hunger
Satiety
Binge
BES
MOS
v2
WEL
84.92
73.61
47.35
9.75
possessing
maintainers
9.1+/-3
7.8+/-3.2
rho=-0.42
rho=-0.22
p=0.15
NCT00589498
heparin-resistant
rhAT
COMP
10-drug
LSA2-L2
Histopathology
nonlymphoblastic
cannulas
Neurosurgical
haematology
mitt
heater
AMSA
4'-
9-Acridinylamino
methanesulfon
-m-anisidide
Regimens
16-91
northeast
choking
16.83
26.17
adventitious
DEX-P
PH
ION
meters
metres
Trakya
Mentally
Physically
Handicapped
iCSO
balloon-tipped
i.c
Collateral
CFI
Poccl
I.c
1.33±1.25
mV
1.85±1.45
Lorentzian
=0.61
0.05-0.20
ICSO
atrial-selective
=45
NCT00281554
recent-onset
Vernakalant
dysgeusia
torsades
pointes
first-in-man
delipidated
delipidation
alphaHDL
prebeta-like
or=1
apheresis/reinfusions
apheresis/reinfusion
plasmas
-12.18
36.75
0.268
Innovative
QSN
Lives
between-condition
60.8
simplifying
responsibilities
Simplifying
REFLEX
posthoc
RTX
PBO-randomized
RTX-randomized
re-baselined
20/50/70
League
Against
Rheumatism
good/moderate
77.2
PJD
5.51
long-cycle
17-beta-estradiol
microg/24
medroxy-progesterone
Self-Report
Traditionally
Assessment-Cancer
wireless
laptops
touch-screen
ESRA-C
Fred
Hutchinson
Carvedilol
nizatidine-controlled
pulsatile-controlled
DGE
egg-beater
Tc99m
CFB
re-training
post-surgically
discriminative
Post-surgery
retrained
non-retrained
Malpura
semi-arid
viz.
GII
GIII
GIV
stall
roughage
climatic
40°C
RH
16:00
17-β
lambing
PURPOSE/OBJECTIVE
IB2-IVA
66-92
40-98
RUL
ECT
electroconvulsive
regularity
postictal
ictal
case-by-case
.0005
palliate
Amoxicillin/metronidazole/omeprazole/clarithromycin
proton-pump-inhibitors
quadruple-regimen
42/44
22/24
42/46
22/25
Five-day
brushings
cytodiagnostic
93.2
87.9
patient-oriented
Para-anaesthetic
ACEi
-8.6m
-30.1
Vasomotor
Effexor
graph
unnoticed
ruptures
explantation
antinuclear
cardiolipin
seepage
intracapsular
extra-capsular
autoantibodies
asymptomatically
PST
burdensome
Solving
two-armed
patient-level
contracting
adherence-improving
PHQ9
IDS-SR
TiC-P
Atlantic
CYC
hexoprenalin
24-less
tocolysis-index
Baumgarten
prolongation-index
Richter
tocolytic
Levosulpiride
levosulpiride
1298
Gastroenterology
bloating
fullness
belching
reach/exceed
12-20
q3w
qw
0.575
0.688
prophylactics
superlimf
1-adamantanamine
stearate
hypothalamic-pituitary-gonadal
escaped
prepubertal
running/exercise-related
Color-Word
Non-perseverative
Errors
Categories
Completed
Tentative
allocates
lengthier
turn-taking
cediranib
Cediranib
RECENTIN™
fed/fasted
fasted/fed
EnF
12-34
20-43
antivascular
6797
SOLVD
3401
3396
2.5-20
2569
4228
11-34
595
9-29
615
14-26
intracavitary
HDR
afterloading
Gy/fraction
0.9096
0.2955
Moderate-to-severe
Kottmeier
dead
0.01-0.08
RF-RLRS
Turgay
Norasept
Sepsis
NORASEPT
factor-receptor-55
sTNF-R55
factor-receptor-75
sTNF-R75
930
oldest
endstage
friction
rub
forge
95.0
rejoin
benzodiazepine-prescribing
prepaid
PPGP
270,000
departmental
PPGP-member
-278
-4,137
2,844
-330
-1,531
1,358
-541
-3,716
2,185
multi-slice
MSCT
Prospectively
combinative
81.7
Combinative
coincidence
DESFLURANE
COMPARED
SEVOFLURANE
CIRRHOTIC
UNDERGOING
MAJOR
LIVER
RESECTION
RANDOMIZED
Desflurane
Entropy
40-60
Haemodynamics
trans-oesophageal
TED
Glutathione-S-transferase
GST
Microalb
Extubation
835.04
12.02
778.16
11.97
dyn.sec.cm
85.72
76.16
6.52
FTc
14.76
l4.24
8.65
141.14
32.90
320.60
114.01
vS
Gluten
I-FABP
gluten-casein
Administrating
enterocyte
Dacarbazine
dacarbazine-vindesine
4/51
5/51
8/59
7/59
IL-1Ra
intimal
subintimal
IL-1ss-mediated
CDSS
CHICA
Automation
post-implementation
Surveys
95-100
physician-reported
mixed-disability
SSTP
GSSTP
Palsy
oronasal
h/night
incisal
auto-positive
downloaded
AHI
events/h
cmH
auto-PAP
4.04
habitus
macroangiopathy
microangiopathy
FDTV
2/180
VCAM-1
trandolapril-verapamil
non-related
streaming
precordial
dye-dilution
water/0.25
echocardiographer
semiquantitatively
Patent
Precordial
Physiologic
Risperidone-induced
21-subject
13.2+/-8.6
31.0+/-11.6
37.9+/-10.4
11.6+/-7.4
93.3+/-54.2
67.8+/-62.9
Personality
parasuicidal
Jelgersma
GGZ
Rivierduinen
attempts/self-harming
design.Participants
three-monthly
dilemma
surplus
DNAemia
preemptively
pp65
antihuman
HCMV
unmanipulated
.259
IVDUs
CHC
non-IVDUs
Non-compliance
risk=1.20
interval=0.55-2.62
risk=1.19
interval=0.89-1.60
risk=1.35
interval=1.00-1.81
disappearing
IVDU
Benelux
justifiable
withhold
conceptualisation
crafts
17-39
31.49
24-38
co-variates
-1.09
CI-1.58
-0.62
1.84-34.9
cathartics
Concise
9-15
gallium-67
magnesia
cascara
alloimmunization
Alloimmunization
multiple-donor
single-donor
alloantibodies
Parotid
House-Brackmann
H-B
electroneurography
ENG
CMAP
mimetic
blink-reflex
BR
1.5-2.4
2.5-3.4
CMAPs
reinnervation
depot-pilocarpine
Polym
Plc
pilocarpine-complex
nycthemeral
cross-overed
consistant
efficacity
~1
underpinnings
bypasses
eye-fixation
second=0.082
CI:0.025-0.14
d=0.86
pre-filled
syringes
Vasopressor
diluting
beforehand
73-140
5.2-55.5
bark
Choerospondias
axillaris
Burns
constraints
obliged
remedies
Vietnam-Sweden
Uong
remedy
16/19
transnasal
Barrett
Unsedated
TNE
short-form
columnar
lined
post-endoscopy
.054
Bradykinin
tissue-type
ε-aminocaproic
EACA
HOE
Real-Time
ecological
palmtop-type
headache-related
Sentinel
popularized
radiotracer
transoperative
lympho-scintigraphy
hematoxylin
upstage
superposition
Upstaging
4/31
THA/TKA
CITATION
Krenk
Jennum
Kehlet
Chandigarh
refill
skipping
AR-C68397AA
Sibenadet
NHRs
PALS
helping-companion
library
Self-Concept
TSCS
Moral-Ethical
altruistic
moral
hormone-resistant
Difficulties
imagination
externally-oriented
talking
N=77
theoretically-related
Actiwatch
5.47
premutation
nonandrogenic
Nestorone
NES
estrogen-sensitive
androgenicity
18-34
NES/EE
150/15
150/30
angiotensinogen
estrogen-
androgen-sensitive
195-262
251.3
218-288
237-389
30-86
Between-treatment
CVR-OC/OC
117-210
18.5-46.8
14.0-69.4
EE-associated
Wide
directories
Canada411
InfoSpace
directory
fluvastatin
CURVES
-38
-46
-51
AOT
N=60
postorthopedic
ambulating
execute
FIM
crutch
nonneurologic
ferumoxytol
inconvenient
Ferumoxytol
carbohydrate-coated
superparamagnetic
nanoparticle
510-mg
injection/infusion
Bodies
Souls
church-based
Soaring
HBHS
community-participatory
3-8-week
Beverages
Desserts
Cooking
Snacking
in-church
congregants
Print
inaccuracies
giveaways
42.0-61.7
48.7-53.7
posters
34.3-65.0
subfractions
heritable
Hitherto
lipid-associated
L1-L15
1791
H-NMR
inter-relationships
lipid-tolerance
LIPC
PLTP
FADS1-2-3
SORT1
GCKR
APOB
APOA1
strengthens
desvenlafaxine
Gainfully
h/wk
HAM-D₁₇
Sheehan
0.78-3.46
0.93-4.22
0.36-3.76
Desvenlafaxine
narrowly
totality
ticagrelor
MICAMI-TICLO
Ticagrelor
cTFC
58.8±10
4.4±2.6
35.2±36.4
42.7±29.5
81.1±29.4
95.1±17.5
frames
24.6±9.3
27.0±13.4
76.4
p=0.41
84.8±23.4
70.8±33.7
volume-depleting
1-blocker
YM617
synthesized
-5-
o-ethoxyphenoxy
-2-
methoxybenzenesulfonamide
forlax
forlaxand
for-lax
intoa
acupointembedding
Tianshu
Daheng
Shangjuxu
Dachangshu
prescribedfor
therapyand
wasas
and2
of2
In2
effectiverate
49/50
43/50
embeddinggroup
11/50
con-stipation
4/49
14/43
23/39
medicaiton
Repair
Inguinal
orchitis
1603
neuralgias
Alinidine
alinidine
thermistor
246.7
120.7
346.6
114.1
0.1-mV
187.2
intercepts
liver-transplant
Cytomegalovirus
solid-organ
Seronegative
98th
R-
D+
herpes-simplex
oxymorphone
K-P
K-D
IoA
K-D.
hypoventilation
Pao2
nystatin
4.3-4.6
Lactobacilli
plentiful
yeasts
coexist
micromazole
equallly
micronazole
thrombus-related
Single-center
Palindrome
Symmetric
Tip
Dialysis
HemoStar
CRBSIs
rheologic
136.5
P=0.8
Definite
CRBSI
0.10/1,000
P=0.3
0.43/1,000
P=0.7
Urokinase
infusions/1,000
304mL/min
nonblinded
rheology
AED
easy-to-administer
post-examination
signed-ranks
Proparacaine
D-Cycloserine
glycineB
N-methyl-D-aspartic
co-agonist
stereotypies/repetitive
Seven-star
qEEG
Questionnaire-45.2
OQ-Analyst
NFB
corroborating
spelling
M=111.02
SD=9.6
Copy
Memorize
write
Word
pseudoword
orthographical
syllable
fertility
i.p
streptozotocin
STZ
Dansk
Droge
A/S
epididymis
spermiogram
intratesticular
seminiferous
Ginseng
or=55
SD±4.3
non-physical
6.5h
ESS
Short-form
p=.049
p=.04
p=.027
p=.036
sub-scores
p=.044
p=.02
p=.017
X-linked
DHAX
XLRP
Biosafety
7-31
cell-DHA
4.4-
3.6-fold
NCT00100230
Paracervical
Thiabendazole
strongyloidiasis
immunosuppressed
condensable
fuchsin
compomer
autoploymerizing
Dunn
cardiotocography
4196
ppv
npv
intra-observer
intraobserver
Cardiotocography
exploited
NFlB
NFκB
Brachial
NFκB-regulated
α-stimulated
CD69
p50
short-course
-resistant
dehydroepiandrostendione
49.8
interatrial
P450s
1A2
2C9
2D6
CYP1A2
CYP2C9
dextromethorphan
CYP2D6
l/h
paraxanthine
+/-0.24
779
dextrorphan
catalytic
HIV-1+
xerosis
photoeruptions
hydroxyzine
moisturization
medium-strength
fewest
late-stage
social/adaptive
ear-occlusion
adaptive/social
quotients
benefiting
educationally
GERA
50-79years
2,223
562
50-59years
worries
SibworkS
siblings
Siblings
focussed
asymmetries
punishment
prisoner
retaliation
payoffs
punish
defectors
iterated
Defecting
cooperated
retaliate
punisher
two-player
begets
punishers
prevail
multi-player
phosphodiesterase-5
P=.67
exopolysaccharides
unencapsulated
7-mo
brachiocephalicus
intrammammary
mechanized
Endophthalmitis
EVS
pars
Vitreous
22-27-gauge
Respective
20/100
Cruciferous
CVs
anticarcinogenic
factor-I
histone
deacetylase
HDAC
Strand
-22.2
purines
-51.0
Broccoli
mcg/kg
multireceptor
HOXB13
G84E
Genetics
ICPCG
Finns
986
TaqMan
MassARRAY
iPLEX
4.9-15.7
≤55
BRCA1/2-negative
Pazopanib
c-Kit
pazopanib
cytokine-pretreated
7-36
Glucagon-like
antroduodenal
Background
pmol/
kg/min
Interdigestive
distensions
supraphysiological
immunoreactivities
259.5
121.1
ml/mm
p=0.0004
impregnated
GIC
BHK-21
Mineral
Trioxide
Aggregate
rotary
NiTi
3mm
microscopes
Glass
direct-mailed
X1
X3
join
cost-efficacy
labor-intensive
Lifetime
PO-dependent
N=22
past-month
amphetamines
skull
moyamoya
OBJECT
normocapnia
encephaloduroarteriomyosynangiosis
EDAMS
hypo-
NB
supraorbital
supratrochlear
auriculotemporal
delirious
NB-treated
colonoscopist
AccuTouch
gastroenterologists
simulator-trained
P=0.0011
succeed
curricula
dacron
endarterectomies
cross-clamp
sponge
16.34
Handling
EPaNIC
American/Canadian
non-commercial
mechanistical
august
NCT00512122
bevacizumab-containing
ARIES
1967
0.2-65.5
31-93
6.3-6.9
12.2-13.8
bevacizumab-associated
John
wort
SJW
AR-13324
PG324
Ophthalmic
Solution
unmedicated
hyperaemia
30/73
29/73
10/73
31/78
NCT02207491
multivitamin/mineral
Determine
0.0000001
near-average
pyridoxal-5-phosphate
sustaining
gamma-treated
dextran-70
venography
'non-choosers
'choosers
Ethanol
Elation
Vigor
non-choosers
choosers
sedative-like
Friendliness
Acamprosate
acetylhomotaurinate
eighty-one
3.19
antabuse
coinduction
ketobemidone
PONV-free
Coinduction
class-II
involvements
furcations
EMD
PDs
/=5
+24
OFD+24
conditioning+EMD
GMP
RVCAL
RHCAL
HBL
osseous
Family-centred
music-making
FCMT
endeavours
36-60
grew
placebo-containing
gastroenteric
brain-penetrating
rhabdomyosarcoma
Rhabdomyosarcoma
Study-IV
IRS
standard-timing
up-front
IRS-IV
CPRV
cmH2O
PRV
CPRVs
deflations
U-test
deflating
micronebulization
endotracheally
fungi
staph
bronchoconstrictions
fluoride/stannous
fluoride-containing
AmF/SnF2
GAP
AmF/SnF2-containing
PlI
AngBI
GMSI
piroxicam
Piroxicam
SPID
TOTAL
Codeine
Hours
PID
Hour
very-low-protein
sVLPD
vegan
keto-analogues
-17
Multicyclic
multicyclic
reinfusing
micrograms/d
Hematopoietic
reinfused
cryopreservation
venesection
120-fold
every-4-weeks
nonresectable
LENT
SOMA
function-vaginal
SVQ
One-quarter
noncleaved-cell
CNS+
masses
neuropathies
CSF+/Mass
CNPs
protocol-based
nominally
CNS-
RFR
=.15
RFRs
=.029
=.76
cylindertype
screwtype
interforaminal
Brå
gingiva
desflurane-based
propofol-infusion-based
21-937
33-642
45-723
desflurane-only
Maddox
Wing
propofol-like
Entry
Bernstein
intraesophageal
Maalox
William
Rorer
heat-treated
Vero-cell
PHT-Erig
Philippines-two
commercially-available
Erig
PVRV
deltoid
buttocks
anaphylactic
0.027-0.117
D7
D28
anti-rabies
WHO-recommended
23.8-46.1
PMC/PVRV
23.4-42.2
PHT-Erig/PVRV
heat-treatment
full-blown
1.5T
BRAINS2
1,47
2,47
0.242
3,81
=2.686
P=0.052
endostatin
E10A
0.154
3.60
chemotherapy-treated
6.50
8.27
4.27
plication
stitch
RARP
bothersome
53.2
membranous
Wrist
Electromyography-Driven
Robot
NMES
20-session
-driven
EMG-driven
co-contraction
session-by-session
shoulder/elbow
wrist/hand
basilic
Creation
AVF
brachial-basilic
BB
brachial-antecubital
BB-AVF
1680+/-156
1450+/-221
AVFs
antiandrogenic
OC/Pr
hyperandrogenemic
mg/wk
N-telopeptide
8g/70kg/day
Residential
ascorbate-ascorbate-placebo
ascorbate-placebo-ascorbate
EVOO
institutionalized
65-96
polyphenol-rich
oleuropein
50ml
hydroxytyrosol
OH-Tyr
catalase
CAT
GH-PX
DMSA
dimercapto
succinic
antimony
tungsten
Rotigotine
Neupro
non-ergot
D3/D2/D1
uptitrated
rotigotine
slow-titration
fast-titration
mg/
telephone-based
Nonsmokers
low-moderate
ladder
refinements
vests
vest
second-grade
lymphoblastoid
units/m2
units/m2/day
interpatient
Iobitridol
iopromide
iobitriodol
nondiagnostic
Nature
iobitridol
THUNDERBEAT
electrosurgery
Catholic
IA2
IB1
IB2
2cm
endometrioid
Feedlot
ruminally
lysine
RPLM
growing-finishing
182.7
steers/treatment
shelled
silage
arranged
SBM
SBM-U
Urea-N
SBM-N
steer
SMB
cubic
high-corn
R317573
Corticotropin-releasing
rCMglu
fluoro-2-deoxy-D
-glucose
putamen
radiotracers
reticulocytosis
or=7
149-169
138-147
hypophosphatemia
Taxotere
non-haematologic
nonazotemic
cell-surface
mitogen-stimulated
histamine-2-receptor
hypoglycaemics
pseudorandom
Loads
imperceptible
R0/E0
perceptible
R1/E1
R2/E2
zeroth-order
pollinosic
Parietaria
June-July
anti-obsessional
Psychopathological
Scale-Obsessive-Compulsive
monoamine
mofegiline
Mofegiline
MAOB
phenylethylamine
proportionately
VX-770
G551D-CFTR
CFTR
potentiator
chloride-free
-66.0
-19.0
P=0.56
Vertex
NCT00457821
Restorative
proctectomy
colo-anal
CAA
colon-j-pouch
CPA
pouch-anal
Pouch
construction
asthenia/fatigue
P=.474
P=.079
weekdays
P=.365
trimeperidine
vagotonia
hypokinetic
Richmond
symmetrically-impacted
diflunisal/bupivacaine
neuromodulation
post-error
Error
fronto-central
error-related
ERN
Pe
WTL
post-TMS/or
disks
ERN/Pe
response-locked
light-for-gestation
2771
biparietal
32nd
37th
Light-for-gestational
LGA
birth-weight
Ho'ouna
Pono
2007-2013
BMS-181101
anti-depressant
AUCtau
II-converting
anti-proteinuric
Creatinine
MSL-109
Retinitis
3.04/person-year
MSL-109-treated
3.05/person-year
P=.98
0.68/person-year
0.31/person-year
0.41/person-year
0.42/person-year
P=.95
0.83/person-year
0.24/person-year
summarises
prognostically
65years
5.5years
matures
PNA
bootstraps
1-compartment
L/h
/70
2-micrograms/kg
micrograms.kg-1.h-1
4-micrograms/kg
g.m-2.h-1
C-1
small-
antishivering
concentration-dependence
CDP571
15-40
=150
8-weekly
=220
QT/QTc
topiroxostat
E14
four-period
QTcF
QT/RR
QT-interval
Moxifloxacin
FemCap
All-Flex
sailor
dome
fornices
conforms
dislodgments
841
spermicide
dislodgement
Armodafinil
R-isomer
SWD
armodafinil
Pooled
Latency
Predicted
µg/mL
placebo-subtracted
milligram-to-milligram
Eberconazole
dermatophytosis
dermatophytoses
eberconazole
dermatophytes
Address
Petersen
10th
Rivermead
migrans
phenoxymethylpenicillin
tds
Lyme
borreliosis
noncumulative
afforded
bronchoconstricting
Leukotriene
Joshi-Idai
ONO-1078
pranlukast
intracavernosal
papaverine
Intracavernosal
priapism
Penile
erection
CONCLCUSION
psychic
Asha
Asha-Life
HIV-trained
Accredited
Activist
WLA
alike
Labor
Gestation
0/7
6/7
25/82
14/79
0.96-3.06
REGISTRACTION
NCT01076062
Hindi
Kulshrestha
sub-Tenon
conspicuously
Sub-Tenon
retrobulbar
1-quadrant
1-QST
Retrobulbar
inferior-nasal
23-gauge
Preinjection
wer
thiol
nitrate-tolerant
nontolerant
venodilator
ml/100
3.47
nitroglycerin-induced
venodilation
middle-sized
attacks/month
Flunarizine
Sibelium
ASS
principals
attack-free
Longtime
cis-platinum
hexamethylmelamine
HAC
melphalan-platinum
44+
variously
halve
Anesthetic
0.38-0.98
0.22-0.95
NCT00235456
D-antigen
Anti-Xa
4,4-6
PaO2/FIO2
NO-treated
overdoses
Resisting
self-consistency
concludes
26.4-41
parenterally
O/O
145.6
+/-17.5
128.8
+/-18.3
126.9
+/-17.1
+/-16.5
2-44
1-732
body-surface
6400
radiation-treated
Graptopetalum
paraguayense
WGP
FG
GPx
NCT01463748
Managing
parent-group
RRB
SPEM
Studio
Policentrico
Elettrocateteri
Membrane
30-microgram
elution
contoured
1400T
1401T
chronaxie
0.280
rheobase
0.264
0.099
13.45
5.87
slew
2.05
V/s
605
518
nonsteroid
microJ
settles
postimplant
Mydriasert
assures
FDA-approved
Non-treatment-seeking
cue-reactivity
'crave
'stimulated
'would
post-MA
timecourse
'anxious
dual-switch
DSV
hydrocephalic
differential-pressure
DP-
Evans
distinctly
overdrainage
preshunt
neglegible
subdural
unphysiological
constructions
LUX-Lung
n=345
n=364
gemcitabine-cisplatin
del19
Leu858Arg
NCT00949650
NCT01121393
35-44
31-37
24.6-33.6
20.7-33.2
0.66-1.17
p=0.39
20.4-27.3
18.0-25.6
0.72-1.22
p=0.61
del19-positive
26.8-41.5
16.3-30.7
0.36-0.79
24.2-35.3
14.6-25.6
0.44-0.94
Leu858Arg-positive
19.8-41.7
24.3-not
estimable
0.80-2.11
17.0-22.1
19.0-27.0
0.81-1.83
p=0.34
afatinib-related
paronychia
2.62
triglyceride-rich
CRI
High-Density
2,531
=1.0
=3.6
1,981
m2/y
=44
nedocromil
overtreatment
melasma
depigmenting
Jessner
kojic
Melasma
MASI
LSD
Trichloroacetic
NORwegian
DIstrict
NORDISTEMI
preferably
NCT00161005
90-396
Computer-delivered
computer-delivered
material-an
probucol
levamlodipine
hepatic/renal
colorimetry
agreater
disintegrating
Breakthrough
BTcP
fast-acting
opioid-tolerant
=17
ODT
NCT00262678
143.0
0.0055
0.0414
sublingually
vigabatrin
Acquired
oscillopsia
pendular
APN
Neuro-ophthalmological
electro-oculographic
EOG
jerk
non-GABAergic
CMRO2
Kety-Schmidt
Pancuronium
Flumazenil
Multitomographic
banded
bearings
bars
assesed
11.83
5.64
2438
seroconversion/sero-protective
A-C
verse
213.16
432.58
451.47
22.07
46.70
56.18
0-1-12
energies
LMX-4
J/cm2
ddI-EC
monotherapy-administered
AUCMB/day
0.45-1.53
0.38-1.40
0.33-1.22
0.774
0.48-1.07
P=0.995
0.0227
P=0.96
sulfadoxine-pyrimethamine
1961
Coast
=1,000
asexual
microliter
CQ-treated
ETFs
LTFs
SP-treated
sulfa-containing
parks
exercises/session
Berg
Go
installations
U-
H-type
TVT
SECUR
TVT-S
SUI
TVT-S.
Sandvik
Incontinence
I-QOL
Consultation
Questionnaire-Female
Tract
ICIQ-FLUTS
cures
U-type
p=0.786
non-valvar
vWf
sP-sel
SPAF
1321
IU/dl
rehabilitating
broaden
hours/day
Myoton-3
BBT
10-Meter
Walk
ABILHAND
as-quickly-as-possible
Irisin
Adropin
Perilipin
irisin
adropin
perilipin
obesity-induced
mentoring
35-week
mentors
midterm-
mentored
Margarines
oxidant/antioxidant
margarines
Consuming
394
11/7
24.5/12.6
fundoscopy
yropicamide
8.57
8.73
Pupil
non-ST-
NSTEMI
TIMI-2
furazolidone
Furazolidone
FZ
70-75
mutagenic
biotransformed
dosage-prediction
analog-computer
linear-regression
empiric-dosing
diode-laser
prethreshold
Prethreshold
Excellent
MASSI
gum-elastic
bevel
posteriorly
rail-roading
rotate
inhalatory
parameter-specific
calculable
exploit
analogy
case/worst
event-based
MacArthur
Inventories
Fenson
follow-in
expansions
talkativeness
attention-following
Explains
Prominent
inferobasal
ECG-CE-CMR
CE-CMR
R/S
Absent
lateral/inferolateral
28/53
25/31
26/47
hemoglobin-O2
innovation
H/K
O2/CO2
Amiloride
OMT
RBC-K
Ion
Transport
±4
mmol/lc
±0.3
CI:1.72
±0.5
±0.8
=0.21
Reversion
x2
uncalculated-time
RR2.1
therapeutical
dalcetrapib
dal-PLAQUE
Dalcetrapib
pro-atherogenic
Coprimary
MRI-assessed
F-fluorodeoxyglucose
no-harm
unblinding
NCT00655473
MRI-derived
-4·01
-7·23
-0·80
p=0·04
most-diseased-segment
target-to-background
TBR
-7·3
-13·5
-0·8
p=0·07
electrofunctional
argon-laser
glaucomatous
pattern-reversal
electroretinograms
PERGs
VEPs
Manipulation
dystonic
spasms
Tofacitinib
TNFi
2:2:1:1
PtGA
DI
SF-36v2
tofacitinib-treated
GAF
GAF-scale
INFORMATION
NCT00169689
5.1+/-0.9
42-75
3.8+/-0.6
3.1+/-0.6
4.9+/-0.8
3.7+/-0.7
time-lapse
videosomnography
Irvine
home-recorded
Androgen-Deprivation
PR.3/Medical
PR07/Intergroup
T94-0110
N0/Nx
lifelong
ADT+RT
602
Deaths
firmly
Optimized
prescreening
1,002
7,350
unscreened
PSA+
Cancers
2,665
Trachoma
gambia
Tanzania
Amplicor
335/5033
1008/3122
flies
NCT00792922
TDM
individualization
40-73
t50
t80
85-31
PCSM
945
788
nonprostate
Covariates
=30
1.02-2.27
1.01-2.66
Abdominoperineal
1292
Sphincter-saving
Thrombin-activatable
hyperthyroxinaemia
TAFI
hyperthyroxinemia
clot-lysis
TAFIa
-dependent
hypofibrinolytic
TAFIa-dependent
Hypothyroidism
CTLA-4
irAEs
ipilimumab-induced
Treatment-naïve
calprotectin
ipilimumab-related
Phytase
1alpha-hydroxycholecalciferol
growing/finishing
1alpha-OHD3
phytase
Ca-
P-deficient
Corn-soybean-meal-and
soybean-oil-based
impervious
tP
grower/finisher
GF
units/kg
Natuphos
P+1A
rickets
dyschondroplasia
Chicks
Birds
ash
single-hemisphere
programs-with
EquiTest
climbing
vision-deprived
free-vision
EFFIC
breed
Imidapril
hysterectomized
E2+P4
E2+T
E2+P4+T
alpha=0.05
54.0
Bone-specific
-14.3
Deoxypyridinoline
-26.9
-24.4
-39.5
+2.2
Getting
anonymous
Postal
Face-to-face
MOF-Strep
6/32
radiotherapy-induced
Radiotherapy-induced
RTIT
TheraBite
Jaw
™
MIO
Casodex
25/41
22/41
gynecomastia
Bicalutamide
rofecoxib
VACT
n=269
n=523
n=259
n=527
Vioxx
Celecoxib
VACT2
VACT1
PGART
or=0.035
50.6
p=0.027
Rofecoxib
VACT1/VACT2
randomized-controlled-treatment
elementary-aged
centrality
friendships
1-2-3
piloted
Autism-1-2-3
vocalization/words
language/communication
clinician-collected
self-collected
screen-and-treat
Screen-and-treat
resource-limited
Hybrid
Capture
CIN2+
n=812
n=1858
colposcopy/biopsy
n=1,455
p=0.31
GN
membranoproliferative
oral-only
hiatal
Extended-Release
Guanfacine
guanfacine
N=53
age=8.5
SD=2.25
N=30
N=32
Checklist-hyperactivity
size=1.67
modal
guanfacine-treated
mianserin
picture-to-object
picture-based
correspondences
prevention-based
graphic-based
referents
-6.4/-4.8
-4.9/-3.8
1.6/1.3
-10.5/-6.9
-3.8/-3.3
U-cas
PELF
assured
megadose
multi-vitamin/mineral
abdominal-transhiatal
subcardia
inaccessibility
n=82
n=85
NCT00149266
40.4-64.1
26.1-49.6
0.89-2.08
p=0.92
Utility
n=127
incision-to-delivery
incision-to-fascial
microhematuria
2-70
18-124
16-178
P=.10
Incision-to-delivery
www.ClinicalTrials.gov
NCT00918996
Web
secobarbital
nontherapeutic
abuse-relevant
Mindfulness-based
MBT
MBT-AS
stearic
palmitic
C16
lauric+myristic
C12+
C14
myristic
Strictly
12-560
12-533
C12
12-534
myristic+lauric
tissue-plasminogen
coagualant
9508
radiosurgery
poststratified
GPA
brainmetgpa.com
3.5-4
30-month
mutants
13-year-old
/mL
tooth-cleaning
tongue-scraping
fluorides
approximally/year
Postlaparoscopic
post-laparoscopic
algesia
Eliminating
analgetics
insufflated
pH-values
pH-value
peritoneum
Components
Load
Lavie
N.
Hirst
De
Fockert
Viding
339-354
proposes
imposed
hinder
5-s
tetanic
GABAA
urate
PK/PD
uricase
=0.9991
Infusions
television
Kids
year-olds
2006-2008
n=253
Interval
Clinic-based
well-received
Thromboembolic
resides
PENTHIFRA
PEGASUS
APOLLO
ARTEMIS
MATISSE
PENTALYSE
PENTUA
Encouraging
MICHELANGELO
nonorthopedic
Yinxing
Damo
betahistine
YXDM
Betahistine
vertebra
VBIV
Xueshuantong
hemorheology
BHT
MONW
MgCl2
≥100
≥150
≥140
≤1.8
-46.5
-12.3
-47.4
Björk-Shiley
Lillehei-Kaster
B-S
L-K
over-represented
Cine-aortography
catheterisation
transseptal
incapacitated
Nos
Peak-to-peak
LVEDP
Endogenous
KITT
S-FFA
P-GIP
glucagon-stimulated
0.0036
polycythemia
Polycythemia
Vera
PVSG
myeloproliferative
PVSG-01
32P
remitters
Empirically
trees
Trails
cut-score
≥82
Psychotherapies
6409
work-based
3148
3277
work-oriented
non-usage
minimal-contact
34.48
acceptance-satisfaction
attrition-provide
Range
HADS
ANIMAL
Wistar
14-gauge
MACISO
hour-1
MACISO+drug
presence/absence
S-nitrosoglutathione
L-Arginine
GSNO
778
C-urea
85.5
ADAPt-C
EUC
maintenance/relapse
PHQ-9
social/family
2.59
2.79
PRL-8-53
2-benzylmethylaminoethyl
benzoic
Retinetion
Three-Arm
Powder
quality-tested
Catterall
toxicity-related
Rose
geranium
Pelargonium
graveolens
Geraniaceae
Ganoderma
tsugae
Ganodermataceae
Codonopsis
pilosula
Campanulaceae
Angelica
sinensis
Apiaceae
RG-CMH
fifty-eight
31·5
13·4
35·6
11·0
chemotherapy/radiotherapy
EPI-NO
primigravidae
Analyze
macro
cigar
pipe
/high-density
LDL/HDL
vasculopathies
Advice
Whiplash-associated
movement/
re
cementum
CIC
Gracey
CIUS
deattachment
CDUS
Full-thickness
RGML
RAL
Localised
PREFERE
ranking
G-BA
MDK
IQWIG
Statutory
Funds
GKV-Spitzenverband
Correction
QTcb
QTcf
Framingham
Transmural
TDR
Tpeak-Tend
Psychoexperimental
valepotriate
valtratum
Cat
8-14
PKRP
I-PSS
Operation
Htc
0001
vidarabine
Acyclovir
pustulation
crusting
nitrate-free
speech-generating
SGD
developmental/behavioral
JASP+EMT
JASP+EMT+SGD
intensifying
information-Developmental
Facilitating
CCNIA
NCT01013545
lumbago
macroscopic
adalimumab
thiopurines
Rutgeerts
≥i2
stepped-up
NCT00989560
1.2-4.8
1.01-7.7
AbbVie
Gutsy
Gandel
Philanthropy
Angior
Colitis
Disc
coablation
discogenic
Discogenic
Coablation
slight-moderate
26.78
inflammation-associated
2007-2010
sTNF-R2
Tolfenamic
tolfenamic
acid-caffeine
castration
anandron
MAB
Anandron
hydronephrosis
ULN
psychostimulant
ed
age=8.8
SD=1.7
SD=16.8
silver-containing
TOISD
swabbed
incisional
mean=1.43±0.63
1.884
8.964
TOSID
exaceration
GSTP1
TERT
co-inheritance
GWAS
disease-causing
tSNPs
multiplexed
MassEXTEND
tSNP
Hardy-Weinberg
HWE
recessive
PLINK
rs1695
rs2853676
ldquo
rdquo
0.47-0.96
1.05-2.15
Lamivudine
safety/tolerability
virologically
=6
Eighty-one
stavudine/PI
+42
invest
billions
marketing
embellish
OXT
OXT-based
celebrity
endorsers
semi-social
Intriguingly
autistic-like
picking
pricking
tapazole
triiodothyronine
TT3
TT4
TRAb
supersensitive
S-TSH
76.67
Pricking
pivot
landings
femoral-ACL
single-leg
custom-built
4×-body
springs
originates
.055
water-washed
milk-protein
hyperlipidemic
g.day-1
100-m
freestyle
rest/recovery
heats
maximal-effort
Heat
ergogenic
Z-score
BMI-Z
decongestive
Taping
Decongestive
CDT
Bandage
Tape
heaviness
debrief
16-community
judicious
Medicaid-insured
community-level
behavior-change
updates
health-plan
person-year
insured
223,135
Antibiotic-use
secular
Lidocaïne
intra-rectally
périprostatique
sustains
0200
next-day
lithium/early
desipramine/sleep
sleep/pharmacologic
pressurised
Permanente/USC
electing
two-filter
simplest
multi-channel
spectral-shape
two-tone
spectral-shape-discrimination
frequency-difference
limens
morality
Similac
Whey
nursery
holmium
prostates
HoLEP
40-200
six,12
Post-void
Continence
77.8+/-5.6
42-152
70.0+/-5.0
46-156
Urology
re-operation
MECC
CECC
polarization
FCD
206.8
cm/cm²
217.8
223.1
.100
211.1
Orthogonal
levo-leucovorin
merged
-39
Liver-only
P=0.0012
1.02-1.93
P=0.0377
13.5-16.6
or=3
irinotecan/5-FU/LV
iron-deficient
erythropoietin-β
rHuEPO-β
TKRA
betweeen
RBCs
0.2±0.5
0.8±0.8
Hemostasis
endometriomas
anti-Mullerian
AMH
endometrioma
endometriotic
liberal
liberal-
restrictive-transfusion
liberal-transfusion
leukomalacia
RBC-transfusion
homeopathy
bio-psycho-social-spiritual
community-recruited
homeopaths
case-taking
Homeopaths
spirituality
=-0.59
=-0.43
=-0.32
selfrated
=-0.31
powerful-others
Homeopathic
stage-of-change
pre-natal
booklet
carbon-monoxide
Maintained
Nonpharmacologic
age-appropriate
Halsted
RDL
EXT
central-medial
anti-HBe-positive
alpha-N1
t.w
972
HBV-DNA
Ehrlich
high-caloric
savory
Behaviorally
under-five-year-old
Nigerian
artemether-lumefantrine
artesunate-amodiaquine
artesunate-amodiaquine-compared
artemether-lumefantrine-treated
Parasite
94.5-97.6
Polymerase
reaction-corrected
93.9-98.2
96.1-99.3
Gametocyte
9.04-10.9
axon
-nitro-l-arginine
L-NAME
neurones
'eutectic
PC4
rHu-EPO
rHu
anaferon
IFN-inducing
IFN-gamma-producing
Desogestrel
lipoprotein2
lipoprotein3
cholesterol/total
E2-desogestrel
2b-interferon
alpha-Interferon
102.1
100.7
interferon-related
Certified
Farm
Farms
9-county
northwestern
on-farm
farmer
374/year
512/year
safest
Hanen
'More
HMTW
'business
residualized
Caries
trimetaphosphate
caries-preventive
1319
TMP
DMF
Be
CHARGE
Cystic
midwestern
40th
cal/d
NCT00006169
indifferent
revert
intonation
CVVHF
venovenous
Lethality
lethality
xie
ping
Rapid-sequence
fasciculations
minidose
Fasciculations
rapid-sequence
defasciculating
70,000
paralytic
cords
dysrhythmias
Traumas
war
mellitus-derived
reintegration
wounding
prosthetics
extensors
abductors
adductors
Newton
-1.99346
-4.629073
-4.9408
-2.00228
amputated
nonamputated
non-amputated
wounded
Gastroesophageal
36-Item
Treated
error+correct
faculty
commentary
Sg
IVGTT
insulin-requiring
CONSAM
BMM
MMD
5-hour
microU
2-stage
CLAMP
.4
transcapillary
Daclizumab
high-yield
SELECT
humanised
daclizumab
HYP
Hungary
Ukraine
annualised
NCT00390221
0·16-0·29
33-68
0·23
0·17-0·31
28-65
p=0·00015
0·37-0·57
p=0·0003
psoas
Biogen
Idec
Biotherapeutics
Michaelis-Menten
Dependency
3-methylxanthine
3-MX
1-methyluric
1-MU
1,3-dimethyluric
DMU
unnaffected
Km
Vmax
2.4+/-0.6
5.1+/-1.8+/-
112.3+/-36.8
3.5+/-0.7
7.5+/-2.6
N-demethylation
3MX
concenntrations
mammograms
Mammograms
Wolfe
Mammographic
active-learning
mock-patient
summative
Refractory
estrous
Barbados
Belly
ewe
37.5±0.9
PGF
d0
200mg
2PPG
ram
2PPG-treated
60-85
estrus
two-progesterone
synchronizing
non-curatively
Jan.
Dec.
1,138
+UFT
556
Three-year-survival
intimately
retinoid-induced
scaling/peeling
vehicles
amsacrine
1022
Douglas
Endoxan
Radical
Robotic
neurorehabilitation
16-PF
IIQ
FLIC
Galactomannan
directing
Empirical
biomarker-based
aspergillus
galactomannan
postive
allocations
NCT00163722
4-26
p=0·002
hepatotoxic
p=0·11
p=0·20
Gilead
Rectally
rectally
Triamcinolone
bursitis
-bupivacaine
RS-bupivacaine
10-ml
top-ups
3-129
7-157
top-up
3-164
22-221
TPDDRS
ESRS
UKU-Side
1,415
1,419
9/1,125
7/1,167
skills-based
competency-based
BLS
Six-hundred
ERC
instructors
crossing-over
end-of-course
competency
0.85-1.84
cefditoren
pivoxil
400mg
pyelonephritis
95.1
estriol
electible
minimum-100
Blatt-Kuperman
karyopyknotic
Hypercholesterolaemic
copper-catalysed
electrophoretic
Letrozole
P024
HR+
HR-
momentum
AIs
letrozole-treated
HER1/HER2+
HER2-
estrogen-regulated
femoral-arterial
dl-leucovorin
dl-LV
FL-therapy
PFL-therapy
26th
Temozolomide
TMZ
adducts
guanine
AGAT
arthralgias/myalgias
Jelly
tingling
dysuria
penis
benzyl
excise
ablate
gynecologists
Kangaroo
KC30
KC15
stick
Beat-to-beat
Stick
PERSPECTIVE
ReoPro-BRIDGING
pPCI
83+/-18
21+/-13
pre-pPCI
55+/-21.4
42.4+/-18.2
58.4+/-32.7
78.9+/-28.4
p=0.018
76.3
/63.5-100/
/73.5-100/
/interquartile
range/
/0-9.25/
/0-3.0/
grey
210+/-209
97+/-95
U/l/h
4.8+/-3.8
7.6+/-3.5
Glycosaminoglycan
noncoagulant
8.91
directs
recorders
Palpitations
CERs
-QoL
CER
n=244
ISC
social-pragmatic
18-36
job-interview
Travel
centre-based
entirety
spirometrically
IFTC
0702
EXPECTED
xeloda
86.66
33.33
15.38
83.33
Medullary
N=82
5d/wk
Swallowing-Related
SWAL-QOL
P≤.01
HBV-carrying
2-year-long
/73.7
/90.3
ALT/AST
255.13+/-31.38/201.88+/-21.25
31.25+/-11.50/25.13+/-9.68
Laparoscopically
Gynaecology
Shore
salpingo-oophrectomy
BSO
LPLA
Proper
Parent-mediated
/=42
Newcastle
-0.24
-0.59
6-20
mcg/mL
slurred
Poststudy
trouble
emotion-regulation
20-item
Stressful
Mind-Reading
26-item
State-trait
Liebowitz
Affective
UMIN000006236
toy
Improvisational
'joy
'emotional
synchronicity
'initiation
'compliant
Ischaemic
TAIST
1.01-1.03
1.01-1.04
thousands
-8.9
P=0.11
ulipristal
451
fibroid
Menstruation
Ulipristal
NCT01629563
PEARL
consolidated
Consultations
Workshop
transcervically
beta-1-selective
data-base
'well-being
microg/drospirenone
microg/DRSP
24/4
microg/desogestrel
microg/DSG
21/7
fluorodeoxyglucose
3min
1-2mg
oleoresin
pepper
Siemens/CTI
931/08-12
pixel-wise
Gaussian
0-30min
seven-fold
thalamus
cuneus
occipito-temporal
fusiformis
Structures
cholinoceptors
27-80
extravertebral
Gluten-free
wheat-gluten/milk-casein
gluten/placebo
N=170
Education/income
Mind-body
intramyocellular
diacylglycerol
ceramide
Intramyocellular
DAG
ceramides
DIWL
IMTG
hyperinsulinaemic-euglycaemic
histochemistry
-40.9
Ceramide
-33.7
Dihydroceramide
Sphingosine
sphingolipids
Stearoyl-coenzyme
desaturase
SCD1
-19.5
Diacylglycerol
DGAT1
Diet-induced
NCT00766298
10,010
primary-outcome
P=0.18
2385
POISE-2
NCT01082874
=.61
=.049
=.67
Health-promotion
federal
Intervention-group
4.11
Control-group
postdifferences
CONCLUSIONS/IMPLICATIONS
HLA-identical
Covariation
multi-behavior
SUN
878
kcals/kg
moderate-vigorous
accelerometery
.53
fruit/vegetables
-.12
inherently
walnut
permutations
walnuts/day
walnuts
walnut-enriched
Inhibits
Femtosecond
Laser-Assisted
Cataract
femtosecond
laser-induced
Aqueous
294.4
66.5
Work-related
sixty-seven
work-place
ancient
Cure-allergic-rhinitis
Syrup
Yu-ping-feng
YS
three-parallel-groups
Equations
placebo=26.13-34.55
placebo=12.81-16.76
'Qi-deficiency
'Yang-deficiency
'Inherited
placebo=7.05-8.12
7.56-8.92
4.48-8.10
P=0.01-
0.001-0.004
0.01-
accordingly
varieties
'Yang-
Qi-deficiency
NCT02027194
61-78
Nimotop
2-s
F3/C3-F4/C4-P3/01-P4/02
FFT
non-A
left-right
alpha-power
baseline-EEG
distinguishable
alpha-activity
A-epochs
Opposite
dorzolamide
OAG
ophthalmoscopy
0.5533
Fixed
0.0279
Flowmeter
ECMO
106-bed
quaternary
ecmo
layering
agglutination
oxygenators
intravenous-access
ADVANCE
preterAx
diamicroN-MR
66+/-6
perindopril-indapamide
4.3-year
1799
reboxetine
NARI
synoptic
BRCA
postcoronary
Group1
P.O
2x0.5
P.O.+metoprolol
n=72
intravenous/24
dose/1
bradykinin-induced
pmol/min
diffusing
gm/120
Condition
IDACC
general-practitioner-based
conferencing
46.3
1455
=16
divorced
biopsychosocial
chronification
Videotaped
instruct
roleplay
actress
docudrama
drinker
roleplays
defensiveness
intervene
Personalized
quit-success
precessation
personalizing
Genome-wide
v1.0
seventy-nine
end-expired
Affymetrix
arrays
Clara
ozagrel
Ozagrel
62.4
6-keto
206.7
diesel
traffic-related
Diesel
Exhaust
multiplex
gm/dL
platelets/mL
-9.5
thrombocytosis
low-starch
Spring-born
Hereford
grazing
dormant
supplement/d
high-starch
drylot
HS-60
HS-30
self-fed
LS-30
limited-fed
High-starch-60
distiller
hull-based
Pubertal
60-d
repetitive/stereotyped
impulsivity/aggression
divalproex
compulsive-like
C-YBOCS
d=1.616
10-36
128.4
69.7
Fluorescence
quinidine-amiodarone
theoretically-guided
sexually-active
laser-powered
hydrokinetic
yttrium-scandium-gallium-garnet
air-water
turbine/bur
lased
Hard-tissue
5628
4382
4998
5012
P=0.92
cost-intensive
costed
Protocol-driven
76,237
Euros
32,565
69,516
183,758
14,761Euros
Euros/patient
geno-identical
first-admission
there-
dissipate
postadmission
grooming
convey
socio-emotional
pharmaco-functional
context-
trait-
touched
pregenual
Patient-Reported
Ocriplasmin
Vitreomacular
Microplasmin
Injection-Traction
MIVI-TRUST
VMA
VMA/vitreomacular
VMT
ocriplasmin
25-item
NEI
VFQ-25
TG-MV-006
TG-MV-007
clinic-based
VMA/VMT
placebo-injected
vision-related
≥5-point
ocriplasmin-treated
NCT00781859
NCT00798317
teens
cross-cultural
Frankel
Items
14.04
13.54
99.39
18.09
100.67
16.97
play/leisure
subdomain
Knowledge-Revised
CLND
non-SLN
mean/median
Breslow
3.4/2.0
5.72/4.0
macrometastasis
micrometastasis
=0.2
submicrometastasis
submicrometastases
macrometastases
non-SLNs
enterococcus
ampicillin/sulbactam
ninety-two
enterococcal
cefoxitin-treated
ghostwriting
corporate-sponsored
bioethics
ghostwritten
archival
GSK
misconduct
filed
deconstruction
conflated
'negative
'positive
19-site
Hepatectomy
36-
P=0.811
P=0.881
P=0.332
Povidone-iodine
re-administered
COX-2-treated
PlGF
PROVE
IT-TIMI
Placental
flt-1
3,761
four-months
3,369
Q1
Q5
adjusted-HR
1.16-1.83
1.37-5.68
1.26-2.51
bland
emollients
hotly
newly-introduced
moisturizing
compatibility
panels
bioengineering
distinction
Emphasis
laid
mercaptopurine
system-directed
system-relapse
Hyperinsulinemia
insulin-mediated
resistance-associated
endothelin-mediated
hyperinsulinemic-euglycemic
mU.m
insulin-stimulated
BQ-123
-monomethyl-l-arginine
Insulin-mediated
109.2
518.4
EHR-generated
consents
EHR
SmartConsents
graphics
Urgent
SmartConsent
communicating
Irritability/aggression
irritability/aggression
gavetheir
9.46+/-2.46
63.3+/-23.9
CGI-irritability
autism/pervasive
autism/PDD
Rapidity
Lansoprazole
MUPS
rapidity
mgomeprazole
continuetreatment
tothe
Alkalinized
corroborate
GAR
0.0363
0.0328
outs
-0.36
self-measurement
nine-point
41.1
patient-week
0.11-1.87
'general
clopamide
pindolol-clopamide
thiazide-type
counterbalance
diuretic-induced
PKC
antimanic
continued-lithium
verapamil/lithium
fosamprenavir
FPV
1,400
APV
tau
0-tau
4.15-fold
4.17-fold
3.99-fold
PI-experienced
alphaEGOT
alphaEGPT
nonpregnant
Allowance
preinduced
constant-workrate
CWT
CWTs
electrostimulation-induced
TwQ
pot
end-exercise
Ve/maximum
PNTREE
overfeeding
short-stay
PEM
post-admission
Kingston
Jamaica
g/kg.day-1
3.31
oxprenolol-treated
ws
beta-adrenoreceptor
dinoprostone
Cytotec
Cervidil
timed-release
formix
1296.7
722.1
1360.0
792.0
misoprostol-treated
dinoprostone-treated
tachysystole
0.0546
resuscitations
Vaginally
Dysfunctional
Augmenting
Psychotherapy
REVAMP
808
non-remitters
leveled
Regulated
Bicuspid
Valve
Ring
Annuloplasty
Annular
bicuspid
BAV
annuloplasty
NCT02071849
Sievers
left-/right-coronary
cusp
right-/noncoronary
Ascending
Dacron-covered
outwardly
flaring
subcommissural
beneath
postrepair
mortalities
annular
tails
specifics
ALL-2
historic
Ph
4-drug
L-20
©
strontium
apatite
crystals
ranelate
substitutions
Sr
SrRan
crystallinity
width/thickness
interplanar
lattice
diffraction
crystal
RRD
Snellen
tractional
Single-operation
9/11
hemodiluted
99mTc
-labeled
indium-oxine
tetrapolar
oncotic
mL/kg/min
impeding
isovolemia
fog
disasters
monodisperse
MMAD
H2SO4
micrograms/m3
equiosmolar
head-only
unfettered
Vr
H+LAW
tON
Tagamet
Mg
Endoscopically
45-item
orthogonally
Tension
KR20
.89
.95
inducement
pre-postcontrol
postcontrol
vacuum-assisted
negative-pressure
NPWT
Vacuum-Assisted
V.A.C
post-amputation
trans-metatarsal
118.0
12-226
6-140
0-106
0-47
27,270
36,096
25,954
38,806
Pegylated
granulocyte-colony
off-label
HuG-CSF
Pichia
pastoris
FeG-CSF
PegFeG-CSF
FIV-infected
FIV-uninfected
HuG-CSF-induced
⩽
HuG-CSF-treated
cross-reactive
Strikingly
Micronefrin
Bird
Palm
Springs
Kanta-Hame
sponges
packings
adenoids
profuse
non-hyperlipidaemic
sympathoinhibition
lipophilic
mean±SD
58±12
homoeostatic
32±12
25±9
bursts/min
55±23
43±17
7.1±3.8
9.7±3.9
r=0.41
p=0.14
cholesterol-independent
set-point
60-
outlasted
cephalad
T-10
milestones
20-30
Ostertagia
ostertagi
climates
producers
parasitized
Enzyme-linked
parasitism
IPDMA
ODRs
ODR
polynomials
p=0.138
Svanovir
kg/cow/day
VA1.3
non-toxigenic
Tor
Kolkata
n=116
Vibriocidal
105/186
5/116
anti-CT
=2-folds
23/30
6/19
Ledner
CLEM
CLEMs
clockwise
counterclockwise
endocarditis
735
polishing
intraligamental
25-45
carboplatin/paclitaxel/cetuximab
paclitaxel/carboplatin
Taxol
/carboplatin
AUC6
four-cycle
Usefulness
neurohormones
angiotensin-II
NT-ANP
768
EDV
ESV
DeltaBNP
DeltaNT-ANP
DeltaESV
DeltaEDV
DeltaEF
+293.7
pmol/ml
-22.3
-48.5
2.04
prognosticators
glucosamine-chondroitin
Glu-Ch
Cats
veterinarian
Owner
owner-assessed
temperament
3-mo
accumulations
pools
accumulates
Ropivacaine-clonidine
-clonidine
subumbilical
R0.2
R0.1C
18/20
11/20
clonidine-ropivacaine
hexaminolevulinate
cystoscopic
nonmuscle
Cystectomy
Hexaminolevulinate
hand-sewn
esophagogastric
Lewis-Tanner
Leakage
infiltrated
esophagi
Arthroscopic
acromioplasty
Rotator
Cuff
WORC
ASES
acromion
Type-2
Type-3
twenty-four-month
3A4
110.2
103.7-117.2
90.0-103.6
114.6
107.0-122.8
90.0-102.6
Conjugated
CEEs
WHI
shocking
DFTs
emulator
memory-based
automaticity
Rickard
Lau
Pashler
alphabet
rilpivirine
reanalysis
Rilpivirine
deuterated
rilpivirine-d6
methyl-tert-butyl
diethyl
Gemini
→
m/z
367.1
373.2
134.2
quadrupole
spectrometer
linearity
0.5-200
spiked
IS-normalized
freeze-thaw
±15
IFCT
0002
PERI
StageI-II
2×2
paclitaxel-carboplatin
528
=1.01
0.79-1.30
75.2
HR=0.97
0.76-1.25
p=0.80
SR-20
50-
100-
nifedipine-SR
appeasing
pheromone
dog-appeasing
sDAP
sprayed
lactotropic
39-43
Pishu
Mingmen
Shenque
Density
deficiency-based
Oman
methylation-dependent
epigenetic
homocysteinylation
Omani
B₁₂
S-adenosylhomocysteine
antiaggressive
anti-herpes
antiherpes
MRI-evident
protocol-planned
3.96
Valacyclovir
MVAC
LN₂
ethylene
trehalose
wt/vol
HEPES-buffered
PZM-5
Cryotop
Blastocysts
cryoprotective
32/36
33/36
34/34
25/36
23/36
32/34
cryopreserved
nightblind
Nepali
Nightblindness
16-52
photoreceptor
Nightblind
d/wk
curry
dish
equivalents/d
6-mg
FeR
Dark
normalize
nightblindness
diathermocoagulation
anogenital
condyloma
cauterization
anti-ischemic
antiischemic
myocard
intracoronarily
echo-contrast
ischemia-caused
++
-blocker
Gallopamil
Enoximone
dromotropic
Clobazam
catamenial
clobazam
tamsulone-FS
Tamsulone-FS
alpha1A/D-adrenoblocker
Farm-Syntez
omnik
Roszdravnadzor
certificate
LC-000859
03.11.2005
sale
APAP
opioidergic
pl
Nal
thermal/painful
witnessing
Amplitude
APAP/pl
pl/pl
t150
-37
APAP/Nal
0-150
-3452
-4705
-2199
-933
-2273
-1731
-3676
90-150
antinociception
parsalmide
arthropathies
tranquillizing
undesired
haemopoietic
HSV-1
1074
493
100-250
Tecnis
Z9000
Pharmacia
AMO
AR40e
Opti-Edge
Sine
mesopic
Longterm
descriptively
TSS
11-beta-hydroxysteroid
INCB13739
11-Beta-hydroxysteroid
cortisone
amplifying
11BetaHSD1
Renin-Angiotensin
I/D
angiotensinogens
AGT
M235T
ATR1
A1166C
TA
retesting
NICU
n=121
mol/l
200mg/dl
46+/-11
45+/-10
TISS-28
P=0.85
2.3-32.4
3.1-32.9
cystostatic
MP-P
MPH-P
Peptichemio
PTC-VCR-P
indefinitely
myelotoxic
hose
PTC
overwhelming
dialyzed
dialyzate
P0
2.55
pleotrophic
palifermin-treated
mucotoxicity
CE-MARC
investigative
3.0-T
resonance-guided
appropriate-use
Excellence
guidelines-based
intension
Ramucirumab
Non-Small
Platinum-Based
ramucirumab
1,253
ramucirumab-treated
receptor-2
uncertainties
harboring
dexanabinol
postinjury
0.68-0.75
0.57-0.64
29-37
standardizing
heme
oxygenase-1
HBO
SnPP
pentobarbital
PMNs/alveoli
LPS-induced
Standard-dose
endoscopically-verified
pindolol/clopamide
Roy
model-based
three-group
three-phase
Phases
higher-quality
sensory-level
high-volt
ondelayed-onset
level-high
volt
HVPC
delayed-onset
DOMS
Delayed-onset
Sensory-level
insertional
heavy-load
Victorian
Sport
Assessment-Achilles
VISA-A
49.4
0.815
0.261
HOPE-The
HOPE-TOO
9541
7030
1382
3994
738
revascularizations
0.84-1.06
0.71-1.09
.24
985
0.96-1.14
1.01-1.26
1.00-1.47
Esberitox
hemopoietic
noxa
irradiations
diverging
hematotoxic
Tele-Airway
TAMS
on-scene
OSD
non-superiority
alpha-7
Alpha7
CDP-choline
allosteric
PAM
transducing
galantamine/CDP-choline
16weeks
5-item
Marder
negative-symptoms
MATRICS
agonist/PAMs
oxide/oxygen
intraexaminer
35-
sedate
IPF
Saint
anchor-
distribution-based
378.1
376.8
361.3
10.8-58.5
Promising
ATA
CGIC
CGIS
multi-arm
MDRU
benzoylecgonine
pentoxyfylline
PLAY
Youngsters
coached
caregiver-child
speech/language
autism-related
category/symptoms
interactional
stress/depression
align
CBA
HPBA
autogenous
non-procedure-related
tesaglitazar
1,707
Tesaglitazar
HbA1C
-0.056
-0.161
pNI
Low-density
MBCT
HFX
interfraction
radio-chemotherapy
n-BCA
AVM
n-BCA/Tantalum
Powder/Ethiodized
Oil
Trufill
polyvinyl
PVA
Powder/Ethiodol
pre-embolization
pedicles
embolized
events/overall
Coils
esophagojejunostomy
Prematurity
Transscleral
retrolental
capsulectomy
lensectomy
Ophthalmology
Labbafinejad
limbus
synechias
TRACIA
preand-
pre-and-post
PPCI
re-infarction
Cardiología
Ignacio
Chávez
Nottingham
Nottinghamshire
Derbyshire
Lincolnshire
Leicestershire
Roland
4.10
discovertebral
reassured
X-rays
RECOMMENDATIONS
FURTHER
educates
flags
Amino
nonesterified
deaminated
20-23
ginkgo
biloba/panax
neurasthenic
biloba/ginseng
F48.0
neurasthenia
CDR
inter-dosing
Checklist-90-revised
special-effect
Crazy
Lenses
Special-effect
decorative
cateyes
stars
isopters
III/4
I/4
I/3
Mesopic
1:2.5
1:7.4
scotopic
Directed
forgetting
forget
autonoetic
noetic
Remember/Know
to-be-forgotten
to-be-learned
Remember
Know
web-
customization
45-70
Usability
draft
print-
NCT00623090
b-type
sphericity
TEI
dP/dt
N-dimethylglycine
dimethylglycine
Domain
IJV
landmarks
ultrasonograph
echocamera
Eskimo
mL/d
blubber
cod
seal/cod
Minke
whale
Triacylglycerol
-stimulated
seal/CLO
LPS-stimulated
TMg
IMg2+
ion-selective
IMg
Dialysate
mM/L
Ionized
ICa2+
ICa2+/IMg2+
59.2
Dofequidar
MS-209
dofequidar
quinoline
days/cycle
.077
.145
lunar
Lunar
Inflow
Dynamics
iridium
MOONLIGHT
ObservatioNal
Iridiumoxide
GrowtH
iridium-oxide
radiopacity
tadalafil
Tadalafil
742
513
Antihistamines
AHs
AH-resistant
R-CIU
sex-
AS-induced
etomidate-induced
myoclonus
Myoclonic
myoclonic
no-music
SSG
withdraw/behaviors
tendonitis
supraspinatus
bicipital
Objectively
Delineation
cryptogenic
Lennox-Gastaut
astatic
cryptogenic/idiopathic
MCA
Interictal
3-Hz
spike-waves
vibratory
myoclonic-astatic
spike-wave
risperidone/placebo
0.01-0.06
Nisonger
Impression-Change
Risperidone-treated
insecure/anxious
overly
dose/dose-schedule
multiple-referral
reduced-and
arrested-during
erythrocyturia
nephritic
acceptably
milkings
forequarter
nonself-face
neurocognitively
polysubstance
submit
non-AD
cocaine-using
effector
Wing-Kristoffersson
concatenation
1367
8-item
alpha=.83
cutpoint
0.28-0.75
0.60-0.87
0.63-0.94
neovascularisation
0.5-mg
-124
-29.7
ranibizumab-only
-86.9
Pre-vaccination
culture-derived
whole-virus
pandemic
antigenically
non-adjuvanted
A/California/07/2009
408
cross-reactivity
seroprotective
2008-09
2009-10
A/New
Caledonia/20/99
circulated
2000-01
2006-07
Pre-adsorption
A/H1N1/New
A/H1N1/California/07/2009
S+M
6/51
8/54
1/52
19/50
PROactive
PROspective
pioglitAzone
macroVascular
5238
n=2605
n=2633
NCT00174993
514
2605
572
2633
0.80-1.02
p=0.095
0.72-0.98
2065
Pegfilgrastim
pegfilgrastim+/-chemotherapy
prechemotherapy
N=61
/ml
8.18
9.96
4.51
carboplatin/paclitaxel
cytokine-only
postthrombotic
IU/h
3,000,000
5,000,000
Postthrombotic
heparin/anticoagulation
limb-threatening
corticosteroid-requiring
beta-agonist
placebo-treatment
8.37
RATIONAL
1.658
63.021
13.580
1.948
74.032
16.811
1.742
66.198
12.104
2.564
97.424
1.469
0.232
1.607
61.075
0.173
0.794
0.802
5.227
IRCT138711091556N2
preverbal
Antecedent
Tsiouri
Greer
Behav
Educat
12:185-206
Lang
Hear
52:643-652
RMIA
parvoviral
enteritis
interferon-omega
Canine
parvovirus
rFeIFN-omega
MU/kg
fulminating
post-inoculation
IFN-treated
antineoplastic
newly-diagnosed
Lactoferrin
preweaning
open-sided
barn
hutches
juncture
Inside
distributing
1,380
specialties
Distributing
venues
neuromotor
nappy
roll
nursed
side-lying
DIOGENES
LGI
low-calorie
LCD
P/LGI
HP/LGI
HP/high
HP/HGI
LP/LGI
LP/HGI
shop
3.0-4.8
N=139
N=256
stepped-wedge
falls-prevention
ward-level
patient-days
ACTRN12612000877886
3606
n=1983
n=1623
n=196
7·80/1000
n=380
13·78/1000
0·60
0·42-0·94
p=0·003
2·63/1000
4·75/1000
0·65
0·42-0·88
p=0·006
8·38
n=248
12·51
0·55
0·81
Individualised
hospital-units
Advisory
3'-azido-2',3'-dideoxythymidine
interferon-α
Feline
FeLV
huIFN-α2a
antigenaemia
FeLV-infected
p27
Aside
gadodiamide
mM/kg
gadopentetate
gadopentate
overwhelm
hypointense
precontrast
relaxivities
propofol/alfentanil/N2O
thiopentone/halothane/N2O
midazolam-atropine
s.e
otolaryngological
ECM
digitally
proteoglycans
biglycan
decorin
versican
steroid-induced
Summing
Steven
satisfactoy
prothetic
HFASDs
face-emotion
non-literal
response-cost
foster
suburb
GNP
.083
Linking
Heparan
heparan
510
liraglutide
7.5-12
4.0-5.5
45.9
-1.79
Double-dummy
Michigan
MEASUREMENTS/MAIN
antipyresis
PCSK9
evolocumab
TESLA
Homozygous
Evolocumab
proprotein
convertase
subtilisin/kexin
lipid-regulating
≥11
funder
ultracentrifugation
NCT01588496
30·9
-43·9
-18·0
anti-evolocumab
Perlane
Zyplast
Nonanimal
nonanimal
Investigator-based
investigator-based
Wrinkle
Aesthetic
reoccur
intensify
Diagnosed
pap
radiochemotherapy-induced
60-74
6-7.5
amifostine-treated
0.414
erythropoiesis-stimulating
Epo-b
gastric/esophagogastric
30000
0.056
ezetimibe-plus-statin
re-increased
lathosterol/TC
campesterol/TC
campesterol/lathosterol
campesterol
Wegener
granulomatosis
Vasculitis
Granulomatosis
P=0.90
colonised
enterobacteria
cultivated
Small-diameter
Versapoint
septate
metroplasty
small-diameter
hundred-sixty
26F
resectoscope
5-mm
hysteroscope
expectantly
cerclage
486.4
222.1
104.9
54/82
ailment
rationing
endovenous
C3-4
Qol
SF36
Varicose
Veins
4.8-20.8
1.2-6.1
1.2-16.3
contradicts
Delaying
NCT00759434
159.5
13.9/101.6
/6.7
/10.2
181.6
17.8/118.6
/7.9
/8.5
207.2
22.2/142.2
/8.4
/7.1
/3.1
215.5
17.3/127.6
AUA
'antioxidant
8-oxodeoxyguanosine
8-oxo-dG
U.K
coulometric
lie
-0.92
looked
half-hour
Within-program
emotion-laden
Piribedil
CECT7315
CECT7316
CECT
7315/7316
A/Wisconsin/67/2005
NYMC
X-161B
A/Solomon
Islands/3/2006
B/Malaysia/2506/2004
2006/2007
5*10
cfu/day
skim
influenza-specific
CECT7315/7316
immunostimulating
=20/h
CPAP-treated
bursts/100
re-establish
operationalize
SADQ
Rand
departures
introductory
AUDIT
credit
×2
Quantity
feedback-based
hypo-manic
Olanzapine-treated
Qualisys
non-visual
cuing
proctitis
BCEI
wait-control
lavage-induced
AV-ECLA
HFOV
pressure-controlled
low-resistance
interposed
AV-ECLA-treated
HFOV-treated
Modifying
Divergence
educator
Simulation-based
self-regulated
SRL
elucidating
'unguided
'directed
DSRL
learners
expert-designed
murmurs
22-item
autonomously
practising
expert-defined
'timing-based
murmur
location-based
unguided
timing-based
conceptions
organising
structuring
articulated
technology-mediated
beta-oestradiol
beta-Oestradiol
Fingertip
fingertip
precooling
syntometrine
oxytocics
peri-partum
low-tilt
capacitor-based
high-tilt
EPS
300V
/=30
91V
voltages
Creon
Minimicrospheres
Minimicrospherestrade
spheres
pancreatin
three-centre
CFA
10,000s
rHCNTF
CNTF
ACTS
nonproductive
Antibodies
neuron
Adenosinergic
deprivation-induced
6.25-8.25
caffeine-sensitive
-insensitive
caffeine-insensitive
judiciously
lubricant
estrogen-androgen
value-congruence
made-in-the-U.S.
made-in-Japan
CulturexType
congruence
xerostomic
Topically
self-application
fluoride-releasing
IFRS
U.
stannous
fluoride-gel-containing
retainers
1100-ppm
parallel-cell
Pre-existing
g/5min
68Gy
60Gy
p=0.047
group=0.55
p=0.705
group=0.80
p=0.781
SnF
0.12mg
hopes
Subgroupings
Breast-feeding
life-styles
price
breast-pumping
three-wave
TIP-C
self-managed
mold
FLU
Subtherapeutic
Trimethoprim-sulfamethoxazole
Proven
<pad>
UNK
